Citrus Sinensis ID: 025997
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 1.0 | 0.692 | 0.783 | 1e-113 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.987 | 0.663 | 0.695 | 6e-95 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.8 | 0.535 | 0.722 | 9e-80 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.8 | 0.542 | 0.712 | 3e-79 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.795 | 0.477 | 0.700 | 2e-78 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.967 | 0.649 | 0.552 | 6e-71 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.742 | 0.257 | 0.473 | 3e-41 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.751 | 0.247 | 0.448 | 9e-41 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.742 | 0.252 | 0.460 | 7e-40 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.979 | 0.526 | 0.403 | 2e-39 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 407 bits (1045), Expect = e-113, Method: Compositional matrix adjust.
Identities = 192/245 (78%), Positives = 220/245 (89%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPE 245
YHAPE
Sbjct: 241 YHAPE 245
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 6e-95, Method: Compositional matrix adjust.
Identities = 176/253 (69%), Positives = 201/253 (79%), Gaps = 11/253 (4%)
Query: 1 MSCFGCC-EEDDIRKASKNG-------PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIA 52
MSCFGCC E+DD+ K + G F P N A + E K V +QPI
Sbjct: 1 MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARH---HQASETAQKGPPVVKLQPIE 57
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQV 112
VP+I ELKE TD+FG+NSLIGEGSYGRVY+GVL + +AIKKLDS+KQPD EFLAQV
Sbjct: 58 VPIIPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQV 117
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
SMVSRLK++N V+L+GY VDG R+L+YE A+ GSLHDILHG+KGVKGA+PGPVLSW QR
Sbjct: 118 SMVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQR 177
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
VKIAVGAARGLEYLHEKA P IIHR+IKSSNVLLF+DD+AKI+DFDLSNQAPD AARLHS
Sbjct: 178 VKIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHS 237
Query: 233 TRVLGTFGYHAPE 245
TRVLGTFGYHAPE
Sbjct: 238 TRVLGTFGYHAPE 250
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 9e-80, Method: Compositional matrix adjust.
Identities = 143/198 (72%), Positives = 168/198 (84%), Gaps = 2/198 (1%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPE 245
ARLHSTRVLGTFGYHAPE
Sbjct: 233 ARLHSTRVLGTFGYHAPE 250
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 141/198 (71%), Positives = 170/198 (85%), Gaps = 2/198 (1%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A A+KKLD + + D E
Sbjct: 50 PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTE 109
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 110 FLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 169
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D AKI+DF+LSNQAPD A
Sbjct: 170 DWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNA 229
Query: 228 ARLHSTRVLGTFGYHAPE 245
ARLHSTRVLGTFGYHAPE
Sbjct: 230 ARLHSTRVLGTFGYHAPE 247
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 138/197 (70%), Positives = 167/197 (84%), Gaps = 2/197 (1%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EF 108
I VP +S+DELKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EF
Sbjct: 96 IDVPALSLDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEF 155
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L QVS VS+LK++N VEL GY V+G R+LAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 156 LTQVSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLD 215
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
W QRV+IAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AA
Sbjct: 216 WIQRVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAA 275
Query: 229 RLHSTRVLGTFGYHAPE 245
RLHSTRVLGTFGYHAPE
Sbjct: 276 RLHSTRVLGTFGYHAPE 292
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 6e-71, Method: Compositional matrix adjust.
Identities = 143/259 (55%), Positives = 186/259 (71%), Gaps = 22/259 (8%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE----------APAKEMKTVTV 48
M C G +E+ + N P N AGNP GG E APAK V
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAK------V 53
Query: 49 QPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQ 106
PI +P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD
Sbjct: 54 LPIEIPSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDS 112
Query: 107 EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+F +Q+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LHG+KGV+GA+PGPV
Sbjct: 113 DFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPV 172
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L+W QRVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D
Sbjct: 173 LNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDT 232
Query: 227 AARLHSTRVLGTFGYHAPE 245
AARLHSTRVLGTFGYHAPE
Sbjct: 233 AARLHSTRVLGTFGYHAPE 251
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 91/192 (47%), Positives = 125/192 (65%), Gaps = 10/192 (5%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVS 113
+ S +EL + T+ F +L+GEG +G VY G+L GR A+K+L Q D+EF A+V
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+SR+ + ++V +VG+ + G R+L Y++ S L+ LHG+K V L WA RV
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV--------LDWATRV 475
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KIA GAARGL YLHE PRIIHR+IKSSN+LL D+ A++SDF L+ A D + +T
Sbjct: 476 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHI-TT 534
Query: 234 RVLGTFGYHAPE 245
RV+GTFGY APE
Sbjct: 535 RVIGTFGYMAPE 546
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 9e-41, Method: Compositional matrix adjust.
Identities = 88/196 (44%), Positives = 123/196 (62%), Gaps = 12/196 (6%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFL 109
++V ++ EL++ TD F ++GEG +GRVY G + G A+K L Q D+EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
A+V M+SRL + N+V+L+G ++G R L YE GS+ LH L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEG----------TLDW 441
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
R+KIA+GAARGL YLHE + PR+IHR+ K+SNVLL DD K+SDF L+ +A + +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501
Query: 230 LHSTRVLGTFGYHAPE 245
+ STRV+GTFGY APE
Sbjct: 502 I-STRVMGTFGYVAPE 516
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 88/191 (46%), Positives = 128/191 (67%), Gaps = 9/191 (4%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSM 114
S +EL E T F +++GEG +G VY G L+ G+ A+K+L + S Q D+EF A+V +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+SR+ + ++V LVGY + R+L YE+ S +L LHGK G+ PVL W++RV+
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGK-GL------PVLEWSKRVR 471
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
IA+G+A+GL YLHE P+IIHR+IKS+N+LL D+ A+++DF L+ + D STR
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVSTR 530
Query: 235 VLGTFGYHAPE 245
V+GTFGY APE
Sbjct: 531 VMGTFGYLAPE 541
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (410), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 107/265 (40%), Positives = 144/265 (54%), Gaps = 25/265 (9%)
Query: 1 MSCFGCCEEDDIRKAS-----------KNGPFVPNNPAGNP-GGFYVKEAPAKEMKTVTV 48
M CF C + D K + ++ P V NN +G P GG + K +
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 49 QP------IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSS 101
P IA + EL T NF ++ +GEG +GRVY G L S G+ A+K+LD +
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 102 K-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG 160
Q ++EFL +V M+S L + N+V L+GY DG R+L YE GSL D LH K
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L W R+KIA GAA+GLE+LH+KA P +I+R+ KSSN+LL + K+SDF L+
Sbjct: 181 A-----LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLA 235
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPE 245
P STRV+GT+GY APE
Sbjct: 236 KLGPTGDKSHVSTRVMGTYGYCAPE 260
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | ||||||
| 170676254 | 354 | Pto kinase interactor 1 [Capsicum annuum | 1.0 | 0.692 | 0.791 | 1e-112 | |
| 1586940 | 370 | Ser/Thr kinase | 1.0 | 0.662 | 0.783 | 1e-111 | |
| 350537875 | 354 | pto-interacting protein 1 [Solanum lycop | 1.0 | 0.692 | 0.783 | 1e-111 | |
| 147828214 | 366 | hypothetical protein VITISV_001482 [Viti | 1.0 | 0.669 | 0.797 | 1e-110 | |
| 225432163 | 360 | PREDICTED: pto-interacting protein 1 [Vi | 1.0 | 0.680 | 0.797 | 1e-110 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 1.0 | 0.514 | 0.764 | 1e-108 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 1.0 | 0.678 | 0.764 | 1e-107 | |
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 1.0 | 0.676 | 0.768 | 1e-107 | |
| 225437716 | 362 | PREDICTED: pto-interacting protein 1 [Vi | 1.0 | 0.676 | 0.768 | 1e-106 | |
| 118485120 | 324 | unknown [Populus trichocarpa] | 1.0 | 0.756 | 0.760 | 1e-105 |
| >gi|170676254|gb|ACB30366.1| Pto kinase interactor 1 [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1052), Expect = e-112, Method: Compositional matrix adjust.
Identities = 194/245 (79%), Positives = 220/245 (89%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CCE+DD+ +AS NGPF+ +N AGN GG + E+ KE +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCEDDDMNRASDNGPFMAHNSAGNNGGLHATESAQKEPQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWVQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPE 245
YHAPE
Sbjct: 241 YHAPE 245
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1586940|prf||2205248A Ser/Thr kinase | Back alignment and taxonomy information |
|---|
Score = 407 bits (1046), Expect = e-111, Method: Compositional matrix adjust.
Identities = 192/245 (78%), Positives = 220/245 (89%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPE 245
YHAPE
Sbjct: 241 YHAPE 245
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350537875|ref|NP_001233803.1| pto-interacting protein 1 [Solanum lycopersicum] gi|75319610|sp|Q41328.2|PTI1_SOLLC RecName: Full=Pto-interacting protein 1; Short=Pti1; AltName: Full=Pto kinase interactor 1 gi|3668069|gb|AAC61805.1| Pto kinase interactor 1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1045), Expect = e-111, Method: Compositional matrix adjust.
Identities = 192/245 (78%), Positives = 220/245 (89%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPE 245
YHAPE
Sbjct: 241 YHAPE 245
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147828214|emb|CAN71112.1| hypothetical protein VITISV_001482 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1038), Expect = e-110, Method: Compositional matrix adjust.
Identities = 197/247 (79%), Positives = 220/247 (89%), Gaps = 2/247 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPA-GNPGGFYVKEAP-AKEMKTVTVQPIAVPVISV 58
MSCF CCEEDDI KAS GP+V NN A G+ G +++ EA + + +TV V PIAV ISV
Sbjct: 1 MSCFSCCEEDDIHKASDTGPYVANNSAVGHNGNYHMTEASRSNDTQTVDVLPIAVSAISV 60
Query: 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
DELKE TDNFG +LIGEGSYGRVY G+L++G+AAAIKKLDSSKQPDQEFLAQVSMVSRL
Sbjct: 61 DELKEITDNFGQQALIGEGSYGRVYHGLLKTGQAAAIKKLDSSKQPDQEFLAQVSMVSRL 120
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KNENVVELVGY VDG LRV+AYE+AS GSLHDILHG+KGVKGA+PGPVLSW+QRVKIAVG
Sbjct: 121 KNENVVELVGYSVDGGLRVVAYEYASNGSLHDILHGRKGVKGAQPGPVLSWSQRVKIAVG 180
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AA+GLEYLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD+AARLHSTRVLGT
Sbjct: 181 AAKGLEYLHEKARPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDSAARLHSTRVLGT 240
Query: 239 FGYHAPE 245
FGYHAPE
Sbjct: 241 FGYHAPE 247
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432163|ref|XP_002267003.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297736804|emb|CBI26005.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1035), Expect = e-110, Method: Compositional matrix adjust.
Identities = 197/247 (79%), Positives = 220/247 (89%), Gaps = 2/247 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPA-GNPGGFYVKEAP-AKEMKTVTVQPIAVPVISV 58
MSCF CCEEDDI KAS GP+V NN A G+ G +++ EA + + +TV V PIAV ISV
Sbjct: 1 MSCFSCCEEDDIHKASDTGPYVANNSAVGHNGNYHMTEASRSNDTQTVDVLPIAVSAISV 60
Query: 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
DELKE TDNFG +LIGEGSYGRVY G+L++G+AAAIKKLDSSKQPDQEFLAQVSMVSRL
Sbjct: 61 DELKEITDNFGQQALIGEGSYGRVYHGLLKTGQAAAIKKLDSSKQPDQEFLAQVSMVSRL 120
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KNENVVELVGY VDG LRV+AYE+AS GSLHDILHG+KGVKGA+PGPVLSW+QRVKIAVG
Sbjct: 121 KNENVVELVGYSVDGGLRVVAYEYASNGSLHDILHGRKGVKGAQPGPVLSWSQRVKIAVG 180
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AA+GLEYLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD+AARLHSTRVLGT
Sbjct: 181 AAKGLEYLHEKARPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDSAARLHSTRVLGT 240
Query: 239 FGYHAPE 245
FGYHAPE
Sbjct: 241 FGYHAPE 247
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1015), Expect = e-108, Method: Compositional matrix adjust.
Identities = 188/246 (76%), Positives = 217/246 (88%), Gaps = 1/246 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 356 GYHAPE 361
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1014), Expect = e-107, Method: Compositional matrix adjust.
Identities = 188/246 (76%), Positives = 217/246 (88%), Gaps = 1/246 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 1 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1007), Expect = e-107, Method: Compositional matrix adjust.
Identities = 189/246 (76%), Positives = 215/246 (87%), Gaps = 1/246 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD+ KA+ +G P+ + AGN GG++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG NSLIGEGSYGRVY+G+L+SG+AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 391 bits (1005), Expect = e-106, Method: Compositional matrix adjust.
Identities = 189/246 (76%), Positives = 215/246 (87%), Gaps = 1/246 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCE+DDI A ++G PF NPAGN GG+ + K + V VQPIAVP I D
Sbjct: 1 MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFGT++LIGEGSYGRVY+G+L++G+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N VEL+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGP+LSWAQRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGL+YLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118485120|gb|ABK94423.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 387 bits (994), Expect = e-105, Method: Compositional matrix adjust.
Identities = 187/246 (76%), Positives = 215/246 (87%), Gaps = 1/246 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD++KA+ NG P+ + AG+ G ++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE T NFGT+SLIGEGSYGRVY+GVL+S +AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+PRIIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 241 GYHAPE 246
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | ||||||
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 1.0 | 0.673 | 0.686 | 4.7e-87 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 1.0 | 0.674 | 0.673 | 2.6e-86 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 1.0 | 0.678 | 0.658 | 1.6e-79 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 1.0 | 0.673 | 0.573 | 2.9e-71 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.853 | 0.578 | 0.649 | 9.4e-66 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.8 | 0.535 | 0.676 | 1.2e-65 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.983 | 0.590 | 0.554 | 1.2e-65 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.853 | 0.618 | 0.620 | 4.7e-64 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.987 | 0.663 | 0.515 | 8.1e-60 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.779 | 0.263 | 0.472 | 6.6e-40 |
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
Identities = 169/246 (68%), Positives = 195/246 (79%)
Query: 1 MSCFGCCEE-DDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
M CFGCC +D R+ S+ GP +N G GG + + P K + + +QPI+V I D
Sbjct: 1 MGCFGCCGGGEDFRRVSETGPKPVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL++ TDN+G+ SLIGEGSYGRV++G+L+SG+AAAIKKLDSSKQPDQEFLAQVSMVSRL+
Sbjct: 61 ELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRLR 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
ENVV L+GY VDGPLRVLAYE+A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 QENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 241 GYHAPE 246
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 165/245 (67%), Positives = 193/245 (78%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D R A+ GP +NPAG GG Y + P + +QPI+VP I VDE
Sbjct: 1 MSCFGWCGSEDFRNATDTGPRPAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ TDN+G+ +LIGEGSYGRV++GVL+SG AAAIKKLDSSKQPDQEFL+Q+SMVSRL++
Sbjct: 61 LRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLRH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
+NV L+GY VDGPLRVLAYE A KGSLHD LH ++W QRVKIAVGAA
Sbjct: 121 DNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGLEYLHEK P++IHR+IKSSNVLLFDDD+AKI DFDLS+QAPD AARLHSTRVLGTFG
Sbjct: 181 RGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPE 245
YHAPE
Sbjct: 241 YHAPE 245
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
Identities = 162/246 (65%), Positives = 185/246 (75%)
Query: 1 MSCFGCCEEDDIRKASKNGPF-VPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCC EDD+ A+ G + GN G E K ++V VQPI V I D
Sbjct: 1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL E T++FGTNSLIGEGSY RVY GVL++G+ AAIKKLDS+KQP++EFLAQVSMVSRLK
Sbjct: 61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
+ N VEL+GY VDG R+L +E A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVL+FD+D+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPE 245
GYHAPE
Sbjct: 241 GYHAPE 246
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
Identities = 141/246 (57%), Positives = 178/246 (72%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D+R + GP +N G G + + P V +QPIAVP I VDE
Sbjct: 1 MSCFGWCGSEDVRNPADTGPSQAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ T+NF + L+G+GSYGRV++GVL+SG+ AAIKKL +KQPDQEFL+QVSMVSRL +
Sbjct: 61 LEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLHH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
ENVV L+ Y VDGPLRVLAYE A+ G+LHD+LH ++W +RVKIA+GAA
Sbjct: 121 ENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV-LGTF 239
RGLEYLH+K P++IHR+IK+SN+LLFDDDIAKI DFDL +QAP+ A RLHS R+ LG
Sbjct: 181 RGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGAS 240
Query: 240 GYHAPE 245
H PE
Sbjct: 241 RSHCPE 246
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
Identities = 139/214 (64%), Positives = 167/214 (78%)
Query: 36 KEAP-AK-EMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA 93
K AP AK E+K + PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A
Sbjct: 35 KPAPVAKHEVKKEAL-PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAV 93
Query: 94 AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151
A+KKLD + + D EFL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDI
Sbjct: 94 ALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDI 153
Query: 152 LHXXXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211
LH L W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D
Sbjct: 154 LHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYK 213
Query: 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
AKI+DF+LSNQAPD AARLHSTRVLGTFGYHAPE
Sbjct: 214 AKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPE 247
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 134/198 (67%), Positives = 156/198 (78%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--E 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPE 245
ARLHSTRVLGTFGYHAPE
Sbjct: 233 ARLHSTRVLGTFGYHAPE 250
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 137/247 (55%), Positives = 170/247 (68%)
Query: 3 CFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQP--IAVPVISVDE 60
C C E+ + P + N G + ++ A +P I VP +S+DE
Sbjct: 48 CCACHVEEPYHSSENEHLRSPKHH--NDFGHHTRKPQAAVKPDALKEPPSIDVPALSLDE 105
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
LKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EFL QVS VS+L
Sbjct: 106 LKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVSKL 165
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVG 178
K++N VEL GY V+G R+LAYE A+ GSLHDILH L W QRV+IAV
Sbjct: 166 KHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIAVD 225
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AARLHSTRVLGT
Sbjct: 226 AARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVLGT 285
Query: 239 FGYHAPE 245
FGYHAPE
Sbjct: 286 FGYHAPE 292
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 131/211 (62%), Positives = 160/211 (75%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
+ P K + PI VP +SVDE+ E+TDNFG NSLIGEGSYGRVY+ L G+A A+K
Sbjct: 16 QKPQDLAKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALK 75
Query: 97 KLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHX 154
KLD + + + EFL+QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH
Sbjct: 76 KLDLAPEDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 135
Query: 155 XXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
L W RVKIAV AARGLEYLHEK +P++IHR+I+SSN+LLFDD AKI
Sbjct: 136 RKGVQDALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKI 195
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+DF+LSNQ+PD AARL STRVLG+FGY++PE
Sbjct: 196 ADFNLSNQSPDNAARLQSTRVLGSFGYYSPE 226
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
Identities = 131/254 (51%), Positives = 172/254 (67%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE-----APAKEMKTVTVQPIAV 53
M C G +E+ + N P N AGNP GG E AP + V PI +
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAP-RSGAPAKVLPIEI 58
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQEFLAQ 111
P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD +F +Q
Sbjct: 59 PSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQ 117
Query: 112 VSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQ 171
+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LH L+W Q
Sbjct: 118 LSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQ 177
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
RVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AARLH
Sbjct: 178 RVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLH 237
Query: 232 STRVLGTFGYHAPE 245
STRVLGTFGYHAPE
Sbjct: 238 STRVLGTFGYHAPE 251
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 6.6e-40, P = 6.6e-40
Identities = 94/199 (47%), Positives = 126/199 (63%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS-KQPDQEF 108
P + +S +ELKE T NF + S++GEG +G+VY G+L G A AIKKL S Q D+EF
Sbjct: 362 PASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEF 421
Query: 109 LAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXX 166
++ M+SRL + N+V+LVGYY D +L YE GSL LH
Sbjct: 422 QVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP----- 476
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L W R+KIA+ AARGL YLHE ++P +IHR+ K+SN+LL ++ AK++DF L+ QAP+
Sbjct: 477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536
Query: 227 AARLHSTRVLGTFGYHAPE 245
STRV+GTFGY APE
Sbjct: 537 RGNHLSTRVMGTFGYVAPE 555
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.7836 | 1.0 | 0.6920 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00019712001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (360 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 245 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.002 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.004 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-40
Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
+GEG +G VY + +G+ AIK + +E L ++ ++ +L + N+V+L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D L E+ GSL D+L +G LS + ++I + GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IIHR++K N+LL D+ K++DF LS + L + GT Y APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-36
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + + E+ G L L K P LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--------KNRPKLSLSDLLSFALQIARGM 115
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
EYL K IHR++ + N L+ ++ + KISDF LS
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + ++ E+ G L D L + LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGM 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
EYL K IHR++ + N L+ ++ + KISDF LS
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 74 IGEGSYGRVYFGVLRSG----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELV 127
+GEG++G VY G L+ A+K L ++ +FL + ++ +L + NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + L E+ G L D L + V + LS + A+ A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K + +HR++ + N L+ +D + KISDF LS
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 18/154 (11%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G VY G L+ + A+K L +S++ +EFL + S++ +L + N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G G + E+ G L D L K G L+ +++A+ A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K +HR++ + N L+ ++ + KISDF LS
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-31
Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 18/176 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEGS+G+VY ++G+ AIK + K + ++ +LK+ N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D+L + LS + LEYLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR++K N+LL +D K++DF L+ Q +T V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-31
Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 18/176 (10%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G GS+G VY + G+ A+K L + DQ ++ ++ RL + N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D L LS + KIA+ RGLEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IIHR++K N+LL ++ + KI+DF L+ + +++ L + +GT Y APE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-28
Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G +G VY R+G+ AIK + + +E + + ++ + K+ N+V+ G Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L + E S GSL D+L L+ +Q + +GLEYLH
Sbjct: 68 KKDELW-IVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN- 117
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IIHR+IK++N+LL D K+ DF LS Q D AR ++GT + APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 20/180 (11%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVG 128
L+G GS+G VY + + +G A+K ++ S++ + ++ ++S L++ N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 129 YYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLEY 185
D L E+ S GSL +L + P PV+ + +++ GL Y
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVIRKYTRQI------LEGLAY 116
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH I+HR+IK +N+L+ D + K++DF + + D + V GT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-26
Identities = 52/152 (34%), Positives = 88/152 (57%), Gaps = 11/152 (7%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+ IG+G +G V G R G+ A+K L Q FLA+ S+++ L++ N+V+L+G +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E+ +KGSL D L ++ V++ AQ++ A+ G+EYL EK
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR-------SRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223
+HR++ + NVL+ +D +AK+SDF L+ +A
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 7e-22
Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVELVG 128
LIG G++G VY G+ L +G AIK++ K ++ + ++ ++ LK+ N+V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ E+A GSL I+ K GP + +GL YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK--------KFGP-FPESLVAVYVYQVLQGLAYLHE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ +IHR+IK++N+L D + K++DF ++ + D + S V+GT + APE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-21
Identities = 55/180 (30%), Positives = 96/180 (53%), Gaps = 17/180 (9%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
F +GEGSYG VY + + +G+ AIK + ++ QE + ++S++ + + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 127 VG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G Y+ + L ++ E+ GS+ DI+ L+ + I +GLEY
Sbjct: 64 YGSYFKNTDLWIVM-EYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLEY 114
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH + IHR+IK+ N+LL ++ AK++DF +S Q D A+ ++ V+GT + APE
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-20
Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 18/184 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ ++G+GS G VY + +G+ A+KK +D ++ ++ L ++ + ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
VV+ G +Y +G + + E+ GSL D+L + P PVL+ IA +
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLH K IIHR+IK SN+L+ KI+DF +S + + +T V GT Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166
Query: 242 HAPE 245
+PE
Sbjct: 167 MSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-20
Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 30/185 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G+VY G+ +K++D S ++E L +V ++ +L + N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP---VLSWAQRVKIAVGAARGLEY 185
+ + + E+A G L + KK K KP P +L W V++ + L+Y
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWF--VQLCLA----LKY 118
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFG 240
LH + +I+HR+IK N+ L + + K+ DF +S L ST V+GT
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPY 168
Query: 241 YHAPE 245
Y +PE
Sbjct: 169 YLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 89.4 bits (220), Expect = 1e-20
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK-NENVVEL 126
+GEGS+G VY R + A+K L + + FL ++ +++ L N+V+L
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
++ D L E+ GSL D+L L ++ LEYL
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI------LSALEYL 117
Query: 187 HEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTR----VLGTFGY 241
H K IIHR+IK N+LL D + K+ DF L+ PD + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 242 HAPE 245
APE
Sbjct: 175 MAPE 178
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-20
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 74 IGEGSYGRVYFGVLR--SGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V GV SG+ A+K L + +EFL + S++++L + +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G +L E A G L L ++ + + + A +V A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K +HR++ + NVLL + AKISDF +S
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 4e-19
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 19/194 (9%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV 112
++S + +E N IGEG+ G VY R +G+ AIKK+ KQ + + ++
Sbjct: 10 DIVSEGDPRELYKNL---EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEI 66
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
++ K+ N+V+ Y V L V E+ GSL DI+ ++ Q
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNF--------VRMNEPQ 117
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+ +GLEYLH + +IHR+IKS N+LL D K++DF + Q ++ +
Sbjct: 118 IAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174
Query: 232 STRVLGTFGYHAPE 245
S V+GT + APE
Sbjct: 175 S--VVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-19
Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 18/193 (9%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L + T F +IGEG+YG+VY ++G+ AIK +D + ++E + +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 120 N-ENVVELVGYYVDGPLRV------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
N N+ G ++ L E GS+ D++ G + +++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
I RGL YLHE ++IHR+IK N+LL + K+ DF +S Q R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 233 TRVLGTFGYHAPE 245
+GT + APE
Sbjct: 173 --FIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-18
Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 24/195 (12%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFL-AQV 112
V+ + + DNF IGEGS G V +GR A+KK+D KQ +E L +V
Sbjct: 11 VVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDIL-HGKKGVKGAKPGPVLSWA 170
++ ++ N+VE+ Y V L V+ E G+L DI+ H + ++
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-----------MNEE 115
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q + + + L +LH + +IHR+IKS ++LL D K+SDF Q R
Sbjct: 116 QIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 231 HSTRVLGTFGYHAPE 245
S ++GT + APE
Sbjct: 173 KS--LVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-18
Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 20/185 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNE 121
+F +G+GSYG VY V R + A+K++D +E + ++ +++ + +
Sbjct: 1 DFKVLKKLGKGSYGSVY-KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAA 180
N++ ++DG + E+A G L + K K K P W +I +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIW----RIFIQLL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+ LHE+ +I+HR++KS+N+LL +D+ KI D +S A+ +GT
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPH 166
Query: 241 YHAPE 245
Y APE
Sbjct: 167 YMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 6e-18
Identities = 55/164 (33%), Positives = 74/164 (45%), Gaps = 27/164 (16%)
Query: 73 LIGEGSYGRVYFGVLRSGR---------AAAIKKLDSSKQPD--QEFLAQVSMVSRLKNE 121
+G+GS FGV+R G A+K L S K D +FL + +++ L +E
Sbjct: 2 KLGDGS-----FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N++ L G + PL + E A GSL D L K G L AV A
Sbjct: 57 NLIRLYGVVLTHPLM-MVTELAPLGSLLDRLR--KDALGHFLISTLC-----DYAVQIAN 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
G+ YL K R IHR++ + N+LL DD KI DF L P
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-18
Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 19/157 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQ----VSMVSRLKNENVVE 125
L+G GS+G VY G+ L G A+K L Q QE + Q ++++S+L++ N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + + E GSL +L G+ P PV+ R + GLEY
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
LH++ +HR+IK +N+L+ + + K++DF ++ Q
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 24/179 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ-EFLAQ-VSMVSRLKNENVVELVGY 129
IG+GS+G VY + R+ + AIK +D + D+ E + Q + +S+ ++ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEYL 186
++ G + E+ GS D+L KPG + IA GLEYL
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---------KPGKL----DETYIAFILREVLLGLEYL 114
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
HE+ IHR+IK++N+LL ++ K++DF +S Q ++ ++ +GT + APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-17
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++ ++ L + TD + IG+G+YG+VY + G AA+K LD D+E A+ +
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70
Query: 114 MVSRLKNE-NVVELVG------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ L N NVV+ G V G L L E + GS+ +++ G G
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQR 124
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L A I GA GL++LH RIIHR++K +N+LL + K+ DF +S Q
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179
Query: 227 AARLHSTRVLGTFGYHAPE 245
+ RL +GT + APE
Sbjct: 180 STRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 58/176 (32%), Positives = 95/176 (53%), Gaps = 19/176 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G V + R +G+ A+K +L+ ++ ++ L ++ ++ + + +V G +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
Y +G + + E+ GSL IL K V+G P +L KIAV +GL YLHEK
Sbjct: 69 YNNGDI-SICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHEK 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IIHR++K SN+L+ K+ DF +S Q ++ A+ T V GT Y APE
Sbjct: 120 H--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-17
Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA------AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+V+ G A+K L + D ++F + +++ ++EN+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV---LSWAQRVKIAVGAA 180
G +G ++ +E+ G L+ L HG P L+ +Q ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
G+ YL A +HR++ + N L+ D + KI DF +S
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-17
Identities = 49/176 (27%), Positives = 89/176 (50%), Gaps = 16/176 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGY 129
IG+GS+G V+ V ++ R A+K++D SK + +E + + ++++L + ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++D + E+A G LH +L ++G +P L Q + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRG----RP---LPEDQVWRFFIQILLGLAHLHSK 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+I+HR+IKS N+ L D KI D ++ D + ++GT Y +PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 58/174 (33%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AIK + D E + Q +SM+ ++ N+V G Y+
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI GP LS Q + +GL YLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IHR+IK +N+LL +D K++DF +S Q A+ S +GT + APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-16
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 34/190 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE------ 121
LIG+G+YGRVY + + +G A+K+++ + + D Q MV L++E
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIETLKD 64
Query: 122 ----NVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKI 175
N+V+ +G+ + E+ GS+ L +G+ + V + ++V
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV-- 117
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GL YLH K I+HR++K+ N+L+ D I KISDF +S ++ D + +
Sbjct: 118 ----LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 236 LGTFGYHAPE 245
G+ + APE
Sbjct: 171 QGSVFWMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 13/155 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G++G VY GVL+ A+K S+ PD ++FL + ++ + + N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V + E GSL L KK L+ + +++++ AA G+EYL K
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
IHR++ + N L+ ++++ KISDF +S +
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEG 145
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-16
Identities = 55/152 (36%), Positives = 78/152 (51%), Gaps = 23/152 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N +E G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS DIL K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHK-----KP------LQEVEIAAICHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217
LH IHR+IK+ N+LL + K++DF
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG++G V+ +G A+KK+ + + L ++ + ++ VV+L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G VL E+ L ++L +P L AQ +G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-----DEERP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR++K +N+L+ D + KI+DF L+ + RL+S +V T Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-16
Identities = 47/165 (28%), Positives = 87/165 (52%), Gaps = 21/165 (12%)
Query: 73 LIGEGSYGRV----YFGVLRSGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENV 123
+GEG++G+V G+ A+K L D++++ + ++++ M+ + K++N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 124 VELVGYYV-DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
+ L+G +GPL V+ E+A+ G+L D L + P L+ V
Sbjct: 79 INLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A ARG+E+L K + IHR++ + NVL+ +D + KI+DF L+
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-16
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+VY G L S + AIK L + +P QEF + ++S L++ N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLH----------DILHGKKGVKGAKPGPVLSWAQRVK 174
L+G + P +L +E+ + G LH D+ L + +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS---LDCSDFLH 128
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IA+ A G+EYL + +HR++ + N L+ + KISDF LS
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-16
Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 17/156 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEG +G V G +G+ A+K K D + Q FL + +++++L ++N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
L ++ E SKG+L + L + ++S Q ++ ++ A G+EYL K
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
+++HR++ + N+L+ +D +AK+SDF L+
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 61/180 (33%), Positives = 87/180 (48%), Gaps = 24/180 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVEL--- 126
IGEG+YG VY SG A+KK+ + D L +++++ L++ N+VEL
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 127 -VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
VG ++D V+ Y SL D + P P S +Q + + RGL+Y
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTP-FSESQVKCLMLQLLRGLQY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LHE IIHR++K SN+LL D KI+DF L+ A T + T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-15
Identities = 59/177 (33%), Positives = 85/177 (48%), Gaps = 14/177 (7%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-QPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
IG G+ VY + L + AIK++D K Q + L + V +S+ + NVV+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V G L + S GSL DI +K + P L A + +GLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR--VLGTFGYHAPE 245
+ IHR+IK+ N+LL +D KI+DF +S D R R +GT + APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-15
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVL--RSGRAAAIKKLDSSKQPDQE 107
P++ I D + +D + IG+G+YG+V F VL ++G AA+K LD D+E
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKV-FKVLNKKNGSKAAVKILDPIHDIDEE 60
Query: 108 FLAQVSMVSRLKNE-NVVELVGYY-----VDGPLRVLAYEHASKGSLHDILHG--KKGVK 159
A+ +++ L + NVV+ G Y +G L E + GS+ D++ G K+G +
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+P ++++ I A GL++LH + IHR++K +N+LL + K+ DF +
Sbjct: 121 MEEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245
S Q + RL +GT + APE
Sbjct: 171 SAQL--TSTRLRRNTSVGTPFWMAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-15
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G+VY V L +G A+K++ D+ + +E ++ ++ LK+ N+V+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
V + E+ S G+L ++L G +L + GL YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR+IK +N+ L + + K+ DF L N + S GT Y APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-15
Identities = 51/154 (33%), Positives = 88/154 (57%), Gaps = 19/154 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 132 D--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G L ++ E+ +KGSL D L ++ VL +K ++ +EYL
Sbjct: 70 EEKGGLYIVT-EYMAKGSLVDYLR-------SRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223
+HR++ + NVL+ +D++AK+SDF L+ +A
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-15
Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AAIK + D + Q + M+ K+ N+V G Y+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E GSL DI H GP LS +Q ++ +GL YLH K +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+HR+IK +N+LL D+ K++DF +S Q A+ S +GT + APE
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-14
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY ++G A+KK LD+ ++ P L ++S++ LK+ N+V+L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-STALREISLLKELKHPNIVKLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L +E+ L L + G P + S ++ RGL Y H
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYCHS 116
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYH 242
RI+HR++K N+L+ D + K++DF L AR T + T Y
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLWYR 165
Query: 243 APE 245
APE
Sbjct: 166 APE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 57/187 (30%), Positives = 93/187 (49%), Gaps = 21/187 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+ S +GEG+ G V L+ +G A+K + + PD ++ L ++ + K+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 123 VVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVG 178
+V+ G ++D + A E+ GSL D ++ K +G + G ++V KIA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAES 113
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YLH + +IIHR+IK SN+LL K+ DF +S + ++ A T GT
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GT 166
Query: 239 FGYHAPE 245
Y APE
Sbjct: 167 SFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 22/194 (11%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSR-LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R K+ N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPE 245
+ ++GT + APE
Sbjct: 173 -STMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL-DSSKQPDQEFLAQVSMVSR 117
E + + D G ++G+G+YG VY L + AIK++ + + Q ++++ S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
LK+ N+V+ +G + + E GSL +L K G ++ + +++
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVL 236
GL+YLH+ +I+HR+IK NVL+ + KISDF S + A +
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFT 170
Query: 237 GTFGYHAPE 245
GT Y APE
Sbjct: 171 GTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 55/174 (31%), Positives = 86/174 (49%), Gaps = 17/174 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V ++S G+ A+KK+D KQ +E L +V ++ ++ENVVE+ Y+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + ++ Q + + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR+IKS ++LL D K+SDF Q R S ++GT + APE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-14
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 22/194 (11%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AI++++ +QP +E +
Sbjct: 12 IVSVGDPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 118
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173
Query: 232 STRVLGTFGYHAPE 245
+ ++GT + APE
Sbjct: 174 -STMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 37/187 (19%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG+VY ++G A+KK+ + F + ++ ++ +L++ N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 129 YYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KGS+ HD+ L VK + +Q
Sbjct: 66 IVTSKG----------KGSIYMVFEYMDHDLTGLLDSPEVK-------FTESQIKCYMKQ 108
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+YLH I+HR+IK SN+L+ +D + K++DF L+ + ++ RV+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 239 FGYHAPE 245
Y PE
Sbjct: 165 LWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-14
Identities = 55/194 (28%), Positives = 101/194 (52%), Gaps = 22/194 (11%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-QV 112
++S+ + K+K + IG+G+ G V+ + + +G+ AIK+++ KQP +E + ++
Sbjct: 11 IVSIGDPKKKYTRY---EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ LKN N+V + ++ G + E+ + GSL D++ + AQ
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS NVLL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPE 245
+ ++GT + APE
Sbjct: 173 -STMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 22/194 (11%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + L++LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPE 245
+ ++GT + APE
Sbjct: 173 -STMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L+ S + +F ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 127 VG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G G L E+ GSL D L + ++ + + + +G++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
YL + R IHR++ + N+L+ +D+ KISDF L+ P
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 54/175 (30%), Positives = 89/175 (50%), Gaps = 18/175 (10%)
Query: 74 IGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G VY G+ R+ AIK +D + D+ + +++++S+ + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L KPGP L I +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSE- 120
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
R IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 56/174 (32%), Positives = 84/174 (48%), Gaps = 16/174 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G+YG VY L +G AA+K + D + Q + MV K+ N+V G Y+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI H GP LS Q + +GL YLH K +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+HR+IK +N+LL D+ K++DF ++ + A+ S +GT + APE
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQV 112
V+S + +E D+F IGEGS G V + +G+ A+KK+D KQ +E L +V
Sbjct: 14 VVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 70
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ +ENVV++ Y+ G + E G+L DI+ + ++ Q
Sbjct: 71 VIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQI 120
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ + R L YLH + +IHR+IKS ++LL D K+SDF Q + S
Sbjct: 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 233 TRVLGTFGYHAPE 245
++GT + APE
Sbjct: 178 --LVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-14
Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 11/152 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
+HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-14
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L K G G L V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
IHR+++S+N+L+ D + KI+DF L+ D
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-14
Identities = 50/171 (29%), Positives = 94/171 (54%), Gaps = 33/171 (19%)
Query: 74 IGEGSYGRVY----FGVLRSGR----AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V +G+ +S A+K L +++ + + ++++ ++ + K++N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP------------VLSW 169
++ L+G +GPL V+ E+A+KG+L + L ++ PGP LS+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSF 133
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
V A ARG+EYL + R IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-13
Identities = 62/180 (34%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + R+K+ N +E G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 140
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++ A A + +GT + APE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 29/180 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF + A+KK+ S KQ + Q+ + +V + +LK+ N +E G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++++ A + +GT + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-13
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 13/156 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
L+G+G++G V+ G L+ A+K K D ++ +FL++ ++ + + N+V+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L KK L Q VK A+ AA G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
IHR++ + N L+ ++++ KISDF +S Q D
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 34/177 (19%)
Query: 74 IGEGSYGRVY----------------FGVLRSGR----AAAIKKLDSSKQPDQEFLAQVS 113
+GEG +G V+ F V R GR A I + D++K +FL +V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNV-RKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL----------HGKKGVKGAKP 163
++SRLK+ N++ L+G VD + E+ G L+ L +G V A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
P +S++ + +A+ A G++YL + +HR++ + N L+ ++ KI+DF +S
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 16/150 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
+G G +G V+ G+ + A+K L ++FLA+ ++ +L++ +++L Y V
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--YAVCT 71
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P+ ++ E GSL + L G G L Q + +A A G+ YL +
Sbjct: 72 LEEPIYIVT-ELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + NVL+ +++I K++DF L+
Sbjct: 123 --NYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 60/181 (33%), Positives = 90/181 (49%), Gaps = 31/181 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAVTHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-DLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH +IHR++K+ N+LL + + K+ DF S AP + +GT + AP
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 180
Query: 245 E 245
E
Sbjct: 181 E 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-13
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
E+TD + L G G YG VY GV + A+K L +EFL + +++ +K+
Sbjct: 4 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+G P + E + G+L D L ++ + VL + +A +
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISS 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+EYL +K IHR++ + N L+ ++ + K++DF LS
Sbjct: 116 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 21/181 (11%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVV 124
+GEG+Y VY +GR AIKK+ ++ + L ++ ++ LK+ N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+ + L +E L ++ K V P + S+ RGLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH I+HR++K +N+L+ D + K++DF L+ ++ + +V+ T Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAP 171
Query: 245 E 245
E
Sbjct: 172 E 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-13
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M+ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 120 N-ENVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ N+ G ++ D L L E GS+ D++ KG L
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKG-------NTLKEEW 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
I RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q R +
Sbjct: 113 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 232 STRVLGTFGYHAPE 245
+ +GT + APE
Sbjct: 170 T--FIGTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-13
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L+++ +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E KGSL D L K+G G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
IHR+++++N+L+ D+ + KI+DF L+ D
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 48/162 (29%), Positives = 86/162 (53%), Gaps = 18/162 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V +++ AAIK L +S+ ++F ++ ++ +L + N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G + +A E+A G+L D L K V P L+ Q ++ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G++YL EK + IHR++ + NVL+ ++ +KI+DF LS
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 52/166 (31%), Positives = 93/166 (56%), Gaps = 23/166 (13%)
Query: 74 IGEGSYGRVYF----GVLRSGRA----AAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + A+K L D++ + + ++++ M+ + K++N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVKGA-----KPGPVLSWAQRVK 174
++ L+G DGPL VL E+ASKG+L + L ++ G+ + P L++ V
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-13
Identities = 52/175 (29%), Positives = 91/175 (52%), Gaps = 18/175 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ GS D+L +PGP L Q I +GL+YLH +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-13
Identities = 51/166 (30%), Positives = 94/166 (56%), Gaps = 23/166 (13%)
Query: 74 IGEGSYGRVYF----GVLR------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + + A + K D++++ + ++++ M+ + K++N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVK-----GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ G++ P LS+ V
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-13
Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 46/198 (23%)
Query: 74 IGEGSYGRVYFGVL---RSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG G+YGRVY + G+ AIKK K+ +++++ LK+ENVV L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 127 VGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW---AQRVKIAVGAAR 181
V ++ V L +++A HD+ ++ + A+RV I +
Sbjct: 68 VEVFLEHADKSVYLLFDYAE----HDLWQ------------IIKFHRQAKRVSIPPSMVK 111
Query: 182 --------GLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN--QAPDAA 227
G+ YLH ++HR++K +N+L+ + + KI D L+ AP
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LK 167
Query: 228 ARLHSTRVLGTFGYHAPE 245
V+ T Y APE
Sbjct: 168 PLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-13
Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F ++G G+YG+VY G +++G+ AAIK +D ++ ++E +++M
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 115 VSRLKNE-NVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+ + + N+ G ++ D L L E GS+ D++ KG +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKE---- 120
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
W + + RGL +LH ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 121 -DWIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 227 AARLHSTRVLGTFGYHAPE 245
R ++ +GT + APE
Sbjct: 175 VGRRNT--FIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-13
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 13/173 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ G+ ++ AIK L S Q+F +V + RL++++++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
G + E KGSL L + G VL A + +A A G+ YL E+
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IHR++ + N+L+ +D + K++DF L+ + ++ + + APE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-13
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLK 119
NF IG+G + VY + L GR A+KK+ + Q+ L ++ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV++ + +++ + E A G L I H KK K P + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LE++H K RI+HR+IK +NV + + K+ D L HS ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 239 FGYHAPE 245
Y +PE
Sbjct: 170 PYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-13
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 73 LIGEGSYGRVYFG----VLRSGRA---AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENV 123
+G G++G VY G +L G A+K L ++ Q +EFL + ++S + N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK-PGPVLSWAQRVKIAVGAARG 182
V+L+G + + + E G D+L + + + P+L+ + + I + A+G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDLS 220
YL + IHR++ + N L+ + + KI DF L+
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 27/182 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKN---ENVVEL 126
LIG G+YG VY G + +GR A+K LD+ + +V+++S+L+ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGL 183
G Y+ GP + E+A GS+ ++ K GP+ A++ I+V L
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPI---AEKY-ISVIIREVLVAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+Y+H+ +IHR+IK++N+L+ + K+ DF ++ A + +GT + A
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMA 169
Query: 244 PE 245
PE
Sbjct: 170 PE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGK-----KGVKGAKPGPVLSWAQRVKIAVGA 179
G +G ++ +E+ G L+ L HG G + PG L+ Q + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+ YL A +HR++ + N L+ + KI DF +S
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 42/148 (28%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ SKGSL D L +G K L Q V +A A G+ YL +
Sbjct: 74 EPIYIVT-EYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N+L+ ++ + KI+DF L+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G AIK L + FLA+ +++ +L++ +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L +G+K L+ + + +A A G+ ++ K
Sbjct: 74 PIYIIT-EYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR+++++N+L+ + KI+DF L+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 24/162 (14%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G+ R A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKIAVGAAR 181
L+G + R + E + G L K ++ +P P L+ + A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLS 220
G +YL E IHR+I + N LL +AKI+DF ++
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD- 132
+G G +G V+ G R AIK + + +F+ + ++ +L + N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ + G L + L +KG G +L V +EYL
Sbjct: 72 RPIFIV-TEYMANGCLLNYLRERKGKLGT--EWLLDMCSDV------CEAMEYLESNG-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N L+ +D++ K+SDF L+
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 71 NSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVV 124
+IG G +G V G L+ G+ AIK L + Q +FL + S++ + + N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 125 ELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L G P+ ++ E+ GSL L G + Q V + G A G+
Sbjct: 69 RLEGVVTKSRPVMIIT-EYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGM 119
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+YL +E +HR++ + N+L+ + + K+SDF LS
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 47/161 (29%), Positives = 86/161 (53%), Gaps = 16/161 (9%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGA 179
+G LA E+A G+L D L + ++ LS Q + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 51/184 (27%), Positives = 101/184 (54%), Gaps = 17/184 (9%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLA---QVSMVSRLKNEN 122
+ IGEGS+G++Y +S IK++D +K P +E A +V +++++K+ N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V + + + E+ G L ++ ++GV ++ +LSW V+I++G
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWF--VQISLG---- 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+++H++ +I+HR+IKS N+ L + +AK+ DF ++ Q D+ ++ +GT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 242 HAPE 245
+PE
Sbjct: 169 LSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D+S ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV--LSWAQRVKIAVGAARG 182
G V+G ++ +E+ G L+ L HG V A+ L+ +Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ YL A +HR++ + N L+ ++ + KI DF +S
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 17/175 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K + + + E F+ ++ ++S K+ N+V L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E G+L I+ ++ + L+ Q + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDSIM-----LELERG---LTEPQIRYVCRQMLEALNFLHSH- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
++IHR++K+ N+LL D K++DF +S + + + +GT + APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 55/174 (31%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V + SGR A+K +D KQ +E L +V ++ +++NVVE+ Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + L+ Q + + L YLH +
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 73 LIGEGSYGRVYF----GVLRSGRAA--AIKKLDSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G +G V+ G+ G +K L +K + EF ++ M +L ++NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L+G + + E+ G L L K + KP P LS Q+V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQKVALCTQIALGM 130
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
++L + R +HR++ + N L+ K+S LS
Sbjct: 131 DHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 66 DNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNE 121
+ + ++GEG+YG V +G AIKK + + + L +V ++ +L++E
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 122 NVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV--LSWAQRVKIAVG 178
N+V L + G L L +E+ + +L ++L G G P V W Q ++
Sbjct: 61 NIVNLKEAFRRKGRL-YLVFEYVER-TLLELLEASPG--GLPPDAVRSYIW-QLLQ---- 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+ Y H IIHR+IK N+L+ + + K+ DF + A T + T
Sbjct: 112 ---AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVAT 164
Query: 239 FGYHAPE 245
Y APE
Sbjct: 165 RWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-12
Identities = 50/175 (28%), Positives = 91/175 (52%), Gaps = 18/175 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L + GP + Q + +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEF-QIATMLKEILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-12
Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 74 IGEGSYGRVY----FGVL--RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G++GRV+ G+L A+K L ++S +F + ++++ + N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILH-------------GKKGVKGAKPGPVLSWAQR 172
L+G G L +E+ + G L++ L K LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ IA A G+ YL +E + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-11
Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 18/162 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNE-NVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G LA E+A G+L D L K V P LS Q + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 19/154 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY GV G AIK L ++S + ++E L + +++ + + +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + L + G L D + K G++ +L+W ++ A+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNWCVQI------AKGMSYL 125
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
EK R++HR++ + NVL+ KI+DF L+
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-11
Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 27/186 (14%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKL-------DSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G+G+YG VY G+ G+ A+K++ ++++ ++ +V ++ LK+ N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G +D + E GS+ IL+ G P PV K G+ Y
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR------VLGTF 239
LH ++HR+IK +NV+L + I K+ DF + + A LH T + GT
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL--AWVGLHGTHSNMLKSMHGTP 172
Query: 240 GYHAPE 245
+ APE
Sbjct: 173 YWMAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 38/192 (19%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKN---ENV 123
+ IGEG+YG VY L +GR A+KK L P L +++++ +L++ N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L G D L++ L +EH + L L K KPG L +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPG--LPPETIKDLMRQ 115
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RG+++LH RI+HR++K N+L+ D KI+DF L AR++S T
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALT 164
Query: 234 RVLGTFGYHAPE 245
V+ T Y APE
Sbjct: 165 SVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-11
Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 28/190 (14%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKN 120
D + + I EG+YG VY ++G A+KKL K+ + F L +++++ +L++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQH 63
Query: 121 ENVVEL----VGYYVDGPLRVLAY-EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
N+V + VG +D V+ Y EH K + P ++ +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET-----------MKQP-FLQSEVKCL 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ G+ +LH+ I+HR++K+SN+LL + I KI DF L+ + T++
Sbjct: 112 MLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQL 166
Query: 236 LGTFGYHAPE 245
+ T Y APE
Sbjct: 167 VVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V+ G+L+ GR A AIK L +++ Q+FL++ S++ + + N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L G S Q V + G A G++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
++ +HR++ + N+L+ + K+SDF LS
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-11
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRA-AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K + PD +FL + ++ + + N+V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L + GP L + +++ AA G+EYL K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
IHR++ + N L+ + ++ KISDF +S + D
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK + ++S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKK-GVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G G ++ E +KG L L ++ + + + +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL K + +HR++ + N ++ +D KI DF ++
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-11
Identities = 42/182 (23%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 74 IGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G V V R G+ K++D ++E +++V+++ LK+ N+V
Sbjct: 8 IGKGSFGTVR-KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 129 YYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+D + L Y E+ G L ++ K + + W +I L
Sbjct: 67 RIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-W----RILTQLLLALYE 120
Query: 186 LH--EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H ++HR++K +N+ L ++ K+ DF L+ ++ + +GT Y +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178
Query: 244 PE 245
PE
Sbjct: 179 PE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-11
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G R AIK + +++F+ + ++ +L + +V+L G +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L ++G S + + + G+ YL
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
+IHR++ + N L+ ++ + K+SDF ++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-11
Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G + A+K L Q FL + +++ L+++ +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ +KGSL D L +G K P + + + A G+ Y+ K
Sbjct: 74 EPIYIIT-EYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
IHR+++++NVL+ + + KI+DF L+ D
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-11
Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKL---------DSSKQPDQEFLA-QVSMVSRLKN 120
+LIG GS+G VY G+ SG A+K++ K+ + LA +++++ L++
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP-VLSWAQRVKIAVGA 179
EN+V+ +G +D + E+ GS+ +L+ GA V ++ +++
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQI------ 115
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----DAAARLHSTRV 235
+GL YLH + IIHR+IK +N+L+ + KISDF +S + +
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 236 LGTFGYHAPE 245
G+ + APE
Sbjct: 173 QGSVFWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-11
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 25/168 (14%)
Query: 74 IGEGSYGRVYF----GVLR---------SGRA--AAIKKL--DSSKQPDQEFLAQVSMVS 116
+GEG +G V+ G+ G+ A+K L D +K +FL ++ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 117 RLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK---GVKGAKPGPVLSWAQR 172
RLKN N++ L+G V D PL + E+ G L+ L ++ A P +S A
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ +AV A G++YL A +HR++ + N L+ + KI+DF +S
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-11
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G V + + SG A+K++ S+ ++ + L + +V +++ + +V +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 130 YVDGPLRVLAYE----------HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
Y L E S + ++ K P +L KIAV
Sbjct: 69 Y-----GALFREGDCWICMELMDISLDKFYKYVYEVL--KSVIPEEILG-----KIAVAT 116
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K E +IIHR++K SN+LL + K+ DF +S Q D+ A+ TR G
Sbjct: 117 VKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCR 171
Query: 240 GYHAPE 245
Y APE
Sbjct: 172 PYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 18/156 (11%)
Query: 71 NSLIGEGSYGRVYFGVLRSGR----AAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVV 124
IGEG +G VY GV S A A+K K +S ++FL + ++ + + ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L+G + P+ ++ E A G L L K L A + + + L
Sbjct: 71 KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL K R +HR+I + NVL+ D K+ DF LS
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 46/166 (27%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 74 IGEGSYGRVYFGVL--------RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V + A+K L D++++ + ++++ M+ + K++N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ P +++ V
Sbjct: 83 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG+EYL A + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRA---AAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L S +++ ++FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E G+L L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
+E +HR++ + N+L+ + + K+SDF LS D + T LG
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-10
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + +Q + +++++ L +EN+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 127 VGYYVDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + + L E+ GSL D L P L+ AQ + A G+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICEGMA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
YLH + IHR++ + NVLL +D + KI DF L+ P+
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GE ++G++Y G L + AIK L P Q EF + S+++ L + N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL-----HGKKGVKGAKPGPV---LSWAQRVKIAVG 178
+G + +E+ ++G LH+ L H G + G V L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
A G+EYL + +H+++ + N+L+ + KISD LS +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRL 118
EK +N G L+GEGSYG V + +G+ AIKK L+S + +A ++ M+ +L
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAV 177
++EN+V L+ + L +E L D+ G+ RV K
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD----------ESRVRKYLF 107
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RG+E+ H IIHR+IK N+L+ + K+ DF + AA T +
Sbjct: 108 QILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVA 162
Query: 238 TFGYHAPE 245
T Y APE
Sbjct: 163 TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 27/190 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
+GEG++G VY +++GR A+KK+ + D F L ++ ++ +LK+ NVV L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL----HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
V+ P + +GS++ + H G+ P L+ +Q + G+
Sbjct: 75 MAVERPDK----SKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLEGIN 129
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL---------SNQAPDAAARLHSTRV 235
YLHE I+HR+IK++N+L+ + I KI+DF L + + T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 236 LGTFGYHAPE 245
+ T Y PE
Sbjct: 187 VVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 39/192 (20%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL-----DSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G++ Y +++G A+K++ SS+Q + + ++ +++RL + +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 125 ELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
++G D + E + GS+ +L K G A + RGL
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGA-FKEAVIINYTEQLLRGL 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST--------- 233
YLHE +IIHR++K +N+L+ +I+DF AAARL +
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADF-------GAAARLAAKGTGAGEFQG 166
Query: 234 RVLGTFGYHAPE 245
++LGT + APE
Sbjct: 167 QLLGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-10
Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV + + AIK K ++ K E + + ++ +L N +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E AS G L+ L GKK ++ + V++ + G++YL
Sbjct: 63 V-CEAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPE 245
K +HR++ + NVLL + AKISDF LS +A A + R G + ++APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 24/179 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY +G AIKK+ + + + L ++ ++ L + N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E D+ +K + G L + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKL---IKDRQRG--LPESLIKSYLYQLLQGLAFCHSH 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH--STRVLGTFGYHAPE 245
I+HR++K N+L+ + + K++DF L+ H TR Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 5e-10
Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 39/187 (20%)
Query: 74 IGEGSYGRVYFGV--LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+GS+G+V V +G+ A+K L ++ + L + +++SR+ + +V+L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----- 181
Y ++ L E+A G L L + + + AR
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLS-----------------KEGRFSEERARFYAAE 101
Query: 182 ---GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LEYLH II+R++K N+LL D K++DF L+ + +R ++ GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 239 FGYHAPE 245
Y APE
Sbjct: 157 PEYLAPE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 26/64 (40%), Positives = 35/64 (54%), Gaps = 6/64 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH K IIHR+IK N+LL + I+DF+++ + +T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGY 165
Query: 242 HAPE 245
APE
Sbjct: 166 MAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 26/181 (14%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEGS+G+ + G+ IK+++ SK +E +V+++S +K+ N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + + ++ G L+ ++ ++GV + +L W ++ +A L+++H++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED-QILDWFVQICLA------LKHVHDR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYHAP 244
+I+HR+IKS N+ L D K+ DF + A L+ST L GT Y +P
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYYLSP 170
Query: 245 E 245
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 36/156 (23%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 73 LIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
L+ EG++GR+++G+L +K + Q L + ++ L ++N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 126 LVGYYVDGPLR-VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ ++ + Y + + G+L L + + P LS Q V +A+ A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACGMS 131
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YLH++ +IH++I + N ++ ++ KI+D LS
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ +L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L ++ K +P +L + V G+ YL K +
Sbjct: 72 RPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDV------CEGMAYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N L+ D K+SDF LS
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 74 IGEGSYGRVYFG------VLRSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV-----LSWAQRVKIAVGA 179
G DG ++ +E+ G L+ L HG + P L +Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+ YL A +HR++ + N L+ + + KI DF +S
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 21/165 (12%)
Query: 66 DNFGTNSLIGEGSYGRVY----FGVLRSGRA--AAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N +G G++G+V +G+ +S A+K L + + ++++ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 118 LKN-ENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
L N EN+V L+G + GP+ V+ E+ G L + L K+ L+ +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRES-------FLTLEDLLSF 146
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+G+ +L K IHR++ + NVLL I KI DF L+
Sbjct: 147 SYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 67 NFGTNSLIGEGSYGRVY--FGVLRSGRAA----AIKKLDSSKQPDQ--EFLAQVSMVSRL 118
N +GEG +G+V GRA A+K L + + + L++ +++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 119 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR----- 172
+ +V++L G DGPL +L E+A GSL L + V P + S R
Sbjct: 61 NHPHVIKLYGACSQDGPL-LLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNRNSSYL 116
Query: 173 -------------VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+ A +RG++YL AE +++HR++ + NVL+ + KISDF L
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245
S + + + ++ + A E
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIE 199
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 27/182 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G+GSYG V R+ G+ IKKL+ +S++ + + ++S+LK+ N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 130 YV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ DG L ++ G L+ L +KG +L Q V+ V A L+YLH
Sbjct: 68 WEGEDGLLYIVM-GFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLH 119
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHA 243
EK I+HR++K+ NV L +I K+ D L NQ D A+ L +GT Y +
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL-----IGTPYYMS 170
Query: 244 PE 245
PE
Sbjct: 171 PE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 42/117 (35%), Positives = 60/117 (51%), Gaps = 16/117 (13%)
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+Y DG + + EH GSL +L KK G P +L KI++ RGL YL E
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLRE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
K + I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 32/83 (38%), Positives = 43/83 (51%), Gaps = 10/83 (12%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P +L KIAV + LEYLH K +IHR++K SNVL+ + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 223 APDAAARLHSTRVLGTFGYHAPE 245
D+ A+ T G Y APE
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQP-DQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L +A AIK L D ++ P +EF + M SRL++ N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLHDIL-----HGKKG-------VKGAKPGPVLSWAQR 172
L+G + PL ++ + + S LH+ L H G VK L A
Sbjct: 73 LLGVVTKEQPLSMI-FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST-----LEPADF 126
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
V I A G+E+L + ++H+++ + NVL+FD KISD L
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G R+ AIK ++ +++F+ + ++ +L + +V+L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
PL ++ E G L + L ++G +LS Q V G+EYL +
Sbjct: 72 KPLYIVT-EFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N L+ + K+SDF ++
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 33/151 (21%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 95 IKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154
+ +L ++ D L ++ ++S L++ N++ +++D ++ E+A+ G+L+D +
Sbjct: 35 LTRLSEKERRDA--LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR 92
Query: 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
+KG + + + Y+H+ I+HR+IK+ N+ L + K+
Sbjct: 93 QKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
DF +S + V+GT Y +PE
Sbjct: 143 GDFGISKILGS--EYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 34/194 (17%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A+K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+E +V+ G D + E+ GS+ D L G + R K
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR----- 234
G+EYLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF-------GASKRLQTICSSGTG 163
Query: 235 ---VLGTFGYHAPE 245
V GT + +PE
Sbjct: 164 MKSVTGTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
K D+F S +G G+ G V F V SG A K + +P + + ++ ++
Sbjct: 3 KDDDFEKISELGAGN-GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 120 NENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V G +Y DG + + EH GSL +L KK G P +L K+++
Sbjct: 62 SPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL--KKA--GRIPEQILG-----KVSIA 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 112 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGT 165
Query: 239 FGYHAPE 245
Y +PE
Sbjct: 166 RSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-09
Identities = 37/147 (25%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L +G K +P P L + + A G+ ++ ++
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR+++++N+L+ + KI+DF L+
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKN 120
K D+F S +G G+ G V + +KL + + + ++ ++ +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 62
Query: 121 ENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+V G +Y DG + + EH GSL +L K + P +L K+++
Sbjct: 63 PYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAV 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL YL EK + I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 166
Query: 240 GYHAPE 245
Y +PE
Sbjct: 167 SYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-09
Identities = 41/168 (24%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 74 IGEGSYGRVY--------------FGVLRSGRA---AAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ F + SG A+K L D++K +FL ++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRLK+ N++ L+ + + E+ G L+ L H + +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ +A A G++YL + +HR++ + N L+ + KI+DF +S
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-09
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L + Q +FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ GSL L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
++ +HR++ + N+L+ + + K+SDF LS D ++TR
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK------KLDSSKQPD-QEFLAQVSMVSRLKNENVVE 125
++GEG +G V G L + +K KLD + +EFL++ + + + NV++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 126 LVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L+G + P+ +L + G LH L + + P+ +K V
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPF--MKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMV 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+EYL + IHR++ + N +L +D ++DF LS
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 23/179 (12%)
Query: 74 IGEGSYGRVYFGVLRS--GRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G+YG VY VL G A+K+ LD SK + + ++ ++ + + +V+
Sbjct: 9 LGKGNYGSVY-KVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFY 65
Query: 128 G-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++++G + + E+ GSL D L+ P VL +I +GL++L
Sbjct: 66 GAFFIEGAV-YMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
K E IIHR++K +NVL+ + K+ DF +S + A+ + +G Y APE
Sbjct: 119 --KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 49/176 (27%), Positives = 92/176 (52%), Gaps = 19/176 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVG-YY 130
+G+G++G+VY + +G AA K +++ + + ++++ ++ +++ + +V+L+G +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 131 VDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
DG L ++ E G++ I L +G L+ Q I L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRG---------LTEPQIQVICRQMLEALQYLHSM 129
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IIHR++K+ NVLL D K++DF +S + R S +GT + APE
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 19/156 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRA----AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVE 125
L+G G +G V+ G+ + G + AIK + S +Q QE + + L + +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G G L + + GSL D + + P +L+W ++ A+G+ Y
Sbjct: 74 LLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQI------AKGMYY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
L E R++HRN+ + N+LL D I +I+DF +++
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 72 SLIGEGSYGRVY-FGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
IG G+ G+VY ++G A+K++ +K+ ++ L + +V + + +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
GY++ + E S + D L K ++G P +L K+ V + L YL
Sbjct: 81 GYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-----KMTVAIVKALHYLK 131
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
EK +IHR++K SN+LL K+ DF +S + D+ A+ TR G Y APE
Sbjct: 132 EKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 30/161 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAI-----------KKLDSSKQPDQEFLAQVSMVSRLKNEN 122
+G+G++ +Y GVLR I K L S + F S++S+L +++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L G V ++ E+ G L LH +K L W ++ +A A
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKN------NVSLHW--KLDVAKQLASA 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDI-------AKISD 216
L YL +K +++H N+ N+L+ + K+SD
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 25/176 (14%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G VY L + R A+K LD + + ++ ++++ ++ + + ++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+V+ + + E GSL V P VL +IAV +GL YL
Sbjct: 69 FVENRISICT-EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL 114
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+I+HR++K SN+L+ K+ DF +S Q ++ A+ + +GT Y APE
Sbjct: 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 44/174 (25%), Positives = 64/174 (36%), Gaps = 48/174 (27%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPD--QE-----FLAQVSMVSRL 118
+IGEGS+ V + + + AIK LD K E L + +L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 119 -----KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--AQ 171
EN+ Y+V E+A G L + G+ + A+
Sbjct: 68 YYTFQDEENL-----YFV--------LEYAPNGELLQYIR----KYGSLDEKCTRFYAAE 110
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
+ LEYLH K IIHR++K N+LL D KI+DF +
Sbjct: 111 ILLA-------LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-08
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G G + A +K+L +S PD++ FL +V L + NV++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ +L E G L + L +G+ + QR +A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IH ++ N L D KI D+ L+
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-08
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 74 IGEGSYGRVYFGVLR---SGRA---AAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G R G A A+K ++ S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG-PVLSWAQRVKIAVGAARGLE 184
L+G G ++ E + G L L + PG P + + +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL+ K + +HR++ + N ++ D KI DF ++
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK ++ + + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLE 184
L+G G ++ E ++G L L + P S + +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL+ + +HR++ + N ++ +D KI DF ++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 39/189 (20%)
Query: 74 IGEGSYGRVYFGVL--RSGRAAAIKKLD-------SSKQPDQEFLAQVSMVSRLKNENVV 124
IG G++G V + V R G+ A+KK+ S K+ +E + M+ K++NV+
Sbjct: 8 IGYGAFG-VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVL 62
Query: 125 ELVGYYVDGPLRVLAYEHA------SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV- 177
+ + P + +E + LH I+ P P LS + VK+ +
Sbjct: 63 SALD--ILQPPHIDPFEEIYVVTELMQSDLHKII--------VSPQP-LS-SDHVKVFLY 110
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVL 236
RGL+YLH I+HR+IK N+L+ + + KI DF L+ + PD H T+ +
Sbjct: 111 QILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEV 165
Query: 237 GTFGYHAPE 245
T Y APE
Sbjct: 166 VTQYYRAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNE 121
+ F ++GEG+YG V + + AIKK S++ ++ L ++ M+ LK E
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+VEL + L +E+ K L + ++ G P V S+ ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IK 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H+ I+HR+IK N+L+ +D+ K+ DF + + + + T + T Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167
Query: 242 HAPE 245
+PE
Sbjct: 168 RSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 30/182 (16%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRLKNENVVELVGY 129
IGEGSYG V+ R +G+ AIKK ++S P + +A ++ M+ +LK+ N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E+ L+++ +GV KI + + + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LIKKIIWQTLQAVNFCHKH 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYHA 243
IHR++K N+L+ K+ DF AR+ + T + T Y A
Sbjct: 120 ---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATRWYRA 168
Query: 244 PE 245
PE
Sbjct: 169 PE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 74 IGEGSYGRV---YFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V + + +S + A+K L ++ E L + +++ +L N +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + +L E A G L+ L K V + +V + G++YL
Sbjct: 63 GI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELVHQVSM------GMKYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
E +HR++ + NVLL AKISDF LS
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-08
Identities = 43/155 (27%), Positives = 83/155 (53%), Gaps = 19/155 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAA----AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ + G AIK L+ + P + EF+ + +++ + + ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + P L + G L D +H K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI------AKGMMY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L E+ R++HR++ + NVL+ + KI+DF L+
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 48/177 (27%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY G ++G+ A+KK L+S ++ P + ++S++ L++ N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E S L L + V S+ ++ +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCHS 119
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ R++HR++K N+L+ + + K++DF L+ +A R+++ V+ T Y APE
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 28/181 (15%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY +GR A+K++ S + +E A ++ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D R L+ EH GS+ D L K L+ K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---------KSYGALTENVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
G+ YLH I+HR+IK +N+L K+ DF A+ RL + + G
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDF-------GASKRLQTICLSG 163
Query: 238 T 238
T
Sbjct: 164 T 164
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-08
Identities = 45/175 (25%), Positives = 93/175 (53%), Gaps = 17/175 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K +D+ + + ++++ ++ +++ + N+V+L+ +Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E + G++ ++ ++ +P L+ Q + L YLHE
Sbjct: 73 YENNLWILI-EFCAGGAVDAVM-----LELERP---LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IIHR++K+ N+L D K++DF +S + R S +GT + APE
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 45/205 (21%)
Query: 71 NSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-----DQEFLAQVSM---------- 114
+ +GEG+YG+V +G+ AIKK+ + D++ + +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK-KGVKGAKPGPVLSWAQRV 173
++ +K+EN++ LV YV+G L + DI+ K V K L+ +Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINL---------VMDIMASDLKKVVDRK--IRLTESQVK 122
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-------------DLS 220
I + GL LH+ +HR++ +N+ + I KI+DF LS
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPE 245
+++V+ T Y APE
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPE 203
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 52/194 (26%), Positives = 81/194 (41%), Gaps = 43/194 (22%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVE 125
IG G+YG V V R+GR AIKK+ S D A+ + ++ L++EN++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 126 LVGYYVDGPLRVLAYEHASKGS------------LHDILHGKKGVKGAKPGPVLSWAQRV 173
L L +L + LH ++ + L+ +
Sbjct: 64 L--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ---------PLT-DDHI 105
Query: 174 K-IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH 231
+ RGL+YLH +IHR++K SN+L+ + KI DF L+ PD +
Sbjct: 106 QYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 232 STRVLGTFGYHAPE 245
T + T Y APE
Sbjct: 163 LTEYVVTRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 37/162 (22%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL---- 126
+GEG+Y VY G R +G A+K LD+ + + ++S++ LK+EN+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 127 --------VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V Y+D L+ H +G+L P V S+ ++
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGAL-------------DPNTVKSFTYQL----- 109
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+G+ + HE R++HR++K N+L+ K++DF L+
Sbjct: 110 -LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 38/192 (19%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG+G++G V+ + + + A+KK +++ K+ F L ++ ++ LK+ENVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNL 76
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIA 176
+ + KGS HD+ L K VK + ++ K+
Sbjct: 77 IEICRTKATP----YNRYKGSFYLVFEFCEHDLAGLLSNKNVK-------FTLSEIKKVM 125
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHST 233
GL Y+H +I+HR++K++N+L+ D I K++DF L+ + + ++ ++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 234 RVLGTFGYHAPE 245
RV+ T Y PE
Sbjct: 183 RVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 15/184 (8%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE 121
NF IG G + VY L G A+KK+ + + + ++ ++ +L +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LE++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPE 245
+PE
Sbjct: 173 MSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 25/70 (35%), Positives = 34/70 (48%), Gaps = 9/70 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS------NQAPDAAARLHSTRV 235
LEYLH IIHR++K N+L+ + K++DF LS Q R+
Sbjct: 105 ALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 236 LGTFGYHAPE 245
+GT Y APE
Sbjct: 162 VGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 15/184 (8%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNE 121
NF IG G + VY L + A+KK+ + D Q+ + ++ ++ +L +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ + +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+E++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPE 245
+PE
Sbjct: 173 MSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 21/187 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKN 120
K D++ +GEGSY VY G + +G+ A+K + ++ F A + S++ LK+
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 121 ENVVEL--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+V L + + + V Y H D K G P V + ++
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMD-----KHPGGLHPENVKLFLFQL----- 112
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL Y+H++ I+HR++K N+L+ D K++DF L+ +A + +S V+ T
Sbjct: 113 -LRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-T 166
Query: 239 FGYHAPE 245
Y P+
Sbjct: 167 LWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 26/179 (14%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKL-----DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
I +G++G VY R +G AIK L + Q + M+ + ++ V +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAARGLEYL 186
+ L E+ + G ++ G + WA+ + G+E L
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIK--------TLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
H++ IIHR+IK N+L+ K++DF LS L + + +GT Y APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 42/161 (26%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 72 SLIGEGSYGRV---YFGVLR--SGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+G++G V + L+ +G A+KKL S+ + ++F ++ ++ L+++N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 126 L--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V Y L E+ GSL D L + + +L +A ++ +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK--LLLYASQI------CKGM 121
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
EYL K R +HR++ + N+L+ ++ KI DF L+ P
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 33/186 (17%)
Query: 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
S +G G+YG+V +GR AIKKL +P Q + ++ ++ + +ENV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS---RPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 125 ELVGYYV-DGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L+ + L V H L++I+ +K LS +
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK----------LSDDHIQFLVYQI 127
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D T + T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATR 179
Query: 240 GYHAPE 245
Y APE
Sbjct: 180 WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 18/185 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK---LDSSKQPDQEFLAQVSMVSRLKN 120
+ ++ T S +G G+ G V KK + + ++ L ++ ++ ++
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G +++ + E GSL I KKG G P +L KIAV
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKG--GPIPVEILG-----KIAVAVV 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GL YL+ RI+HR+IK SN+L+ K+ DF +S + ++ A T V GT
Sbjct: 114 EGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTST 167
Query: 241 YHAPE 245
Y +PE
Sbjct: 168 YMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 38/168 (22%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 40 AKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKL 98
+K K++T+ I + LKE ++I G G Y G +++G +K++
Sbjct: 677 SKVSKSITINDI------LSSLKE-------ENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 99 DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV 158
+ +A + +L++ N+V+L+G L +E+ +L ++L
Sbjct: 724 NDVNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776
Query: 159 KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206
LSW +R KIA+G A+ L +LH + P ++ N+ +++
Sbjct: 777 --------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816
|
Length = 968 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 44/164 (26%), Positives = 83/164 (50%), Gaps = 19/164 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGR----AAAIKKLDSSKQP--DQEFLAQVSMVS 116
K F ++G G++G VY G+ + G AIK+L + P ++E L + +++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K G++ +L+W
Sbjct: 65 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNWC------ 115
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
V A+G+ YL E+ R++HR++ + NVL+ KI+DF L+
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-07
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 46/191 (24%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
+G+G +G V ++ +G+ A KKLD ++ +Q L + ++ ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSWAQRVK 174
AY +K L ++ G+ P A+ +
Sbjct: 59 ----------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIF 99
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A GLE+LH++ RI++R++K NVLL D +ISD L A +
Sbjct: 100 YAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKG 153
Query: 235 VLGTFGYHAPE 245
GT GY APE
Sbjct: 154 RAGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 25/63 (39%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ E RI+HR++ +N++L +DD I+DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 243 APE 245
PE
Sbjct: 181 CPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 41/178 (23%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQ--VSMVSRLKNENVVELVG 128
++G G++G V+ ++ + I K +Q D+ AQ ++ L + N++E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+++ ++ E+A G+L + + K+ +L + ++ +A L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLA------LHHVHT 119
Query: 189 KAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
K I+HR++K+ N+LL + KI DF +S + + V+GT Y +PE
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-06
Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVEL 126
++G G +G + G L + AI L + Q FLA+ + + + N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G G ++ E+ S G+L L +G L Q + + G A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217
+E +H+ + + VL+ D + KIS F
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGF 151
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 34/163 (20%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG+G +G VY G L A+K L+ + + ++FL + ++ + NV+ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 127 VGYYVD---GPLRVLAYEHASKGSLHDILHG--KKGVKGAKPGPVLSWAQRVKIAVG--- 178
+G + PL VL Y + HG + ++ P VK +G
Sbjct: 62 LGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPT------VKDLIGFGL 105
Query: 179 -AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A+G+EYL A + +HR++ + N +L + K++DF L+
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLKNE 121
NF IGEG+YG VY +G A+KK+ ++ P + ++S++ L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E LH L KK + + + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSG-IPLPLIKSYLFQLLQ 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 166
Query: 242 HAPE 245
APE
Sbjct: 167 RAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 89 SGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKNENVVELVGYYVDGPLRVLA-YEHA 143
+G AIK L + ++ F + ++ +RL + N+V L+ P + A +E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203
+L ++L A G L + ++ + L H + I+HR++K N
Sbjct: 62 PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109
Query: 204 VLLFDDDI---AKISDFDLSNQAPDA--AARLHSTR---VLGTFGYHAPE 245
+++ + AK+ DF + P A TR VLGT Y APE
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 45/189 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G+ R +G+ A+K + + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIA 176
LHDI+H K+ + PG + + R+
Sbjct: 67 ----------------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y+H + I+HR++K N+L+ K++DF L+ +A ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165
Query: 237 GTFGYHAPE 245
T Y P+
Sbjct: 166 -TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 23/179 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY +G A+KK L++ + P + ++S++ L + N+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVGAARGLEYL 186
L +E D+ KK + + P+ + +G+ Y
Sbjct: 66 VVHSENKLYLVFEFLD----LDL---KKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y APE
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYRAPE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 24/171 (14%)
Query: 74 IGEGSYGRVYF-----------------GVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ + A+K L D+S ++FL +V +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRL + N+ L+G P + E+ G L+ L H + A LS++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223
+ +A A G+ YL +HR++ + N L+ + KI+DF +S
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELV 127
++G+G +G V +R +G+ A KKL+ + + + L + ++ ++ + VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 128 GYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
Y D VL + H G+ G + + V A GLE
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA---------VFYAAEICCGLED 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ RI++R++K N+LL D +ISD L+ P+ + RV GT GY APE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 56/201 (27%), Positives = 78/201 (38%), Gaps = 60/201 (29%)
Query: 74 IGEGSYGRVY---------FGVLRSGRA---------------AAIKKLDSSKQPDQEFL 109
IG G+YG VY F L+S R A +K+L++ P+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
V SR E V LV +VD LR + K P P L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRT----YLDKV----------------PPPGLPA 107
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ RGL++LH I+HR++K N+L+ K++DF L AR
Sbjct: 108 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------AR 156
Query: 230 LHS-----TRVLGTFGYHAPE 245
++S T V+ T Y APE
Sbjct: 157 IYSCQMALTPVVVTLWYRAPE 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 37/155 (23%), Positives = 80/155 (51%), Gaps = 19/155 (12%)
Query: 73 LIGEGSYGRVYFGV-------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ ++ A + + ++S + ++E L + +++ + + V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + ++ L + G L D + K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNWCVQI------AKGMSY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L E R++HR++ + NVL+ + KI+DF L+
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 47/183 (25%), Positives = 88/183 (48%), Gaps = 29/183 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV-G 128
++GEGS+GR + S + A+K +L S ++ + +++++K+ N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ DG L ++ E+ G L + ++G K +L W ++ + V +++HE
Sbjct: 67 FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV------LGTFGYH 242
K R++HR+IKS N+ L + K+ DF +ARL ++ +GT Y
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDF--------GSARLLTSPGAYACTYVGTPYYV 167
Query: 243 APE 245
PE
Sbjct: 168 PPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-06
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKN 120
F ++G+G +G V L+ S + A+K L + S +EFL + + + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 121 ENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
NV++L+G + P+ ++ G LH L + G +P L V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVR 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+ A G+EYL K IHR++ + N +L ++ ++DF LS +
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 22/163 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G V G L + A+K + ++ ++FL++ + + NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 128 GYYVDG------PLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQR-VKIAVGA 179
G + P V+ G LH +L+ + G P Q VK
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLVKFMTDI 121
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
A G+EYL K IHR++ + N +L ++ ++DF LS +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 33/197 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN 120
D F IGEG+YG+VY + +G A+KK LD+ K+ P + ++ ++ +L +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNH 65
Query: 121 ENVVELVGYYVDGPLRV----------LAYEHASKGSLHDILHG--KKGVKGAKPGPVLS 168
N+V L D + L +E+ HD L G + G+ + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HD-LMGLLESGLVHFSEDHIKS 120
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ +++ GL Y H+K +HR+IK SN+LL + K++DF L+ +
Sbjct: 121 FMKQL------LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 229 RLHSTRVLGTFGYHAPE 245
R ++ +V+ T Y PE
Sbjct: 172 RPYTNKVI-TLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 22/189 (11%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D + L E+ GS+ D L K L+ + K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---------KAYGALTESVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
G+ YLH I+HR+IK +N+L K+ DF S + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 237 GTFGYHAPE 245
GT + +PE
Sbjct: 171 GTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 51/202 (25%), Positives = 79/202 (39%), Gaps = 61/202 (30%)
Query: 74 IGEGSYGRVY----------FGVLRSGRA---------------AAIKKLDSSKQPDQEF 108
IGEG+YG+V+ F L+ R A ++ L++ + P+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L V VSR E + LV +VD L + P P +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------------------VPEPGVP 108
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL++LH R++HR++K N+L+ K++DF L A
Sbjct: 109 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------A 157
Query: 229 RLHS-----TRVLGTFGYHAPE 245
R++S T V+ T Y APE
Sbjct: 158 RIYSFQMALTSVVVTLWYRAPE 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-06
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 12/153 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G + SG A +K+L S ++ FL + L++ N+++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E G L L + + P P QR +A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT--LQR--MACEIALGLLHLHK 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
IH ++ N LL D KI D+ LS+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSH 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G+ G VY + R +GR A+K + + + ++ ++ ++ + + NVV+ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 131 -VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G ++VL E GSL +G + +A G+ YLH +
Sbjct: 142 DHNGEIQVL-LEFMDGGSL----------EGTH---IADEQFLADVARQILSGIAYLHRR 187
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR+IK SN+L+ KI+DF +S Q D +GT Y +PE
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 26/64 (40%), Positives = 40/64 (62%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE+LH++ RII+R++K NVLL +D +ISD L+ + D ++ + GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGF 163
Query: 242 HAPE 245
APE
Sbjct: 164 MAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 37/197 (18%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMV 115
E + + S +G G+YG V ++G A+KKL +P Q + ++ ++
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLL 70
Query: 116 SRLKNENVVELVGYYVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
+K+ENV+ L+ + P R V H L++I+ +K L+
Sbjct: 71 KHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LT 118
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 175
Query: 229 RLHSTRVLGTFGYHAPE 245
+TR Y APE
Sbjct: 176 GYVATR-----WYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + + ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 127 VGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + L E GSL + L K K Q++K AV +G++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--------QQLKYAVQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL + + +HR++ + NVL+ + KI DF L+
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 27/64 (42%), Positives = 37/64 (57%), Gaps = 6/64 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE LH + RI++R++K N+LL D +ISD L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 242 HAPE 245
APE
Sbjct: 168 MAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 53/189 (28%), Positives = 79/189 (41%), Gaps = 26/189 (13%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSR 117
K +F +G GS+GRV + +G AIK L KQ Q + S++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME 74
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQRVKIA 176
L + +V ++ + D E G L H +K G P V + + +A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA 130
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
EYLH K II+R++K N+LL + K++DF + + PD L
Sbjct: 131 ------FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----C 176
Query: 237 GTFGYHAPE 245
GT Y APE
Sbjct: 177 GTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 45/189 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAV 177
+LHDI+H ++ + G ++S VKI +
Sbjct: 67 ----------------TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHNVKIFM 109
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H++ +I+HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 110 FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV 165
Query: 237 GTFGYHAPE 245
T Y P+
Sbjct: 166 -TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 29/155 (18%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLK-NENVVELV 127
IGEG++ V ++G+ AIK + S +Q + L ++ + RL + N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 128 GYYVDGPLRVLAYE-HASKGSLHDILHGKKGVKGAKPGP---VLSWA-QRVKIAVGAARG 182
D LA +L++++ G+K +P P V S+ Q +K
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLK-------S 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217
L+++H I HR+IK N+L+ DDI K++DF
Sbjct: 113 LDHMHRNG---IFHRDIKPENILI-KDDILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 22/185 (11%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNEN 122
F ++G+G +G V +R +G+ A K+L+ + + + L + ++ ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 123 VVELVGYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
VV L Y D VL + H G G + + L +A +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER---ALFYAAEILC----- 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GLE LH + ++R++K N+LL D +ISD L+ + P+ RV GT G
Sbjct: 114 -GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVG 166
Query: 241 YHAPE 245
Y APE
Sbjct: 167 YMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 35/185 (18%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
+G G+YG V + R+G AIKKL Q + + ++ ++ +K+ENV+ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 130 YV-DGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV-GAA 180
+ D L V+ + G L + H K R++ V
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKL--MKHEKLS------------EDRIQFLVYQML 128
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H IIHR++K N+ + +D KI DF L+ Q TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 241 YHAPE 245
Y APE
Sbjct: 181 YRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 15/137 (10%)
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L + ++ + + +V+ + V G + + H L+ L + L
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRP--------LP 155
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
Q + I GL YLH + RIIHR++K+ N+ + D D I D + Q P A
Sbjct: 156 IDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAP 211
Query: 229 RLHSTRVLGTFGYHAPE 245
+ GT +APE
Sbjct: 212 AFLG--LAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 53/193 (27%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G + +G+ A+K++ + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----------------V 173
+LHDI+H KK + V + V
Sbjct: 67 ----------------TLHDIIHTKKTLT-----LVFEYLDTDLKQYMDDCGGGLSMHNV 105
Query: 174 KIAV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
++ + RGL Y H++ R++HR++K N+L+ + K++DF L+ +A ++ +S
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYS 161
Query: 233 TRVLGTFGYHAPE 245
V+ T Y P+
Sbjct: 162 NEVV-TLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 5/66 (7%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L++LH II+R++K N+LL ++ K++DF LS ++ D + +S GT
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 240 GYHAPE 245
Y APE
Sbjct: 163 EYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 28/184 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------PDQEFLAQV--SMVSRLKNENVV 124
+G+GS+G VY +++ +A A ++L K+ P++ A ++S+L + +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ +++ + E+ L L K G LS Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLGTFGY 241
Y+H++ RI+HR++K+ N+ L +++ KI DF +S + D A T GT Y
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA-----TTFTGTPYY 171
Query: 242 HAPE 245
+PE
Sbjct: 172 MSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 23/109 (21%), Positives = 56/109 (51%), Gaps = 17/109 (15%)
Query: 111 QVSMVSRLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ + R+ + N++++ G+ +D P L E+ ++G L ++L +K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--------- 118
Query: 167 LSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKI 214
LS+ ++ +A+ +GL L++ +P ++N+ S + L+ ++ KI
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKI 164
|
Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 32/154 (20%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFL---AQVSMVSRLKNENVVE 125
+LIG+ + + + + A+KK++ ++ ++ +L++ N++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V ++ + + GS D+L H +G+ P L+ A +K L
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL------PELAIAFILK---DVLNAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217
+Y+H K IHR++K+S++LL D +S
Sbjct: 115 DYIHSKG---FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 27/65 (41%), Positives = 36/65 (55%), Gaps = 8/65 (12%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SNV + +D +I DF L+ QA D +TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 241 YHAPE 245
Y APE
Sbjct: 181 YRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 10/66 (15%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLGTF 239
RGL+Y+H ++HR++K SN+L+ ++ KI DF L+ Q P T + T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP------QMTGYVSTR 169
Query: 240 GYHAPE 245
Y APE
Sbjct: 170 YYRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 35/198 (17%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR--AAAIKKLDSSK-----QPDQEFLAQV 112
+ K K ++F +G GS+GRV ++ AIK+ + SK Q D F ++
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SER 82
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--A 170
+++ + + V L G + D L E G L K P V + A
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAA 138
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q V I EYL I++R++K N+LL D K++DF A++
Sbjct: 139 QIVLI-------FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKV 180
Query: 231 HSTR---VLGTFGYHAPE 245
TR + GT Y APE
Sbjct: 181 VDTRTYTLCGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 38/187 (20%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-----QVSMVSRLKNENVVEL 126
+G G+YG V + R+G AIKKL Q E A +++++ +++ENV+ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 127 VGYYVDGPL--------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + V+ Y L I+ G LS + +
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLSEDKVQYLVYQ 125
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+Y+H IIHR++K N+ + +D KI DF L+ A DA T + T
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA-DA----EMTGYVVT 177
Query: 239 FGYHAPE 245
Y APE
Sbjct: 178 RWYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD-SSKQPDQEF---LAQVSMVSRLKNENVVELV 127
L+G+G GRV+ L+ +G+ A+K LD + L + +++ L + + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAAR 181
+ L ++ G L +L +PG LS +A V +A
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA----- 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
LEYLH I++R++K N+LL + +SDFDLS Q+
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-05
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 27/191 (14%)
Query: 67 NFGTNSLIGEGSYGRVYF----GVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN 122
NF ++G G+YG+V+ G +G+ A+K L + + A+ + R
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER----Q 56
Query: 123 VVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ-----RVKIA 176
V+E V P V L Y + LH IL V G + L + V++
Sbjct: 57 VLEAVR---RCPFLVTLHYAFQTDTKLHLIL---DYVNGGELFTHLYQREHFTESEVRVY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
+ L++LH+ II+R+IK N+LL + ++DF LS + + R +S
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165
Query: 235 VLGTFGYHAPE 245
GT Y APE
Sbjct: 166 FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K+ LD + L ++ ++ LK++N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 130 YVDGPLRVLAYEHASKG--SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
L +E+ + D +G P V S+ ++ +GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD-----IDPEIVKSFMFQL------LKGLAFCH 116
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
++HR++K N+L+ + K++DF L+ +A R +S V+ T Y P+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPD 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 7/68 (10%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLG 237
RGL+Y+H +IHR++K SN+L+ +D +I DF ++ +P T +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 238 TFGYHAPE 245
T Y APE
Sbjct: 174 TRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 27/64 (42%), Positives = 36/64 (56%), Gaps = 6/64 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE L + RI++R++K N+LL D +ISD L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRV-GTVGY 167
Query: 242 HAPE 245
APE
Sbjct: 168 MAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-05
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 38/187 (20%)
Query: 74 IGEGSYGRV-YFGVLRSGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G+G +G V V +G+ A KKLD K+ E +A L + ++E V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA-------LLEKEILEKV--- 50
Query: 131 VDGPLRV-LAYEHASKGSL---HDILHGKK--------GVKGAKPGPVLSWAQRVKIAVG 178
+ P V LAY SK L +++G G +G + V+ ++ ++
Sbjct: 51 -NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI----- 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G+ +LH I++R++K NVLL D ++SD L+ + D T+ GT
Sbjct: 105 -TCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGT 157
Query: 239 FGYHAPE 245
GY APE
Sbjct: 158 NGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 45/189 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H K + K K G ++S VKI +
Sbjct: 68 ----------------TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFL 110
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 111 YQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV 166
Query: 237 GTFGYHAPE 245
T Y P+
Sbjct: 167 -TLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 45/184 (24%), Positives = 86/184 (46%), Gaps = 34/184 (18%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEF-----LAQVSMVSRLK-NENVVEL 126
+G+G++G VY + G AIKK+ K+ + L +V + +L + N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + +E+ +G+L+ ++ +KG + + S ++ +GL ++
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQI------LQGLAHI 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS----TRVLGTFGY 241
H+ HR++K N+L+ ++ KI+DF L AR + S T + T Y
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYVSTRWY 164
Query: 242 HAPE 245
APE
Sbjct: 165 RAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-- 124
NF ++G G+YG+V+ SG DS K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 125 --ELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----VKIA 176
+++ + P V L Y + LH IL + G + LS +R V+I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
G LE+LH+ II+R+IK N+LL + ++DF LS + D R +S
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165
Query: 235 VLGTFGYHAPE 245
GT Y AP+
Sbjct: 166 FCGTIEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 38/188 (20%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S A+ A
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPE 245
T GY APE
Sbjct: 158 THGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 16/182 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G GS G V+ V + A+KK+ + Q + L ++ ++ RL ++N+V++ Y V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--YEV 70
Query: 132 DGPL-RVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEY 185
GP L + S L+ + ++ + + GP+ R+ RGL+Y
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA-KISDFDLSN-QAPDAAARLHSTRVLGTFGYHA 243
+H ++HR++K +NV + +D+ KI DF L+ P + + + + L T Y +
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 244 PE 245
P
Sbjct: 187 PR 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 43/188 (22%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y VY G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H +K + K K G ++
Sbjct: 68 ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166
Query: 238 TFGYHAPE 245
T Y P+
Sbjct: 167 TLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 49/196 (25%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V +G AIKK+ + Q L ++ ++ R K+EN++ ++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 129 YYVDGPLRVLAYEHASKGSLHDI----------LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+R ++E S +D+ L+ K +K LS
Sbjct: 71 I-----IRPPSFE-----SFNDVYIVQELMETDLY--KLIKTQH----LSNDHIQYFLYQ 114
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------ 232
RGL+Y+H ++HR++K SN+LL + KI DF L AR+
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHT 163
Query: 233 ---TRVLGTFGYHAPE 245
T + T Y APE
Sbjct: 164 GFLTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 38/188 (20%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S + A
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-----------VFSEKEMRFYATEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPE 245
T GY APE
Sbjct: 158 THGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 37/142 (26%), Positives = 67/142 (47%), Gaps = 20/142 (14%)
Query: 74 IGEGSYGRVYFGVLRS----GRA----AAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ G+ R G +K LD S + + F SM+S+L ++++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G ++ E+ GSL L K + SW ++++A A L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SW--KLEVAKQLAWALH 114
Query: 185 YLHEKAEPRIIHRNIKSSNVLL 206
+L +K + H N+ + NVLL
Sbjct: 115 FLEDKG---LTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E +++HR++KS+N+ L I K+ DF S Q D+ + ++ GT Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 17/41 (41%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 220
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 44/186 (23%), Positives = 73/186 (39%), Gaps = 24/186 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRA-AAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+ +G G++GRV+ R A+K + KQ +Q + ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++ L D + E+ G L L L +A + A
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCA--- 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
LEYLH K I++R++K N+LL + K++DF + + D L GT
Sbjct: 114 ---LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162
Query: 240 GYHAPE 245
Y APE
Sbjct: 163 EYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G G++G VY +GR A+K++ S++ +E A ++ ++ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
++ +V+ G D + L+ E+ GS+ D L GA V R +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL-- 116
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+G+ YLH I+HR+IK +N+L K+ DF S +
Sbjct: 117 ---QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 17/41 (41%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 23/65 (35%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H ++HR++K SN+LL + KI DF L+ + + T + T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRW 173
Query: 241 YHAPE 245
Y APE
Sbjct: 174 YRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 36/186 (19%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
IG+GS+G+V ++ G+ A+K L K+ + +A+ +++ LKN LVG
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL--LKNVKHPFLVG 60
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVGA 179
L Y + L+ +L G G + QR + A
Sbjct: 61 ---------LHYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAEI 105
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L YLH II+R++K N+LL ++DF L + ++ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 240 GYHAPE 245
Y APE
Sbjct: 161 EYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 9e-04
Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAA-AIKKLDSS-----KQPDQEFLAQVSMVSRLK 119
++F T LI G+YG VY + R A+KK++ Q Q F + +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKI 175
N VV + + + E+ G +L K PV + +A+ V
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETV-- 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
LEYLH I+HR++K N+L+ K++DF LS
Sbjct: 112 -----LALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 19/41 (46%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215
I GA RGL YLH+ IHRNIK+S++L+ D + +S
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 24/70 (34%), Positives = 36/70 (51%), Gaps = 5/70 (7%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A GL++LHE+ II+R++K NVLL + KI+DF + + ++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 236 LGTFGYHAPE 245
GT Y APE
Sbjct: 157 CGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 50/193 (25%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG VY R + A+KK+ +Q D+ + ++S++ +++ N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQR-VKI 175
D++H +K + K P + R +K
Sbjct: 67 --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 176 AV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHS 232
+ RG+ Y H R++HR++K N LL D + K++DF L+ +A R +
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQN-LLIDRRTNALKLADFGLA-RAFGIPVRTFT 161
Query: 233 TRVLGTFGYHAPE 245
V+ T Y APE
Sbjct: 162 HEVV-TLWYRAPE 173
|
Length = 294 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 22/159 (13%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
K+ D FG N E + V G +K+ D+++ V M+ +
Sbjct: 148 KKDLDIFGINP-ADESTRSYVILSFENKGDYMDMKQADTTQY--------VPMLEIKEAS 198
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
++ D P +Y+ ++ + ++L G +G +LS+ +V AR
Sbjct: 199 KYSDIQRSNYDRPA---SYKGSNDSEVKNLL-SDDGSEGLTTLDLLSFTYQV------AR 248
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
G+E+L K +HR++ + NVLL I KI DF L+
Sbjct: 249 GMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLA 284
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 16/41 (39%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A+G+E+L A + IHR++ + N+LL ++++ KI DF L+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 226
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 242 HAPE 245
APE
Sbjct: 163 IAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 35/198 (17%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-----FLAQVS---MVS 116
D + IGEG+YG+VY +G+ A+KK D+E L ++S M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLS 58
Query: 117 R-------LKNENVVELVGYYVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLS 168
L E+V E G P L +E+ S +G+ + + S
Sbjct: 59 ESIYIVRLLDVEHVEEKNG----KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAA 227
+ ++ G+ + H+ ++HR++K N+L+ + KI+D L +A
Sbjct: 115 FMYQLLK------GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIP 164
Query: 228 ARLHSTRVLGTFGYHAPE 245
+ ++ ++ T Y APE
Sbjct: 165 VKSYTHEIV-TLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 41/164 (25%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ----------------VSMVS 116
I G++G+VY G + + + A+K + + ++ + Q V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
L++ N V LV Y+ G G + +LH + G + VK
Sbjct: 72 SLQSANNVYLVMEYLIG------------GDVKSLLH----IYGYFDEEM-----AVKYI 110
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L+YLH IIHR++K N+L+ ++ K++DF LS
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
GL+YLHE +I++R++K N+LL + KI+DF L
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.002
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 6/68 (8%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
+ L+Y+H +IHR++K SN+LL D K++DF L+ ++ + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 238 TFGYHAPE 245
T Y APE
Sbjct: 175 TRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 39/197 (19%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----- 121
NF ++G G+YG+V+ +G D+ K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGH-------DTGKLYAMKVLQKAALVQKAKTVEHTRT 53
Query: 122 --NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQR----- 172
NV+E V P V L Y ++ LH IL G G + + QR
Sbjct: 54 ERNVLEHVR---QSPFLVTLHYAFQTEAKLHLILDYVSG------GEMFTHLYQRDNFSE 104
Query: 173 --VKIAVGAA-RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAA 228
V+ G LE+LH+ I++R+IK N+LL + ++DF LS + +
Sbjct: 105 DEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 229 RLHSTRVLGTFGYHAPE 245
R +S GT Y APE
Sbjct: 162 RTYS--FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 30/144 (20%), Positives = 55/144 (38%), Gaps = 20/144 (13%)
Query: 77 GSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
GS G V+ + +K + K P +E + ++ + + ++ L+ Y
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGRE----IDILKTISHRAIINLIHAYRWK 158
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ D+ V + P L Q + I L YLH +
Sbjct: 159 STVCMVMPKYK----CDLF---TYVDRSGP---LPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 194 IIHRNIKSSNVLLFDDDIAKISDF 217
IIHR++K+ N+ L + + A + DF
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 19/56 (33%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
P LS+ V + A G+E+L K +HR++ + NVL+ + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLA 286
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H +IHR+IKS+N+LL + + K+ DF S + GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 23/58 (39%), Positives = 31/58 (53%), Gaps = 10/58 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARL 230
A+G+++L K IHR++ + NVLL D +AKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 6/64 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 183
Query: 242 HAPE 245
APE
Sbjct: 184 RAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 25/68 (36%), Positives = 33/68 (48%), Gaps = 9/68 (13%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPDAAARLHSTRVLG 237
A GL +LH K II+R++K NV+L + KI+DF + N R G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCG 163
Query: 238 TFGYHAPE 245
T Y APE
Sbjct: 164 TPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.004
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+F +G GS+GRV + SG+ A+K L KQ + L + ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIR 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILH--GKKGVKGAKPGPVLSWAQRVKIAV 177
+ +V L G + D L E+ G L L G+ A+ +A +V +A
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLA- 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217
LEYLH I++R++K N+LL D KI+DF
Sbjct: 114 -----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 23/63 (36%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APE 245
APE
Sbjct: 163 APE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.86 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.86 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.82 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.67 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.6 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.57 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.54 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.47 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.45 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.38 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.91 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.72 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.51 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.47 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.4 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.27 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.2 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.68 | |
| PLN02236 | 344 | choline kinase | 97.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.55 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.53 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.38 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.27 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.18 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.05 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 96.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.7 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.6 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.56 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.55 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.46 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.45 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.32 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.74 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.19 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.15 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.13 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=290.25 Aligned_cols=167 Identities=29% Similarity=0.441 Sum_probs=148.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
..++|.+.+.||.|+||+||+|+++ ++..||||.+.+... ..+.+..|+.+|+.|+|||||.++++..+++++|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3578999999999999999999976 678999999966532 345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC------CceE
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD------DIAK 213 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~------~~vk 213 (245)
||||.||+|.++++..+. +++..+..++.||+.||++||+++ ||||||||+||||... -.+|
T Consensus 88 MEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999998753 899999999999999999999998 9999999999999764 4689
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+|+.+...... .+.+|++.|||||
T Consensus 156 IADFGfAR~L~~~~~a---~tlcGSplYMAPE 184 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMA---ETLCGSPLYMAPE 184 (429)
T ss_pred ecccchhhhCCchhHH---HHhhCCccccCHH
Confidence 9999999988754432 5689999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=286.35 Aligned_cols=184 Identities=51% Similarity=0.863 Sum_probs=163.9
Q ss_pred ccceeeHHHHHHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEE
Q 025997 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYY 130 (245)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~ 130 (245)
....+++.++...+++|.....||+|+||.||+|...++..||||++...... ..+|.+|+.++.+++|+|+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999998899999998776554 66799999999999999999999999
Q ss_pred EeCCc-eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 131 VDGPL-RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 131 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
.+.+. .+||+||+++|+|.+.|...... .++|..+++|+.++|+||.|||....++||||||||+|||+|++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 99884 99999999999999999876431 38999999999999999999999887789999999999999999
Q ss_pred CceEEecccCCCCCCc-cccccccccc-cccccccCCC
Q 025997 210 DIAKISDFDLSNQAPD-AAARLHSTRV-LGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~-~~~~~~~~~~-~gt~~y~APE 245 (245)
+++||+|||+|+.... .... ... .||.+|+|||
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PE 248 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPE 248 (361)
T ss_pred CCEEccCccCcccCCccccce---eeecCCCCccCChh
Confidence 9999999999976654 2221 112 7999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=277.68 Aligned_cols=167 Identities=26% Similarity=0.426 Sum_probs=145.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCc--------hHHHHHHHHHHHccCCCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 134 (245)
..+.|.+.+.||+|+||.|.+|. .++++.||||++.+.... ...+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567888999999999999999 558999999999654321 234679999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---Cc
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DI 211 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~~ 211 (245)
..|+||||+.||+|.+++-.++. +.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceE
Confidence 99999999999999999987764 777788899999999999999998 9999999999999765 78
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+|+......- ..++||||.|.|||
T Consensus 318 lKItDFGlAK~~g~~sf---m~TlCGTpsYvAPE 348 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSF---MKTLCGTPSYVAPE 348 (475)
T ss_pred EEecccchhhcccccee---hhhhcCCccccChh
Confidence 99999999998864322 35689999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=285.25 Aligned_cols=166 Identities=27% Similarity=0.457 Sum_probs=152.1
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCC----CCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..|...+.||+|+|+.||+++. .+|..||+|++.+ .....+.+.+||++.+.|+|||||+++++|++.+++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999997 7899999999976 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|+|.+++|..+++.++ .+++.++..+.+||+.||.|||+++ |+|||||..|++++++.+|||+|||||
T Consensus 98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence 9999999999998654 3999999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..+....++. .+++|||.|+|||
T Consensus 166 t~le~~~Erk--~TlCGTPNYIAPE 188 (592)
T KOG0575|consen 166 TQLEYDGERK--KTLCGTPNYIAPE 188 (592)
T ss_pred eeecCccccc--ceecCCCcccChh
Confidence 9887654443 5689999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=270.99 Aligned_cols=168 Identities=27% Similarity=0.373 Sum_probs=149.0
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|+++++||+|+||+||.++.+ +++.+|+|++++... ......+|..+|.+++||+||+++..|++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999955 788999999976542 34567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|+||+.||.|...|.+... +++..+..++.+|+.||.|||+++ ||||||||+|||++.+|+++|+|||
T Consensus 103 Vld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred EEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 9999999999999987653 888889999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++....... .+.+++||+.|||||
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPE 195 (357)
T ss_pred cchhcccCCC--ccccccCCccccChH
Confidence 9986543322 235689999999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=270.11 Aligned_cols=164 Identities=29% Similarity=0.422 Sum_probs=145.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCc-eEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL-RVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 141 (245)
++.+....||+|+.|+||+++++ +++.+|+|.+.... ...+++.+|+++++..+||+||.+|+.|..... +.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45677889999999999999987 78899999994433 345789999999999999999999999998884 999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||.+|||.+++...+. +++...-.|+.+|++||.|||+ ++ ||||||||+|||++..|+|||||||.|
T Consensus 159 YMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred hcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence 9999999999987542 8899999999999999999996 54 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+.... ..+++||..|||||
T Consensus 227 ~~lvnS~----a~tfvGT~~YMsPE 247 (364)
T KOG0581|consen 227 GILVNSI----ANTFVGTSAYMSPE 247 (364)
T ss_pred HHhhhhh----cccccccccccChh
Confidence 8876542 25689999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=266.64 Aligned_cols=173 Identities=25% Similarity=0.407 Sum_probs=147.7
Q ss_pred hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeE-EEEeCCc-eEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVG-YYVDGPL-RVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~l 138 (245)
..+|++++.||+|+||+||++. ..++..+|.|.+.-... ..++...|+.+|++|+|||||++++ .+..++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4568899999999999999999 45899999999974433 3567889999999999999999998 4555555 899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEEcCCCceEEec
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR--IIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|||+|.+|+|.++++..+.. ...+++..+++++.|++.||..+|++ .++ |+||||||.||+|+.+|.|||+|
T Consensus 98 vmE~c~~GDLsqmIk~~K~q-----kr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQ-----KRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHhhcccCHHHHHHHHHhc-----cccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence 99999999999999865433 34589999999999999999999993 234 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++.+....... .+.+|||.||+||
T Consensus 172 fGL~r~l~s~~tfA--~S~VGTPyYMSPE 198 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFA--HSLVGTPYYMSPE 198 (375)
T ss_pred chhHhHhcchhHHH--HhhcCCCcccCHH
Confidence 99999887654432 4579999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=265.20 Aligned_cols=168 Identities=35% Similarity=0.544 Sum_probs=142.5
Q ss_pred CCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC-ceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 142 (245)
+....+.||+|+||+||+|.++....||||++...... .+.|.+|+.+|++++|||||+++|++.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455669999999999999996556999999765433 458999999999999999999999999887 79999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfGla~ 221 (245)
+++|+|.+++..... ..+++..++.++.||+.||.|||+++. ||||||||+|||++.++ ++||+|||+++
T Consensus 122 ~~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccce
Confidence 999999999987411 139999999999999999999999852 99999999999999997 99999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ...+...||+.|||||
T Consensus 193 ~~~~~~--~~~~~~~GT~~wMAPE 214 (362)
T KOG0192|consen 193 EKVISK--TSMTSVAGTYRWMAPE 214 (362)
T ss_pred eecccc--ccccCCCCCccccChh
Confidence 654322 1123367999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=251.13 Aligned_cols=165 Identities=28% Similarity=0.361 Sum_probs=149.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|+....||.|+||+|.+++.+ ++.-+|+|++++...- .+...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4578999999999999999999966 6788999999765432 3557789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||.+||.|..++++.+. +++..+..++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||
T Consensus 122 vmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999988654 888999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+...... .++||||.|+|||
T Consensus 190 FAK~v~~rT-----~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 190 FAKRVSGRT-----WTLCGTPEYLAPE 211 (355)
T ss_pred ceEEecCcE-----EEecCCccccChH
Confidence 999876542 5679999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=253.20 Aligned_cols=166 Identities=25% Similarity=0.384 Sum_probs=143.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
+.|+.+.++|+|+||.||+|+++ +|+.||||++..+..+ .+-.++|+.+|++|+|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999966 7999999998655443 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
||.. ++.+-+....+. ++...+..+++|++.|+.|+|+++ +|||||||+||||..+|.+||||||+|+
T Consensus 82 ~~dh-TvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ecch-HHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 9987 666666655443 888999999999999999999998 9999999999999999999999999999
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+...... .+..+.|.+|.|||
T Consensus 150 ~L~~pgd~--YTDYVATRWYRaPE 171 (396)
T KOG0593|consen 150 TLSAPGDN--YTDYVATRWYRAPE 171 (396)
T ss_pred hhcCCcch--hhhhhhhhhccChh
Confidence 88743332 24567899999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=261.28 Aligned_cols=168 Identities=27% Similarity=0.427 Sum_probs=144.0
Q ss_pred hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 138 (245)
.+.|+..+.||+|.||.||+|+ ..+++.||+|++...... ..-..+||.+|++|+||||++|.+..... ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568888999999999999999 558999999999665432 34567899999999999999999988765 68999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|+|||+. ||.-++....- .|+..++..++.||+.||.|||+++ |+|||||.+|||||.+|.+||+|||
T Consensus 196 VFeYMdh-DL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEecccc-hhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccc
Confidence 9999987 99988876432 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+.+........ +..+-|++|.|||
T Consensus 264 LAr~y~~~~~~~~-T~rVvTLWYRpPE 289 (560)
T KOG0600|consen 264 LARFYTPSGSAPY-TSRVVTLWYRPPE 289 (560)
T ss_pred ceeeccCCCCccc-ccceEEeeccChH
Confidence 9997765543333 3456799999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=239.35 Aligned_cols=166 Identities=29% Similarity=0.446 Sum_probs=146.5
Q ss_pred CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|...+.||+|.||.||+|+ ..+++.||||+++..... ....++|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 458999999999765433 4567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|++. +|..+++.... .++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++
T Consensus 82 fm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred eccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence 9986 99999987643 4889999999999999999999997 9999999999999999999999999999
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+........ ..+-|.+|.|||
T Consensus 150 ~f~~p~~~~~--~~V~TRWYRAPE 171 (318)
T KOG0659|consen 150 FFGSPNRIQT--HQVVTRWYRAPE 171 (318)
T ss_pred ccCCCCcccc--cceeeeeccChH
Confidence 8876554432 226799999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=258.09 Aligned_cols=172 Identities=28% Similarity=0.386 Sum_probs=149.4
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
.....+|..++.||+|+|++|++|+. .+++.||||++.+... ....+..|-..|.+| .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999994 4899999999976432 234566788889999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
+|+|+||+++|+|.++|+..+. |++..+..++.+|+.||+|||++| ||||||||+|||+++++++||+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 9999999999999999998753 888899999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccc---------ccc--ccccccccccCCC
Q 025997 216 DFDLSNQAPDAAAR---------LHS--TRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~---------~~~--~~~~gt~~y~APE 245 (245)
|||.|+.+...... ... .+++||..|.+||
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE 257 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE 257 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence 99999877543222 122 4589999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=256.96 Aligned_cols=167 Identities=28% Similarity=0.454 Sum_probs=146.3
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CC--chHHHHHHHHHHHccC-CCCcceEeEEEEeCCc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPL 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 135 (245)
..+.|.+.+.||+|+||+|++|.+. ++..||+|++... .. ..+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999854 7899999987653 11 2445668999999998 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKI 214 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl 214 (245)
+++||||+.||+|.+++..... +.+.++..++.|++.|+.|||+++ |+||||||+|||++.+ +++||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEE
Confidence 9999999999999999988432 888999999999999999999998 9999999999999999 99999
Q ss_pred ecccCCCCCC-ccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAP-DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~-~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++.... ... ...+.+||+.|+|||
T Consensus 163 ~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 163 SDFGLSAISPGEDG---LLKTFCGSPAYAAPE 191 (370)
T ss_pred eccccccccCCCCC---cccCCCCCcccCCHH
Confidence 9999998773 222 235679999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=263.50 Aligned_cols=165 Identities=32% Similarity=0.454 Sum_probs=148.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch---HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+..... ..+.+|+++++.|+||||+.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 78899999998766554 457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.| +|..++..... ++++.+..++.++..||.|||+++ |+|||+||+|||++..+.+|+||||+|+
T Consensus 82 ~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 9987 99999987653 999999999999999999999997 9999999999999999999999999999
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ..+++.|||.|||||
T Consensus 149 ~m~~~t~--vltsikGtPlYmAPE 170 (808)
T KOG0597|consen 149 AMSTNTS--VLTSIKGTPLYMAPE 170 (808)
T ss_pred hcccCce--eeeeccCcccccCHH
Confidence 8765432 235678999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=255.21 Aligned_cols=166 Identities=27% Similarity=0.433 Sum_probs=149.5
Q ss_pred hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCch----HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
..+|++.+.||+|.||+|-+|. +..|+.||||.+.++...+ -.+++|+++|+.|+||||+.+|++|.+.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3468999999999999999999 5789999999997765432 3578999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||..+|.|+|++.+.+. |++.++..+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||+
T Consensus 132 MEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred EEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence 999999999999988764 999999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..+..... .++++|+|-|.+||
T Consensus 200 SNly~~~kf---LqTFCGSPLYASPE 222 (668)
T KOG0611|consen 200 SNLYADKKF---LQTFCGSPLYASPE 222 (668)
T ss_pred hhhhccccH---HHHhcCCcccCCcc
Confidence 977654432 26789999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=260.72 Aligned_cols=167 Identities=25% Similarity=0.433 Sum_probs=148.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCchHH--HHHHHHHHHccC-CCCcceEeEEEEeCC-ceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLK-NENVVELVGYYVDGP-LRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~l 138 (245)
..++|.+.+.||.|.||.||+|+ ..++..||||++++.....++ -++|+..|++|+ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45779999999999999999999 558899999999776655554 467999999998 999999999999888 8999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|||||.- +|+++++.+.. .+++..+..|+.||++||.|+|.+| +.||||||+|||+.....+||+|||
T Consensus 88 VfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred eHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccc
Confidence 9999964 99999998743 4999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+........ +..+-|.+|.|||
T Consensus 156 LARev~SkpPY---TeYVSTRWYRAPE 179 (538)
T KOG0661|consen 156 LAREVRSKPPY---TEYVSTRWYRAPE 179 (538)
T ss_pred cccccccCCCc---chhhhcccccchH
Confidence 99988765544 5568899999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=254.16 Aligned_cols=147 Identities=26% Similarity=0.341 Sum_probs=134.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|+++.+||+|+||.||+|+.+ +|..+|+|+++++... ...++.|-.+|....+++||+++..|.+.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999955 8999999999876543 3567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||++||++..+|.... .|++..+..++.+.+.|+..||..| +|||||||+|+|||..|++||+|||
T Consensus 219 iMEylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence 999999999999998765 3899999999999999999999998 9999999999999999999999999
Q ss_pred CCCC
Q 025997 219 LSNQ 222 (245)
Q Consensus 219 la~~ 222 (245)
|++-
T Consensus 287 Ls~g 290 (550)
T KOG0605|consen 287 LSTG 290 (550)
T ss_pred ccch
Confidence 9853
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=243.61 Aligned_cols=170 Identities=30% Similarity=0.486 Sum_probs=143.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCC--ceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 140 (245)
..+|...+.||+|+||.||++... ++...|||.+...... .+.+.+|+.+|++|+|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 346788899999999999999965 5899999988654222 466889999999999999999999855444 689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGl 219 (245)
||+++|+|.+++.+..+ . |++..+..++.||++||.|||+++ ||||||||+|||++. ++.+||+|||+
T Consensus 96 Ey~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999998764 2 899999999999999999999998 999999999999999 79999999999
Q ss_pred CCCCCccccc-cccccccccccccCCC
Q 025997 220 SNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
++........ .......||+.|||||
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPE 191 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPE 191 (313)
T ss_pred ccccccccccccccccccCCccccCch
Confidence 9876531111 1123467999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=256.94 Aligned_cols=165 Identities=30% Similarity=0.503 Sum_probs=149.2
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCch-HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..|.....||+|+.|.||.|.. .+++.||||.+....... +-+.+|+.+|+..+|+|||++++.|...+.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577788999999999999994 578899999998776664 45779999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+||+|.|++.... +++.++..|++++++||.|||.++ |+|||||.+|||++.+|.+||+|||++.++
T Consensus 353 ~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred CCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999998754 899999999999999999999998 999999999999999999999999999988
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ...+.+|||+|||||
T Consensus 420 ~~~~~--KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 420 SEEQS--KRSTMVGTPYWMAPE 439 (550)
T ss_pred ccccC--ccccccCCCCccchh
Confidence 76553 236689999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=235.14 Aligned_cols=168 Identities=30% Similarity=0.449 Sum_probs=148.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|++.+.||+|.||.||+|+.+ ++-.||+|++.++. ....++.+|+++.+.|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4688999999999999999999954 77899999997654 235678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
++||...|+|+..|...+... +++.....++.|++.||.|+|..+ ++||||||+|+|++..+.+||+|||
T Consensus 100 ilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred EEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCC
Confidence 999999999999998655432 777888899999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+...+.. ...+++||.-|.+||
T Consensus 170 wsV~~p~~----kR~tlcgt~dyl~pE 192 (281)
T KOG0580|consen 170 WSVHAPSN----KRKTLCGTLDYLPPE 192 (281)
T ss_pred ceeecCCC----CceeeecccccCCHh
Confidence 98766522 125689999999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=249.06 Aligned_cols=172 Identities=35% Similarity=0.487 Sum_probs=140.1
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---------------chHHHHHHHHHHHccCCCCcce
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------------PDQEFLAQVSMVSRLKNENVVE 125 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~ 125 (245)
....+.|++...||+|.||.|.+|+.. +++.||||++.+... ..+...+||.+|++|.|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 334678999999999999999999954 788999999864321 1257889999999999999999
Q ss_pred EeEEEEeC--CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 025997 126 LVGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (245)
Q Consensus 126 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~N 203 (245)
|+++..+. +.+|||+|||..|.+...-... ..+++.++++++.++..||+|||.++ ||||||||+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN 240 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 99998653 5799999999988875432211 12889999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEecccCCCCCCcc---ccccccccccccccccCCC
Q 025997 204 VLLFDDDIAKISDFDLSNQAPDA---AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 204 ill~~~~~vkl~DfGla~~~~~~---~~~~~~~~~~gt~~y~APE 245 (245)
+|++++|+|||+|||.+...... .........+|||.|||||
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE 285 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE 285 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence 99999999999999998755211 1111123468999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=252.29 Aligned_cols=167 Identities=28% Similarity=0.443 Sum_probs=145.2
Q ss_pred CCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
+.+.+.||+|.||.||+|.++....||+|.++......++|.+|+++|++|+|+|||++++++..+..++||||||+.|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 44567899999999999999988899999998888888999999999999999999999999999889999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
|.++|...... .+...+.+.++.||++|++||++++ +|||||..+|||++++..+||+|||+|+...+..
T Consensus 288 Ll~yLr~~~~~-------~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 288 LLDYLRTREGG-------LLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred HHHHhhhcCCC-------ccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999873322 3888999999999999999999997 9999999999999999999999999999554443
Q ss_pred cccccccccccccccCCC
Q 025997 228 ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~~~~~~gt~~y~APE 245 (245)
..... ..-=...|.|||
T Consensus 358 Y~~~~-~~kfPIkWtAPE 374 (468)
T KOG0197|consen 358 YTASE-GGKFPIKWTAPE 374 (468)
T ss_pred eeecC-CCCCCceecCHH
Confidence 32221 112246799998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=258.11 Aligned_cols=170 Identities=25% Similarity=0.384 Sum_probs=147.5
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
.....++|.+.++||+|+||+|+++..+ +++.+|||.+++.. .+.+....|..++... +||.+++++..|.+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4456789999999999999999999976 67899999998754 3456677888887776 5999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
++|+||||+.||++..+.+.. .+++..+..++..|+.||+|||+++ ||+||||.+|||+|.+|.+||
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~----------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTD----------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred eEEEEEEecCCCcEEEEEecc----------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEe
Confidence 999999999999965554433 2899999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++....... .+.+++|||.|||||
T Consensus 510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPE 538 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPE 538 (694)
T ss_pred cccccccccCCCCC--ccccccCChhhcChh
Confidence 99999987653332 347899999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=238.93 Aligned_cols=168 Identities=27% Similarity=0.395 Sum_probs=144.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (245)
..++|+.+..|++|.||.||+|+. +++..||+|+++.+... .-..++||.+|.+++|||||.+.++.... +.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 356788999999999999999995 47889999999765432 23568999999999999999999887643 5699
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+|||||+. +|..++..... .+...++..++.|++.|++|||++. |+||||||+|+|+...|.+||+||
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 99999987 99999987652 2888999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|+.+++.... .+..+-|++|.|||
T Consensus 222 GLAR~ygsp~k~--~T~lVVTLWYRaPE 247 (419)
T KOG0663|consen 222 GLAREYGSPLKP--YTPLVVTLWYRAPE 247 (419)
T ss_pred chhhhhcCCccc--CcceEEEeeecCHH
Confidence 999998766433 24567799999998
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=236.85 Aligned_cols=170 Identities=25% Similarity=0.373 Sum_probs=143.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCC-cceEeEEEEeCC-----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNEN-VVELVGYYVDGP----- 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 134 (245)
...|+..+.||+|.||+||+|+. .+|+.||+|++..... ......+|+.+++.|+|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999995 5889999999965544 3456789999999999999 999999998877
Q ss_pred -ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
.+++|+||+.. +|.+++....... ..++...+..++.||+.||.|||+++ |+||||||+|||++++|.+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEe
Confidence 78999999975 9999998765321 12666789999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+|+........ .+..++|.+|.|||
T Consensus 161 laDFGlAra~~ip~~~--yt~evvTlWYRaPE 190 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT--YTPEVVTLWYRAPE 190 (323)
T ss_pred eeccchHHHhcCCccc--ccccEEEeeccCHH
Confidence 9999999866533332 24567999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=239.48 Aligned_cols=172 Identities=26% Similarity=0.350 Sum_probs=149.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..++|++.+.||.|.-++||+|+. ..+..||||++...+. +...+++|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 356799999999999999999995 4779999999966543 3468899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
.||.+||+.++++..... -+.+..+..|.+++++||.|||.+| -||||||+.||||+++|.|||+|||.+
T Consensus 104 pfMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred hhhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 999999999999875432 2888899999999999999999998 999999999999999999999999998
Q ss_pred CCCCcccccc-cc-ccccccccccCCC
Q 025997 221 NQAPDAAARL-HS-TRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~-~~-~~~~gt~~y~APE 245 (245)
..+.....+. .. .+++||++|||||
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPE 200 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPE 200 (516)
T ss_pred eeecccCceeeEeeccccCcccccChH
Confidence 7654433221 11 4578999999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.52 Aligned_cols=173 Identities=29% Similarity=0.465 Sum_probs=146.0
Q ss_pred HHHHHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
.++....+.+.+...||+|.||+||+|+|. ..||||+++..... .+.|++|+..+++-+|.||+-+.|++...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455555666788899999999999999987 37999999766544 4679999999999999999999999988776
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.||+.+|+|.+|+.+++..... |...+.+.|+.||++|+.|||.++ |||||||..||++.++++|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred -eeeehhccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 9999999999999999876532 888999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++..-.-...........|...|||||
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPE 560 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPE 560 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHH
Confidence 999986433222221223345888999998
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=230.75 Aligned_cols=169 Identities=27% Similarity=0.441 Sum_probs=146.9
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-----c----hHHHHHHHHHHHcc-CCCCcceEeEEE
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-----P----DQEFLAQVSMVSRL-KNENVVELVGYY 130 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~----~~~~~~E~~~l~~l-~h~niv~~~~~~ 130 (245)
...-+.|.-.+.||.|..+.|.++.++ +++.+|+|++..... . .+.-+.|+.+|+++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334566788889999999999999865 789999999853221 1 24456799999998 799999999999
Q ss_pred EeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 131 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
.++.+.++|+|.|+.|.|.|+|.+.- .+++....+|+.|+.+|+.|||.++ ||||||||+|||++++.
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNM 160 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecccc
Confidence 99999999999999999999998754 3899999999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++||+|||+|.++...... ...+|||+|+|||
T Consensus 161 ~i~isDFGFa~~l~~GekL---relCGTPgYLAPE 192 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKL---RELCGTPGYLAPE 192 (411)
T ss_pred ceEEeccceeeccCCchhH---HHhcCCCcccChh
Confidence 9999999999998765543 4579999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=243.76 Aligned_cols=146 Identities=23% Similarity=0.330 Sum_probs=130.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|... +++.||+|++.+.. .....+.+|+.++.+++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999965 68899999986432 12346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence 99999999999976432 889999999999999999999998 999999999999999999999999998
Q ss_pred CCC
Q 025997 221 NQA 223 (245)
Q Consensus 221 ~~~ 223 (245)
+..
T Consensus 149 ~~~ 151 (363)
T cd05628 149 TGL 151 (363)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=244.48 Aligned_cols=168 Identities=21% Similarity=0.330 Sum_probs=143.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|++.+.||+|+||.||++... +++.+|+|.+.+.. .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567999999999999999999975 67899999885421 223457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 121 v~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999996542 788889999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ .......||+.|||||
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~Y~aPE 213 (370)
T cd05621 188 TCMKMDETGM-VRCDTAVGTPDYISPE 213 (370)
T ss_pred cceecccCCc-eecccCCCCcccCCHH
Confidence 9976543221 1123457999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=240.79 Aligned_cols=164 Identities=27% Similarity=0.386 Sum_probs=143.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467899999999999999999965 68899999985432 2335688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999976432 788888999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...... ....||+.|+|||
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE 185 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPE 185 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHH
Confidence 97654322 2357999999998
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=242.14 Aligned_cols=145 Identities=26% Similarity=0.335 Sum_probs=129.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999954 78899999885432 12346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999987543 2788889999999999999999998 999999999999999999999999998
Q ss_pred CC
Q 025997 221 NQ 222 (245)
Q Consensus 221 ~~ 222 (245)
+.
T Consensus 149 ~~ 150 (377)
T cd05629 149 TG 150 (377)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=242.49 Aligned_cols=146 Identities=26% Similarity=0.358 Sum_probs=130.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999965 68899999986432 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence 9999999999987643 2889999999999999999999998 999999999999999999999999998
Q ss_pred CCC
Q 025997 221 NQA 223 (245)
Q Consensus 221 ~~~ 223 (245)
+.+
T Consensus 149 ~~~ 151 (364)
T cd05599 149 TGL 151 (364)
T ss_pred eec
Confidence 654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=238.97 Aligned_cols=165 Identities=25% Similarity=0.408 Sum_probs=146.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 138 (245)
...|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+... +.+.+.+|+.+|+++. ||||+.++++|.+.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888999999999999999976 599999999976543 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC----CceEE
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIAKI 214 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~----~~vkl 214 (245)
|||++.||.|.+.+... . +++.++..++.|++.++.|||+.+ |+||||||+|+|+... +.+|+
T Consensus 114 vmEL~~GGeLfd~i~~~-~---------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-H---------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred EEEecCCchHHHHHHHc-c---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEE
Confidence 99999999999999865 1 889999999999999999999998 9999999999999643 47999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++...... . .....+||+.|+|||
T Consensus 181 ~DFGla~~~~~~-~--~~~~~~Gtp~y~APE 208 (382)
T KOG0032|consen 181 IDFGLAKFIKPG-E--RLHTIVGTPEYVAPE 208 (382)
T ss_pred eeCCCceEccCC-c--eEeeecCCccccCch
Confidence 999999887652 1 225678999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=246.46 Aligned_cols=166 Identities=24% Similarity=0.315 Sum_probs=146.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+-|++++.||.|+-|.|.+|++. +|+.+|||++.+.. .....+.+|+.+|+-|.||||+++|++|.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356899999999999999999964 89999999996652 2235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
+||+++|.|++++-..+. +++.++.+++.||+.|+.|+|..+ |+||||||+|+||+..+++||+|||+
T Consensus 91 lEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred EEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999987654 889999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|..-....- ..+-||+|+|.|||
T Consensus 159 AsLe~~gkl---LeTSCGSPHYA~PE 181 (786)
T KOG0588|consen 159 ASLEVPGKL---LETSCGSPHYAAPE 181 (786)
T ss_pred eecccCCcc---ccccCCCcccCCch
Confidence 975543322 24569999999998
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=236.35 Aligned_cols=163 Identities=25% Similarity=0.351 Sum_probs=142.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999965 78899999985432 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 81 EYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence 99999999999976532 788899999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+...... ....||+.|+|||
T Consensus 149 ~~~~~~~-----~~~~gt~~y~aPE 168 (291)
T cd05612 149 KKLRDRT-----WTLCGTPEYLAPE 168 (291)
T ss_pred hhccCCc-----ccccCChhhcCHH
Confidence 7654321 2357999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=233.43 Aligned_cols=178 Identities=25% Similarity=0.364 Sum_probs=143.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC-----------------CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~ 125 (245)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999998532 336999988654322 357889999999999999999
Q ss_pred EeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 025997 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 195 (245)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iv 195 (245)
+++++.+.+..+++|||+.+++|.+++........ ......+++..++.++.||+.||.|||+++ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999865432110 011134788899999999999999999998 99
Q ss_pred ecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 196 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 196 HrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||||||+|||++.++.+||+|||+++...............++..|||||
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence 99999999999999999999999997654332222223345688999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=242.48 Aligned_cols=169 Identities=24% Similarity=0.436 Sum_probs=149.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCc-eEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL-RVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv 139 (245)
.++|..++++|+|+||.+++.+++ +.+.+++|++...... ++...+|+.++++++|||||.+.+.|..++. .+|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999976 6778999998655433 4567889999999999999999999998887 9999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|+||+||++.+.+...++. .+++..+..++.|++.|+.|||++. |+|||||++||++..++.|||+|||+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhh
Confidence 9999999999999887633 3899999999999999999999886 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+.+...... ..+.+||+.||+||
T Consensus 153 aK~l~~~~~~--a~tvvGTp~YmcPE 176 (426)
T KOG0589|consen 153 AKILNPEDSL--ASTVVGTPYYMCPE 176 (426)
T ss_pred hhhcCCchhh--hheecCCCcccCHH
Confidence 9998766532 25678999999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=241.76 Aligned_cols=144 Identities=22% Similarity=0.275 Sum_probs=128.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|...+.||+|+||+||+|+.. +++.||+|++.... .....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999964 78899999986532 123467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 999999999987643 2788888999999999999999998 9999999999999999999999999975
Q ss_pred C
Q 025997 222 Q 222 (245)
Q Consensus 222 ~ 222 (245)
.
T Consensus 150 ~ 150 (381)
T cd05626 150 G 150 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=235.65 Aligned_cols=160 Identities=24% Similarity=0.328 Sum_probs=136.8
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 78899999986432 12345778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 9999987543 2889999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCCC
Q 025997 227 AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~~~~~~gt~~y~APE 245 (245)
... ....+||+.|||||
T Consensus 149 ~~~--~~~~~gt~~y~aPE 165 (323)
T cd05571 149 GAT--MKTFCGTPEYLAPE 165 (323)
T ss_pred CCc--ccceecCccccChh
Confidence 111 23457999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.45 Aligned_cols=145 Identities=22% Similarity=0.276 Sum_probs=129.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.+|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999965 68899999986432 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++.... .++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 9999999999997643 2788888899999999999999998 999999999999999999999999997
Q ss_pred CC
Q 025997 221 NQ 222 (245)
Q Consensus 221 ~~ 222 (245)
..
T Consensus 149 ~~ 150 (376)
T cd05598 149 TG 150 (376)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=238.82 Aligned_cols=165 Identities=25% Similarity=0.380 Sum_probs=142.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-C-CcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
..++|.+.+.||+|+||.||+|.+. + +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3567999999999999999999854 3 358999988542 223456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+.+|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecC
Confidence 99999999999999976542 888899999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...... ....||+.|||||
T Consensus 176 G~a~~~~~~~-----~~~~gt~~y~aPE 198 (340)
T PTZ00426 176 GFAKVVDTRT-----YTLCGTPEYIAPE 198 (340)
T ss_pred CCCeecCCCc-----ceecCChhhcCHH
Confidence 9997654321 3457999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=230.63 Aligned_cols=166 Identities=26% Similarity=0.363 Sum_probs=140.6
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999995 4789999998864321 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+|+|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 99999999887643221 2788999999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....||+.|||||
T Consensus 151 ~~~~~~~~---~~~~g~~~y~aPE 171 (285)
T cd05631 151 QIPEGETV---RGRVGTVGYMAPE 171 (285)
T ss_pred EcCCCCee---cCCCCCCCccCHh
Confidence 65432211 3347999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=249.00 Aligned_cols=160 Identities=34% Similarity=0.510 Sum_probs=140.7
Q ss_pred CCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 68 FGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
|..++.||.|+||.||.|+ .++...||||++.-+.. ..++++.|+..|.+++|||+|.+.++|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 7778889999999999999 45788999999965432 357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
|-| |-.|++.-.+. .+.+-++..|+.+.+.||.|||+++ .||||||..|||+.+.|.|||+|||.|..
T Consensus 108 ClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred Hhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence 975 77777765543 2888889999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... .+++|||+|||||
T Consensus 176 ~~PA------nsFvGTPywMAPE 192 (948)
T KOG0577|consen 176 MAPA------NSFVGTPYWMAPE 192 (948)
T ss_pred cCch------hcccCCccccchh
Confidence 5432 5689999999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=236.55 Aligned_cols=163 Identities=27% Similarity=0.420 Sum_probs=142.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 68899999986432 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 9999999999997543 2788899999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....||+.|+|||
T Consensus 149 ~~~~~~-----~~~~~gt~~y~aPE 168 (333)
T cd05600 149 KGIVTY-----ANSVVGSPDYMAPE 168 (333)
T ss_pred cccccc-----cCCcccCccccChh
Confidence 765431 23457999999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=238.60 Aligned_cols=161 Identities=25% Similarity=0.418 Sum_probs=138.5
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
.++||+|.||+||-|.++ +|+.||||++.+.. ...+.+++|+++|.++.||.||.+...|++.+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 468999999999999965 89999999997654 3356789999999999999999999999999999999999965
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---CceEEecccCCCCC
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDFDLSNQA 223 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~~vkl~DfGla~~~ 223 (245)
+..+++...... .|++.....++.||+.||.|||.++ |+|+||||+|||+.+. -++||||||+|+.+
T Consensus 648 DMLEMILSsEkg-------RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 648 DMLEMILSSEKG-------RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred hHHHHHHHhhcc-------cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 665655443322 2888888899999999999999998 9999999999999754 48999999999999
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...+ .+++|||.|+|||
T Consensus 718 gEksFR---rsVVGTPAYLaPE 736 (888)
T KOG4236|consen 718 GEKSFR---RSVVGTPAYLAPE 736 (888)
T ss_pred chhhhh---hhhcCCccccCHH
Confidence 876554 5678999999998
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=240.10 Aligned_cols=172 Identities=20% Similarity=0.319 Sum_probs=145.4
Q ss_pred HHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCC
Q 025997 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (245)
Q Consensus 60 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 134 (245)
++....++|++.+.||+|+||.||++++. +++.+|+|.+.... .....+.+|+.+++.++||||+++++.+.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999966 67899999985421 22345778999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++||||+++|+|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999987542 778888899999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++........ ......+||+.|||||
T Consensus 184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE 213 (371)
T cd05622 184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPE 213 (371)
T ss_pred EeCCceeEcCcCCc-ccccCcccCccccCHH
Confidence 99999976543221 1123457999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=240.48 Aligned_cols=144 Identities=22% Similarity=0.263 Sum_probs=128.2
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|...+.||+|+||.||+|+.. +++.+|+|++..... ....+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999965 688999999865321 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 999999999987643 2788888999999999999999998 9999999999999999999999999975
Q ss_pred C
Q 025997 222 Q 222 (245)
Q Consensus 222 ~ 222 (245)
.
T Consensus 150 ~ 150 (382)
T cd05625 150 G 150 (382)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=235.11 Aligned_cols=178 Identities=22% Similarity=0.374 Sum_probs=140.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC-C
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG-P 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 134 (245)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467999999999999999999742 3467999998654322 35688999999999 899999999988754 4
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC-----------------------------------------------------C
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG-----------------------------------------------------A 161 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-----------------------------------------------------~ 161 (245)
.++++|||+++|+|.+++........ .
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58899999999999999975421100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccc
Q 025997 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (245)
Q Consensus 162 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y 241 (245)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............+|+.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 00123788889999999999999999998 999999999999999999999999999865433222222334567889
Q ss_pred cCCC
Q 025997 242 HAPE 245 (245)
Q Consensus 242 ~APE 245 (245)
||||
T Consensus 243 ~aPE 246 (338)
T cd05102 243 MAPE 246 (338)
T ss_pred cCcH
Confidence 9998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=232.95 Aligned_cols=160 Identities=26% Similarity=0.341 Sum_probs=137.0
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
+.||+|+||.||+++.. +++.||+|++.... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999965 78899999986432 22356778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9999886543 2889999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCCC
Q 025997 227 AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~~~~~~gt~~y~APE 245 (245)
... .....||+.|||||
T Consensus 149 ~~~--~~~~~gt~~y~aPE 165 (328)
T cd05593 149 AAT--MKTFCGTPEYLAPE 165 (328)
T ss_pred ccc--cccccCCcCccChh
Confidence 211 13457999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=238.96 Aligned_cols=168 Identities=21% Similarity=0.327 Sum_probs=143.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|++.+.||+|+||.||+++.. +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567999999999999999999965 68899999985422 223457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 121 v~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecc
Confidence 999999999999986532 778888899999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ .......||+.|||||
T Consensus 188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE 213 (370)
T cd05596 188 TCMKMDANGM-VRCDTAVGTPDYISPE 213 (370)
T ss_pred ceeeccCCCc-ccCCCCCCCcCeECHH
Confidence 9876543221 1123457999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=233.15 Aligned_cols=160 Identities=25% Similarity=0.347 Sum_probs=136.3
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
+.||+|+||.||+++.. +++.||+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999964 78999999986432 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9999887543 2889999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCCC
Q 025997 227 AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~~~~~~gt~~y~APE 245 (245)
... .....||+.|||||
T Consensus 149 ~~~--~~~~~gt~~y~aPE 165 (323)
T cd05595 149 GAT--MKTFCGTPEYLAPE 165 (323)
T ss_pred CCc--cccccCCcCcCCcc
Confidence 211 13457999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=228.60 Aligned_cols=167 Identities=23% Similarity=0.380 Sum_probs=141.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 567999999999999999999965 788999998864432 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+ +|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 9975 99998865432 2788899999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....||+.|+|||
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE 173 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPD 173 (288)
T ss_pred eccCCCcc--ccCceecccccChH
Confidence 54322211 12346899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=233.07 Aligned_cols=164 Identities=35% Similarity=0.527 Sum_probs=148.0
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
|.++..||+|+||.||+|.++ +|+.+|||.+... .+.+++.+|+.+|.++..+++|++|+.|.....+|+|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 677889999999999999976 7999999998654 46688999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
++.+++..++. .|++.++..+....++||+|||... -+|||||..|||++.+|.+||+|||++-++.+.
T Consensus 114 SiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 114 SISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred cHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999986643 3999999999999999999999985 899999999999999999999999999988765
Q ss_pred ccccccccccccccccCCC
Q 025997 227 AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~~~~~~gt~~y~APE 245 (245)
.... .+++|||.|||||
T Consensus 183 MAKR--NTVIGTPFWMAPE 199 (502)
T KOG0574|consen 183 MAKR--NTVIGTPFWMAPE 199 (502)
T ss_pred HHhh--CccccCcccccHH
Confidence 5443 5678999999998
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=236.11 Aligned_cols=146 Identities=25% Similarity=0.338 Sum_probs=130.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|+..+.||+|+||.||++... +++.||+|++.... .....+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 68899999985422 22356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence 99999999999876432 888899999999999999999998 999999999999999999999999998
Q ss_pred CCC
Q 025997 221 NQA 223 (245)
Q Consensus 221 ~~~ 223 (245)
+..
T Consensus 149 ~~~ 151 (360)
T cd05627 149 TGL 151 (360)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=231.32 Aligned_cols=158 Identities=23% Similarity=0.296 Sum_probs=135.5
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||+|+||.||+|+.. +++.||+|.+... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 6789999988542 22335677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQREGR---------FDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 999975432 788999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
......||+.|||||
T Consensus 149 --~~~~~~gt~~y~aPE 163 (312)
T cd05585 149 --KTNTFCGTPEYLAPE 163 (312)
T ss_pred --ccccccCCcccCCHH
Confidence 123457999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=233.63 Aligned_cols=168 Identities=21% Similarity=0.279 Sum_probs=142.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||++... +++.||+|++.+.. ...+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 68899999986421 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence 99999999999975322 2888899999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... ......||+.|||||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (331)
T cd05597 150 LRLLADGTV-QSNVAVGTPDYISPE 173 (331)
T ss_pred eecCCCCCc-cccceeccccccCHH
Confidence 765432211 112246999999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=234.63 Aligned_cols=163 Identities=25% Similarity=0.391 Sum_probs=137.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|+..+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 456778889999999999999965 7899999998654332 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 153 ~~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 153 FMDGGSLEGTH-------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred cCCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999986432 1566778889999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....||..|+|||
T Consensus 217 ~~~~~~~~--~~~~~gt~~y~aPE 238 (353)
T PLN00034 217 ILAQTMDP--CNSSVGTIAYMSPE 238 (353)
T ss_pred eccccccc--ccccccCccccCcc
Confidence 65432211 13357999999998
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=228.72 Aligned_cols=168 Identities=26% Similarity=0.403 Sum_probs=141.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
+.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999976 788999999865432 2346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+. ++|.+++..... .++...+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 83 e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 83 EYVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred ECCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 9996 588888765432 2788889999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ .....||+.|+|||
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE 173 (303)
T cd07869 151 RAKSVPSHT--YSNEVVTLWYRPPD 173 (303)
T ss_pred eeccCCCcc--CCCCcccCCCCChH
Confidence 754322211 13346899999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=233.98 Aligned_cols=168 Identities=23% Similarity=0.273 Sum_probs=143.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||++... +++.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 788999999865322 3345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999976532 2888999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... ......||+.|+|||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPE 173 (330)
T ss_pred eECCCCCce-eeecccCCccccCHH
Confidence 766433221 123346999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=230.80 Aligned_cols=160 Identities=26% Similarity=0.348 Sum_probs=135.4
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++..++|+||+++++++...+..++||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 78899999986432 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
+|.+++.... .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999886543 28899999999999999999997 66 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....||+.|||||
T Consensus 149 ~~~~--~~~~~gt~~y~aPE 166 (325)
T cd05594 149 DGAT--MKTFCGTPEYLAPE 166 (325)
T ss_pred CCcc--cccccCCcccCCHH
Confidence 2211 13457999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=233.27 Aligned_cols=168 Identities=21% Similarity=0.270 Sum_probs=142.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||+++.. +++.||+|.+.+.. .....+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 67889999986422 12345778899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999976322 2788899999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ ......||+.|||||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (331)
T cd05624 150 LKMNQDGTV-QSSVAVGTPDYISPE 173 (331)
T ss_pred eeccCCCce-eeccccCCcccCCHH
Confidence 765433221 112356999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=238.97 Aligned_cols=172 Identities=31% Similarity=0.460 Sum_probs=141.5
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEECC--C--cE-EEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEE
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRS--G--RA-AAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYV 131 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~--~--~~-vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 131 (245)
+....++..+.++||+|+||.||+|.++. + .. ||+|..+.+. ....++.+|+++|++++|+|||++||+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44455666777899999999999999652 2 23 8999886422 23467899999999999999999999999
Q ss_pred eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
....++||||+|.||+|.++|+.... .++..+.+.++.+.+.||+|||+++ ++||||-.+|+|+..++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGV 300 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCe
Confidence 99999999999999999999998754 2899999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++......... ..-.-...|+|||
T Consensus 301 vKISDFGLs~~~~~~~~~~--~~~klPirWLAPE 332 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPE 332 (474)
T ss_pred EEeCccccccCCcceeecc--ccccCcceecChh
Confidence 9999999987654111110 0111346899998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=229.90 Aligned_cols=164 Identities=27% Similarity=0.401 Sum_probs=132.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 140 (245)
.|...+++|.|+||.||+|... ++..||||+...+..- -.+|+++|+++.|||||++.-+|.... +..+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 3667789999999999999955 6789999998554332 235899999999999999988876422 346899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl~DfGl 219 (245)
||++. +|.++++..... ...++...+..+..||..||.|||+.+ |+||||||+|+|+|.+ |.+||||||.
T Consensus 102 eymP~-tL~~~~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HhchH-HHHHHHHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCc
Confidence 99986 999999842110 112677778889999999999999987 9999999999999965 9999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+.+...... .+...|..|.|||
T Consensus 173 AK~L~~~epn---iSYicSRyYRaPE 195 (364)
T KOG0658|consen 173 AKVLVKGEPN---ISYICSRYYRAPE 195 (364)
T ss_pred ceeeccCCCc---eeEEEeccccCHH
Confidence 9988655443 3446789999998
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=231.94 Aligned_cols=166 Identities=23% Similarity=0.316 Sum_probs=140.1
Q ss_pred CCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCC-----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCce
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (245)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. ...+.+..|+.+++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999853 57899999885421 2234577899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 999999999999999875432 888999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++........ ......||+.|||||
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE 176 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPE 176 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHH
Confidence 9998765332221 123457999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=236.62 Aligned_cols=165 Identities=30% Similarity=0.466 Sum_probs=146.2
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.|...+.||+|+||.||+|.. ++++.||+|++..... ..+++.+|+.+|..++++||.++|+.|..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 477778999999999999995 5889999999976543 3578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.||++.+.++.... +.+..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++.++
T Consensus 94 ~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred cCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence 99999999986542 466677778999999999999997 999999999999999999999999999888
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .+++|||.|||||
T Consensus 162 ~~~~~rr--~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 162 TNTVKRR--KTFVGTPFWMAPE 181 (467)
T ss_pred echhhcc--ccccccccccchh
Confidence 7655443 6789999999998
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=235.64 Aligned_cols=167 Identities=26% Similarity=0.338 Sum_probs=149.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
....|.+...||+|.|+.|.+|.+. ++..||||.++++... .+.+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567999999999999999999965 7999999999877654 35578999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|.+++++.+... .....+..++.|+..|++|||+++ |||||||.+||||+.+.++||+|||+
T Consensus 134 ~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred EEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence 999999999999988764 555778889999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..+.... ...+.+|++.|.|||
T Consensus 202 S~~~~~~~---~lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 202 STFFDYGL---MLQTFCGSPPYAAPE 224 (596)
T ss_pred ceeecccc---cccccCCCCCccChH
Confidence 98876433 236789999999998
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=228.91 Aligned_cols=160 Identities=26% Similarity=0.372 Sum_probs=135.2
Q ss_pred CeeccCCceEEEEEEE----CCCcEEEEEEcCCCC-----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 72 SLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.||+|+||.||+++. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999986432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999987643 2778888889999999999999998 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE 170 (323)
T cd05584 150 SIHEGTV--THTFCGTIEYMAPE 170 (323)
T ss_pred cccCCCc--ccccCCCccccChh
Confidence 4322211 23357999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=234.72 Aligned_cols=168 Identities=27% Similarity=0.387 Sum_probs=144.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999965 78999999986432 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999997652 2888999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccc---------------------------cccccccccccccccCCC
Q 025997 221 NQAPDAA---------------------------ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~---------------------------~~~~~~~~~gt~~y~APE 245 (245)
....... .........||+.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 7664432 001123356999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=230.39 Aligned_cols=168 Identities=20% Similarity=0.269 Sum_probs=141.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.+.. .....+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 57789999985421 12345778899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence 99999999999976322 2788889999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... ......||+.|||||
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE 173 (332)
T cd05623 150 LKLMEDGTV-QSSVAVGTPDYISPE 173 (332)
T ss_pred eecccCCcc-eecccccCccccCHH
Confidence 765332221 123357999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=227.24 Aligned_cols=166 Identities=28% Similarity=0.432 Sum_probs=143.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||+++.. ++..+|+|.+...... ...+.+|++++++++|+||+++++++..++..+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999965 6788999988654322 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++++|.+++..... +++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 84 HMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999976432 788899999999999999999853 39999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....||+.|+|||
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE 172 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPE 172 (331)
T ss_pred cccccc----cccCCCCcCcCCHh
Confidence 654322 13457999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=240.16 Aligned_cols=171 Identities=18% Similarity=0.219 Sum_probs=141.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-C-CcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.|.+.+.||+|+||.||+|... + +..||+|.+...... ...+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999854 3 577888877544322 345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+|+|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 148 ~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 148 SGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999988643211 113788889999999999999999997 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
............+||+.|||||
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE 241 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPE 241 (478)
T ss_pred CCccccccccccCCCccccCHh
Confidence 4432222234567999999998
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=229.24 Aligned_cols=163 Identities=26% Similarity=0.421 Sum_probs=136.0
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHH---HccCCCCcceEeEEEEeCCceEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMV---SRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
|.+.+.||+|+||.||+|... +++.||||.+.... ...+.+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 78899999986432 2234566666554 567899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|...+.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999998886432 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....+||+.|||||
T Consensus 148 ~~~~~~~~~~--~~~~~g~~~y~aPE 171 (324)
T cd05589 148 CKEGMGFGDR--TSTFCGTPEFLAPE 171 (324)
T ss_pred CccCCCCCCc--ccccccCccccCHh
Confidence 8754322211 23467999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=228.78 Aligned_cols=160 Identities=23% Similarity=0.320 Sum_probs=135.6
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.||+|.++.... ....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 688999999865322 234577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 999998865432 899999999999999999999998 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... .....+||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (329)
T cd05588 149 PGD--TTSTFCGTPNYIAPE 166 (329)
T ss_pred CCC--ccccccCCccccCHH
Confidence 111 123457999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=233.14 Aligned_cols=170 Identities=26% Similarity=0.362 Sum_probs=148.0
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+...+++.||+|.||.|.+|+...+..||||+++..... +.+|.+|+++|.+|+||||+.++++|..++.+++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345668899999999999999988899999999765443 478999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.+++.++.... +.-...++|+.||+.|++||.+.+ +|||||.++|||++.++++||+|||+++.+
T Consensus 618 EnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999998764321 344556779999999999999987 999999999999999999999999999988
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
..........+.+-.++|||||
T Consensus 688 ysg~yy~vqgr~vlpiRwmawE 709 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWE 709 (807)
T ss_pred ccCCceeeecceeeeeeehhHH
Confidence 7666655445556678999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=246.24 Aligned_cols=177 Identities=26% Similarity=0.439 Sum_probs=148.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.+....+.||+|+||+||+|+.. ....||||.++..... +++|.+|++++..|+|||||+|+|++..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44566778999999999999843 3567999999765543 578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAK-P----GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
+|+|||..|||.++|.......... . ...|+..+.+.||.|||.|+.||-++. +|||||..+|+|+.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999998765432211 1 223889999999999999999999996 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++.....+.+.....-.=..+||+||
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE 675 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE 675 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence 999999999887766654432223467899998
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=227.88 Aligned_cols=165 Identities=24% Similarity=0.294 Sum_probs=138.2
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCC-CcceEeEEEEeCCceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 140 (245)
+|.+.+.||+|+||.||+|... +++.||+|++.+.. ...+.+..|+.++..+.|+ +|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 67899999986432 2345677889999999765 6888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 99999999999875432 788899999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+....... .....+||+.|+|||
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE 171 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPE 171 (324)
T ss_pred eecCCCCC--ceeeecCCccccChh
Confidence 65322111 123457999999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=224.55 Aligned_cols=166 Identities=25% Similarity=0.411 Sum_probs=142.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC---CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.+.|++.+.||+|.|+.||++.+. +|+.+|+|.+... ..+.+++.+|+.+.+.|+||||+++.+.+....+.|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467889999999999999999965 7899999988543 345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---CceEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~~vkl~Df 217 (245)
|++.|++|..-+-.+. ..++..+-..+.||+++|.|+|.++ |||||+||.|+|+.+. .-+||+||
T Consensus 90 e~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeeccc
Confidence 9999999976554432 3788888999999999999999998 9999999999999643 47999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++..+...... ..++|||.|||||
T Consensus 158 GvAi~l~~g~~~---~G~~GtP~fmaPE 182 (355)
T KOG0033|consen 158 GLAIEVNDGEAW---HGFAGTPGYLSPE 182 (355)
T ss_pred ceEEEeCCcccc---ccccCCCcccCHH
Confidence 999888733221 4568999999998
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=232.34 Aligned_cols=162 Identities=20% Similarity=0.297 Sum_probs=138.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..+|.+.+.||+|+||.||+|... +++.||+|... ...+.+|+.++++++||||+++++++......++++|++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 467999999999999999999964 78899999753 245678999999999999999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
. ++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 166 ~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 166 K-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred C-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 5 689888865432 788999999999999999999998 999999999999999999999999998754
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......||+.|+|||
T Consensus 233 ~~~~~~-~~~~~~gt~~y~aPE 253 (391)
T PHA03212 233 VDINAN-KYYGWAGTIATNAPE 253 (391)
T ss_pred cccccc-ccccccCccCCCChh
Confidence 322111 123457999999998
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=226.49 Aligned_cols=166 Identities=27% Similarity=0.435 Sum_probs=142.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|++++++++|+||+++++++.+++..+++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 6788999987654322 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 999999999997643 2788888999999999999999742 39999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....||+.|+|||
T Consensus 153 ~~~~~~----~~~~~~~~~y~aPE 172 (333)
T cd06650 153 QLIDSM----ANSFVGTRSYMSPE 172 (333)
T ss_pred hhhhhc----cccCCCCccccCHH
Confidence 653321 13356899999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=227.20 Aligned_cols=160 Identities=23% Similarity=0.323 Sum_probs=134.7
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.+|+|.+.+... ....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 678999999865321 234567788888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 999988865432 889999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPE 166 (329)
T ss_pred CCC--ccccccCCccccCHH
Confidence 211 123457999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=234.56 Aligned_cols=164 Identities=24% Similarity=0.276 Sum_probs=138.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
...|.+.+.||+|+||.||+|.+. +++.||||... ...+.+|+.++++|+|+||+++++++..++..+++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999965 57889999642 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
. ++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 243 ~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 243 R-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred C-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 5 689888865432 2899999999999999999999998 999999999999999999999999999765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
.............||+.|||||
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE 332 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPE 332 (461)
T ss_pred ccccccccccccCCCcCCcCHH
Confidence 4322221223457999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=239.27 Aligned_cols=167 Identities=28% Similarity=0.478 Sum_probs=141.8
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCC--CCchHHHHHHHHHHHccCCCCcceEeEEEEeC------CceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 137 (245)
.|...+.||+|+||.||++++ .+|+.||||..... ....+..-+|+++|++|+|+|||+++++-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 356678899999999999994 58999999998654 34567788999999999999999999886543 3568
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc--CCC--ceE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IAK 213 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~--~~~--~vk 213 (245)
++||||.+|||...+....+. .-|++.+++.+...+..||.|||.++ |+||||||.||++. .+| --|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~------~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA------YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc------cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEe
Confidence 999999999999999865443 23899999999999999999999997 99999999999984 334 469
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||.|+.+.+... ..+++||+.|.+||
T Consensus 165 LtDfG~Arel~d~s~---~~S~vGT~~YLhPe 193 (732)
T KOG4250|consen 165 LTDFGAARELDDNSL---FTSLVGTEEYLHPE 193 (732)
T ss_pred eecccccccCCCCCe---eeeecCchhhcChH
Confidence 999999998876653 36689999999997
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=226.46 Aligned_cols=160 Identities=24% Similarity=0.342 Sum_probs=136.5
Q ss_pred CeeccCCceEEEEEEE----CCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 72 SLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
+.||+|+||.||+++. .+++.+|+|++..... ....+.+|+.++++++||||+++++++.+.+..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999884 3678999999865322 23456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999986543 2889999999999999999999998 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... .....||+.|||||
T Consensus 150 ~~~~~--~~~~~g~~~y~aPE 168 (318)
T cd05582 150 DHEKK--AYSFCGTVEYMAPE 168 (318)
T ss_pred CCCCc--eecccCChhhcCHH
Confidence 33211 23457999999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=230.82 Aligned_cols=178 Identities=22% Similarity=0.363 Sum_probs=142.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEEcCCCCC--chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
.++|.+.+.||+|+||.||+|.+ .++..||||+++.... ..+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999973 2456899999865432 245688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC-------------------------------------------------------
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------- 160 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------- 160 (245)
.++||||+++|+|.+++........
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975431000
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccc
Q 025997 161 -----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (245)
Q Consensus 161 -----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 229 (245)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 000124788899999999999999999997 999999999999999999999999999765433221
Q ss_pred cccccccccccccCCC
Q 025997 230 LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 230 ~~~~~~~gt~~y~APE 245 (245)
.......++..|||||
T Consensus 271 ~~~~~~~~~~~y~aPE 286 (375)
T cd05104 271 VVKGNARLPVKWMAPE 286 (375)
T ss_pred cccCCCCCCcceeChh
Confidence 1112234567899998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=225.75 Aligned_cols=160 Identities=25% Similarity=0.353 Sum_probs=133.0
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHc-cCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.||+|.+.... ...+.+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 67889999986432 223445566666665 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999999875432 788899999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... .....+||+.|||||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (316)
T cd05592 149 GEG--KASTFCGTPDYIAPE 166 (316)
T ss_pred CCC--ccccccCCccccCHH
Confidence 221 123457999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=226.62 Aligned_cols=160 Identities=22% Similarity=0.319 Sum_probs=134.6
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.||+|++.... ...+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 67899999986532 2234567788888766 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 999998875432 788899999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....||+.|||||
T Consensus 149 ~~~~--~~~~~gt~~y~aPE 166 (321)
T cd05591 149 NGVT--TTTFCGTPDYIAPE 166 (321)
T ss_pred CCcc--ccccccCccccCHH
Confidence 2211 23457999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=226.59 Aligned_cols=165 Identities=24% Similarity=0.296 Sum_probs=138.0
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (245)
+|.+.+.||+|+||.||+|+.. +++.||+|.+.+... ....+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999965 678999999865321 223456677777777 5899999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence 99999999999875432 788999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+....... ......||+.|||||
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE 171 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPE 171 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHH
Confidence 75432221 123457999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=226.31 Aligned_cols=160 Identities=25% Similarity=0.360 Sum_probs=134.7
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|+.. +++.||+|++.... ...+.+..|..++..+ +||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 67899999986432 2234567788888776 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 999998875432 888999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|||||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (320)
T cd05590 149 NGK--TTSTFCGTPDYIAPE 166 (320)
T ss_pred CCC--cccccccCccccCHH
Confidence 211 123457999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=222.64 Aligned_cols=167 Identities=25% Similarity=0.388 Sum_probs=140.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||.||+|+.+ +++.+|+|++..... ..+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999976 678899998865432 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.++.+..+..... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999876665543221 2888899999999999999999997 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ......||+.|+|||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE 171 (287)
T cd07848 149 NLSEGSNA-NYTEYVATRWYRSPE 171 (287)
T ss_pred cccccccc-cccccccccccCCcH
Confidence 76432211 123457999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=222.16 Aligned_cols=167 Identities=28% Similarity=0.387 Sum_probs=141.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC---CCchHHHHHHHHHHHccCCCCcceEeEEEEe-----CCce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVD-----GPLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 136 (245)
..|...+.||+|+||.|..+... ++..||||++... ....++..+|+.+|+.++|+||+.+.+.+.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45666789999999999999954 8899999998632 2345678899999999999999999999875 2468
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|+|+|+|+ .+|.++++.... |+...+..+++||+.||.|+|+.+ |+||||||+|+|++.+..+||+|
T Consensus 102 YiV~elMe-tDL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred EEehhHHh-hHHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 99999995 599999987653 888999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|+...........+..+-|.+|.|||
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPE 197 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPE 197 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHH
Confidence 99998775431222224567899999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=230.93 Aligned_cols=179 Identities=25% Similarity=0.398 Sum_probs=142.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
..++|++.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.+++.+ +|+||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4567999999999999999999842 3357999998654332 35678899999999 8999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCC--------------------------------------------------------
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGV-------------------------------------------------------- 158 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 158 (245)
..+++|||+.+|+|.+++......
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999998643210
Q ss_pred -----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccccccc
Q 025997 159 -----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233 (245)
Q Consensus 159 -----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 233 (245)
........+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 00001123788899999999999999999998 9999999999999999999999999997654332211112
Q ss_pred cccccccccCCC
Q 025997 234 RVLGTFGYHAPE 245 (245)
Q Consensus 234 ~~~gt~~y~APE 245 (245)
...+++.|||||
T Consensus 273 ~~~~~~~y~aPE 284 (374)
T cd05106 273 NARLPVKWMAPE 284 (374)
T ss_pred CCCCccceeCHH
Confidence 234567899998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=225.34 Aligned_cols=160 Identities=24% Similarity=0.378 Sum_probs=132.9
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHH-HHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||+||+|... +++.||+|++.... .....+..|.. +++.++||||+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 78899999986432 12234455544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 99999887543 2788899999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|||||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (323)
T cd05575 149 HSK--TTSTFCGTPEYLAPE 166 (323)
T ss_pred CCC--ccccccCChhhcChh
Confidence 221 123457999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=222.15 Aligned_cols=166 Identities=27% Similarity=0.379 Sum_probs=140.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
+|++.+.||+|+||.||++... +++.||+|++..... ....+.+|+.++++++|+||+++++.+.+++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 788999999865322 12456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 99999999888653221 2889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....||+.|||||
T Consensus 151 ~~~~~~~~---~~~~~~~~y~aPE 171 (285)
T cd05605 151 EIPEGETI---RGRVGTVGYMAPE 171 (285)
T ss_pred ecCCCCcc---ccccCCCCccCcH
Confidence 65432211 2346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=225.49 Aligned_cols=160 Identities=24% Similarity=0.374 Sum_probs=132.3
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHH-HHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|+.. +++.||+|++.+.. .....+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 67899999985432 12234555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 99998886543 2788888999999999999999997 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (321)
T cd05603 149 PEE--TTSTFCGTPEYLAPE 166 (321)
T ss_pred CCC--ccccccCCcccCCHH
Confidence 221 123457999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=225.75 Aligned_cols=160 Identities=24% Similarity=0.379 Sum_probs=132.8
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHH-HHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.+|+|++.... .....+..|.. +++.++||||+++++++...+..+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999965 78899999985432 22234555554 46779999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 999988865432 888999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|||||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPE 166 (325)
T ss_pred CCC--CcccccCChhhCCHH
Confidence 211 123457999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=225.99 Aligned_cols=160 Identities=23% Similarity=0.343 Sum_probs=131.7
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHH-HHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQV-SMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|+.. +++.+|+|++.... .....+..|. .+++.++|+||+++++++...+..+++|||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999966 67789999986432 1223344444 356788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 999999876432 777888889999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|||||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (325)
T cd05602 149 HNG--TTSTFCGTPEYLAPE 166 (325)
T ss_pred CCC--CcccccCCccccCHH
Confidence 221 123457999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-33 Score=230.20 Aligned_cols=168 Identities=35% Similarity=0.502 Sum_probs=142.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHc--cCCCCcceEeEEEEeCC----ceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP----LRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l 138 (245)
.+...+.++||+|.||.||+|.+.+ +.||||++... ..+.|.+|-++++- ++|+||++|+++-.... .++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4456677889999999999999874 89999998533 45677888777665 58999999999877655 7999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecCCCCCCeEEcCCCce
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK------AEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~~ivHrDlkp~Nill~~~~~v 212 (245)
|++|.+.|+|.++|+.+. ++|....+|+..++.||+|||.. ..+.|+|||||.+|||+.++++.
T Consensus 286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 999999999999999864 99999999999999999999973 24679999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.|+|||+|..+.........-..+||.+|||||
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPE 388 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPE 388 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence 999999998776444333333468999999998
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=216.19 Aligned_cols=168 Identities=23% Similarity=0.409 Sum_probs=144.0
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|++.+.||+|+||.||++.+.++..+|+|.+........++.+|+.++++++||||+++++++...+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45788889999999999999988878899999876666677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999875432 2788999999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ......++..|+|||
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE 171 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPE 171 (256)
T ss_pred Ccee-ccCCCCCchhhCChh
Confidence 2221 112223567899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=224.66 Aligned_cols=160 Identities=25% Similarity=0.358 Sum_probs=133.7
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHc-cCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... ++..||+|.++... ........|..++.. ++|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999986532 233456677777765 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 999998875432 788899999999999999999998 99999999999999999999999999874322
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|+|||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (316)
T cd05620 149 GDN--RASTFCGTPDYIAPE 166 (316)
T ss_pred CCC--ceeccCCCcCccCHH
Confidence 111 123457999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=222.42 Aligned_cols=148 Identities=26% Similarity=0.335 Sum_probs=132.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+.|++.+.||.|.-|+||+++.+ ++..+|+|++.+.... ..+...|-+||+.++||.+++||..|..+.+.|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 456888899999999999999976 5689999999765433 23456688999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||||+||+|..+.+.+.+. .+++..+..++.+|+.||+|||-.| ||+|||||+|||+-++|++-|+||.|
T Consensus 156 meyCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred EecCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccc
Confidence 9999999999999887654 4999999999999999999999998 99999999999999999999999998
Q ss_pred CCC
Q 025997 220 SNQ 222 (245)
Q Consensus 220 a~~ 222 (245)
+..
T Consensus 226 S~~ 228 (459)
T KOG0610|consen 226 SLR 228 (459)
T ss_pred ccc
Confidence 654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=225.74 Aligned_cols=165 Identities=23% Similarity=0.299 Sum_probs=138.1
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 140 (245)
+|+..+.||+|+||.||+|... +++.||+|++.+.. ...+.+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999965 78899999986432 22345677888888885 577888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999987543 2889999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+....... ......||+.|||||
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE 171 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPE 171 (323)
T ss_pred cccCCCCc--cccCccCCccccCHH
Confidence 75432221 123456999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=226.72 Aligned_cols=166 Identities=25% Similarity=0.408 Sum_probs=137.0
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (245)
+|++.+.||+|+||.||+|+.. ++..||||++.... .....+.+|+.++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 78999999986432 22346788999999999999999999876432 479
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+. ++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 9999995 689998875432 889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025997 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
|+++........ .......||+.|+|||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE 176 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPE 176 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHH
Confidence 999764322211 1113357999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=236.93 Aligned_cols=163 Identities=24% Similarity=0.402 Sum_probs=137.9
Q ss_pred CCCCeeccCCceEEEEEEEC-CCcEEEEEEc---CCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCc--eEEEE
Q 025997 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKL---DSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--RVLAY 140 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~---~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 140 (245)
+...+||+|+|-+||+|.+. +|..||.-.+ +..+ ...+.|..|+.+|+.|+|+||+++|.+|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34567999999999999965 6777775433 2222 334789999999999999999999999997765 77899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGl 219 (245)
|++..|+|..++++.+. +....+..+++||++||.|||++ .|+|+|||||.+||+|+. .|.|||+|+||
T Consensus 123 EL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred ecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 99999999999998764 78888999999999999999998 578999999999999975 58999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+....... ...+|||.|||||
T Consensus 193 Atl~r~s~a----ksvIGTPEFMAPE 214 (632)
T KOG0584|consen 193 ATLLRKSHA----KSVIGTPEFMAPE 214 (632)
T ss_pred HHHhhcccc----ceeccCccccChH
Confidence 987654332 3478999999998
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=223.91 Aligned_cols=160 Identities=24% Similarity=0.353 Sum_probs=133.7
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHc-cCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.||+|.+.... .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 67899999986532 223456677777776 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 999999975432 788899999999999999999998 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
... ......||+.|||||
T Consensus 149 ~~~--~~~~~~gt~~y~aPE 166 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPE 166 (316)
T ss_pred CCC--ceeeecCCccccCHH
Confidence 211 123457999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=241.12 Aligned_cols=167 Identities=24% Similarity=0.402 Sum_probs=143.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC-CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+-|.+...||.|+||.||+|..+ ++-..|.|++... ....++|+-||++|..+.||+||++++.|...+.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34677788999999999999966 4445567877543 344678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.||.+..++-.... .|.+.++..+++|++.||.|||++. |||||||..|||+.-+|.++|+|||++...
T Consensus 112 ~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 99999998876653 4999999999999999999999997 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ...+++|||+|||||
T Consensus 181 ~~t~q--kRDsFIGTPYWMAPE 200 (1187)
T KOG0579|consen 181 KSTRQ--KRDSFIGTPYWMAPE 200 (1187)
T ss_pred hhHHh--hhccccCCcccccch
Confidence 43332 236789999999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=228.07 Aligned_cols=179 Identities=23% Similarity=0.360 Sum_probs=143.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccC-CCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||.||+|.+. ....||||++...... .+.+.+|+.+++++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567889999999999999999853 2346999999654332 457889999999996 999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC------------------------------------------------------
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------ 160 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 160 (245)
..++||||+++|+|.+++........
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999865421000
Q ss_pred ---------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc
Q 025997 161 ---------------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 161 ---------------------------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~ 207 (245)
......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 000123788888999999999999999997 99999999999999
Q ss_pred CCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++.+||+|||+++...............+++.|||||
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 99999999999987654332222223345778899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=219.44 Aligned_cols=162 Identities=25% Similarity=0.373 Sum_probs=135.2
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||+|+||+||++... +++.+|+|.+...... .+.+..|+.+++.++|+||+++.+++...+..+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 7889999998643222 24567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+.+...... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9887542211 123889999999999999999999998 99999999999999999999999999876543322
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
. .....||+.|+|||
T Consensus 153 ~--~~~~~g~~~y~aPE 167 (280)
T cd05608 153 K--TKGYAGTPGFMAPE 167 (280)
T ss_pred c--ccccCCCcCccCHH
Confidence 1 23457999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=224.55 Aligned_cols=160 Identities=24% Similarity=0.322 Sum_probs=135.2
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.+|+|++..... ..+.+.+|+.++.++ +|+||+.+++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 678999999865422 234577889988888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 99999886543 2889999999999999999999998 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....+||+.|+|||
T Consensus 149 ~~~~--~~~~~gt~~y~aPE 166 (327)
T cd05617 149 PGDT--TSTFCGTPNYIAPE 166 (327)
T ss_pred CCCc--eecccCCcccCCHH
Confidence 1111 13457999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=222.89 Aligned_cols=162 Identities=24% Similarity=0.340 Sum_probs=137.0
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
...+|.+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++|+||+++++++...+..++++|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4457999999999999999999965 5678999975432 235689999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+. ++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 139 YS-SDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred cC-CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence 95 589888865432 2889999999999999999999998 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....||+.|+|||
T Consensus 207 ~~~~~~---~~~~~gt~~y~aPE 226 (357)
T PHA03209 207 PVVAPA---FLGLAGTVETNAPE 226 (357)
T ss_pred cccCcc---cccccccccccCCe
Confidence 432211 13456999999998
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=236.36 Aligned_cols=174 Identities=21% Similarity=0.298 Sum_probs=142.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC-----
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 134 (245)
..++|.+.+.||+|+||.||+|.. .+++.||||.+...... ...+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999995 47899999998654433 345778999999999999999988765432
Q ss_pred ---ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 135 ---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 135 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
.+++||||+.+|+|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 368999999999999998754321 123888999999999999999999997 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++...............||+.|||||
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE 215 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHH
Confidence 9999999997654332222224467999999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=235.34 Aligned_cols=177 Identities=32% Similarity=0.521 Sum_probs=155.1
Q ss_pred eHHHHHHhhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEe--
Q 025997 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD-- 132 (245)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-- 132 (245)
+++.+....+.|++.++||.|.+|.||+++ .++++..|+|++......++++..|.++++.+ .|||++.++++|.-
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 334444556789999999999999999999 45889999999988888888999999999888 69999999999863
Q ss_pred ---CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 133 ---GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 133 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
++.+|||||||.+||..|++++..+. .+.|..+..|++.++.||.+||.+. ++|||+|-.|||++.+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTEN 159 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEecc
Confidence 57899999999999999999887643 2899999999999999999999996 9999999999999999
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.|||.|||++.++.....+ ..+.+|||.|||||
T Consensus 160 ~~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPE 193 (953)
T ss_pred CcEEEeeeeeeeeeeccccc--ccCcCCCcccccce
Confidence 99999999999888655443 35678999999998
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=215.68 Aligned_cols=170 Identities=24% Similarity=0.416 Sum_probs=145.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+...+..++++||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46789999999999999999998888889999987665566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 ~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 85 KGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence 99999999754322 2788889999999999999999997 9999999999999999999999999997664
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....++..|+|||
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE 174 (261)
T cd05072 155 DNEYTA-REGAKFPIKWTAPE 174 (261)
T ss_pred CCceec-cCCCccceecCCHH
Confidence 322111 12234677899998
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=221.25 Aligned_cols=169 Identities=25% Similarity=0.411 Sum_probs=138.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
..+|++.+.||+|+||.||+|.+. ++. .||+|.+..... ..+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457999999999999999999854 333 489999864432 246788999999999999999999998764 577
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccc
Confidence 99999999999999976432 2788889999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............++..|||||
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE 181 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALE 181 (316)
T ss_pred cccccccCCCcceeccCCccceeecChH
Confidence 9998765433222112223467899998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=223.05 Aligned_cols=158 Identities=25% Similarity=0.285 Sum_probs=130.6
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc---CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
||+|+||.||+|+.. +++.||+|++..... .......|..++..+ .||||++++..+...+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 688999999854321 122344566666554 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 999998875432 888999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....||+.|||||
T Consensus 149 ~~~~--~~~~~gt~~y~aPE 166 (330)
T cd05586 149 DNKT--TNTFCGTTEYLAPE 166 (330)
T ss_pred CCCC--ccCccCCccccCHH
Confidence 2211 23457999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=214.94 Aligned_cols=168 Identities=25% Similarity=0.401 Sum_probs=139.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+|++.+.||+|+||.||+|.+. .+..||+|.++..... ...+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999853 3568999998765332 35688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++++|||.
T Consensus 85 ~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence 999999999999976432 2889999999999999999999998 99999999999999999999999998
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+......... ......++..|+|||
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE 178 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPE 178 (266)
T ss_pred cccccccchh-cccCCCCceeecCHH
Confidence 7654322111 111234567899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=213.52 Aligned_cols=170 Identities=24% Similarity=0.414 Sum_probs=144.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||+|...+++.||+|.+.......+++.+|+.++++++|+||+++++++...+..+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 35688899999999999999998777889999987766667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++...
T Consensus 85 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 85 YGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 99999999764321 2889999999999999999999998 9999999999999999999999999987665
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......+..|+|||
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE 174 (261)
T cd05068 155 EDIYEA-REGAKFPIKWTAPE 174 (261)
T ss_pred CCcccc-cCCCcCceeccCcc
Confidence 322111 11112345799998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=226.80 Aligned_cols=168 Identities=26% Similarity=0.383 Sum_probs=146.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+.|..-++||+|+||.|+-|+.+ +|+.+|.|++.+.. ......++|-.+|++++.+.||.+--+|.+.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456888899999999999999955 89999999885432 2334567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
+..|.||+|.-.|.+..+. .+++..++.++.+|+.||++||+.. ||.|||||+|||+|+.|+++|+|+|+
T Consensus 264 LtlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred EEeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccce
Confidence 9999999999888876542 3899999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|..+...... ...+||.+|||||
T Consensus 334 Avei~~g~~~---~~rvGT~GYMAPE 356 (591)
T KOG0986|consen 334 AVEIPEGKPI---RGRVGTVGYMAPE 356 (591)
T ss_pred EEecCCCCcc---ccccCcccccCHH
Confidence 9888765443 2348999999998
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=219.14 Aligned_cols=167 Identities=22% Similarity=0.375 Sum_probs=140.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++++++|+||+++++++..++..+++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 467999999999999999999965 678899998864432 23467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+ +|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 9975 88888865432 2788889999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....+|+.|+|||
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~aPE 174 (309)
T cd07872 153 AKSVPTKT--YSNEVVTLWYRPPD 174 (309)
T ss_pred ecCCCccc--cccccccccccCCH
Confidence 54332211 12346899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=217.13 Aligned_cols=166 Identities=26% Similarity=0.394 Sum_probs=134.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC--CCcEEEEEEcCCCCC---chHHHHHHHHHHHcc---CCCCcceEeEEEE-----e
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL---KNENVVELVGYYV-----D 132 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~ 132 (245)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999963 467899998854322 234566777776665 6999999999885 2
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
....++++||+. ++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 456899999996 5999998754321 2788999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++...... ......||+.|+|||
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE 179 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPE 179 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChH
Confidence 999999987654321 123456899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=232.33 Aligned_cols=154 Identities=31% Similarity=0.548 Sum_probs=135.3
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHH
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (245)
.++-||.|+-|.||+|+.+ ++.||||+++..+ ..+|..|++|+|+||+.|.|+|.....++||||||..|-|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 3567999999999999988 5799999874321 24688899999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccc
Q 025997 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (245)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 229 (245)
.+|+.... +.....+.+..+|+.|+.|||.+. |||||||.-||||..+..|||+|||.++........
T Consensus 201 ~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 201 EVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred HHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh
Confidence 99987653 777788889999999999999996 999999999999999999999999999877655322
Q ss_pred cccccccccccccCCC
Q 025997 230 LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 230 ~~~~~~~gt~~y~APE 245 (245)
-.++||..|||||
T Consensus 269 ---MSFaGTVaWMAPE 281 (904)
T KOG4721|consen 269 ---MSFAGTVAWMAPE 281 (904)
T ss_pred ---hhhhhhHhhhCHH
Confidence 4579999999998
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=221.41 Aligned_cols=160 Identities=24% Similarity=0.346 Sum_probs=134.8
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||++... +++.||+|.+.+.. .....+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 67899999986432 2234567788888887 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 999998876532 889999999999999999999998 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....+||+.|||||
T Consensus 149 ~~~~--~~~~~g~~~y~aPE 166 (318)
T cd05570 149 GGVT--TSTFCGTPDYIAPE 166 (318)
T ss_pred CCCc--ccceecCccccCHH
Confidence 2111 13356999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=215.00 Aligned_cols=178 Identities=28% Similarity=0.432 Sum_probs=143.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC------CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|++.+.||+|+||.||+|.... ...+++|.+...... ...+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998542 257899988654332 35688999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAK-------PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
++++||+++++|.+++.......... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 99999999999999997643211100 0134788899999999999999999998 9999999999999999
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++|+|||+++...............+++.|||||
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPE 196 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHH
Confidence 999999999987654332222223345788999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=212.42 Aligned_cols=168 Identities=24% Similarity=0.393 Sum_probs=142.7
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
.+|++.+.||+|+||.||++.++++..+|+|.+.........+.+|+.++++++|+||+++++++...+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35888899999999999999988777899999876655667888999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999975432 2789999999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
..... .....++..|+|||
T Consensus 153 ~~~~~-~~~~~~~~~y~~Pe 171 (256)
T cd05059 153 DQYTS-SQGTKFPVKWAPPE 171 (256)
T ss_pred ccccc-cCCCCCCccccCHH
Confidence 22111 11122456799998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=212.55 Aligned_cols=168 Identities=25% Similarity=0.386 Sum_probs=143.3
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|.+.+.||+|+||.||++.+..+..+|+|.+.......+.+.+|+.++++++||||+++++++...+..+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45788889999999999999987777899999876666667899999999999999999999999988899999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999875432 2789999999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ......++..|+|||
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe 171 (256)
T cd05113 153 DEYT-SSVGSKFPVRWSPPE 171 (256)
T ss_pred Ccee-ecCCCccChhhCCHH
Confidence 2211 111223567899997
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=215.84 Aligned_cols=165 Identities=25% Similarity=0.369 Sum_probs=139.5
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
|...+.||+|+||.||++... +++.+|+|.+..... ....+.+|++++++++|+||+.+.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999964 788999999865432 224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 82 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 82 MNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred ccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCccee
Confidence 9999999888653321 2899999999999999999999998 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ....|++.|+|||
T Consensus 152 ~~~~~~~---~~~~g~~~~~aPE 171 (285)
T cd05632 152 IPEGESI---RGRVGTVGYMAPE 171 (285)
T ss_pred cCCCCcc---cCCCCCcCccChH
Confidence 5332211 2346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=215.69 Aligned_cols=166 Identities=27% Similarity=0.390 Sum_probs=139.9
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|+..+.||+|+||.||++... +++.+|+|.+...... ...+.+|+.++++++|++|+.+++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999965 7889999988644222 2356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 81 LMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 99999999988654321 2788899999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....||+.|||||
T Consensus 151 ~~~~~~~~---~~~~g~~~y~aPE 171 (285)
T cd05630 151 HVPEGQTI---KGRVGTVGYMAPE 171 (285)
T ss_pred ecCCCccc---cCCCCCccccChH
Confidence 55432211 2346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=239.00 Aligned_cols=177 Identities=22% Similarity=0.292 Sum_probs=143.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999965 6889999998654322 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 141 EHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||++|++|.+++......... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211100 01123567788999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCcccc----------------ccccccccccccccCCC
Q 025997 219 LSNQAPDAAA----------------RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~----------------~~~~~~~~gt~~y~APE 245 (245)
+++....... .......+||+.|||||
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 9976521100 00112357999999998
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=211.22 Aligned_cols=170 Identities=27% Similarity=0.446 Sum_probs=141.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|.+. +...||+|.+...... ...+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357899999999999999999964 2457899988654333 3568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||
T Consensus 83 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccc
Confidence 9999999999999976432 2889999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++................+++.|+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe 178 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPE 178 (266)
T ss_pred hhhcccccccceeccCCCCCccccChh
Confidence 998765222211112223567899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=213.70 Aligned_cols=159 Identities=25% Similarity=0.359 Sum_probs=133.8
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||+|+||.||++... +++.+|+|.+..... ....+..|++++++++||||+++++++.++...+++|||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999964 689999999864321 233456799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVGER-------GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 9888654321 2788889999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
. ....||+.|+|||
T Consensus 151 ~---~~~~~~~~y~aPE 164 (277)
T cd05607 151 I---TQRAGTNGYMAPE 164 (277)
T ss_pred e---eccCCCCCccCHH
Confidence 1 2346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=214.26 Aligned_cols=178 Identities=22% Similarity=0.393 Sum_probs=142.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|++.+.||+|+||.||+|.+. ++..+|+|++..... ...++.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 467999999999999999999853 246799998854332 234688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAK-PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
+++|||+++++|.+++.......... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEEC
Confidence 99999999999999997543211100 1123678889999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++...............+++.|||||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChh
Confidence 999987654332221112234678899998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.92 Aligned_cols=170 Identities=24% Similarity=0.383 Sum_probs=132.8
Q ss_pred CCeeccCCceEEEEEEEC---CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe--CCceEEEEEecCC
Q 025997 71 NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAYEHASK 145 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 145 (245)
...||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 457999999999999964 46789999986543 23457789999999999999999998864 4568899999864
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----cCCCceEEecccCCC
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN 221 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill----~~~~~vkl~DfGla~ 221 (245)
+|.+++..............+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 89888764432211111223888999999999999999999998 9999999999999 456789999999997
Q ss_pred CCCccccc-cccccccccccccCCC
Q 025997 222 QAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
........ .......||+.|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred ccCCCCccccccCCccccccccCCH
Confidence 65432211 1123457899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=224.05 Aligned_cols=166 Identities=23% Similarity=0.369 Sum_probs=147.2
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCch---HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.-|.+.+.||+|.|..|.+|++ -+|..||||++.+.+.+. ..+.+|+..|+-++|||||++|++..++..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588899999999999999995 589999999998877653 568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGla 220 (245)
+-.+|+|+++|-.+... +.+..+.+++.||+.|+.|+|... +|||||||+|+.+.+ -|-|||+|||++
T Consensus 98 LGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred ecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecccc
Confidence 99999999999766432 889999999999999999999987 999999999998764 589999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..+...... .+.+|++.|-|||
T Consensus 167 Nkf~PG~kL---~TsCGSLAYSAPE 188 (864)
T KOG4717|consen 167 NKFQPGKKL---TTSCGSLAYSAPE 188 (864)
T ss_pred ccCCCcchh---hcccchhhccCch
Confidence 877654433 5679999999998
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=228.41 Aligned_cols=163 Identities=26% Similarity=0.360 Sum_probs=141.3
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccC-C-----CCcceEeEEEEeCCceEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N-----ENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv 139 (245)
+|++.++||+|.||.|.+|.. .+++.||||+++....-..+-..|+.+|..|+ | -|+|+++++|...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 367788999999999999994 58999999999887777777788999999997 4 3899999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC--CceEEecc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDF 217 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~--~~vkl~Df 217 (245)
+|.+.. +|+++++.+.... |+...+..++.||+.||.+||..+ |||+||||+||||.+. ..|||+||
T Consensus 267 fELL~~-NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 999965 9999999876432 899999999999999999999997 9999999999999754 48999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|.|........ +.+-+..|.|||
T Consensus 336 GSSc~~~q~vy-----tYiQSRfYRAPE 358 (586)
T KOG0667|consen 336 GSSCFESQRVY-----TYIQSRFYRAPE 358 (586)
T ss_pred ccccccCCcce-----eeeeccccccch
Confidence 99987654332 345678899998
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=214.22 Aligned_cols=156 Identities=19% Similarity=0.328 Sum_probs=133.8
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCch----HHHHHHHHHHHccCCCCcceEeEEEEe----CCceEEEEEec
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAYEHA 143 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 143 (245)
..||+|+++.||+|.+ +++.||||.+....... +.+.+|+.+|++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 57899999997654433 566799999999999999999999876 35789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
.+|+|.+++.... .+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.
T Consensus 105 ~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 9999999997643 278889999999999999999984 5 88999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ....||+.|+|||
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE 190 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYK 190 (283)
T ss_pred hcccc-----ccccCcccccCHH
Confidence 54322 2346899999998
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=228.67 Aligned_cols=166 Identities=23% Similarity=0.335 Sum_probs=133.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeC--------Cc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG--------PL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~ 135 (245)
..+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457999999999999999999965 68899999885432 2345799999999999999999887532 24
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKI 214 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl 214 (245)
++++|||+++ +|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceee
Confidence 6799999975 787776532111 123889999999999999999999998 99999999999998664 7999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++........ ....||+.|||||
T Consensus 213 ~DFGla~~~~~~~~~---~~~~~t~~y~aPE 240 (440)
T PTZ00036 213 CDFGSAKNLLAGQRS---VSYICSRFYRAPE 240 (440)
T ss_pred eccccchhccCCCCc---ccCCCCcCccCHH
Confidence 999999866433221 3357899999998
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=211.77 Aligned_cols=166 Identities=25% Similarity=0.377 Sum_probs=132.4
Q ss_pred eeccCCceEEEEEEEC---CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++|+||+++++.+...+..+++|||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999743 2346888877544322 3467889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
|.+++....... ....++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 82 LKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred HHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 999997654211 112467778899999999999999997 9999999999999999999999999986543322
Q ss_pred cccccccccccccccCCC
Q 025997 228 ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~~~~~~gt~~y~APE 245 (245)
.........+++.|+|||
T Consensus 155 ~~~~~~~~~~~~~y~aPE 172 (269)
T cd05042 155 YYITKDCHAVPLRWLAPE 172 (269)
T ss_pred heeccCCCCCcccccCHH
Confidence 111122334677899997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=221.58 Aligned_cols=164 Identities=25% Similarity=0.316 Sum_probs=136.3
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC-----
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 134 (245)
..++|.+.+.||+|+||.||++... ++..||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 688999999865422 2456788999999999999999999986543
Q ss_pred -ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
..+++|||+.+ +|.+.+... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 47999999975 677766431 778888999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++....... .....||+.|+|||
T Consensus 164 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE 192 (359)
T cd07876 164 ILDFGLARTACTNFM---MTPYVVTRYYRAPE 192 (359)
T ss_pred EecCCCccccccCcc---CCCCcccCCCCCch
Confidence 999999976432211 13356899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=211.37 Aligned_cols=167 Identities=30% Similarity=0.433 Sum_probs=142.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.++++++|+||+++++++...+..++++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999996 4778999998864432 345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||++++++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999886543 2788999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 156 ~~~~~~~--~~~~~~~~~y~~PE 176 (267)
T cd06646 156 ITATIAK--RKSFIGTPYWMAPE 176 (267)
T ss_pred ecccccc--cCccccCccccCHh
Confidence 5432211 12346889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=213.29 Aligned_cols=178 Identities=25% Similarity=0.383 Sum_probs=142.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|++.+.||+|+||.||+|.. .++..+++|.+...... ...+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 35688889999999999999984 24578999998653332 246788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 138 LAYEHASKGSLHDILHGKKGVKG--------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
++|||+.+++|.+++........ ......+++..++.++.|++.||.|||+++ ++||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 99999999999999864321100 001123788899999999999999999998 9999999999999999
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+||+|||+++...............++..|+|||
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChH
Confidence 999999999997654332222223345677899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=211.01 Aligned_cols=168 Identities=26% Similarity=0.454 Sum_probs=141.4
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|.+.+.||+|+||.||+|...+...||+|++.......+.+.+|++++++++|+||+++++.+. .+..+++|||+.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 568999999999999999999776678999999876666678899999999999999999999874 4568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 85 GSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999754321 2788999999999999999999997 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ......++..|+|||
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE 173 (262)
T cd05071 155 NEYT-ARQGAKFPIKWTAPE 173 (262)
T ss_pred cccc-cccCCcccceecCHh
Confidence 2221 112234677899998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=227.67 Aligned_cols=165 Identities=19% Similarity=0.337 Sum_probs=132.1
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC------CcceEeEEEEeC-C
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------NVVELVGYYVDG-P 134 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~-~ 134 (245)
...++|.+.+.||+|+||.||+|... +++.||||+++...........|+.+++.++|. +++++++++... .
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 34578999999999999999999965 678899999865444445566778777777654 588888888754 4
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCC---
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDD--- 210 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~--- 210 (245)
..++|||++ +++|.+++.... .+++..+..++.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 688999987 668998887543 28889999999999999999997 46 99999999999998765
Q ss_pred -------------ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 -------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 -------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||++...... ....+||+.|||||
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE 315 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPE 315 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcH
Confidence 4999999987543221 23467999999998
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=213.30 Aligned_cols=178 Identities=24% Similarity=0.424 Sum_probs=144.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888999999999999999864 2478999998655433 46788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
+++|||+++++|.+++........ ......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999976532110 111234788899999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++...............+++.|+|||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChh
Confidence 9999999987543322211122335678899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=223.62 Aligned_cols=165 Identities=28% Similarity=0.399 Sum_probs=137.9
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (245)
+|++.+.||+|+||.||++.. .+++.||+|++..... ....+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999996 4789999999865322 2356788999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence 9999997 58888876543 2889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++........ ......+|+.|+|||
T Consensus 148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE 174 (372)
T cd07853 148 GLARVEEPDESK-HMTQEVVTQYYRAPE 174 (372)
T ss_pred cceeecccCccc-cCCCCCcCCCcCCHH
Confidence 998765332211 112346899999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=224.97 Aligned_cols=164 Identities=18% Similarity=0.285 Sum_probs=138.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC---CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
..+|.+.+.||+|+||.||+|... ++..|++|.+... ....+|+.++++++|+||+++++++......+++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 356999999999999999999853 4568999987543 345679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
++. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 167 ~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 167 KYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred hcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 986 58988885432 2899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...............||+.|+|||
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE 257 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPE 257 (392)
T ss_pred ccCcccccccccccccccCccCHh
Confidence 665433322223467999999998
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=214.56 Aligned_cols=180 Identities=31% Similarity=0.454 Sum_probs=146.6
Q ss_pred eeHHHHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEE--
Q 025997 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV-- 131 (245)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-- 131 (245)
+..+.+....++|++.+.||+|+||.||++... +++.+|+|.+.........+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 334455566789999999999999999999964 678999998866544456788899999999 6999999999874
Q ss_pred ---eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC
Q 025997 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (245)
Q Consensus 132 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~ 208 (245)
.++..+++|||+++++|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+||++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~ 159 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTT 159 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECC
Confidence 345789999999999999987643211 113788889999999999999999997 999999999999999
Q ss_pred CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.+||+|||+++........ .....|++.|+|||
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 194 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPE 194 (286)
T ss_pred CCCEEEccCCceeecccCCCc--cccccCCCcccChh
Confidence 999999999998765432211 13346899999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.24 Aligned_cols=174 Identities=25% Similarity=0.430 Sum_probs=144.1
Q ss_pred CCCCCCeeccCCceEEEEEEEC--CCc----EEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR--SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~--~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
+.++.+.||+|+||.||.|... .+. .||+|.+..... ...+|++|..+|++++|||||+++|++.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3456778999999999999965 233 489999976643 35689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
++|||++|+|..+|++.+..... ...++..+.+.++.+||+|+.||++++ +|||||..+|+|++....|||+|||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999987433222 234899999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+.+.....+.......=...|||||
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PE 874 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPE 874 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHH
Confidence 999665544443322211235899998
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=220.05 Aligned_cols=163 Identities=30% Similarity=0.422 Sum_probs=137.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeC------
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 133 (245)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 356899999999999999999995 4788999999865432 234577899999999999999999887543
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
...+++++++ +++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEE
Confidence 3468999987 679998886432 889999999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++...... ....||+.|+|||
T Consensus 159 l~Dfg~~~~~~~~~-----~~~~~t~~y~aPE 185 (343)
T cd07878 159 ILDFGLARQADDEM-----TGYVATRWYRAPE 185 (343)
T ss_pred EcCCccceecCCCc-----CCccccccccCch
Confidence 99999997654321 3457899999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=210.06 Aligned_cols=167 Identities=23% Similarity=0.328 Sum_probs=135.2
Q ss_pred CeeccCCceEEEEEEEC---CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
+.||+|+||.||+|... ++..+|+|.+...... ...+.+|+.++++++||||+++++++.+....+++|||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999854 3457899988655432 346888999999999999999999999889999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
+|.+++....... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997543211 112567778889999999999999998 999999999999999999999999998754433
Q ss_pred ccccccccccccccccCCC
Q 025997 227 AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~~~~~~gt~~y~APE 245 (245)
..........|++.|+|||
T Consensus 154 ~~~~~~~~~~~~~~y~aPE 172 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPE 172 (269)
T ss_pred ceeecCCCcCCcccccCHh
Confidence 2222223346788999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=222.28 Aligned_cols=179 Identities=27% Similarity=0.430 Sum_probs=143.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccC-CCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||.||+|+++ .+..||+|++...... .+.+.+|+.++.++. |+||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999853 3467999999754332 346889999999997 999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCC-------------------------------------------------------
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVK------------------------------------------------------- 159 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------- 159 (245)
..++|+||+.+|+|.+++.......
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999997543200
Q ss_pred ----------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 025997 160 ----------------------------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (245)
Q Consensus 160 ----------------------------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nil 205 (245)
.......+++..++.++.||+.||.|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 0011234788889999999999999999997 999999999999
Q ss_pred EcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 206 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++++.+||+|||+++...............+++.|||||
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 9999999999999997653322211112345788999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=213.27 Aligned_cols=179 Identities=24% Similarity=0.388 Sum_probs=141.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...... ...+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999753 2457999988654432 3457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.+++|||+.+|+|.+++......... .....+++..+..++.||+.||.|||+++ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999754321111 11223567788899999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...............++..|+|||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE 191 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHH
Confidence 9999987654332222122234577899998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=209.31 Aligned_cols=169 Identities=26% Similarity=0.441 Sum_probs=142.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4578999999999999999999888888999999776666778999999999999999999999875 456899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 84 KGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 99999999754321 2789999999999999999999998 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......++..|+|||
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE 173 (260)
T cd05070 154 DNEYT-ARQGAKFPIKWTAPE 173 (260)
T ss_pred Ccccc-cccCCCCCccccChH
Confidence 32211 111223567899998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=210.20 Aligned_cols=169 Identities=25% Similarity=0.408 Sum_probs=142.9
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.+|.+.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45778889999999999999965 67899999987665556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 86 ~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 86 YGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 99999998754321 2788899999999999999999997 9999999999999999999999999987665
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....++..|+|||
T Consensus 156 ~~~~~~-~~~~~~~~~y~aPE 175 (263)
T cd05052 156 GDTYTA-HAGAKFPIKWTAPE 175 (263)
T ss_pred cceeec-cCCCCCccccCCHH
Confidence 432211 11223467899998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=213.99 Aligned_cols=164 Identities=28% Similarity=0.427 Sum_probs=141.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+|++++++++||||+++++++..++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 6788899987654322 34678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++|+||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 81 MDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence 99999999997643 27888999999999999999997 45 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....|++.|+|||
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE 168 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPE 168 (308)
T ss_pred cccccc----cccCCCCcCccChh
Confidence 653322 13457899999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=197.04 Aligned_cols=166 Identities=22% Similarity=0.368 Sum_probs=142.1
Q ss_pred CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|...++||+|.||+||+|+ +.+++.||+|.+.....+ ....++|+-+++.++|.|||++++....+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 346667789999999999999 457889999988654433 4678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
||.. +|..+.....+. ++...+..++.|++.||.++|+++ ++||||||+|+||+.+|++|++|||+++
T Consensus 82 ~cdq-dlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred HhhH-HHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 9964 899998876543 888889999999999999999997 9999999999999999999999999999
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.++..... .+..+-|++|.+|.
T Consensus 150 afgipvrc--ysaevvtlwyrppd 171 (292)
T KOG0662|consen 150 AFGIPVRC--YSAEVVTLWYRPPD 171 (292)
T ss_pred hcCCceEe--eeceeeeeeccCcc
Confidence 87655432 23446689998884
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=208.84 Aligned_cols=171 Identities=26% Similarity=0.442 Sum_probs=146.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..++|.+.+.||+|+||.||+|...+++.+|+|.+........++.+|+.++++++|+||+++++++......+++|||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34679999999999999999999887788999999876667788999999999999999999999999888999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++...
T Consensus 84 ~~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 84 SKGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CCCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence 999999999764322 2889999999999999999999998 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....++..|+|||
T Consensus 154 ~~~~~~~-~~~~~~~~~y~~PE 174 (261)
T cd05034 154 EDDEYTA-REGAKFPIKWTAPE 174 (261)
T ss_pred cchhhhh-hhccCCCccccCHH
Confidence 5322111 11223466899997
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=215.92 Aligned_cols=168 Identities=24% Similarity=0.321 Sum_probs=145.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|+.+++||+|.||+|.+++- .+++.+|+|++++...- ...-+.|-.+|+..+||.+..+.-.|.+.+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 467899999999999999999994 58999999999765422 2334568899999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||..||.|.-.|.+.+ .+++.....+..+|..||.|||+++ ||.||||.+|+|+|.+|++||+|||
T Consensus 246 VMeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 999999999998887654 3888888889999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++.-..... ...+++|||.|+|||
T Consensus 314 LCKE~I~~g~--t~kTFCGTPEYLAPE 338 (516)
T KOG0690|consen 314 LCKEEIKYGD--TTKTFCGTPEYLAPE 338 (516)
T ss_pred cchhcccccc--eeccccCChhhcCch
Confidence 9985433222 236789999999998
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=208.91 Aligned_cols=169 Identities=24% Similarity=0.418 Sum_probs=143.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|...+++.+|+|.+........++.+|+.++++++|+||+++++++ ..+..++++||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 467899999999999999999988889999999987776778899999999999999999999986 4567899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 84 NGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999998754322 2788999999999999999999998 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....++..|+|||
T Consensus 154 ~~~~~~-~~~~~~~~~y~~pe 173 (260)
T cd05067 154 DNEYTA-REGAKFPIKWTAPE 173 (260)
T ss_pred CCCccc-ccCCcccccccCHH
Confidence 222111 12234567899998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=212.83 Aligned_cols=178 Identities=23% Similarity=0.333 Sum_probs=143.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC-----------------CcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVE 125 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~ 125 (245)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999988542 24589998865443 2457888999999999999999
Q ss_pred EeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 025997 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (245)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~N 203 (245)
+++++..++..++++|++.+++|.+++......... .....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999999765421100 11123889999999999999999999997 9999999999
Q ss_pred eEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 204 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++.++.++|+|||+++...............+++.|||||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence 999999999999999987654332222223445678899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=212.78 Aligned_cols=178 Identities=25% Similarity=0.356 Sum_probs=141.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC---------------CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELV 127 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~ 127 (245)
.++|++.+.||+|+||.||+|+... ...||+|.+...... ...+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999987532 235899988654322 35688999999999999999999
Q ss_pred EEEEeCCceEEEEEecCCCCHHHHHhcCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 025997 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (245)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Ni 204 (245)
+++...+..+++|||+.+++|.+++....... .......+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532111 0011123688899999999999999999998 99999999999
Q ss_pred EEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 205 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++++++.+||+|||++................+++.|+|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 99999999999999987654322211122334577899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=210.60 Aligned_cols=169 Identities=28% Similarity=0.453 Sum_probs=145.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..+|.+.+.||.|+||.||+|....+..+++|.+..... ....+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 356889999999999999999988889999999876554 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++++|.+++...... .+++..+..++.||+.||.|||+++ ++|+||||+||++++++.+||+|||++...
T Consensus 85 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 85 EKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999764322 2788999999999999999999998 999999999999999999999999999766
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ....++..|+|||
T Consensus 155 ~~~~~~~--~~~~~~~~~~~PE 174 (261)
T cd05148 155 KEDVYLS--SDKKIPYKWTAPE 174 (261)
T ss_pred CCccccc--cCCCCceEecCHH
Confidence 4332221 1234577899997
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=206.65 Aligned_cols=163 Identities=26% Similarity=0.426 Sum_probs=133.9
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
+.||+|+||.||+|... +++.+|+|.+..... ....+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 788999998754332 235688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 999865432 2788999999999999999999998 99999999999999999999999999876543211
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
........++..|+|||
T Consensus 150 ~~~~~~~~~~~~y~aPE 166 (252)
T cd05084 150 ASTGGMKQIPVKWTAPE 166 (252)
T ss_pred cccCCCCCCceeecCch
Confidence 11111112345799998
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=243.47 Aligned_cols=175 Identities=25% Similarity=0.309 Sum_probs=152.7
Q ss_pred HHHHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEe
Q 025997 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (245)
Q Consensus 58 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 132 (245)
..+++...++|+++++||+|+||.|..++++ +++.||+|++.+.. ....-|+.|-.+|..-+.+.|++++-+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566777899999999999999999999975 78899999997632 234567888899999899999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
..++|+||||++||+|..++.... .+++..+..++..|..||.-||+.| +|||||||+|||||..|++
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcE
Confidence 999999999999999999998654 2889999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||.+-.+.... ...+...+|||-|++||
T Consensus 215 kLADFGsClkm~~dG-~V~s~~aVGTPDYISPE 246 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADG-TVRSSVAVGTPDYISPE 246 (1317)
T ss_pred eeccchhHHhcCCCC-cEEeccccCCCCccCHH
Confidence 999999987665432 33445678999999998
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=209.70 Aligned_cols=170 Identities=22% Similarity=0.379 Sum_probs=142.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999954 788999998754221 2346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++...... ...++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999988643211 113788889999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....|++.|+|||
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~aPE 176 (267)
T cd08228 154 RFFSSKTTA--AHSLVGTPYYMSPE 176 (267)
T ss_pred eeccchhHH--HhcCCCCccccChh
Confidence 766543221 12346889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=211.91 Aligned_cols=167 Identities=32% Similarity=0.450 Sum_probs=142.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|.++.... ....+.+|+.+++.++||||+++++++...+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 356888889999999999999964 688999998865432 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++..... +++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 88 CGGGSLQDIYHVTGP---------LSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999875432 889999999999999999999998 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......||+.|+|||
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE 176 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPE 176 (267)
T ss_pred ccCccc--ccccccCcccccChh
Confidence 543221 113357899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=211.72 Aligned_cols=169 Identities=31% Similarity=0.493 Sum_probs=143.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeC------Cce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG------PLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~ 136 (245)
.+.|++.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 456888889999999999999965 678999999876666667888999999998 799999999998753 458
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++|+|
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999998764322 2888999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||++........ ......|++.|+|||
T Consensus 155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE 181 (272)
T cd06637 155 FGVSAQLDRTVG--RRNTFIGTPYWMAPE 181 (272)
T ss_pred CCCceecccccc--cCCcccccccccCHh
Confidence 999876543221 123457899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=233.77 Aligned_cols=171 Identities=22% Similarity=0.335 Sum_probs=136.2
Q ss_pred CCCCCCeeccCCceEEEEEEECCC-cEEEEEEcCCC-CCchHHHHHHHHHHHccC-CCCcceEeE-EEEe------CCce
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSG-RAAAIKKLDSS-KQPDQEFLAQVSMVSRLK-NENVVELVG-YYVD------GPLR 136 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~------~~~~ 136 (245)
++.+.++|.+|||+.||+|....+ ..+|+|++-.. ....+.+.+||.+|+.|. |+|||.|++ .... .-.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 356678899999999999997655 99999988544 334567889999999995 999999999 3321 1246
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+|.||||.||.|-|++..+.... |++.++++|+.++++|+.+||.. .++|||||||-+||||..+++.||||
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 79999999999999998654322 89999999999999999999998 46799999999999999999999999
Q ss_pred ccCCCCCCcccccccc-------ccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHS-------TRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~-------~~~~gt~~y~APE 245 (245)
||.+............ -....|+.|.|||
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPE 225 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPE 225 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChH
Confidence 9998643221111000 0123699999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=209.84 Aligned_cols=160 Identities=24% Similarity=0.379 Sum_probs=137.7
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||+|+||.||+|.. .+++.+|+|.+...... ...+.+|+.++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999995 47889999988654322 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|..+.. +++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 99999965421 678888999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... .....||..|+|||
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE 163 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPE 163 (279)
T ss_pred ccccc----ccCCCCChhhcCce
Confidence 54321 13357899999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=220.29 Aligned_cols=165 Identities=25% Similarity=0.312 Sum_probs=137.3
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC-----
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 133 (245)
...++|.+.+.||+|+||.||++... +++.+|+|++...... ...+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34678999999999999999999964 6889999998654322 35677899999999999999999988643
Q ss_pred -CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
...+++|||+.+ +|.+.+... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 346999999975 777776532 788889999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++....... .....||+.|+|||
T Consensus 159 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE 188 (355)
T cd07874 159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPE 188 (355)
T ss_pred EEeeCcccccCCCccc---cCCccccCCccCHH
Confidence 9999999976543221 13357899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=212.37 Aligned_cols=163 Identities=29% Similarity=0.412 Sum_probs=142.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|++++++++||||+++++++..++..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 68899999885432 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++..... ++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999976532 888999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....|++.|+|||
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE 168 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPE 168 (290)
T ss_pred cccCCC-----CCCCCCCccccChh
Confidence 876543 13456899999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=218.02 Aligned_cols=178 Identities=23% Similarity=0.384 Sum_probs=140.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEe-CC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-GP 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~ 134 (245)
.++|++.+.||+|+||.||+|... +++.||+|++...... .+.+..|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999732 3478999998654322 34577899999999 89999999998764 45
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC----------------------------------------------------CC
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG----------------------------------------------------AK 162 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~----------------------------------------------------~~ 162 (245)
.+++++||+++++|.+++........ ..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999999865322100 00
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccccccccccccccccc
Q 025997 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242 (245)
Q Consensus 163 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 242 (245)
....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.++|+|||+++.+.............++..||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0124789999999999999999999998 9999999999999999999999999998764333222223345678899
Q ss_pred CCC
Q 025997 243 APE 245 (245)
Q Consensus 243 APE 245 (245)
|||
T Consensus 243 aPE 245 (337)
T cd05054 243 APE 245 (337)
T ss_pred CcH
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=212.86 Aligned_cols=179 Identities=25% Similarity=0.415 Sum_probs=143.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCC--CchHHHHHHHHHHHcc-CCCCcceEeEEEEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 132 (245)
..++|.+.+.||+|+||.||+|++. ++..+|+|.+.... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567889999999999999999742 23478999886432 2235688999999999 89999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nil 205 (245)
....+++|||+.+++|.+++......... .+...+++..++.++.||+.||.|||+++ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 99999999999999999999764321100 11234788899999999999999999998 999999999999
Q ss_pred EcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 206 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.++.+||+|||+++...............+++.|+|||
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 209 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence 9999999999999998664432222222234677899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=211.61 Aligned_cols=178 Identities=22% Similarity=0.392 Sum_probs=142.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ....+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457889999999999999999842 345688998865432 2457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKG----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
+++||+.+++|.+++........ ......+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975432100 011123899999999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++...............+++.|+|||
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 192 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHH
Confidence 99999987654322211122334678899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=229.41 Aligned_cols=173 Identities=18% Similarity=0.256 Sum_probs=132.0
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECC--CcEEEEE------------------EcCCCCCchHHHHHHHHHHHccCCCCc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRS--GRAAAIK------------------KLDSSKQPDQEFLAQVSMVSRLKNENV 123 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~ni 123 (245)
..++|.+.+.||+|+||+||+|..+. +...+.| .+.........+.+|+.++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 2222222 111112223467889999999999999
Q ss_pred ceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 025997 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (245)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~N 203 (245)
+++++++...+..|++++++. ++|.+++....... ........+..++.||+.||.|||+++ |+||||||+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~N 297 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLEN 297 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999999999999999985 47888775432110 011345667789999999999999998 9999999999
Q ss_pred eEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 204 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||++.++.+||+|||+++.+...... ......||+.|+|||
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE 338 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPE 338 (501)
T ss_pred EEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCch
Confidence 99999999999999999876443221 123457999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=216.22 Aligned_cols=168 Identities=26% Similarity=0.442 Sum_probs=140.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHc--cCCCCcceEeEEEEeCC----ceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP----LRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l 138 (245)
..+..+.+.||+|.||.||+|.++ |..||||++.. .+...+.+|.+++.. |+|+||+.|++.-..++ .+||
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 445677889999999999999999 78999999853 355667777777655 69999999998765443 5799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCeEEcCCCceE
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-----~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
|++|.+.|||+|+|.... ++....++++..++.||.+||- +|.|.|.|||||..|||+..+++..
T Consensus 287 vTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 999999999999998754 8999999999999999999995 6778899999999999999999999
Q ss_pred EecccCCCCCCccccc--cccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
|+|+|||......... ......+||-+|||||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPE 390 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPE 390 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChH
Confidence 9999999654433211 1224458999999998
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=209.79 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=136.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|++.+.||+|+||.||+|.+. +++ .+++|.+..... ...++..|+..++++.|+||+++++++. +...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 357888999999999999999964 344 477787753322 2346677888899999999999999875 45678
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+++|+|.+++..... .+++..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+||
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCC
Confidence 89999999999999975432 2889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............++..|+|||
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE 181 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALE 181 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHH
Confidence 9997654332222223345778899998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=212.13 Aligned_cols=168 Identities=23% Similarity=0.370 Sum_probs=141.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
+.++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++...+..++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3567999999999999999999965 678999998864432 3456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+. ++|.+++..... .+++..+..++.||+.||.|||+++ |+|+||||+||++++++.+||+|||++
T Consensus 84 e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred eccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence 9997 589988875432 2788899999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....+++.|+|||
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~~PE 174 (301)
T cd07873 152 RAKSIPTKT--YSNEVVTLWYRPPD 174 (301)
T ss_pred hccCCCCCc--ccccceeecccCcH
Confidence 754332211 12335789999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=206.94 Aligned_cols=168 Identities=26% Similarity=0.442 Sum_probs=140.7
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|.+.+.||+|+||.||+|....+..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 568888999999999999999877778999998766556678899999999999999999998874 5668999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 85 GSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999754321 2788999999999999999999997 99999999999999999999999999876533
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ......++..|+|||
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe 173 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPE 173 (260)
T ss_pred Cccc-ccCCCccchhhCCHH
Confidence 2211 112234677899998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=209.69 Aligned_cols=178 Identities=24% Similarity=0.384 Sum_probs=143.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|... ++..+|+|.+...... ...+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467889999999999999999864 2368999998654322 34678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
+++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321110 11223788899999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++...............+|..|+|||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHH
Confidence 999987654332221223345788999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=233.16 Aligned_cols=167 Identities=24% Similarity=0.333 Sum_probs=143.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+..|+.+++.++|+||++++.++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467999999999999999999976 7889999998654322 25677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++.... .+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+
T Consensus 83 mEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 99999999999997543 2788889999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ .....+|+.|++||
T Consensus 151 s~~~~~~~~~--~~~~~~t~~~~~pe 174 (669)
T cd05610 151 SKVTLNRELN--MMDILTTPSMAKPK 174 (669)
T ss_pred CccccCCccc--ccccccCccccCcc
Confidence 9866433222 23457899999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=211.69 Aligned_cols=164 Identities=31% Similarity=0.509 Sum_probs=138.7
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchH---HHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
|++.+.||+|+||.||++... +++.+|+|.+........ ...+|+.++++++|+||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 566899999976654433 2345999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+++|.+++.... .+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999998322 2899999999999999999999998 999999999999999999999999998653
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......+|..|+|||
T Consensus 149 ~~~~~--~~~~~~~~~~y~aPE 168 (260)
T PF00069_consen 149 SENNE--NFNPFVGTPEYMAPE 168 (260)
T ss_dssp TSTTS--EBSSSSSSGGGSCHH
T ss_pred ccccc--ccccccccccccccc
Confidence 11111 123456899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=206.39 Aligned_cols=168 Identities=27% Similarity=0.412 Sum_probs=141.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
++|.+.+.||+|+||.||+|... +++.+++|.+...... ...+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999954 6889999987543221 2457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
++||+++++|.+++.... .++...+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999987643 2788889999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccc-cccccccccccCCC
Q 025997 219 LSNQAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
+++.......... .....|+..|+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPE 177 (263)
T ss_pred cceeccccccccccccCCCcCccccCcc
Confidence 9876543211111 12345888999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=210.63 Aligned_cols=165 Identities=28% Similarity=0.408 Sum_probs=133.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHcc---CCCCcceEeEEEEe-----CC
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL---KNENVVELVGYYVD-----GP 134 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~ 134 (245)
+|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 788999998864322 224566777776655 79999999998764 24
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++++||+.+ +|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 57999999975 898888754321 2789999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++....... .....||+.|+|||
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 177 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPE 177 (288)
T ss_pred CccCccccccCccc---CCCccccccccCch
Confidence 99999876543221 13346899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=218.97 Aligned_cols=164 Identities=24% Similarity=0.307 Sum_probs=136.8
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeC------
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 133 (245)
..++|.+.+.||+|+||.||++... +++.||||++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999965 688999999865322 245678899999999999999999987643
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
...++||||+.+ +|.+.+... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 357999999975 787777532 778889999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++....... .....||+.|+|||
T Consensus 167 L~DfG~a~~~~~~~~---~~~~~~t~~y~aPE 195 (364)
T cd07875 167 ILDFGLARTAGTSFM---MTPYVVTRYYRAPE 195 (364)
T ss_pred EEeCCCccccCCCCc---ccCCcccCCcCCHH
Confidence 999999976543221 13357899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=212.80 Aligned_cols=178 Identities=28% Similarity=0.419 Sum_probs=141.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCC--chHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
.++|.+.+.||+|+||.||++... +...+|+|.+..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356899999999999999999853 234699999875432 235678899999999 799999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
+..+++|||+++++|.+++....... ...+...+++.+++.++.|++.||.|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997643211 0012234889999999999999999999997 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............+++.|||||
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 212 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence 999999999999987654322111111123457899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=211.86 Aligned_cols=177 Identities=28% Similarity=0.371 Sum_probs=140.9
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.+|.+.+.||+|+||.||+|... .++.||+|.+...... .+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45777889999999999999853 2468999998754332 356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 138 LAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
+++||+.+++|.+++....... .......+++..++.++.|++.||.|||+++ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999986432100 0001123788889999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||+++...............+++.|+|||
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE 196 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHH
Confidence 99999999988664332221122335678999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=211.21 Aligned_cols=175 Identities=27% Similarity=0.422 Sum_probs=145.2
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-C----CcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe-C
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-G 133 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 133 (245)
+....|+....||+|.||.||+|... + .+.+|||+++.++.. .....+|+.+++.|+|+||+.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45567999999999999999999743 2 237899999765332 3567789999999999999999999887 7
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC----
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---- 209 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---- 209 (245)
..+++++||.+. +|.++++..+.... ..++...+..|+.||+.|+.|||++= |+||||||+|||+..+
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPER 172 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCcc
Confidence 789999999987 99999987665432 35888999999999999999999986 9999999999999876
Q ss_pred CceEEecccCCCCCCcccccc-ccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
|.|||+|||+++.+....... ....++-|.+|.|||
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 899999999998776543322 334567899999998
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=206.63 Aligned_cols=165 Identities=20% Similarity=0.300 Sum_probs=131.7
Q ss_pred eeccCCceEEEEEEECCC---cEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.||+|+||.||++...++ ..+++|.+..... ..+.+.+|+.+++.++||||+++++.+.+....+++|||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 3456776654432 34678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
|.+++...... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence 99999764321 112566778889999999999999997 9999999999999999999999999986432221
Q ss_pred cccccccccccccccCCC
Q 025997 228 ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~~~~~~gt~~y~APE 245 (245)
.........|+..|+|||
T Consensus 154 ~~~~~~~~~~~~~y~aPE 171 (268)
T cd05086 154 YIETEDDKCVPLRWLAPE 171 (268)
T ss_pred hhhcccCCcCcccccCch
Confidence 111123456889999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=205.23 Aligned_cols=167 Identities=23% Similarity=0.369 Sum_probs=141.7
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+|++.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999965 78899999875432 23457788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++++|.+++...... .++...++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 81 DGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 999999988654322 2788889999999999999999998 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....|++.|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~~aPE 170 (255)
T cd08219 151 TSPGAY--ACTYVGTPYYVPPE 170 (255)
T ss_pred cccccc--cccccCCccccCHH
Confidence 432221 13356899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=209.03 Aligned_cols=176 Identities=24% Similarity=0.363 Sum_probs=140.1
Q ss_pred CCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
+|.+.+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 2246888887654332 3568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 025997 139 AYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~N 203 (245)
++||+.+++|.+++....... .......+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999987542110 0111234789999999999999999999997 9999999999
Q ss_pred eEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 204 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++++.+||+|||+++...............++..|+|||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE 199 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE 199 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence 999999999999999987654332221122334677899998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=216.64 Aligned_cols=178 Identities=22% Similarity=0.376 Sum_probs=139.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC-C
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG-P 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 134 (245)
.++|++.+.||+|+||.||+|.+ .+++.||||.+...... ...+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999974 24678999998654332 34678899999999 689999999987654 5
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC------------------------------------------------------
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------ 160 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 160 (245)
..+++|||+.+|+|.+++........
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999875321000
Q ss_pred ----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccccccccccc
Q 025997 161 ----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236 (245)
Q Consensus 161 ----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 236 (245)
......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 000124788888999999999999999998 9999999999999999999999999987654332221122234
Q ss_pred ccccccCCC
Q 025997 237 GTFGYHAPE 245 (245)
Q Consensus 237 gt~~y~APE 245 (245)
+++.|+|||
T Consensus 243 ~~~~y~aPE 251 (343)
T cd05103 243 LPLKWMAPE 251 (343)
T ss_pred CCcceECcH
Confidence 567899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=206.90 Aligned_cols=169 Identities=26% Similarity=0.434 Sum_probs=139.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-C---CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+|++.+.||+|+||.||+|... + ...+|+|.++..... .+.+.+|+.++++++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999854 2 337899988654332 35788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence 999999999999975432 2788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccc-cccccccccccCCC
Q 025997 220 SNQAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
+........... .....++..|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe 179 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPE 179 (267)
T ss_pred ccccccccceeeecCCCccceeecCHh
Confidence 987654322111 11122456899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=209.07 Aligned_cols=168 Identities=25% Similarity=0.402 Sum_probs=142.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.+.|++.+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999965 588999999865432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|..++..... .+++..+..++.|++.+|.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 91 CPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999888764332 2788999999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....+++.|+|||
T Consensus 160 ~~~~~~~--~~~~~~~~~y~aPE 180 (292)
T cd06644 160 NVKTLQR--RDSFIGTPYWMAPE 180 (292)
T ss_pred ccccccc--cceecCCccccCce
Confidence 4322111 12346889999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=209.84 Aligned_cols=177 Identities=21% Similarity=0.332 Sum_probs=141.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-----------------CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-----------------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVEL 126 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~ 126 (245)
++|++.+.||+|+||.||++... +...+|+|.+..... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998632 234689998865432 24578899999999999999999
Q ss_pred eEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 025997 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (245)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Ni 204 (245)
++++...+..+++|||+.+++|.+++........ ......+++..+..++.|++.||.|||+++ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999976542211 112234788899999999999999999998 99999999999
Q ss_pred EEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 205 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++.++.++|+|||+++............+..+++.|+|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 202 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE 202 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence 99999999999999987654322211112234567899997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=210.15 Aligned_cols=179 Identities=26% Similarity=0.404 Sum_probs=142.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
..++|++.+.||+|+||.||++... ....+|+|.+...... ...+.+|+.+++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467888999999999999999864 2357899988654332 34678899999999 8999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~ 207 (245)
..+++|||+++++|.+++........ ......+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 99999999999999999975421100 011234889999999999999999999997 99999999999999
Q ss_pred CCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++.+||+|||+++...............++..|+|||
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 204 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE 204 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence 99999999999998664432221112223567899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=211.43 Aligned_cols=170 Identities=23% Similarity=0.378 Sum_probs=132.5
Q ss_pred CCeeccCCceEEEEEEEC---CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe--CCceEEEEEecCC
Q 025997 71 NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAYEHASK 145 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 145 (245)
...||+|+||.||+|... ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999999965 45689999886543 23467889999999999999999998854 4578999999875
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----cCCCceEEecccCCC
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN 221 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill----~~~~~vkl~DfGla~ 221 (245)
+|.+++..............+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 88888764322111111224788899999999999999999998 9999999999999 456799999999998
Q ss_pred CCCccccc-cccccccccccccCCC
Q 025997 222 QAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
........ .......||+.|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred ccCCCcccccccCcceecccccCcH
Confidence 65433221 1123456899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=208.50 Aligned_cols=169 Identities=24% Similarity=0.398 Sum_probs=137.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|++.+.||+|+||.||+|.+. ++. .||+|.+...... ...+.+|+.+++.+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467888999999999999999854 444 4899988654332 4567889999999999999999998865 4578
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+||
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence 99999999999999875432 2889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............+++.|||||
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALE 181 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHH
Confidence 9998664332221112223567899998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=211.23 Aligned_cols=172 Identities=24% Similarity=0.405 Sum_probs=142.0
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||.||++... ++..+|+|.+...... .+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457899999999999999999742 3457999988654332 35688999999999 7999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..+++|||+.+++|.+++...... .+++.++..++.|++.||.|||+++ |+|+||||+|||++.++.++|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence 999999999999999999754321 2789999999999999999999997 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...............+++.|+|||
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 213 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHh
Confidence 9999998664432211112234678899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=225.47 Aligned_cols=160 Identities=31% Similarity=0.465 Sum_probs=137.9
Q ss_pred eeccCCceEEEEEEEC-CCcEEEEEEcCCC-CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHHH
Q 025997 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (245)
+||+|.||+||-|+.. +...+|||.+... ....+-+..|+.+.++|+|.|||+++|.+..++++-|.||-.+||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 5667899998543 3445678889999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccCCCCCCccc
Q 025997 151 ILHGKKGVKGAKPGPVL--SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 151 ~l~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~ 227 (245)
++....+. + .+...-.+..||++||.|||++. |||||||-+|+|++. .|.+||+|||.++.+..-
T Consensus 662 LLrskWGP--------lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi- 729 (1226)
T KOG4279|consen 662 LLRSKWGP--------LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI- 729 (1226)
T ss_pred HHHhccCC--------CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-
Confidence 99876543 4 55667778999999999999997 999999999999974 689999999999877532
Q ss_pred cccccccccccccccCCC
Q 025997 228 ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~~~~~~gt~~y~APE 245 (245)
.+.+.++.||+.|||||
T Consensus 730 -nP~TETFTGTLQYMAPE 746 (1226)
T KOG4279|consen 730 -NPCTETFTGTLQYMAPE 746 (1226)
T ss_pred -CccccccccchhhhChH
Confidence 33456789999999998
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=210.18 Aligned_cols=166 Identities=28% Similarity=0.457 Sum_probs=142.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..+|.+.+.||+|+||.||+|... +++.+++|.+...... .+.+.+|+.+++.+.|+||+++++.+..+...++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888999999999999999954 7889999988654433 46688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++.... +++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred cCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 99999999986532 788899999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 166 ~~~~~~~--~~~~~~~~~y~aPE 186 (296)
T cd06654 166 ITPEQSK--RSTMVGTPYWMAPE 186 (296)
T ss_pred ccccccc--cCcccCCccccCHH
Confidence 5432211 12346899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=208.48 Aligned_cols=166 Identities=34% Similarity=0.537 Sum_probs=134.0
Q ss_pred CCCeeccCCceEEEEEEEC-----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 70 TNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.+.||.|.||.||+|.+. .+..|+||.++..... .+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999966 3568999999654333 46899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++|+|.+++...... .+++..++.++.||+.||.|||+++ ++|+||+++||++++++.+||+|||++..
T Consensus 83 ~~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp -TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred cccccccccccccccc-------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999886211 2899999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..............+...|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE 175 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPE 175 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HH
T ss_pred ccccccccccccccccccccccc
Confidence 63222221222334678899997
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=208.44 Aligned_cols=177 Identities=21% Similarity=0.377 Sum_probs=142.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.+|.+.+.||+|+||.||+|... +...+++|.+...... ...+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999843 3456888888654332 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 139 AYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
+|||+++++|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997643210 0011123789999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++|+|||++................+++.|+|||
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 195 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence 9999999997654332221223345788999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=207.37 Aligned_cols=168 Identities=24% Similarity=0.382 Sum_probs=139.0
Q ss_pred CCCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (245)
.|++.+.||+|+||.||++.. .++..||+|.+...... ...+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999984 25778999998654322 35788999999999999999999998765 5689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+++++|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCC
Confidence 99999999999999865432 2789999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025997 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
|+++........ .......|+..|+|||
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE 182 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPE 182 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHH
Confidence 999866433221 1112345777899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=234.26 Aligned_cols=174 Identities=22% Similarity=0.358 Sum_probs=140.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe--CCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 137 (245)
..++|.+.+.||+|+||.||+|.+. ++..+|+|.+...... ...+..|+.++++|+||||++++++|.. ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4578999999999999999999965 6778899988654322 4568889999999999999999998864 35689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEecCCCCCCeEEcC-----
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE----PRIIHRNIKSSNVLLFD----- 208 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~----~~ivHrDlkp~Nill~~----- 208 (245)
|||||+.+++|.++|...... ...+++..++.|+.||+.||.|||+.+. .+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 999999999999998753211 1138999999999999999999998531 24999999999999964
Q ss_pred ------------CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 ------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 ------------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+.+||+|||++........ .....||+.|||||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPE 211 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHH
Confidence 23589999999976643221 13457999999998
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=204.67 Aligned_cols=167 Identities=29% Similarity=0.434 Sum_probs=142.5
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|.+.+.||+|+||.||+|... +++.|++|.+.... .....+.+|+.++++++|+||+++++++...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999965 68899999886432 2346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 9999999999764221 3888999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE 171 (256)
T cd08529 151 LSDNTNF--ANTIVGTPYYLSPE 171 (256)
T ss_pred ccCccch--hhccccCccccCHH
Confidence 6543221 13346889999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=204.89 Aligned_cols=156 Identities=26% Similarity=0.424 Sum_probs=131.7
Q ss_pred CeeccCCceEEEEEEECC-C----------cEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 72 SLIGEGSYGRVYFGVLRS-G----------RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
+.||+|+||.||+|.+.. + ..+++|.+.........+.+|+.++++++|+||+++++++.. +..++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 468999999999999753 3 247778765544446788899999999999999999999888 7789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-------ceE
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-------IAK 213 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-------~vk 213 (245)
||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 80 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence 99999999999976542 2888999999999999999999997 99999999999999887 799
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++...... ....++..|+|||
T Consensus 149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE 174 (259)
T cd05037 149 LSDPGIPITVLSR------EERVERIPWIAPE 174 (259)
T ss_pred eCCCCcccccccc------cccccCCCccChh
Confidence 9999998765431 2235678899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=207.33 Aligned_cols=165 Identities=24% Similarity=0.420 Sum_probs=139.7
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
|++.+.||+|+||.||++... ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++++..++..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677788999999999999965 577889998864432 345688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|..++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 87 GAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999988764321 2889999999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....||+.|+|||
T Consensus 156 ~~~~--~~~~~~~~~y~aPE 173 (282)
T cd06643 156 TIQR--RDSFIGTPYWMAPE 173 (282)
T ss_pred cccc--cccccccccccCHh
Confidence 2211 13356899999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=207.37 Aligned_cols=167 Identities=25% Similarity=0.389 Sum_probs=139.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|.+.+.||+|+||.||+|... ++..||+|++..... ....+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999965 788999998864322 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+. ++|.+++..... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 97 589888865432 113889999999999999999999997 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....+++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE 171 (285)
T cd07861 151 FGIPVRV--YTHEVVTLWYRAPE 171 (285)
T ss_pred cCCCccc--ccCCcccccccChH
Confidence 5432211 12235789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=209.19 Aligned_cols=167 Identities=25% Similarity=0.414 Sum_probs=141.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+|+.++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999965 7889999988653222 35788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+++++|..++..... ...+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 81 MDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred cCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999998875321 11388999999999999999999974 5 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ....|++.|+|||
T Consensus 152 ~~~~~~~----~~~~~~~~y~aPE 171 (286)
T cd06622 152 NLVASLA----KTNIGCQSYMAPE 171 (286)
T ss_pred cccCCcc----ccCCCccCccCcc
Confidence 6543221 2346888999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=206.10 Aligned_cols=176 Identities=24% Similarity=0.388 Sum_probs=142.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
++|++.+.||+|+||.||+|+.+ +.+.+++|.+...... ...+.+|+.++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999954 2457899988654333 457889999999999999999999999889999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+++++|.+++..............+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976542211111123899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++......... ......++..|+|||
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE 188 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPE 188 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChh
Confidence 998754322111 112335778899998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=203.59 Aligned_cols=165 Identities=33% Similarity=0.561 Sum_probs=142.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|... ++.||+|.+.......+.+.+|+.++++++|+||+++++++.+.+..+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 457889999999999999999876 7889999997665556678899999999999999999999998999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999765321 2889999999999999999999998 9999999999999999999999999998763
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ...++..|+|||
T Consensus 154 ~~~~-----~~~~~~~~~ape 169 (256)
T cd05039 154 QGQD-----SGKLPVKWTAPE 169 (256)
T ss_pred cccc-----cCCCcccccCch
Confidence 3221 123456799998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=209.98 Aligned_cols=166 Identities=27% Similarity=0.445 Sum_probs=143.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..+|.+.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999995 4789999999865433 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++.... +++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred cCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999986532 788899999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE 185 (297)
T cd06656 165 ITPEQSK--RSTMVGTPYWMAPE 185 (297)
T ss_pred ccCCccC--cCcccCCccccCHH
Confidence 5432211 12346889999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=207.62 Aligned_cols=163 Identities=26% Similarity=0.444 Sum_probs=139.5
Q ss_pred CCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCC-chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 71 NSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.+.||+|+|+.|-.|. ..++..+|||++.+... .+..+.+|++++... .|+||++++++|+++..+|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3579999999999998 67999999999977654 367899999999999 59999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC---ceEEecccCCCCCC
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAP 224 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~---~vkl~DfGla~~~~ 224 (245)
|...|..+.. +++.++.+++.+|+.||.+||.+| |.||||||+|||-.+.. -|||+||.+...+.
T Consensus 163 lLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 163 LLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred HHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999987764 899999999999999999999998 99999999999986554 68999998875432
Q ss_pred cc-----ccccccccccccccccCCC
Q 025997 225 DA-----AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~-----~~~~~~~~~~gt~~y~APE 245 (245)
.. ...+...+.+|+..|||||
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPE 256 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPE 256 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchh
Confidence 21 1122234568999999998
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=204.84 Aligned_cols=169 Identities=21% Similarity=0.409 Sum_probs=142.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||++....+..+++|.+.......+.+.+|+.++++++|+||+++++.+.. ...+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46789999999999999999997777889999887655556788999999999999999999999877 77899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 84 KGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999764322 2788889999999999999999997 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......++..|+|||
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE 173 (260)
T cd05073 154 DNEYT-AREGAKFPIKWTAPE 173 (260)
T ss_pred CCCcc-cccCCcccccccCHh
Confidence 32211 112224567799998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=209.82 Aligned_cols=168 Identities=26% Similarity=0.400 Sum_probs=143.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++..++..+++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456899999999999999999965 688999998864432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++..... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 84 CDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred cCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999875432 2889999999999999999999998 99999999999999999999999999866
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~PE 173 (280)
T cd06611 153 NKSTLQK--RDTFIGTPYWMAPE 173 (280)
T ss_pred hcccccc--cceeecchhhcCHH
Confidence 5432221 13346899999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=204.42 Aligned_cols=167 Identities=26% Similarity=0.440 Sum_probs=140.5
Q ss_pred CCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc-------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
+|...+.||+|+||.||+|...+++.+|+|.+...... ...+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999999888899999988643321 14577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
+||+++++|.+++..... +++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 81 MEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 999999999999975432 788889999999999999999997 99999999999999999999999999
Q ss_pred CCCCCcccc----ccccccccccccccCCC
Q 025997 220 SNQAPDAAA----RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~----~~~~~~~~gt~~y~APE 245 (245)
+........ ........|+..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe 178 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChh
Confidence 875422110 11112346899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=201.64 Aligned_cols=162 Identities=30% Similarity=0.470 Sum_probs=135.2
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHH
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (245)
++||+|+||.||+|...+++.+|+|.+...... ...+.+|+.++++++|+||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888889999998654432 346888999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccc
Q 025997 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (245)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 229 (245)
+++..... .+++..++.++.|++.+|.|+|+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 99865432 2788999999999999999999998 999999999999999999999999998654322211
Q ss_pred cccccccccccccCCC
Q 025997 230 LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 230 ~~~~~~~gt~~y~APE 245 (245)
. .....+++.|+|||
T Consensus 150 ~-~~~~~~~~~y~aPE 164 (250)
T cd05085 150 S-SGLKQIPIKWTAPE 164 (250)
T ss_pred c-CCCCCCcccccCHH
Confidence 1 11123466799998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=206.05 Aligned_cols=169 Identities=26% Similarity=0.415 Sum_probs=138.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|++.+.||+|+||.||+|... ++. .+|+|.+...... ...+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356888999999999999999854 332 5899988655432 3568889999999999999999999887 7889
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCC
Confidence 99999999999999976532 2889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............++..|+|||
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALE 181 (279)
T ss_pred cccccccCcccceecCCCcccccccCHH
Confidence 9998765332221111122456899998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=205.36 Aligned_cols=172 Identities=24% Similarity=0.346 Sum_probs=133.8
Q ss_pred CCCCCeeccCCceEEEEEEECC-Cc--EEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeC------Cc
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRS-GR--AAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------PL 135 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~-~~--~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 135 (245)
|.+.+.||+|+||.||+|.... +. .+|+|.++.... ..+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999653 33 589998865432 245678899999999999999999987532 34
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++++||+.+|+|.+++....... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence 689999999999999875332111 1123789999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++...............+++.|+|||
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHH
Confidence 999998764332211112234667899987
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=205.98 Aligned_cols=165 Identities=28% Similarity=0.409 Sum_probs=135.4
Q ss_pred CCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 138 (245)
|...+.||+|+||+||++.. .++..||+|.+..... ....+.+|++++++++|+||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988753 3577899999865433 346788999999999999999999987653 45889
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++.... +++..++.++.|++.||.|||+++ |+||||||+|||+++++.++|+|||
T Consensus 86 v~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecc
Confidence 999999999999997542 899999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccc-cccccccccccCCC
Q 025997 219 LSNQAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
+++.......... .....++..|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE 180 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVE 180 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHh
Confidence 9876643222111 11223567799998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=207.56 Aligned_cols=167 Identities=24% Similarity=0.351 Sum_probs=138.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|.+...... ...+.+|+.+++.++|+||+++++++..++..++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 6889999998654322 3467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+. ++|.+++..... .+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 84 YMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred ccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 996 678777654322 1677888889999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....+++.|+|||
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE 173 (291)
T cd07870 152 AKSIPSQT--YSSEVVTLWYRPPD 173 (291)
T ss_pred ccCCCCCC--CCCccccccccCCc
Confidence 64332211 12345789999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=209.68 Aligned_cols=178 Identities=26% Similarity=0.414 Sum_probs=140.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
.++|.+.+.||+|+||.||++... ....+|+|.+...... ...+.+|+.+++++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999742 2457899988654332 34678899999999 699999999999988
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
+..++++||+.+|+|.+++....... .......+++.++..++.||+.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997643210 0011234889999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............+++.|||||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence 999999999999998664322211112223456799998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=203.14 Aligned_cols=168 Identities=24% Similarity=0.456 Sum_probs=143.2
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
.+|++.+.||+|+||.||++.+.++..+|+|.+.........+.+|++++++++|+|++++++++......++++||+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46778889999999999999987788999999876666667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... .+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999875432 2788899999999999999999997 99999999999999999999999999875543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
..... .....++..|+|||
T Consensus 153 ~~~~~-~~~~~~~~~~~aPe 171 (256)
T cd05112 153 DQYTS-STGTKFPVKWSSPE 171 (256)
T ss_pred Ccccc-cCCCccchhhcCHh
Confidence 22111 11223567899998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=208.73 Aligned_cols=175 Identities=28% Similarity=0.436 Sum_probs=138.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc--EEEEEEcCCCCC--chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+..... ....+.+|+.++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 467899999999999999999965 444 457777654322 235678899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
++||+++++|.+++......... .....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 99999999999999765321100 11224889999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||++........ .....++..|+|||
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 193 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIE 193 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHH
Confidence 99999999864321111 11123466799997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=203.99 Aligned_cols=157 Identities=27% Similarity=0.423 Sum_probs=129.9
Q ss_pred CeeccCCceEEEEEEECC-------------CcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 72 SLIGEGSYGRVYFGVLRS-------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
+.||+|+||.||+|.... ...+++|.+...... ...+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 225888887654333 346788899999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc------
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------ 211 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~------ 211 (245)
++|||+.+++|..++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence 99999999999988865432 2788899999999999999999997 999999999999986654
Q ss_pred -eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 -vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++++|||++...... ....|+..|||||
T Consensus 150 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE 178 (262)
T cd05077 150 FIKLSDPGIPITVLSR------QECVERIPWIAPE 178 (262)
T ss_pred eeEeCCCCCCccccCc------ccccccccccChh
Confidence 899999998655322 2235788999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=202.62 Aligned_cols=171 Identities=30% Similarity=0.453 Sum_probs=140.8
Q ss_pred CeeccCCceEEEEEEECC----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|.... +..+++|.+...... ...+.+|+.+++.++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999653 788999998765444 46788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..............+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521100000123899999999999999999999998 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
...........+++.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE 177 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPE 177 (262)
T ss_pred ccccccccCCCcCccccCHH
Confidence 33211223345788999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=203.95 Aligned_cols=172 Identities=24% Similarity=0.351 Sum_probs=136.6
Q ss_pred CCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCc-----
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 135 (245)
|.+.+.||+|+||.||+|... .+..+|+|.+...... ...+.+|+..++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2367999998654332 3468889999999999999999998865544
Q ss_pred -eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.++++||+++++|.+++....... ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence 799999999999999986543211 1123888999999999999999999997 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...............++..|+|||
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHh
Confidence 9999987654332221112223567899997
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=207.17 Aligned_cols=170 Identities=22% Similarity=0.381 Sum_probs=142.7
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||++.. .++..++||.+..... ...++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999995 4789999998754322 2356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999988643211 123889999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....|+..|+|||
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~ape 176 (267)
T cd08229 154 RFFSSKTTA--AHSLVGTPYYMSPE 176 (267)
T ss_pred hccccCCcc--cccccCCcCccCHH
Confidence 765433221 12346889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=204.20 Aligned_cols=165 Identities=20% Similarity=0.293 Sum_probs=136.7
Q ss_pred hhCCCCC-CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEe----CCce
Q 025997 64 KTDNFGT-NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPLR 136 (245)
Q Consensus 64 ~~~~~~~-~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~ 136 (245)
.+++|.+ .++||-|-.|.|..|.++ +++.+|+|++.. .+..++|+++.-.. .|+|||+++++|.+ ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4677876 367999999999999965 788999999853 35567788875444 79999999998864 3457
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceE
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vk 213 (245)
.+|||+|+||.|+..+..++.. .+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred EeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceE
Confidence 8999999999999999887654 3899999999999999999999998 999999999999964 45899
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+|+....... ..+.+-||+|.|||
T Consensus 205 LtDfGFAK~t~~~~~---L~TPc~TPyYvaPe 233 (400)
T KOG0604|consen 205 LTDFGFAKETQEPGD---LMTPCFTPYYVAPE 233 (400)
T ss_pred ecccccccccCCCcc---ccCCcccccccCHH
Confidence 999999987654322 24557899999998
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=203.51 Aligned_cols=170 Identities=25% Similarity=0.420 Sum_probs=143.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999976 88999999875422 12457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++...... ...+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred ecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 999999999998653211 123788999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....|++.|+|||
T Consensus 154 ~~~~~~~~~--~~~~~~~~~y~apE 176 (267)
T cd08224 154 RFFSSKTTA--AHSLVGTPYYMSPE 176 (267)
T ss_pred eeccCCCcc--cceecCCccccCHH
Confidence 765432211 12346889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=205.64 Aligned_cols=169 Identities=25% Similarity=0.391 Sum_probs=137.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-----CCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEe--CCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 137 (245)
.+|++.+.||+|+||.||++... ++..||+|.+...... .+.+.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999742 5778999998654332 4578899999999999999999998653 34689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 99999999999999975432 2788999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccc-cccccccccccCCC
Q 025997 218 DLSNQAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
|++........... .....++..|+|||
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 181 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPE 181 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHH
Confidence 99986643322111 11112345699998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=207.13 Aligned_cols=167 Identities=24% Similarity=0.399 Sum_probs=140.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 477999999999999999999965 678999999864332 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 9985 99998875432 2788999999999999999999997 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....++..|+|||
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~aPE 173 (291)
T cd07844 152 AKSVPSKT--YSNEVVTLWYRPPD 173 (291)
T ss_pred ccCCCCcc--ccccccccccCCcH
Confidence 54322111 12234688899998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=205.79 Aligned_cols=169 Identities=28% Similarity=0.453 Sum_probs=137.9
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CC---cEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+|++.+.||+|+||.||+|... ++ ..||+|.+..... ....+..|+.++++++||||+++++++.++...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788899999999999999965 33 3699999865432 245788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++..... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999875432 2788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccc-ccc--ccccccCCC
Q 025997 220 SNQAPDAAARLHST-RVL--GTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~-~~~--gt~~y~APE 245 (245)
+............. ... .+..|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHh
Confidence 87654322211111 111 245799998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=202.81 Aligned_cols=168 Identities=32% Similarity=0.460 Sum_probs=144.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999964 678899998865433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++..
T Consensus 82 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 82 CGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred CCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999876422 2888999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....++..|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~y~~Pe 171 (262)
T cd06613 151 LTATIAK--RKSFIGTPYWMAPE 171 (262)
T ss_pred hhhhhhc--cccccCCccccCch
Confidence 5433211 13356889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=203.34 Aligned_cols=168 Identities=27% Similarity=0.410 Sum_probs=138.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---c---hHHHHHHHHHHHccCCCCcceEeEEEEeC--Cce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---P---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (245)
.+|.+.+.||+|+||.||++... ++..||+|.+..... . .+.+.+|+.+++++.|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999964 688999998753221 1 24677899999999999999999988763 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++++||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence 899999999999999875432 788888999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
||++......... .......|+..|+|||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPE 179 (265)
T ss_pred CccccccccccccccccccCCCCccccChh
Confidence 9998765321111 0112346899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=207.75 Aligned_cols=175 Identities=30% Similarity=0.496 Sum_probs=144.6
Q ss_pred HHHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEe----
Q 025997 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD---- 132 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---- 132 (245)
.++....+.|++.+.||+|+||.||+|... +++.+|+|.+.........+..|+.+++++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 334445578999999999999999999964 678999998866555556788899999998 79999999999853
Q ss_pred --CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 133 --GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 133 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
.+..+++|||+.+++|.+++...... .+++..+..++.||+.||.|||+++ |+|+||||+||++++++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~ 158 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENA 158 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCC
Confidence 45789999999999999999764432 2778888899999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.++|+|||++......... .....|++.|+|||
T Consensus 159 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 191 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPE 191 (282)
T ss_pred CEEEeeCcchhhhhccccC--CCcccccccccCHh
Confidence 9999999998765432211 13456899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=205.05 Aligned_cols=176 Identities=27% Similarity=0.426 Sum_probs=140.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|.+. .+..|++|.+...... ...+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 356889999999999999999965 3567899987644332 35688999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC---ceE
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~---~vk 213 (245)
+++|||+.+++|.+++........ ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 999999999999999976542111 1124889999999999999999999997 99999999999998654 699
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++................+..|||||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHH
Confidence 99999998663322211112223456899998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=202.91 Aligned_cols=164 Identities=30% Similarity=0.501 Sum_probs=137.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEE-eCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||.||++... +..+++|.+... ...+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 457889999999999999999765 678999988543 23567889999999999999999999764 456789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 83 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence 999999998764321 2788999999999999999999998 999999999999999999999999998755
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....++..|+|||
T Consensus 153 ~~~~-----~~~~~~~~y~aPE 169 (256)
T cd05082 153 SSTQ-----DTGKLPVKWTAPE 169 (256)
T ss_pred cccC-----CCCccceeecCHH
Confidence 3322 2234567899998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=211.21 Aligned_cols=178 Identities=26% Similarity=0.408 Sum_probs=141.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
..+|.+.+.||+|+||.||+|... ....+|+|.+...... .+.+.+|+.+++++ +|+||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 356889999999999999999742 1236899988654322 35788999999999 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
+..++++||+++|+|.+++....... ...+...+++..++.++.|++.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999997643210 0112334888999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............++..|||||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 206 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE 206 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence 999999999999987654322211112223457899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=208.01 Aligned_cols=165 Identities=29% Similarity=0.475 Sum_probs=140.0
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
+|++.+.||+|+||.||+|... +++.||+|.+...... ...+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 6889999998654322 34567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+ +++|.+++..... .+++..++.++.||++||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 8899999976431 2889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... ....+++.|+|||
T Consensus 149 ~~~~~~~~~~~--~~~~~~~~y~aPE 172 (298)
T cd07841 149 ARSFGSPNRKM--THQVVTRWYRAPE 172 (298)
T ss_pred eeeccCCCccc--cccccceeeeCHH
Confidence 97664432211 2235688899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=234.85 Aligned_cols=173 Identities=28% Similarity=0.409 Sum_probs=137.0
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeC-----
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 133 (245)
..-..+|+....||+||||.||+++.+ +|+.||||+|.... ..-..+.+|+.+|++|+|||||+++..|...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345677899999999999999999965 89999999997654 2335688999999999999999998765310
Q ss_pred --------------------------------------------------------------------------------
Q 025997 134 -------------------------------------------------------------------------------- 133 (245)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (245)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHH
Q 025997 134 ----------------------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179 (245)
Q Consensus 134 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i 179 (245)
..+||.||||+...|.+++..+... -.....++++++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREI 706 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHH
Confidence 1246778888887777777665421 0356688999999
Q ss_pred HHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC----------------ccccccccccccccccccC
Q 025997 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----------------DAAARLHSTRVLGTFGYHA 243 (245)
Q Consensus 180 ~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~A 243 (245)
++||.|+|++| ||||||||.||+++++..|||+|||+|+... ........++.+||.-|+|
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999998 9999999999999999999999999998621 0011112345789999999
Q ss_pred CC
Q 025997 244 PE 245 (245)
Q Consensus 244 PE 245 (245)
||
T Consensus 784 PE 785 (1351)
T KOG1035|consen 784 PE 785 (1351)
T ss_pred HH
Confidence 98
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=202.96 Aligned_cols=167 Identities=21% Similarity=0.382 Sum_probs=142.4
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|+..+.||.|+||.||.++. .++..+++|.+.... .....+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999985 468899999875433 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++...... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 9999999999765321 2788999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......|++.|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape 171 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPE 171 (256)
T ss_pred cccccc--cccccCCCccccCHh
Confidence 544332 123456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=205.29 Aligned_cols=166 Identities=27% Similarity=0.390 Sum_probs=140.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|+....||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 688999998754322 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++++|..++.... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 999988887765432 2889999999999999999999997 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....++..|+|||
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~aPE 170 (286)
T cd07847 149 ILTGPGDD--YTDYVATRWYRAPE 170 (286)
T ss_pred ecCCCccc--ccCcccccccCCHH
Confidence 66443211 12345788999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=207.60 Aligned_cols=168 Identities=26% Similarity=0.363 Sum_probs=139.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||.||++... +++.|++|.+..... ....+.+|+.+++.++|+||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999965 678999998865432 2346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence 9999999999997643 2788889999999999999999997 999999999999999999999999998
Q ss_pred CCCCccc-------------cccccccccccccccCCC
Q 025997 221 NQAPDAA-------------ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~-------------~~~~~~~~~gt~~y~APE 245 (245)
+...... .........|+..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 186 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCch
Confidence 6321000 000111245788999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-29 Score=202.53 Aligned_cols=167 Identities=28% Similarity=0.459 Sum_probs=139.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----------hHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
+|.+...||+|+||.||+|... +++.+|+|.+...... .+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999964 6789999987543221 1357789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++++||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 9999999999999999976432 788889999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCcccccc----ccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARL----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~----~~~~~~gt~~y~APE 245 (245)
|||+++......... ......|+..|+|||
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe 182 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChh
Confidence 999987664321110 112345889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=207.03 Aligned_cols=177 Identities=33% Similarity=0.469 Sum_probs=145.2
Q ss_pred HHHHHhhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeC---
Q 025997 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG--- 133 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--- 133 (245)
..+....++|.+.+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|+|++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 33444578899999999999999999996 4788999999876555566778899999998 899999999998754
Q ss_pred --CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 134 --PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 134 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
+..++++||+.+++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 3589999999999999988643211 112788999999999999999999997 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||++......... .....|+..|+|||
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 198 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPE 198 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChh
Confidence 999999998765432221 12346889999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=201.41 Aligned_cols=161 Identities=29% Similarity=0.463 Sum_probs=130.3
Q ss_pred eeccCCceEEEEEEEC---CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.||+|+||.||+|.++ .+..||+|.+...... .+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 3456999988654322 356889999999999999999999875 457899999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 81 L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999875432 2889999999999999999999998 9999999999999999999999999987554322
Q ss_pred cccc-cccccccccccCCC
Q 025997 228 ARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~-~~~~~gt~~y~APE 245 (245)
.... .....+++.|+|||
T Consensus 150 ~~~~~~~~~~~~~~y~aPE 168 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPE 168 (257)
T ss_pred cceeccCCCCCCcccCCHH
Confidence 2111 11112357899998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=206.58 Aligned_cols=178 Identities=25% Similarity=0.374 Sum_probs=142.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+|+.++++++|+||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 4678999988654332 35688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~N 203 (245)
++++||+++++|.+++......... .....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 9999999999999999754321100 11123788889999999999999999997 9999999999
Q ss_pred eEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 204 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++++++.++|+|||++................+++.|+|||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE 202 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHH
Confidence 999999999999999987553322211112234567799997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=205.57 Aligned_cols=156 Identities=27% Similarity=0.396 Sum_probs=127.6
Q ss_pred eeccCCceEEEEEEECC-------------------------CcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceE
Q 025997 73 LIGEGSYGRVYFGVLRS-------------------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVEL 126 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~ 126 (245)
.||+|+||.||+|.... ...|++|.+...... ...+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 135788888654332 3567888999999999999999
Q ss_pred eEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
++++...+..++||||+++++|..++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 9999999999999999999999999865332 2788999999999999999999997 9999999999999
Q ss_pred cCCC-------ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDD-------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~-------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..+ .+|++|||++...... ....++..|+|||
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe 190 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPE 190 (274)
T ss_pred eccCcccCccceeeecCCccccccccc------cccccCCcccCch
Confidence 7643 4899999987644322 1235788899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=217.58 Aligned_cols=165 Identities=24% Similarity=0.402 Sum_probs=142.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchH---------HHHHHHHHHHccC---CCCcceEeEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ---------EFLAQVSMVSRLK---NENVVELVGYYV 131 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~---------~~~~E~~~l~~l~---h~niv~~~~~~~ 131 (245)
..+|...+.+|.|+||.|++|.++ +...|+||.+.+++--.. .+-.|+++|..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456899999999999999999976 556899999876543211 2345999999997 999999999999
Q ss_pred eCCceEEEEEec-CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 132 DGPLRVLAYEHA-SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 132 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
+++++||+||-. ++.+|++++..... +++.++..|+.||+.|+++||+++ |||||||=+|++++.+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG 707 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence 999999999965 56799999987654 889999999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
-+||+|||.|....... ...++||..|.|||
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aape 738 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPE 738 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchh
Confidence 99999999987654432 25678999999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=207.88 Aligned_cols=148 Identities=28% Similarity=0.425 Sum_probs=130.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|+..+.||+|+||.||+|... +++.+|+|.+...... ...+.+|+++++.++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 5889999998655432 346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 81 DYCPGGELFRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred EecCCCCHHHHHHhCCCC-------ccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence 999999999998754322 3888999999999999999999998 999999999999999999999999998
Q ss_pred CCC
Q 025997 221 NQA 223 (245)
Q Consensus 221 ~~~ 223 (245)
...
T Consensus 151 ~~~ 153 (316)
T cd05574 151 KQS 153 (316)
T ss_pred hcc
Confidence 654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=203.56 Aligned_cols=177 Identities=21% Similarity=0.344 Sum_probs=142.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC-----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEe-CCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 136 (245)
.++|.+.+.||+|+||.||+|.+.. +..|++|.+...... ...+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999999764 678999988644322 3567889999999999999999998776 4678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++++|+.+++|.+++........ .....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 999999999999999876432110 11124889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++.+.............++..|+|||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE 189 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALE 189 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHH
Confidence 99998654332222122334677899998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=206.85 Aligned_cols=166 Identities=29% Similarity=0.471 Sum_probs=143.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..+|...+.||.|+||.||+|.. .+++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++++||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34688899999999999999985 4788999998864433 346778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... +++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 98 LAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred cCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999886532 789999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE 185 (296)
T cd06655 165 ITPEQSK--RSTMVGTPYWMAPE 185 (296)
T ss_pred ccccccc--CCCcCCCccccCcc
Confidence 5433221 12346899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=203.56 Aligned_cols=167 Identities=27% Similarity=0.439 Sum_probs=139.0
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---c--------hHHHHHHHHHHHccCCCCcceEeEEEEeCC
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---P--------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 134 (245)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... . .+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999854 688999998753211 0 135678999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++|+||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999987652 2788889999999999999999997 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++................|+..|+|||
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 180 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180 (272)
T ss_pred eeccccccccccccccccccccCCccccCHH
Confidence 9999987654322111122345889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=207.54 Aligned_cols=165 Identities=21% Similarity=0.361 Sum_probs=138.7
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|++.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999965 788999998864322 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+ +|.+++..... .+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CDQ-DLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 974 88888765332 2889999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....+++.|+|||
T Consensus 149 ~~~~~~~--~~~~~~~~~y~aPE 169 (284)
T cd07839 149 FGIPVRC--YSAEVVTLWYRPPD 169 (284)
T ss_pred cCCCCCC--cCCCccccCCcChH
Confidence 5432211 12345789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=205.38 Aligned_cols=178 Identities=21% Similarity=0.363 Sum_probs=141.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
..+|...+.||+|+||.||++... ++..+++|.+..... ....+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999732 356788998764432 3457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 138 LAYEHASKGSLHDILHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
+++||+.+++|.+++....... .......+++..++.++.||+.||.|||+++ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 9999999999999997643210 0111234789999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||++................+++.|+|||
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHH
Confidence 9999999987553322211112234678899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=208.57 Aligned_cols=166 Identities=16% Similarity=0.247 Sum_probs=134.6
Q ss_pred CCCeeccC--CceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 70 TNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 70 ~~~~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+.++||+| +|++||++..+ +++.||+|.+...... .+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78999999964 7899999998654332 245677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++++|.+++...... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+.+...
T Consensus 82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999998654321 2788999999999999999999998 999999999999999999999999865433
Q ss_pred Ccccccc-----ccccccccccccCCC
Q 025997 224 PDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
....... ......++..|||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPE 178 (327)
T ss_pred ccccccccccccccccccceecccChH
Confidence 2111100 011235778899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=204.29 Aligned_cols=166 Identities=27% Similarity=0.407 Sum_probs=142.1
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|++.+.||+|+||.||+|... +++.+++|++..... ....+.+|+.++++++|+||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999965 788999999865432 245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+ +++|.+++..... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 9999999875432 2889999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ......|+..|+|||
T Consensus 149 ~~~~~~~-~~~~~~~~~~y~aPE 170 (286)
T cd07832 149 FSEEEPR-LYSHQVATRWYRAPE 170 (286)
T ss_pred ccCCCCC-ccccccCcccccCce
Confidence 6543211 112346899999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=201.15 Aligned_cols=167 Identities=29% Similarity=0.444 Sum_probs=139.2
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEe-CCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 141 (245)
+|++.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.++++++|+|++++++.+.. ....++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 678899999864332 23467889999999999999999998764 446899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++++|.+++...... .+++.+++.++.+++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 81 FCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred ccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 99999999999764321 3789999999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ......|++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE 172 (257)
T cd08223 151 VLENQCD--MASTLIGTPYYMSPE 172 (257)
T ss_pred EecccCC--ccccccCCcCccChh
Confidence 6543221 123456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=200.99 Aligned_cols=164 Identities=25% Similarity=0.421 Sum_probs=140.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC------chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
+|...+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999966 788999998754321 235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
+||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999997543 2788889999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ .....|+..|+|||
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~~pe 171 (258)
T cd06632 149 AKQVVEFSF---AKSFKGSPYWMAPE 171 (258)
T ss_pred ceecccccc---ccccCCCcceeCHH
Confidence 876543321 13456899999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=205.51 Aligned_cols=174 Identities=28% Similarity=0.423 Sum_probs=137.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCc--EEEEEEcCCCCC--chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (245)
++|++.+.||+|+||.||+|... ++. .+++|.++.... ..+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999865 333 468887764222 235688899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 140 YEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
+||+++++|.+++......... .....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999764321100 01124888999999999999999999997 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||++......... .....+..|+|||
T Consensus 159 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE 188 (297)
T cd05089 159 KIADFGLSRGEEVYVKK---TMGRLPVRWMAIE 188 (297)
T ss_pred EECCcCCCccccceecc---CCCCcCccccCch
Confidence 99999998643221111 1112355799998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=199.84 Aligned_cols=160 Identities=28% Similarity=0.441 Sum_probs=131.3
Q ss_pred eeccCCceEEEEEEEC---CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
.||+|+||.||+|.++ ++..+|+|++...... .+.+.+|+.+++.++|+||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5678999998654332 357888999999999999999999875 45678999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999997543 2788999999999999999999998 999999999999999999999999999765433
Q ss_pred ccccc-cccccccccccCCC
Q 025997 227 AARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~-~~~~~gt~~y~APE 245 (245)
..... .....+++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE 168 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPE 168 (257)
T ss_pred CCeeeecCCCCCCccccCHh
Confidence 22111 11223467899998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=200.99 Aligned_cols=167 Identities=32% Similarity=0.510 Sum_probs=144.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|+..+.||+|+||.||+|... +++.+++|.+..... .+.+.+|+.++++++|+||+++++.+......++++||+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 367999999999999999999976 478999999865433 678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 81 GAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred CCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 99999999875432 2889999999999999999999997 999999999999999999999999998876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....|+..|+|||
T Consensus 150 ~~~~~~--~~~~~~~~~y~~PE 169 (256)
T cd06612 150 TDTMAK--RNTVIGTPFWMAPE 169 (256)
T ss_pred ccCccc--cccccCCccccCHH
Confidence 543211 13345889999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=206.58 Aligned_cols=169 Identities=25% Similarity=0.446 Sum_probs=136.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+...... ...+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCce
Confidence 456888899999999999999854 443 4788887654332 2367889999999999999999998865 4567
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccc
Confidence 89999999999999876432 2788899999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............++..|+|||
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALE 181 (303)
T ss_pred cccccccCcccccccCCCccccccCCHH
Confidence 9998654332221222334677899997
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=208.67 Aligned_cols=164 Identities=31% Similarity=0.496 Sum_probs=138.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.|.....||+|+||.||++... ++..||||.+..... ..+.+.+|+..++.++|+||+++++.+..++..+++|||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999964 688999998865432 24567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+||++++++.++|+|||++....
T Consensus 103 ~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 103 GGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999886432 788899999999999999999997 9999999999999999999999999987554
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... .....|++.|+|||
T Consensus 170 ~~~~~--~~~~~~~~~y~aPE 188 (292)
T cd06658 170 KEVPK--RKSLVGTPYWMAPE 188 (292)
T ss_pred ccccc--CceeecCccccCHH
Confidence 32221 12346899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=198.57 Aligned_cols=163 Identities=30% Similarity=0.506 Sum_probs=135.9
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHH
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (245)
+.||+|+||.||++....++.|++|.+...... ...+.+|+.++++++|+||+++++++.+....++++||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999766899999988654433 457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccc
Q 025997 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (245)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 229 (245)
+++..... .+++..++.++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99865432 2788889999999999999999997 999999999999999999999999998765422211
Q ss_pred cccccccccccccCCC
Q 025997 230 LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 230 ~~~~~~~gt~~y~APE 245 (245)
.......++..|+|||
T Consensus 150 ~~~~~~~~~~~y~~PE 165 (251)
T cd05041 150 VSDGLKQIPIKWTAPE 165 (251)
T ss_pred eccccCcceeccCChH
Confidence 1111223456799998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=199.96 Aligned_cols=168 Identities=26% Similarity=0.393 Sum_probs=138.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC------chHHHHHHHHHHHccCCCCcceEeEEEEe--CCce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 136 (245)
.+|...+.||+|+||.||+|... ++..+++|.+..... ....+.+|+.++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36899999999999999999964 688999998754321 12457789999999999999999998875 3568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++++||+++++|.+++..... +++...+.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 899999999999999975432 788889999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCcccc-ccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAA-RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~-~~~~~~~~gt~~y~APE 245 (245)
||+++....... ........++..|+|||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPE 179 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHH
Confidence 999876532111 11112345889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=203.07 Aligned_cols=172 Identities=31% Similarity=0.489 Sum_probs=144.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCC------c
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP------L 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~ 135 (245)
..++|++.+.||+|+||.||+|... +++.+++|.+.......+.+.+|+.+++++ .|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 3578999999999999999999975 678899999876665667889999999999 7999999999997644 4
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.+++|||+.+++|.+++...... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence 89999999999999988653310 113888999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++......... .....|++.|+|||
T Consensus 156 d~~~~~~~~~~~~~--~~~~~~~~~y~aPE 183 (275)
T cd06608 156 DFGVSAQLDSTLGR--RNTFIGTPYWMAPE 183 (275)
T ss_pred CCccceecccchhh--hcCccccccccCHh
Confidence 99998755432221 13346899999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=203.42 Aligned_cols=168 Identities=27% Similarity=0.367 Sum_probs=137.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHH-HHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||.||++... +++.||+|.++.... ....+..|+.. ++.++|+||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 789999999865433 23455666665 566789999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|++ ++|.+++...... ...+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 997 5888887653221 12389999999999999999999987 6 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....|+..|+|||
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~aPE 173 (283)
T cd06617 152 GYLVDSVA---KTIDAGCKPYMAPE 173 (283)
T ss_pred cccccccc---cccccCCccccChh
Confidence 76543221 12346889999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=206.32 Aligned_cols=166 Identities=28% Similarity=0.439 Sum_probs=140.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||.||+|... +++.+|+|.+..... ..+.+.+|+++++.++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 688999998754332 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.++..... .+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999988888765432 2789999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....++..|+|||
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~aPE 170 (286)
T cd07846 149 TLAAPGEV--YTDYVATRWYRAPE 170 (286)
T ss_pred eccCCccc--cCcccceeeccCcH
Confidence 65433211 12346889999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=203.72 Aligned_cols=166 Identities=23% Similarity=0.333 Sum_probs=139.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCC-----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCce
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (245)
+|++.+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+.+++++ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999853 67899999886432 2235677899999999 589999999999998999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++++||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER---------FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 999999999999999875432 788888889999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||++......... ......|+..|+|||
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE 176 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPD 176 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChh
Confidence 9998765432211 112356899999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=201.97 Aligned_cols=167 Identities=23% Similarity=0.408 Sum_probs=140.1
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC-------chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999995 5788999998864331 13567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDF 217 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~Df 217 (245)
++||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .+||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 999999999999987543 2788899999999999999999998 99999999999998775 6999999
Q ss_pred cCCCCCCcccccc--ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
|++.......... ......||..|+|||
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE 178 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178 (268)
T ss_pred ccccccccccccCCccccccccccceeCHh
Confidence 9987665332111 112346889999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=198.58 Aligned_cols=167 Identities=30% Similarity=0.464 Sum_probs=140.5
Q ss_pred CCCCCeeccCCceEEEEEEECC-----CcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
+.+.+.||.|+||.||++.... +..+|+|.+..... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999653 37899999966544 3567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 999999999999764321 1788999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
............ ...+++.|+|||
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~y~~Pe 174 (258)
T smart00219 151 RDLYDDDYYKKK-GGKLPIRWMAPE 174 (258)
T ss_pred eecccccccccc-cCCCcccccChH
Confidence 766544222111 123678999997
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=205.01 Aligned_cols=167 Identities=27% Similarity=0.399 Sum_probs=140.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 138 (245)
.++|+..+.||+|+||.||+|... +++.+++|.++..... ...+.+|+.++++++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 457899999999999999999975 6889999998644322 23567899999999999999999998877 88999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
++||+.+ +|.+++..... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 84 v~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 9999975 99998875432 2889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... .....+++.|+|||
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE 176 (293)
T cd07843 152 LAREYGSPLKP--YTQLVVTLWYRAPE 176 (293)
T ss_pred ceeeccCCccc--cccccccccccCch
Confidence 98866543211 12345788999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=213.92 Aligned_cols=169 Identities=21% Similarity=0.303 Sum_probs=144.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCC---CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (245)
+...|++.+.||+||.+.||++...+.+.+|+|++.... .....|.+|+.+|.+| .|.+||++++|-..++++|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 344689999999999999999998888889998774433 3356799999999999 589999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||- ..+|.++|...... .+...+..+..|+++++.++|.+| |||.||||+|+|+. .|.+||+|||+
T Consensus 439 mE~G-d~DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGI 505 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGI 505 (677)
T ss_pred eecc-cccHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeech
Confidence 9975 46999999876542 332367788999999999999998 99999999999885 57899999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|..+..........+.+||+.||+||
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPE 531 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPE 531 (677)
T ss_pred hcccCccccceeeccccCcccccCHH
Confidence 99888776666666779999999998
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=200.97 Aligned_cols=171 Identities=29% Similarity=0.419 Sum_probs=139.3
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
..+++.....||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.++++++|+||+++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3455556678999999999999955 677899998865433 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGla 220 (245)
|+.+++|.+++...... ...+...+..++.||+.||.|||+++ |+||||||+||+++. ++.++|+|||++
T Consensus 86 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 86 QVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred cCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999754211 01267788889999999999999997 999999999999976 679999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ......|++.|+|||
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~aPE 179 (268)
T cd06624 157 KRLAGINP--CTETFTGTLQYMAPE 179 (268)
T ss_pred eecccCCC--ccccCCCCccccChh
Confidence 76533221 112345889999998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=201.06 Aligned_cols=169 Identities=25% Similarity=0.432 Sum_probs=140.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEe--CCce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 136 (245)
..|.+.+.||+|+||.||++.+. ++..+|+|.+...... .+.+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778889999999999999853 4678999998766553 5678999999999999999999999876 5678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+++++|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999976542 2889999999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccc-cccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
||++........... .....++..|+|||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe 182 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcH
Confidence 999987653221111 11123456789997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=204.91 Aligned_cols=165 Identities=25% Similarity=0.368 Sum_probs=141.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||++... +++.+|+|++..... ....+.+|+++++.++|+||+++++++...+..++++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888899999999999999965 688899998754332 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|+++++|.+++.... .+++..+..++.+++.+|.|||+ ++ ++|+||||+||++++++.++|+|||++
T Consensus 84 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 84 FMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred cCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 999999999887543 27889999999999999999997 45 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||..|+|||
T Consensus 152 ~~~~~~~----~~~~~~~~~~~aPE 172 (284)
T cd06620 152 GELINSI----ADTFVGTSTYMSPE 172 (284)
T ss_pred cchhhhc----cCccccCcccCCHH
Confidence 6543221 13357899999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=204.03 Aligned_cols=166 Identities=27% Similarity=0.439 Sum_probs=142.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||++... +++.+++|.+..... ..+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 467999999999999999999854 678999999864432 345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred CCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999987542 788899999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 165 ~~~~~~~--~~~~~~~~~y~~PE 185 (293)
T cd06647 165 ITPEQSK--RSTMVGTPYWMAPE 185 (293)
T ss_pred ccccccc--cccccCChhhcCch
Confidence 5433221 12346889999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=200.83 Aligned_cols=164 Identities=29% Similarity=0.440 Sum_probs=140.2
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
-|+..+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999864 678999998754432 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+++|.+++.... +++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 85 GGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9999999986432 788999999999999999999998 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......|+..|+|||
T Consensus 152 ~~~~~--~~~~~~~~~~y~~PE 171 (277)
T cd06641 152 TDTQI--KRNTFVGTPFWMAPE 171 (277)
T ss_pred ccchh--hhccccCCccccChh
Confidence 43221 123346889999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=202.04 Aligned_cols=165 Identities=29% Similarity=0.448 Sum_probs=143.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||.|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++|+||+++++++.++...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68899999886543 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999987542 889999999999999999999997 99999999999999999999999999977
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......|++.|+|||
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE 168 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPE 168 (274)
T ss_pred eccccc--ccccccCCccccChh
Confidence 654321 123456899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=208.57 Aligned_cols=159 Identities=20% Similarity=0.202 Sum_probs=123.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEEcCCCC------CchHHHHHHHHHHHccCCCCcce-EeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVE-LVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||+||+|.++ +++.+|||++.... ...+.+.+|+.+|++++|+|++. ++. .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 4578999999999999999999865 56778999865321 12456889999999999999985 443 24
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeEEcCCCceE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIAK 213 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDl-kp~Nill~~~~~vk 213 (245)
..++||||++|++|... .. .. ...++.+++++|.|||+++ |+|||| ||+|||++.++.+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 58999999999999632 10 11 1356789999999999998 999999 99999999999999
Q ss_pred EecccCCCCCCccccccc------cccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLH------STRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~------~~~~~gt~~y~APE 245 (245)
|+|||+|+.......... -....+++.|+|||
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence 999999986643321111 12456888999998
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=198.91 Aligned_cols=163 Identities=31% Similarity=0.454 Sum_probs=135.5
Q ss_pred CeeccCCceEEEEEEECC--C--cEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLRS--G--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|.+.+ + ..+|+|.+..... ..+.+.+|+.++++++|+||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999643 2 3689999876554 34578899999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999976532 12889999999999999999999998 99999999999999999999999999987644
Q ss_pred ccccc-ccccccccccccCCC
Q 025997 226 AAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~-~~~~~~gt~~y~APE 245 (245)
..... ......++..|+|||
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE 170 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPE 170 (257)
T ss_pred cccceecccCCCCCceecCHH
Confidence 22211 112235778899998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=203.27 Aligned_cols=164 Identities=29% Similarity=0.396 Sum_probs=141.9
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
+|++.+.||.|+||.||+|... ++..+|+|.+.... .....+.+|++++++++||||+++++.+..++..++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 68899999986533 224578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++.... .+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999997652 2788999999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|+..|+|||
T Consensus 149 ~~~~~~~---~~~~~~~~~y~~PE 169 (258)
T cd05578 149 KVTPDTL---TTSTSGTPGYMAPE 169 (258)
T ss_pred ccCCCcc---ccccCCChhhcCHH
Confidence 6654321 13346888999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=202.40 Aligned_cols=166 Identities=24% Similarity=0.386 Sum_probs=139.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|+..+.||.|+||.||+|... +++.||||.+...... ...+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999965 7889999988644322 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+. ++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 5899888654322 2889999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....+++.|+|||
T Consensus 150 ~~~~~~~--~~~~~~~~~y~aPE 170 (284)
T cd07860 150 FGVPVRT--YTHEVVTLWYRAPE 170 (284)
T ss_pred cccCccc--cccccccccccCCe
Confidence 5432211 12235788999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=200.45 Aligned_cols=169 Identities=28% Similarity=0.469 Sum_probs=138.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCc---EEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~---~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
++|+..+.||+|+||.||+|... ++. .+++|.+..... ..+.+.+|+.++++++|+||+++.+++...+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46888899999999999999964 333 689998865432 245788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 85 TEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence 999999999999875432 2788999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccc-cccccccccccCCC
Q 025997 220 SNQAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
+........... ......++.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE 180 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPE 180 (268)
T ss_pred ceecccccccceeccCCCcCceecCHH
Confidence 876543221111 11112345799998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=199.07 Aligned_cols=168 Identities=24% Similarity=0.384 Sum_probs=138.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC------CchHHHHHHHHHHHccCCCCcceEeEEEEeC--Cce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (245)
.+|.+.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999954 68899999874321 1224678899999999999999999998764 458
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++++||+++++|.+++..... +++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence 899999999999999875432 788889999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
||+++........ .......|+..|+|||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPE 179 (264)
T ss_pred cccccccccccccCccccccCCcccccCHh
Confidence 9999765321110 1112356899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=198.56 Aligned_cols=171 Identities=32% Similarity=0.415 Sum_probs=144.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||.|+||.||+|... ++..+++|++..... ....+.+|+.+++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 678899999865432 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++..... ...+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999976432 112788999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccc--ccccccccccccCCC
Q 025997 223 APDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
........ ......|+..|+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe 176 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPE 176 (267)
T ss_pred hccCccccccccccccCChhhcChH
Confidence 55432221 123346899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=206.18 Aligned_cols=163 Identities=32% Similarity=0.460 Sum_probs=138.4
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
|.....||+|+||.||++... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444557999999999999964 68899999985433 3345688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++.... +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99999876432 788999999999999999999998 99999999999999999999999999875543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....|+..|+|||
T Consensus 170 ~~~~--~~~~~~~~~y~aPE 187 (297)
T cd06659 170 DVPK--RKSLVGTPYWMAPE 187 (297)
T ss_pred cccc--ccceecCccccCHH
Confidence 2211 13356899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=204.15 Aligned_cols=164 Identities=29% Similarity=0.440 Sum_probs=139.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.|...+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566678999999999999854 678899998864432 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 85 GGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence 9999999886432 788899999999999999999997 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......|+..|+|||
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE 171 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPE 171 (277)
T ss_pred cCcch--hhhcccCcccccCHH
Confidence 43321 112346889999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=200.89 Aligned_cols=164 Identities=27% Similarity=0.467 Sum_probs=140.8
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCC--CchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 140 (245)
.|+..+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++++++ |+|++++++++...+..+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999996 478899999886543 23456888999999986 999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 82 EYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred ecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence 999999999998653 2889999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....|+..|+|||
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE 171 (277)
T cd06917 149 ALLNQNSSK--RSTFVGTPYWMAPE 171 (277)
T ss_pred eecCCCccc--cccccCCcceeCHH
Confidence 766543321 13346899999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=203.78 Aligned_cols=171 Identities=27% Similarity=0.436 Sum_probs=138.7
Q ss_pred CCCCCCeeccCCceEEEEEEEC---CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeC--CceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (245)
.|.+.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778889999999999999965 47899999987632 2245678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC----CCceE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAK 213 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~----~~~vk 213 (245)
+||||+.+ +|.+++....... ...++...++.++.||+.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence 99999975 7777775433211 113788899999999999999999998 999999999999999 89999
Q ss_pred EecccCCCCCCcccc-ccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAA-RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~APE 245 (245)
|+|||++........ ........+|+.|+|||
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 185 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHH
Confidence 999999886643322 11123346889999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=197.60 Aligned_cols=166 Identities=22% Similarity=0.360 Sum_probs=140.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 788999998865432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl~DfGla~ 221 (245)
+++++|.+++...... .+++..+..++.+++.+|.|||+++ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 9999999999764321 2788999999999999999999997 9999999999999855 568999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....|+..|+|||
T Consensus 151 ~~~~~~~~---~~~~~~~~y~aPE 171 (256)
T cd08220 151 ILSSKSKA---YTVVGTPCYISPE 171 (256)
T ss_pred ecCCCccc---cccccCCcccCch
Confidence 66543221 2346899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=197.20 Aligned_cols=161 Identities=29% Similarity=0.443 Sum_probs=132.0
Q ss_pred CeeccCCceEEEEEEEC-C---CcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|.+. . ...+|+|.+..... ..+.+.+|+.+++++.|+||+++++++. .+..+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999853 2 26899999876554 3467889999999999999999999875 5568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++..... +++..+..++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999976542 789999999999999999999997 99999999999999999999999999876643
Q ss_pred cccccc-cccccccccccCCC
Q 025997 226 AAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~-~~~~~gt~~y~APE 245 (245)
...... .....++..|+|||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE 168 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPE 168 (257)
T ss_pred CCcccccccCccccccccCHH
Confidence 322111 11112456799998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=202.01 Aligned_cols=157 Identities=26% Similarity=0.419 Sum_probs=130.5
Q ss_pred CeeccCCceEEEEEEECC--------CcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 72 SLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.||+|+||.||+|.... ...+++|.+..... ..+.+.+|+.+++.+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 23477887754432 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc--------eEE
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--------AKI 214 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~--------vkl 214 (245)
+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +++
T Consensus 81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999976542 2788899999999999999999998 999999999999987664 699
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++...... ....+++.|+|||
T Consensus 150 ~d~g~~~~~~~~------~~~~~~~~y~aPE 174 (258)
T cd05078 150 SDPGISITVLPK------EILLERIPWVPPE 174 (258)
T ss_pred cccccccccCCc------hhccccCCccCch
Confidence 999998655322 2346888999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=201.11 Aligned_cols=157 Identities=27% Similarity=0.355 Sum_probs=128.4
Q ss_pred eeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHH---HHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSM---VSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.||+|+||.||++... +++.+|+|.+...... ...+.+|..+ +....|+||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6889999988554321 2233444433 334479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||+++++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999887543 2899999999999999999999998 9999999999999999999999999987554
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....||+.|+|||
T Consensus 149 ~~~~----~~~~~~~~y~aPE 165 (279)
T cd05633 149 KKKP----HASVGTHGYMAPE 165 (279)
T ss_pred ccCc----cCcCCCcCccCHH
Confidence 3221 2346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=198.52 Aligned_cols=162 Identities=28% Similarity=0.520 Sum_probs=135.3
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|.+.+.||+|+||.||++.. +++.+|+|.+... ...+.+.+|+.++++++|+|++++++++.. +..+++|||+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence 5688999999999999999875 5778999988543 235678899999999999999999999865 457999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 83 GNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred CCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 9999999764321 2788899999999999999999997 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.. .....+..|+|||
T Consensus 153 ~~-----~~~~~~~~y~~pe 167 (254)
T cd05083 153 GV-----DNSKLPVKWTAPE 167 (254)
T ss_pred cC-----CCCCCCceecCHH
Confidence 11 1223456799997
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=201.68 Aligned_cols=167 Identities=26% Similarity=0.367 Sum_probs=140.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|++++++++|+||+++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999966 678999998865322 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.++.+..+..... .+++..+..++.||+.||.|||.++ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 81 YVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 999866666554322 2788999999999999999999997 9999999999999999999999999988
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ......++..|+|||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~PE 171 (288)
T cd07833 149 ALRARPAS-PLTDYVATRWYRAPE 171 (288)
T ss_pred ccCCCccc-cccCcccccCCcCCc
Confidence 76544321 113356889999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=198.49 Aligned_cols=167 Identities=25% Similarity=0.422 Sum_probs=141.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++++++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999954 78899999885432 2335788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++...... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 9999999998754321 2788899999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~pe 171 (256)
T cd08218 151 LNSTVEL--ARTCIGTPYYLSPE 171 (256)
T ss_pred cCcchhh--hhhccCCccccCHH
Confidence 5433221 12346889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=200.22 Aligned_cols=167 Identities=28% Similarity=0.411 Sum_probs=136.2
Q ss_pred CCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
++|.+.+.||+|+||.||+|.+.+ ...+++|....... ..+.+.+|+.++++++|+||+++++++.+ +..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999998643 24688998765432 24578899999999999999999998865 557899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence 999999999999975432 2789999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... .....+++.|+|||
T Consensus 154 ~~~~~~~~~~~-~~~~~~~~~y~aPE 178 (270)
T cd05056 154 SRYLEDESYYK-ASKGKLPIKWMAPE 178 (270)
T ss_pred eeeccccccee-cCCCCccccccChh
Confidence 87654332211 11223456899998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=234.39 Aligned_cols=168 Identities=27% Similarity=0.394 Sum_probs=142.0
Q ss_pred CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
-+|.....||.|.||.||.|. ..+|...|+|.+.... .....+.+|..++..++|||+|++|++-...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 356777889999999999999 5688899999875433 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
||.+|+|.+.+...+. .++.....+..|++.|+.|||.+| ||||||||+||+++.+|.+|++|||.|.
T Consensus 1315 yC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999986543 566666678899999999999998 9999999999999999999999999998
Q ss_pred CCCcccccc--ccccccccccccCCC
Q 025997 222 QAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
.+....... ......||+.|||||
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCch
Confidence 765443221 123467999999998
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=199.35 Aligned_cols=157 Identities=28% Similarity=0.362 Sum_probs=129.0
Q ss_pred eeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHH---HHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQV---SMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.||+|+||.||++... +++.||+|.+...... ...+..|. ..++...|++|+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 6889999988653221 12233343 34555689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999886543 2899999999999999999999997 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....||..|+|||
T Consensus 149 ~~~~----~~~~~~~~y~aPE 165 (278)
T cd05606 149 KKKP----HASVGTHGYMAPE 165 (278)
T ss_pred ccCC----cCcCCCcCCcCcH
Confidence 3221 2346899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=198.30 Aligned_cols=168 Identities=29% Similarity=0.462 Sum_probs=132.3
Q ss_pred CeeccCCceEEEEEEEC-CCc--EEEEEEcCCCC--CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... ++. .+++|.+.... ...+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999965 443 46888876432 2345788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 146 GSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
++|.+++......... .....+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 9999999764321100 11124789999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... .....+..|+|||
T Consensus 158 l~~~~~~~~~~---~~~~~~~~y~apE 181 (270)
T cd05047 158 LSRGQEVYVKK---TMGRLPVRWMAIE 181 (270)
T ss_pred Cccccchhhhc---cCCCCccccCChH
Confidence 98643211111 1122456799998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=212.65 Aligned_cols=165 Identities=29% Similarity=0.445 Sum_probs=140.2
Q ss_pred CCCCCeeccCCceEEEEEEECC---C--cEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRS---G--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~---~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..+.+.||.|.||.||.|.+.+ | -.||||..+.+.. +.+.|+.|..+|++++||||++++|++.+ ...||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 4456789999999999999642 2 2588998766443 35789999999999999999999999965 5689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|+++-|.|..+++.++.. |+......++.||+.+|.|||+.. +|||||..+|||+.+..-|||+|||++
T Consensus 470 EL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 999999999999987653 888999999999999999999996 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+.+...+..+ +..-...|||||
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPE 562 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPE 562 (974)
T ss_pred hhccccchhhcc-ccccceeecCcc
Confidence 998876655433 223356899998
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=199.61 Aligned_cols=165 Identities=28% Similarity=0.444 Sum_probs=140.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..|+..+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999965 688999998865432 245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999986532 788889999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......++..|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE 171 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPE 171 (277)
T ss_pred ccCCcc--ccccccCcccccCHh
Confidence 543221 123346888999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=197.69 Aligned_cols=167 Identities=26% Similarity=0.439 Sum_probs=142.2
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|.+.+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.++++++|+||+++++.+...+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999965 788999999865544 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 99999999997643 2778889999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccc--cccccccccccCCC
Q 025997 223 APDAAARLH--STRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~--~~~~~gt~~y~APE 245 (245)
......... .....+++.|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE 173 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPE 173 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChh
Confidence 643322111 11245788999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=199.76 Aligned_cols=167 Identities=25% Similarity=0.385 Sum_probs=139.9
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+|+..+.||.|++|.||+|... ++..||+|.+..... ....+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999975 688999998865432 2456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+ +|.+++...... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 81 DK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred Cc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 85 898888654321 13889999999999999999999997 999999999999999999999999998755
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....+|+.|+|||
T Consensus 151 ~~~~~~--~~~~~~~~~y~~PE 170 (284)
T cd07836 151 GIPVNT--FSNEVVTLWYRAPD 170 (284)
T ss_pred cCCccc--cccccccccccChH
Confidence 332211 12345788999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=209.40 Aligned_cols=169 Identities=26% Similarity=0.352 Sum_probs=138.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchH--------HHHHHHHHHHccCCCCcceEeEEEE-eCCce
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ--------EFLAQVSMVSRLKNENVVELVGYYV-DGPLR 136 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~ 136 (245)
+|-++.+||+|+|+.||+|..- ..+.||||+-...+.+.+ ..-+|..+.+.|.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 3556778999999999999954 566788887654443322 2456899999999999999999986 55678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceE
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vk 213 (245)
|-|+|||+|.+|.-+|+.++ .+++.++..|+.||+.||.||... .++|||-||||.|||+.+ -|.+|
T Consensus 544 CTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 99999999999999998765 389999999999999999999987 467999999999999964 47999
Q ss_pred EecccCCCCCCcccccc-----ccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
|+|||+++.+....... .++...||.+|++||
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPE 650 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPE 650 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcc
Confidence 99999999875543321 234568999999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=214.48 Aligned_cols=144 Identities=22% Similarity=0.276 Sum_probs=125.2
Q ss_pred CCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 68 FGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
|...+.||-|+||+|-+++ ..+...+|.|.|.+... ....+..|-.||..-.++.||+||-.|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5556789999999999998 44667889998865432 123466788999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
++||++..+|-... ++.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-
T Consensus 711 IPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999987654 3788888888999999999999998 99999999999999999999999999864
Q ss_pred C
Q 025997 223 A 223 (245)
Q Consensus 223 ~ 223 (245)
+
T Consensus 779 f 779 (1034)
T KOG0608|consen 779 F 779 (1034)
T ss_pred c
Confidence 4
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=196.45 Aligned_cols=163 Identities=23% Similarity=0.380 Sum_probs=129.5
Q ss_pred CeeccCCceEEEEEEEC----CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEE-eCCceEEEEEecC
Q 025997 72 SLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHAS 144 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 144 (245)
+.||+|+||.||+|... ....+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 235789998854322 2457788999999999999999999776 4556899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999975432 1567778889999999999999997 9999999999999999999999999987553
Q ss_pred cccccc--ccccccccccccCCC
Q 025997 225 DAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~--~~~~~~gt~~y~APE 245 (245)
...... ......++..|+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE 172 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALE 172 (262)
T ss_pred CCcceeecccccCcCCccccChh
Confidence 321110 011234677899998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=196.62 Aligned_cols=166 Identities=28% Similarity=0.419 Sum_probs=144.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||+|++|.||+|... +++.+++|++..... ....+.+|+..+.+++|+||+++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999976 589999999866543 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+++++|.+++.... .++...++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999997642 28899999999999999999999 87 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... ....++..|+|||
T Consensus 149 ~~~~~~~~~--~~~~~~~~y~~pE 170 (264)
T cd06623 149 VLENTLDQC--NTFVGTVTYMSPE 170 (264)
T ss_pred ecccCCCcc--cceeecccccCHh
Confidence 664433221 2346889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=200.80 Aligned_cols=165 Identities=30% Similarity=0.446 Sum_probs=142.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|+..+.||+|+||.||++... +++.+++|.+..... ....+.+|++++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788889999999999999976 688999998865532 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+.+++|.+++..... .++...+..++.|++.||.|||+ .+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 81 MDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 999999999976431 27888999999999999999999 87 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ....|+..|+|||
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE 169 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPE 169 (265)
T ss_pred hhHHHHh----hcccCChhccCHH
Confidence 6543221 1256889999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=197.42 Aligned_cols=157 Identities=23% Similarity=0.347 Sum_probs=136.0
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||.|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 588999999865432 235688899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++..... ++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 81 WTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred HHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence 999976432 788889999999999999999997 99999999999999999999999999987654321
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
.....|++.|+|||
T Consensus 149 ---~~~~~~~~~~~~PE 162 (262)
T cd05572 149 ---TWTFCGTPEYVAPE 162 (262)
T ss_pred ---cccccCCcCccChh
Confidence 13346899999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=206.65 Aligned_cols=167 Identities=28% Similarity=0.386 Sum_probs=137.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 136 (245)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999954 78899999986432 22456788999999999999999998876443 47
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++++||+.+ +|.+++.... +++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred EEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECc
Confidence 999999975 8888886532 889999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
||++.......... ......||+.|||||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPE 179 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChH
Confidence 99987654322111 112346899999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=199.50 Aligned_cols=159 Identities=27% Similarity=0.359 Sum_probs=134.2
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999855 68899999885432 1234567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++...... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 81 KYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred HHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence 9998765421 2889999999999999999999998 99999999999999999999999999876543211
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
.....++..|+|||
T Consensus 151 ---~~~~~~~~~y~~PE 164 (277)
T cd05577 151 ---IKGRAGTPGYMAPE 164 (277)
T ss_pred ---cccccCCCCcCCHH
Confidence 12346788999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=199.37 Aligned_cols=167 Identities=23% Similarity=0.343 Sum_probs=137.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999965 788999998855432 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGla 220 (245)
|+. ++|.+.+...... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++
T Consensus 82 ~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred ccc-ccHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 996 5888887654321 2577888899999999999999997 999999999999985 567999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....+++.|+|||
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~~PE 173 (294)
T PLN00009 151 RAFGIPVRT--FTHEVVTLWYRAPE 173 (294)
T ss_pred cccCCCccc--cccCceeecccCHH
Confidence 765332111 12235788999998
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=195.84 Aligned_cols=167 Identities=28% Similarity=0.449 Sum_probs=136.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++.+.+..||.|..|.|++++++ ++...|||.+..+... .++++..+.++.+. ..|+||+.+|+|..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 344556678999999999999976 6889999999765433 35677777776665 4799999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|.|.- .+..+++.... .+++.-+-++...+..||.||..+. .|+|||+||+|||+|+.|++||||||++
T Consensus 171 elMs~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHH-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 99853 55666655443 2777777888999999999999865 6999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
-.+.+.... ++..|.+.|||||
T Consensus 240 GrlvdSkAh---trsAGC~~YMaPE 261 (391)
T KOG0983|consen 240 GRLVDSKAH---TRSAGCAAYMAPE 261 (391)
T ss_pred ceeeccccc---ccccCCccccCcc
Confidence 877665544 4457999999998
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=199.74 Aligned_cols=170 Identities=24% Similarity=0.347 Sum_probs=137.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccC-CCCcceEeEEEEeCCc-----
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPL----- 135 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 135 (245)
++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 688999998754432 2356788999999995 6999999999887665
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKI 214 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl 214 (245)
.|++|||+.+ +|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence 8999999986 898888654321 1123789999999999999999999998 999999999999998 889999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++......... .....+++.|+|||
T Consensus 153 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE 181 (295)
T cd07837 153 ADLGLGRAFSIPVKS--YTHEIVTLWYRAPE 181 (295)
T ss_pred eecccceecCCCccc--cCCcccccCCCChH
Confidence 999998765332211 12235788899998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=200.99 Aligned_cols=170 Identities=25% Similarity=0.399 Sum_probs=137.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC-----
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 134 (245)
..++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4567999999999999999999965 688999998854322 2335678999999999999999999887654
Q ss_pred ---ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 135 ---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 135 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
..++++||+.+ +|.+.+..... .+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI 157 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence 35999999975 88888765431 2889999999999999999999997 999999999999999999
Q ss_pred eEEecccCCCCCCccccc--cccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
+||+|||++......... .......++..|+|||
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcH
Confidence 999999998765432211 1112345788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=219.33 Aligned_cols=167 Identities=28% Similarity=0.467 Sum_probs=143.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
...+.++||.|.||.|++|+++ ....||||.++.... .+.+|+.|+.+|.++.||||++|.|+........||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3467789999999999999965 235799999987654 3568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|||++|+|..+|..+.+. +.+.+...+.+.|+.|++||-+.+ .|||||..+|||++.+-..||+|||++
T Consensus 710 EyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred hhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999987653 888899999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccc--cccccCCC
Q 025997 221 NQAPDAAARLHSTRVLG--TFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~g--t~~y~APE 245 (245)
+.+.+..... .++.-| ..+|.|||
T Consensus 779 Rvledd~~~~-ytt~GGKIPiRWTAPE 804 (996)
T KOG0196|consen 779 RVLEDDPEAA-YTTLGGKIPIRWTAPE 804 (996)
T ss_pred eecccCCCcc-ccccCCccceeecChh
Confidence 9876554221 122222 36899998
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=202.10 Aligned_cols=168 Identities=33% Similarity=0.440 Sum_probs=138.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (245)
..++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3578999999999999999999965 6889999988543222 23567899999999999999999998755 4689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.+ +|.+++..... .+++.++..++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred EEEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 99999975 89888875432 2889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++.......... ....+++.|+|||
T Consensus 153 g~~~~~~~~~~~~--~~~~~~~~y~aPE 178 (309)
T cd07845 153 GLARTYGLPAKPM--TPKVVTLWYRAPE 178 (309)
T ss_pred ceeeecCCccCCC--CcccccccccChh
Confidence 9987665332111 2234688899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=195.82 Aligned_cols=169 Identities=22% Similarity=0.337 Sum_probs=139.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe--CCceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 140 (245)
+|++.+.||.|+||.||++... ++..+|+|.+...... .+.+.+|+.++++++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999954 7789999988654332 3467789999999999999999998764 45679999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-----EKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
||+++++|.+++...... ...+++..++.++.||+.||.||| +.+ ++|+||||+||++++++.+||+
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 999999999999764211 123889999999999999999999 665 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++......... .....|++.|+|||
T Consensus 153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE 180 (265)
T cd08217 153 DFGLAKILGHDSSF--AKTYVGTPYYMSPE 180 (265)
T ss_pred cccccccccCCccc--ccccccCCCccChh
Confidence 99998876543321 12346899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=215.02 Aligned_cols=176 Identities=26% Similarity=0.414 Sum_probs=149.8
Q ss_pred HHHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
+++.....+.....+||-|.||.||.|.|+ -.-.||||.++.+....++|+.|+.+|+.++|||+|+|+++|.....+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 555555566666788999999999999977 4568999999988888999999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
||+|||.+|+|.++|.+.... .++.-..+.++.||..|+.||..++ +|||||..+|+|+.++..|||+||
T Consensus 340 IiTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred EEEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 999999999999999876532 2666667889999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++.+..+........ .=.+.|.|||
T Consensus 410 GLsRlMtgDTYTAHAGA-KFPIKWTAPE 436 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGA-KFPIKWTAPE 436 (1157)
T ss_pred chhhhhcCCceecccCc-cCcccccCcc
Confidence 99998876544322110 1145789987
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=204.62 Aligned_cols=163 Identities=29% Similarity=0.403 Sum_probs=137.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC-----
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 134 (245)
..++|++.+.||+|+||.||++... ++..||+|.+...... ...+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999854 7889999988543222 346778999999999999999999987654
Q ss_pred -ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
..++++||+ +++|.+++.... +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 358999998 679998886432 889999999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++....... ....+++.|+|||
T Consensus 159 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE 185 (343)
T cd07880 159 ILDFGLARQTDSEM-----TGYVVTRWYRAPE 185 (343)
T ss_pred EeecccccccccCc-----cccccCCcccCHH
Confidence 99999987654321 2346789999997
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=198.48 Aligned_cols=168 Identities=26% Similarity=0.428 Sum_probs=134.5
Q ss_pred eeccCCceEEEEEEECC-------CcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 73 LIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.||+|+||.||+|.... +..+++|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998642 2578999875443 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-----ceEEeccc
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-----~vkl~DfG 218 (245)
++++|.+++....... .....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 82 ~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 82 EGGDLLSYLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred CCCcHHHHHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999997543211 01223788999999999999999999997 99999999999999877 89999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++...............++..|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPE 183 (269)
T ss_pred cccccccccccccCcccCCCccccCHH
Confidence 987654332211112234578899998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=217.21 Aligned_cols=166 Identities=23% Similarity=0.345 Sum_probs=144.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCc-EEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGR-AAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
..+++....||-|+||.|-++...+.. .+|+|.+++.. ...+.+..|-.+|..++++.||++|..|.++.+.|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 445667778999999999999866433 48888886543 2345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||-|-||.|+.++..+.. +.......++..+++|+.|||+++ ||+|||||+|++++.+|.+||.|||+
T Consensus 499 mEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred HHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhh
Confidence 999999999999987654 777788889999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+.+...... -+++|||.|.|||
T Consensus 567 AKki~~g~KT---wTFcGTpEYVAPE 589 (732)
T KOG0614|consen 567 AKKIGSGRKT---WTFCGTPEYVAPE 589 (732)
T ss_pred HHHhccCCce---eeecCCcccccch
Confidence 9998766543 5689999999998
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=204.89 Aligned_cols=164 Identities=25% Similarity=0.325 Sum_probs=136.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeC------
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 133 (245)
..++|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 788999999864322 234677899999999999999999988643
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
...++||||+.+ +|.+.+... ++...+..++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 357999999964 888887542 678888999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++....... .....||+.|+|||
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE 187 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPE 187 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHH
Confidence 999999976543221 12346889999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=197.04 Aligned_cols=162 Identities=27% Similarity=0.396 Sum_probs=134.4
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccC-CCCcceEeEEEEeC--CceEEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLAYE 141 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 141 (245)
|.+.+.||+|+||.||+|... +++.+|+|.+...... .....+|+.++.++. |+||+++++++.+. +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567788999999999999954 6889999988654322 234457888899885 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+. ++|.+.+..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||+++
T Consensus 81 ~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMD-MNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cCC-ccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 997 488888865432 2889999999999999999999998 999999999999999 999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....++..|+|||
T Consensus 148 ~~~~~~~~---~~~~~~~~y~aPE 168 (282)
T cd07831 148 GIYSKPPY---TEYISTRWYRAPE 168 (282)
T ss_pred ccccCCCc---CCCCCCcccCChh
Confidence 66433221 2346889999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=193.15 Aligned_cols=165 Identities=30% Similarity=0.494 Sum_probs=143.0
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|.+.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++++++|+|++++++++.+++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999866543 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999987653 2889999999999999999999998 99999999999999999999999999976
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|+..|+|||
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe 169 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPE 169 (254)
T ss_pred cCCCccc--ccccccchhhcCHh
Confidence 6543321 12346889999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-28 Score=199.32 Aligned_cols=162 Identities=34% Similarity=0.485 Sum_probs=137.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..|...+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 688999998854322 1246788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+. |+|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++
T Consensus 95 e~~~-g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 95 EYCL-GSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred HhhC-CCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence 9997 578777754322 2889999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ....|++.|+|||
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE 181 (307)
T cd06607 163 SLVSPA------NSFVGTPYWMAPE 181 (307)
T ss_pred eecCCC------CCccCCccccCce
Confidence 655322 2346888999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=220.98 Aligned_cols=169 Identities=31% Similarity=0.457 Sum_probs=149.3
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
...++|+++..+|.|.||.||+++. ++++..|+|+++....+ ...+..|+-+++..+|+||+.+++.|...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3467899999999999999999994 58899999999776544 355677999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|||.+|+|++.-+... .+++.++..++++.++||.|||+.+ -+|||||-.|||+.+.|.+|++|||.+
T Consensus 92 EycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCch
Confidence 9999999999876543 2888999999999999999999998 899999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.++...... ...++||++|||||
T Consensus 160 aqitati~K--rksfiGtpywmapE 182 (829)
T KOG0576|consen 160 AQITATIAK--RKSFIGTPYWMAPE 182 (829)
T ss_pred hhhhhhhhh--hhcccCCccccchh
Confidence 887655443 35678999999998
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=197.76 Aligned_cols=169 Identities=31% Similarity=0.466 Sum_probs=145.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..+.|+....||+|+||.||++.+. ++..+++|.+.......+.+.+|+++++.++|+||+++++.+...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3566888899999999999999976 688999999876554566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 97 ~~~~~L~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 97 MDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred cCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 999999999987531 2889999999999999999999997 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....++..|+|||
T Consensus 166 ~~~~~~~--~~~~~~~~~y~~PE 186 (286)
T cd06614 166 LTKEKSK--RNSVVGTPYWMAPE 186 (286)
T ss_pred hccchhh--hccccCCcccCCHh
Confidence 5432211 12345788999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=197.49 Aligned_cols=163 Identities=31% Similarity=0.493 Sum_probs=138.5
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
|...+.||+|++|.||++... +++.+++|++..... ..+.+.+|+.+++.++|+||+++++++...+..++++||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 455578999999999999964 788999998854332 345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++.... +++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++.....
T Consensus 101 ~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 99999987632 788899999999999999999998 99999999999999999999999998875543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....|++.|+|||
T Consensus 168 ~~~~--~~~~~~~~~y~aPE 185 (285)
T cd06648 168 EVPR--RKSLVGTPYWMAPE 185 (285)
T ss_pred CCcc--cccccCCccccCHH
Confidence 2211 12346899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=198.25 Aligned_cols=168 Identities=31% Similarity=0.412 Sum_probs=138.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 140 (245)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....+.+|++++++++|+||+++++++... +..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778889999999999999975 678899998865433 345788999999999999999999988653 4689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++...... ...++...+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence 999999999887643211 112788889999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....++..|+|||
T Consensus 153 ~~~~~~~~----~~~~~~~~y~~pE 173 (287)
T cd06621 153 GELVNSLA----GTFTGTSFYMAPE 173 (287)
T ss_pred cccccccc----ccccCCccccCHH
Confidence 75543221 2345788999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=203.23 Aligned_cols=166 Identities=29% Similarity=0.420 Sum_probs=137.7
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeC---
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG--- 133 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--- 133 (245)
+....++|.+.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 344568899999999999999999985 4788999999865432 235677899999999999999999988643
Q ss_pred ---CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 134 ---PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 134 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
...+++++++ +++|.+++.... +++..+..++.|++.||.|||+++ |+||||||+||++++++
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 3467888776 679998886432 888999999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||++....... ....||..|+|||
T Consensus 158 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE 187 (345)
T cd07877 158 ELKILDFGLARHTDDEM-----TGYVATRWYRAPE 187 (345)
T ss_pred CEEEecccccccccccc-----cccccCCCccCHH
Confidence 99999999987653221 2346889999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=199.89 Aligned_cols=168 Identities=28% Similarity=0.378 Sum_probs=142.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 139 (245)
++|.+.+.||+|+||.||++... +++.+++|++.... .....+.+|+.++++++ |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999965 78999999986532 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||++.+++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence 99999999999997653 2899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccc------------------cccccccccccccCCC
Q 025997 220 SNQAPDAAAR------------------LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~------------------~~~~~~~gt~~y~APE 245 (245)
+......... .......|+..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe 192 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHH
Confidence 8765433210 1122346889999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=198.51 Aligned_cols=169 Identities=28% Similarity=0.393 Sum_probs=139.0
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCC-----
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 134 (245)
..++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999975 67899999986432 22356778999999999999999999987654
Q ss_pred -----ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
..++++||+.+ ++.+.+..... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 78999999986 78777765421 2889999999999999999999998 9999999999999999
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+||+|||++.......... .....++..|+|||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE 187 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPE 187 (302)
T ss_pred CcEEeCcccccccccCCcccc-cccceeccCccChH
Confidence 999999999987664332211 12234678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=196.48 Aligned_cols=165 Identities=24% Similarity=0.350 Sum_probs=138.7
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
|++.+.||.|++|.||+|... ++..||+|++..... ....+.+|+.+++.++|+|++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999965 789999998865432 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
. ++|.+++...... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 81 D-LDLKKYMDSSPLT-------GLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred C-cCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 5 6999998765421 2889999999999999999999997 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....+++.|+|||
T Consensus 150 ~~~~~~--~~~~~~~~~~~aPE 169 (283)
T cd07835 150 GVPVRT--YTHEVVTLWYRAPE 169 (283)
T ss_pred CCCccc--cCccccccCCCCCc
Confidence 332211 12235788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=193.90 Aligned_cols=172 Identities=23% Similarity=0.352 Sum_probs=134.4
Q ss_pred CCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
|.+.+.||+|+||.||+|... +++.+|+|.+...... .+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 4678999988654322 346788999999999999999999886532
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..+++++|+.+|+|.+++....... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence 2478889999999998875432111 0123788899999999999999999997 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...............+++.|++||
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHh
Confidence 9999988664332221122334567889987
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-27 Score=190.49 Aligned_cols=165 Identities=33% Similarity=0.529 Sum_probs=144.0
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
+|...+.||+|++|.||++... ++..+++|++..... ....+.+|+.++++++|+|++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999975 688999999866544 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++..... .+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 81 GGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 9999999876521 2899999999999999999999987 9999999999999999999999999987765
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....|+..|+|||
T Consensus 150 ~~~~---~~~~~~~~~~~~PE 167 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPE 167 (253)
T ss_pred cccc---ccceecCCcccCHH
Confidence 4332 13456889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=203.47 Aligned_cols=168 Identities=25% Similarity=0.376 Sum_probs=138.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHcc-CCCCcceEeEEEEeC--Cce
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDG--PLR 136 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 136 (245)
..++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567999999999999999999965 67899999885432 2234567899999999 999999999988643 368
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++|+||+. ++|.+++.... +++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 85 YLVFEYME-TDLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred EEEecccc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 99999997 49999886541 788888999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccc---cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR---LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~---~~~~~~~gt~~y~APE 245 (245)
||++......... .......||..|+|||
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 182 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPE 182 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCce
Confidence 9998765433211 1123356899999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=195.49 Aligned_cols=167 Identities=27% Similarity=0.487 Sum_probs=140.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|.+.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999965 67889999985532 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfGla~ 221 (245)
+++++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++ .+||+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence 9999999998754321 2789999999999999999999997 99999999999998875 56999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....|++.|+|||
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~ape 172 (257)
T cd08225 151 QLNDSMEL--AYTCVGTPYYLSPE 172 (257)
T ss_pred hccCCccc--ccccCCCccccCHH
Confidence 66433221 12245899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=195.77 Aligned_cols=160 Identities=28% Similarity=0.405 Sum_probs=135.5
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||.|+||.||++... +++.+++|.+..... ..+.+.+|+.++++++|+||+++++.+...+..++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999865433 245678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++.... .+++..+..++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 99997643 2889999999999999999999998 99999999999999999999999999875433211
Q ss_pred ------ccccccccccccccCCC
Q 025997 229 ------RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ------~~~~~~~~gt~~y~APE 245 (245)
........++..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe 171 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPE 171 (265)
T ss_pred cccccccccccCcccCccccCHH
Confidence 00113346888999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=190.89 Aligned_cols=176 Identities=30% Similarity=0.372 Sum_probs=144.8
Q ss_pred hhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ce
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 136 (245)
+..+|.+.+.||+|||+.||+++ ..++..+|+|++.-.. .+.+..++|++..++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34679999999999999999999 5578899999986554 55677899999999999999999988765433 48
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
||++.|...|+|.+.+....... ..+++.+++.++.+|++||++||+.. ++..||||||.|||+.+.+.++|.|
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence 99999999999999998765432 23899999999999999999999984 5699999999999999999999999
Q ss_pred ccCCCCCCccccccc-------cccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLH-------STRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~-------~~~~~gt~~y~APE 245 (245)
||.+....-...... -.....|..|.|||
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE 208 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPE 208 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCch
Confidence 999876543221110 01124688999998
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=198.41 Aligned_cols=160 Identities=33% Similarity=0.497 Sum_probs=136.3
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
...||+|+||.||++... ++..+|+|++..... ....+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999864 788999998854332 345688899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++.... +++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 105 TDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred HHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99875432 788899999999999999999997 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
. .....||+.|+|||
T Consensus 172 ~--~~~~~~~~~y~~pE 186 (292)
T cd06657 172 R--RKSLVGTPYWMAPE 186 (292)
T ss_pred c--ccccccCccccCHH
Confidence 1 12346899999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=203.41 Aligned_cols=167 Identities=25% Similarity=0.392 Sum_probs=137.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEe----CCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 137 (245)
++|++.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67999999999999999999954 78899999986542 234567789999999999999999988753 35689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~df 151 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDF 151 (334)
T ss_pred EEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccc
Confidence 9999996 58999886543 2889999999999999999999997 999999999999999999999999
Q ss_pred cCCCCCCcccccc--ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
|++.......... ......|+..|+|||
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (334)
T cd07855 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPE 181 (334)
T ss_pred ccceeecccCcCCCcccccccccccccChH
Confidence 9987653322111 112346899999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=197.47 Aligned_cols=161 Identities=34% Similarity=0.484 Sum_probs=136.5
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|...+.||+|+||.||++... ++..+|+|.+...... ...+.+|++++++++|+|++++++++..++..+++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999964 6889999998644322 2467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+ +|.+++..... .+++.++..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++.
T Consensus 106 ~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 106 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred CCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcc
Confidence 9975 88887754332 2889999999999999999999998 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ....|++.|+|||
T Consensus 174 ~~~~~------~~~~~~~~y~aPE 191 (317)
T cd06635 174 IASPA------NSFVGTPYWMAPE 191 (317)
T ss_pred ccCCc------ccccCCccccChh
Confidence 54322 2346889999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=191.62 Aligned_cols=167 Identities=29% Similarity=0.426 Sum_probs=143.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 140 (245)
+|...+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999976 788999999866542 356788999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999997653 2899999999999999999999997 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
................++..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE 173 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPE 173 (260)
T ss_pred EecccccccccccCCCCCccccCHh
Confidence 7665443211113346889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=194.20 Aligned_cols=168 Identities=23% Similarity=0.411 Sum_probs=136.4
Q ss_pred CCCCCCeeccCCceEEEEEEECC--CcEEEEEEcCCCC-----------CchHHHHHHHHHHHc-cCCCCcceEeEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSK-----------QPDQEFLAQVSMVSR-LKNENVVELVGYYVD 132 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 132 (245)
+|++.+.||+|+||.||++.... ++.+|+|.+.... ....++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888899999999999999654 6789999874321 112346678887765 799999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCc
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
++..+++|||+++++|.+++...... ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence 99999999999999999988542211 1138889999999999999999996 55 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||++....... ......|+..|+|||
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe 183 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPE 183 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChh
Confidence 9999999987654432 123456899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=191.26 Aligned_cols=169 Identities=26% Similarity=0.454 Sum_probs=143.7
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|.+.+.||.|+||.||++... ++..+++|++..... ....+.+|+++++.++|+|++++.+.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999965 688999999865543 345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++...... ...+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKKE-----GKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhcc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999765310 123899999999999999999999997 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....|++.|+|||
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~pe 173 (258)
T cd08215 153 LSSTVDL--AKTVVGTPYYLSPE 173 (258)
T ss_pred cccCcce--ecceeeeecccChh
Confidence 6443211 13346899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=192.23 Aligned_cols=165 Identities=24% Similarity=0.254 Sum_probs=133.5
Q ss_pred HHHHHhhCCCCCCCee--ccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 59 DELKEKTDNFGTNSLI--GEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~l--G~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
.+.....++|.+.+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +|+||+++++.+...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3445556677777666 99999999999964 678899998764432211 22222222 7999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAK 213 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vk 213 (245)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEE
Confidence 9999999999999999997653 2899999999999999999999998 99999999999999988 999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++..... ....|+..|+|||
T Consensus 151 l~dfg~~~~~~~~------~~~~~~~~y~aPE 176 (267)
T PHA03390 151 LCDYGLCKIIGTP------SCYDGTLDYFSPE 176 (267)
T ss_pred EecCccceecCCC------ccCCCCCcccChh
Confidence 9999998765422 2346899999998
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=194.98 Aligned_cols=165 Identities=26% Similarity=0.422 Sum_probs=138.4
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAYE 141 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 141 (245)
|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++|+|++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999966 57899999987653 2245688899999999999999999999887 78999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++ +|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.
T Consensus 81 ~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9975 89988865421 2889999999999999999999997 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ......++..|+|||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~PE 171 (287)
T cd07840 149 PYTKRNSA-DYTNRVITLWYRPPE 171 (287)
T ss_pred eccCCCcc-cccccccccccCCce
Confidence 66443211 112235788899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=196.17 Aligned_cols=164 Identities=26% Similarity=0.439 Sum_probs=137.9
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEec
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
|.+.+.||+|+||.||+|... +++.+++|.+..... ......+|+..+++++ |+||+++++++..++..+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578899998865433 2234567899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+++|.+.+..... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 7899998876541 12799999999999999999999997 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ....|+..|+|||
T Consensus 150 ~~~~~~---~~~~~~~~~~aPE 168 (283)
T cd07830 150 RSRPPY---TDYVSTRWYRAPE 168 (283)
T ss_pred cCCCCc---CCCCCcccccCce
Confidence 432221 2346889999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=196.98 Aligned_cols=166 Identities=23% Similarity=0.320 Sum_probs=138.2
Q ss_pred CCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCC-----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCce
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (245)
+|.+.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777889999999999999843 56789999886432 1234577899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++||||+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999986543 2788899999999999999999997 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++........ ......|++.|+|||
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE 176 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPE 176 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHH
Confidence 9998765433221 112346899999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=201.10 Aligned_cols=166 Identities=27% Similarity=0.376 Sum_probs=137.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeC-----Cc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (245)
.++|.+.+.||+|+||.||+|... ++..||||.+.... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999954 78899999886432 2234677899999999999999999987644 34
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 799999996 68998887543 2889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++......... .....+|..|+|||
T Consensus 151 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 178 (337)
T cd07858 151 DFGLARTTSEKGDF--MTEYVVTRWYRAPE 178 (337)
T ss_pred cCccccccCCCccc--ccccccccCccChH
Confidence 99999766433211 13346889999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=203.60 Aligned_cols=168 Identities=25% Similarity=0.303 Sum_probs=139.8
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (245)
...+|..+.+||+|+||+|.+|..+ +...+|||+++++.. +.+--..|-.+|.-. +-|.+++++..|.+-+++|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4567888999999999999999966 567899999976532 223334566666555 5689999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.||+|.-.++.... +.+..++.++.+|+-||-+||+++ |+.||||.+|||++.+|++||+||
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred eEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeec
Confidence 99999999999988876553 666778889999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++.-.... .++.+++|||.|+|||
T Consensus 495 GmcKEni~~~--~TTkTFCGTPdYiAPE 520 (683)
T KOG0696|consen 495 GMCKENIFDG--VTTKTFCGTPDYIAPE 520 (683)
T ss_pred ccccccccCC--cceeeecCCCcccccc
Confidence 9998543332 2346789999999998
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=199.12 Aligned_cols=168 Identities=27% Similarity=0.432 Sum_probs=136.5
Q ss_pred hCCCC-CCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch---------------HHHHHHHHHHHccCCCCcceEe
Q 025997 65 TDNFG-TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---------------QEFLAQVSMVSRLKNENVVELV 127 (245)
Q Consensus 65 ~~~~~-~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~ 127 (245)
.++|. +.+.||+|+||.||+|... +++.||+|++....... ..+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4567999999999999965 78899999885432211 2467899999999999999999
Q ss_pred EEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc
Q 025997 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~ 207 (245)
+++...+..+++|||+. ++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 99999999999999997 59999987543 2788999999999999999999998 99999999999999
Q ss_pred CCCceEEecccCCCCCCccc------------cccccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAA------------ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~------------~~~~~~~~~gt~~y~APE 245 (245)
.++.++|+|||++....... .........+++.|+|||
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 203 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE 203 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCCh
Confidence 99999999999987654110 000112235788999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=183.57 Aligned_cols=170 Identities=28% Similarity=0.357 Sum_probs=136.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++......||+|+||.|-+-++. +|...|+|.+..+-.. ....++|+.+..+. ..|.+|.+||.+.+....|+.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344555667999999999888854 7899999998665433 45677888876554 7899999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|.|.- ||..+-..-... ...+++...-+|+..+..||.|||++- .++|||+||+||||+.+|+||+||||++
T Consensus 125 E~M~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred HHhhh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 99964 777665432211 123788888899999999999999975 5999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
-.+.+.... +.-.|.-.|||||
T Consensus 197 G~L~dSiAk---t~daGCkpYmaPE 218 (282)
T KOG0984|consen 197 GYLVDSIAK---TMDAGCKPYMAPE 218 (282)
T ss_pred eeehhhhHH---HHhcCCCccCChh
Confidence 877655443 2236888999998
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=199.00 Aligned_cols=164 Identities=26% Similarity=0.368 Sum_probs=137.5
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEe-CCceE
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRV 137 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 137 (245)
...++|++.+.||+|+||.||++... ++..+|+|++.... ...+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999955 78899999875432 234667889999999999999999999875 56789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+ +++|.+++.... ++...+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+||
T Consensus 87 lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred EEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcc
Confidence 999998 468998886432 777888889999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++....... ....+++.|+|||
T Consensus 153 g~~~~~~~~~-----~~~~~~~~y~aPE 175 (328)
T cd07856 153 GLARIQDPQM-----TGYVSTRYYRAPE 175 (328)
T ss_pred ccccccCCCc-----CCCcccccccCce
Confidence 9987543221 2346788999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=191.47 Aligned_cols=156 Identities=27% Similarity=0.357 Sum_probs=129.7
Q ss_pred CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHH-HHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|... +++.||+|.+...... ...+..|..+ ...++|+|++++++++...+..++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 6889999998654321 1233445444 4455899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 99999997543 2788899999999999999999997 99999999999999999999999999875433
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
. ....|++.|+|||
T Consensus 150 ~------~~~~~~~~y~~pe 163 (260)
T cd05611 150 N------KKFVGTPDYLAPE 163 (260)
T ss_pred c------ccCCCCcCccChh
Confidence 1 3346889999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=198.35 Aligned_cols=166 Identities=24% Similarity=0.310 Sum_probs=133.5
Q ss_pred CCCCCCeeccCCceEEEEEEEC-C--CcEEEEEEcCCCCC---chHHHHHHHHHHHcc-CCCCcceEeEEEEeC----Cc
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-S--GRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVDG----PL 135 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 135 (245)
+|.+.+.||+|+||.||++... + +..+|+|.+..... ..+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999965 4 67899998864321 245678899999999 599999999875432 45
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.+++++++. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 788888886 58999886543 2889999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccc--cccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
|||+++........ .......||+.|+|||
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE 179 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPE 179 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcH
Confidence 99999765432211 1112357899999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=196.22 Aligned_cols=166 Identities=30% Similarity=0.410 Sum_probs=133.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|...+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++. |+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45667788999999999999965 688999999865432 2456788999999996 9999999999999899999999
Q ss_pred ecCCCCHHHHHh---cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 142 HASKGSLHDILH---GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 142 ~~~~gsL~~~l~---~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
|+.. ++.++.. .... ..+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+||
T Consensus 84 ~~~~-~l~~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLK-------SVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred cccC-CHHHHHHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeec
Confidence 9864 6655432 1111 1288899999999999999999974 5 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++......... ....||+.|+|||
T Consensus 153 g~~~~~~~~~~~---~~~~~~~~y~aPE 177 (288)
T cd06616 153 GISGQLVDSIAK---TRDAGCRPYMAPE 177 (288)
T ss_pred chhHHhccCCcc---ccccCccCccCHH
Confidence 998755432211 2335889999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-30 Score=198.20 Aligned_cols=170 Identities=28% Similarity=0.385 Sum_probs=133.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++.+.+..||.|+||+|++-.++ +|+..|||++..... ..++++.|.+...+- +.||||++||+....+..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 44555678999999999999876 799999999965543 456788888775554 78999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+|.- ||..+.+.-.... ...+++.-.-.|......||.||-..- +|+|||+||+|||++..|.+||||||++-
T Consensus 144 LMd~-SlDklYk~vy~vq----~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQ----KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred HHhh-hHHHHHHHHHHHH----hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence 9953 6655443211100 112777777788888899999998754 69999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...... +.-+|...|||||
T Consensus 217 qLv~SiAk---T~daGCrpYmAPE 237 (361)
T KOG1006|consen 217 QLVDSIAK---TVDAGCRPYMAPE 237 (361)
T ss_pred hHHHHHHh---hhccCCccccChh
Confidence 77654433 3347999999998
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=193.40 Aligned_cols=160 Identities=34% Similarity=0.514 Sum_probs=135.4
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
|.....||+|+||.||+|... ++..+++|.+..... ....+.+|+.+++.++|+|++++++++.+.+..|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999964 688999999864322 124677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+. ++|.+++..... .+++..+..++.||+.+|.|||+++ ++|+||+|+||+++.++.+||+|||++..
T Consensus 103 ~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 103 CL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 96 588887765332 2788999999999999999999998 99999999999999999999999999864
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....|+..|+|||
T Consensus 171 ~~~~------~~~~~~~~y~aPE 187 (313)
T cd06633 171 SSPA------NSFVGTPYWMAPE 187 (313)
T ss_pred cCCC------CCccccccccChh
Confidence 3221 2356899999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=195.91 Aligned_cols=169 Identities=28% Similarity=0.418 Sum_probs=136.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 688999998854322 2346778999999999999999998875433
Q ss_pred --ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
..++++||+.+ +|...+..... .+++..+..++.|+++||.|||+++ |+|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 46999999875 77777764321 2899999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCcccccc---------ccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARL---------HSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~---------~~~~~~gt~~y~APE 245 (245)
+|+|||++.......... ......|++.|+|||
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChH
Confidence 999999987553322111 112345788999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=205.27 Aligned_cols=179 Identities=24% Similarity=0.366 Sum_probs=130.6
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEE-----------------CCCcEEEEEEcCCCCCc-hHH--------------HHH
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVL-----------------RSGRAAAIKKLDSSKQP-DQE--------------FLA 110 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~-~~~--------------~~~ 110 (245)
...++|.+.++||+|+||.||+|.. ..++.||||++...... .++ ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4567899999999999999999964 23467999998643221 122 334
Q ss_pred HHHHHHccCCCCc-----ceEeEEEEe--------CCceEEEEEecCCCCHHHHHhcCCCCC---------------CCC
Q 025997 111 QVSMVSRLKNENV-----VELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVK---------------GAK 162 (245)
Q Consensus 111 E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~ 162 (245)
|+.++.+++|.++ +++++++.. .+..+|||||+++++|.++++...... ...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766544 566666642 356899999999999999997532110 001
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccccccccccccccccc
Q 025997 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242 (245)
Q Consensus 163 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 242 (245)
....+++..+..++.|++.+|.|||+++ |+||||||+|||++.++.+||+|||++......... ......+|+.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 1223567888999999999999999997 999999999999999999999999998755332211 111123588999
Q ss_pred CCC
Q 025997 243 APE 245 (245)
Q Consensus 243 APE 245 (245)
|||
T Consensus 378 aPE 380 (507)
T PLN03224 378 PPE 380 (507)
T ss_pred Chh
Confidence 998
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=196.17 Aligned_cols=164 Identities=22% Similarity=0.295 Sum_probs=130.9
Q ss_pred CeeccC--CceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
..||+| +||+||++.+. +++.||+|.+...... .+.+.+|+.+++.++|+||+++++++..++..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999965 7899999998654433 35677899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++++||+.+.....
T Consensus 84 ~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 84 GSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred CCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 9999998764321 2788888999999999999999997 99999999999999999999999986432211
Q ss_pred cccc-----cccccccccccccCCC
Q 025997 226 AAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~-----~~~~~~~gt~~y~APE 245 (245)
.... .......++..|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE 178 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPE 178 (328)
T ss_pred cCccccccccccccccCccCccChh
Confidence 1100 0001123567799998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=195.00 Aligned_cols=168 Identities=22% Similarity=0.307 Sum_probs=141.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (245)
..++|.++++||+|+|++|.++++. +.+.+|+|++++.-.. ..=...|-.++.+- +||.+|-+...|.+...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4678999999999999999999954 7789999998654322 12234566666655 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+|.||.+||+|.-.++.++. ++++.+..+..+|..||.|||++| |+.||||.+|+|++..|.+||+|+
T Consensus 328 fvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred EEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeeccc
Confidence 99999999999887776653 899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++.--.... .+++++|||.|+|||
T Consensus 396 gmcke~l~~gd--~tstfcgtpnyiape 421 (593)
T KOG0695|consen 396 GMCKEGLGPGD--TTSTFCGTPNYIAPE 421 (593)
T ss_pred chhhcCCCCCc--ccccccCCCcccchh
Confidence 99975432222 236789999999998
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=193.02 Aligned_cols=167 Identities=28% Similarity=0.470 Sum_probs=136.3
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (245)
..++|++.+.||+|+||.||+|.+. +++.+|||.+...... ...+..|+.++.++ .|+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4577899999999999999999976 4889999998654322 34566777766666 599999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|||+.+ +|.+++..... .+++..+..++.|++.||.|||+ .+ |+||||+|+||++++++.+||+|||
T Consensus 93 ~e~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 93 MELMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eeccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccc
Confidence 999854 78777765332 28889999999999999999997 46 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... ....+++.|+|||
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~y~aPE 184 (296)
T cd06618 161 ISGRLVDSKAK---TRSAGCAAYMAPE 184 (296)
T ss_pred cchhccCCCcc---cCCCCCccccCHh
Confidence 98765432221 2235788999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=189.87 Aligned_cols=164 Identities=29% Similarity=0.419 Sum_probs=134.0
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHcc---CCCCcceEeEEEEeCCc-----
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYVDGPL----- 135 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 135 (245)
|++.+.||+|+||.||+|..+ +++.+|+|.+...... ...+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 5889999998643322 23566777776655 69999999999988776
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.+++|||+.+ +|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence 8999999975 899988754321 2889999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++......... ....++..|+|||
T Consensus 150 dfg~~~~~~~~~~~---~~~~~~~~~~~PE 176 (287)
T cd07838 150 DFGLARIYSFEMAL---TSVVVTLWYRAPE 176 (287)
T ss_pred ccCcceeccCCccc---ccccccccccChH
Confidence 99998766433221 2335788999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=192.53 Aligned_cols=167 Identities=19% Similarity=0.232 Sum_probs=121.4
Q ss_pred CCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCCch--H----------HHHHHHHHHHccCCCCcceEeEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD--Q----------EFLAQVSMVSRLKNENVVELVGY 129 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~--~----------~~~~E~~~l~~l~h~niv~~~~~ 129 (245)
++|.+.+.||+|+||.||+|...+ ...+|+|......... + ....++..+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999664 3456666543222111 1 11223344567789999999987
Q ss_pred EEeCC----ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 025997 130 YVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (245)
Q Consensus 130 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nil 205 (245)
+.... ..+++++++.. ++.+.+..... .++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 66443 34677777643 67776654321 567778899999999999999997 999999999999
Q ss_pred EcCCCceEEecccCCCCCCccccc-----cccccccccccccCCC
Q 025997 206 LFDDDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 206 l~~~~~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~APE 245 (245)
++.++.++|+|||+|+........ .......||+.|+|||
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape 203 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD 203 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence 999999999999999765322111 1112346999999997
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=196.67 Aligned_cols=161 Identities=27% Similarity=0.398 Sum_probs=133.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
.++|.+...||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367999999999999999999964 788999998865322 2346788999999999999999999987543
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++++||+.. +|.+++.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 46899999864 77776532 1788899999999999999999997 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...... ....+|+.|+|||
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE 184 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPE 184 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChh
Confidence 9999987653221 2346789999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=194.91 Aligned_cols=164 Identities=18% Similarity=0.196 Sum_probs=129.2
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.+.+|.|+++.|+++.. +++.||+|++.... .....+.+|+.+++.++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33444454544444443 68899999986542 234578899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+.......
T Consensus 86 l~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 86 CEDLLKTHFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 99999764322 2788889999999999999999997 9999999999999999999999999886543221
Q ss_pred cc-----cccccccccccccCCC
Q 025997 228 AR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~-----~~~~~~~gt~~y~APE 245 (245)
.. .......++..|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPE 178 (314)
T ss_pred ccccccccccccccccccccCHH
Confidence 10 0112345788899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=197.37 Aligned_cols=166 Identities=28% Similarity=0.392 Sum_probs=139.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (245)
+|.+.+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999965 58899999886543 23457889999999999999999999988765 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+.+ +|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 81 lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 99999984 8999887543 2889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccc-cccccccccccccCCC
Q 025997 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
|++......... .......+|..|+|||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 176 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPE 176 (330)
T ss_pred CceEeecccccccccccccccccCcCCce
Confidence 998766543210 1113346899999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=189.77 Aligned_cols=167 Identities=28% Similarity=0.453 Sum_probs=140.9
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+|++.+.||+|+||.||++... +++.+++|.+..... ....+.+|+.++++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 778999999865432 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999998763211 123788999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ....|++.|+|||
T Consensus 153 ~~~~~~----~~~~~~~~~~~Pe 171 (256)
T cd08530 153 LKKNMA----KTQIGTPHYMAPE 171 (256)
T ss_pred hccCCc----ccccCCccccCHH
Confidence 654311 2345888999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=191.03 Aligned_cols=164 Identities=24% Similarity=0.401 Sum_probs=138.4
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
|...+.||+|++|.||+|... +++.+++|.+...... ...+.+|+.++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567788999999999999965 7889999988654332 456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+ +|.+++..... .+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||.+...
T Consensus 81 ~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 75 88888876421 2889999999999999999999998 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....++..|+|||
T Consensus 149 ~~~~~~--~~~~~~~~~~~~PE 168 (283)
T cd05118 149 GSPVRP--YTHYVVTRWYRAPE 168 (283)
T ss_pred CCCccc--ccCccCcccccCcH
Confidence 543311 12245788999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=193.93 Aligned_cols=161 Identities=32% Similarity=0.492 Sum_probs=135.3
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|...+.||+|+||.||+|... ++..+++|.+..... ...++.+|+.+++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3677788999999999999965 678899998854321 23467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+. ++|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 96 ~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 96 YCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred ccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence 997 588887754322 2788899999999999999999997 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ....|++.|+|||
T Consensus 164 ~~~~~------~~~~~~~~y~aPE 181 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPE 181 (308)
T ss_pred eecCc------ccccCCccccCHH
Confidence 54322 2346889999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=198.55 Aligned_cols=163 Identities=31% Similarity=0.447 Sum_probs=137.5
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCc----
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL---- 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 135 (245)
..++|.+...||+|+||.||+|+.. ++..||+|++..... ....+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999965 678999998864322 23457789999999999999999988766554
Q ss_pred --eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 136 --RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 136 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
.++++||+ +++|.+++.... +++..+..++.|++.||.|||+.+ |+||||||+||++++++.++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEE
Confidence 89999998 569999987532 889999999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++....... ....+|..|+|||
T Consensus 159 L~dfg~~~~~~~~~-----~~~~~~~~y~aPE 185 (343)
T cd07851 159 ILDFGLARHTDDEM-----TGYVATRWYRAPE 185 (343)
T ss_pred Eccccccccccccc-----cCCcccccccCHH
Confidence 99999987664321 2346888999997
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=217.24 Aligned_cols=159 Identities=23% Similarity=0.431 Sum_probs=131.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
...|.....||+|+||.||+|.. .++..||+|++....... ..|++.+++++||||+++++++.+.+..++||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 45677788999999999999996 478899999986443222 34688899999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.++++. ++|..+..++.|++.||.|||....++|+||||||+||+++.++..++. ||.+...
T Consensus 766 ~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999953 7889999999999999999996544459999999999999998888875 6655432
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
... ....||+.|||||
T Consensus 833 ~~~------~~~~~t~~y~aPE 848 (968)
T PLN00113 833 CTD------TKCFISSAYVAPE 848 (968)
T ss_pred ccC------CCccccccccCcc
Confidence 211 2236899999998
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=186.21 Aligned_cols=158 Identities=30% Similarity=0.407 Sum_probs=135.5
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
||+|+||.||++... +++.+++|.+..... ....+..|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 588999998865432 234678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 228 (245)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 99997653 2788999999999999999999987 99999999999999999999999999876543321
Q ss_pred ccccccccccccccCCC
Q 025997 229 RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 229 ~~~~~~~~gt~~y~APE 245 (245)
. .....++..|+|||
T Consensus 149 ~--~~~~~~~~~~~~Pe 163 (250)
T cd05123 149 R--TNTFCGTPEYLAPE 163 (250)
T ss_pred c--ccCCcCCccccChH
Confidence 1 13346888999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=189.84 Aligned_cols=164 Identities=29% Similarity=0.420 Sum_probs=138.5
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
|+..+.||+|.||.||+|... +++.+++|.+.... ...+.+..|+.++++++|+||+++++++...+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556778999999999999965 68999999987643 22456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
. ++|.+++..... .+++..+..++.|++.||.|||+++ |+|+||+|+||++++++.++|+|||+++..
T Consensus 81 ~-~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 D-MDLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred C-cCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 8 599999986531 2889999999999999999999998 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....++..|+|||
T Consensus 149 ~~~~~~--~~~~~~~~~~~aPE 168 (282)
T cd07829 149 GIPLRT--YTHEVVTLWYRAPE 168 (282)
T ss_pred CCCccc--cCccccCcCcCChH
Confidence 443221 12234678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=195.79 Aligned_cols=167 Identities=23% Similarity=0.321 Sum_probs=134.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeC---------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDG--------- 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 133 (245)
..+|.+.+.||.|+||.||+|... +++.||+|++..... ..+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999964 688999998855433 345688899999999999999999776543
Q ss_pred -----CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC
Q 025997 134 -----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (245)
Q Consensus 134 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~ 208 (245)
...++++||+. ++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 35789999997 58988886432 788999999999999999999998 999999999999974
Q ss_pred -CCceEEecccCCCCCCcccccc-ccccccccccccCCC
Q 025997 209 -DDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 -~~~vkl~DfGla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
++.+||+|||++.......... ......|+..|+|||
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 188 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHH
Confidence 5678999999987553221111 112235788999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=188.15 Aligned_cols=168 Identities=23% Similarity=0.354 Sum_probs=132.9
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC------CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
+|.+.+.||+|+||.||++... .+..+++|.++.. ......+..|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999865 3444555554321 11233566789999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
+||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.++|+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence 9999999999988642211 123889999999999999999999998 999999999999975 5699999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ .....|++.|+|||
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~pe 175 (260)
T cd08222 152 SRLLMGSCDL--ATTFTGTPYYMSPE 175 (260)
T ss_pred eeecCCCccc--ccCCCCCcCccCHH
Confidence 8765432221 12346888999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=204.91 Aligned_cols=167 Identities=29% Similarity=0.438 Sum_probs=138.2
Q ss_pred CCCCCeeccCCceEEEEEEEC--CC--cEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
..+.++||+|.||.|++|.|. +| ..||||.+..... ...+|++|+.+|.+|+|+|+++|||+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 456678999999999999976 33 3689999976544 35789999999999999999999999887 67889999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+++.|+|.+.|+.... ..|.......++.||+.|+.||.+++ +|||||..+|+|+.....|||+||||.+
T Consensus 191 LaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence 9999999999987322 23777888899999999999999997 9999999999999999999999999999
Q ss_pred CCCccccccc-cccccccccccCCC
Q 025997 222 QAPDAAARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~-~~~~~gt~~y~APE 245 (245)
.+........ .....-...|.|||
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPE 285 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPE 285 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHh
Confidence 8876544321 11112345689998
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=183.52 Aligned_cols=148 Identities=22% Similarity=0.233 Sum_probs=123.8
Q ss_pred CCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHHHHHhcC
Q 025997 77 GSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK 155 (245)
Q Consensus 77 G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 155 (245)
|.||.||+++.. +++.+|+|.+.... .+.+|...+....||||+++++++...+..+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 789999999964 78899999986543 2334445555667999999999999999999999999999999998754
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccc
Q 025997 156 KGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235 (245)
Q Consensus 156 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 235 (245)
.. +++..+..++.|++.||.|||+++ |+||||||+||+++.++.++++|||++....... ...
T Consensus 80 ~~---------l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~ 142 (237)
T cd05576 80 LN---------IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE 142 (237)
T ss_pred cC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence 32 889999999999999999999998 9999999999999999999999999876554321 223
Q ss_pred cccccccCCC
Q 025997 236 LGTFGYHAPE 245 (245)
Q Consensus 236 ~gt~~y~APE 245 (245)
.++..|+|||
T Consensus 143 ~~~~~y~aPE 152 (237)
T cd05576 143 AVENMYCAPE 152 (237)
T ss_pred CcCccccCCc
Confidence 4677899998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-29 Score=192.35 Aligned_cols=168 Identities=28% Similarity=0.451 Sum_probs=134.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC--C-CchHHHHHHHHHHHccCCCCcceEeEEEEe--------C
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--K-QPDQEFLAQVSMVSRLKNENVVELVGYYVD--------G 133 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 133 (245)
..|+...+||+|.||.||+|+.+ +++.||+|++-.. + .-....++|+.+|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666778999999999999955 6788898876332 2 224567899999999999999999887653 2
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
..+|+|+.+|+. +|.-++....- .++..++.+++.++..||.|+|+.. |+|||+|++|+||+.+|.+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 348999999987 89888876532 2888999999999999999999997 99999999999999999999
Q ss_pred EecccCCCCCCccccc--cccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
|+|||+++.+...... ...+..+-|++|.+||
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHH
Confidence 9999999765433221 1123345699999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=203.57 Aligned_cols=175 Identities=21% Similarity=0.229 Sum_probs=119.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-C----CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEE------EEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY------YVD 132 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~ 132 (245)
..++|.+.+.||+|+||.||+|.+. + +..||+|++..... .+...+| .+....+.++..+... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4678999999999999999999975 4 68999998754321 1111111 1222222222222211 234
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVK-----------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
....++++||+.+++|.+++....... ............+..++.||+.||.|||+++ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 567899999999999999987543110 0000001123345678999999999999997 99999999
Q ss_pred CCeEEcC-CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 202 SNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 202 ~Nill~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++. ++.+||+|||+|+.+...... ......||+.|||||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE 327 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPE 327 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChH
Confidence 9999985 579999999999865433222 124467999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=176.45 Aligned_cols=139 Identities=18% Similarity=0.169 Sum_probs=106.9
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc----------hHH-----------------HHHHHHHHHccCCCCc
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----------DQE-----------------FLAQVSMVSRLKNENV 123 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------~~~-----------------~~~E~~~l~~l~h~ni 123 (245)
...||+|+||.||+|...+|+.||||+++..... ... ...|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999999878999999998654211 011 2348899999988776
Q ss_pred ceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCC
Q 025997 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEPRIIHRNIKSS 202 (245)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~ivHrDlkp~ 202 (245)
.....+.. ...++||||++++++........ .++..++..++.|++.+|.++ |+.+ |+||||||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 44333322 22389999999877765432221 278889999999999999999 6887 999999999
Q ss_pred CeEEcCCCceEEecccCCCCCC
Q 025997 203 NVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 203 Nill~~~~~vkl~DfGla~~~~ 224 (245)
|||++ ++.++|+|||+|....
T Consensus 148 NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE-CCcEEEEEccccccCC
Confidence 99998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=190.70 Aligned_cols=165 Identities=28% Similarity=0.394 Sum_probs=133.9
Q ss_pred CCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC-----ceE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (245)
+.+-.+.||-|+||.||...+ ++|+.||+|++..-.. ....+.+|+.+|.-++|.|++..++...... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455567899999999999884 5899999998854322 3467889999999999999999988765432 367
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++|+|.. +|.+++-.... ++-..+.-+.+||+.||+|||+.+ |+||||||.|+|++++..+|||||
T Consensus 134 V~TELmQS-DLHKIIVSPQ~---------Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQA---------LTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHHh-hhhheeccCCC---------CCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence 88888864 88888765432 777888889999999999999997 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++.-.......+ +..+-|.+|.|||
T Consensus 201 GLARvee~d~~~hM-TqEVVTQYYRAPE 227 (449)
T KOG0664|consen 201 GLARTWDQRDRLNM-THEVVTQYYRAPE 227 (449)
T ss_pred ccccccchhhhhhh-HHHHHHHHhccHH
Confidence 99986654443333 3345688999998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=171.09 Aligned_cols=139 Identities=17% Similarity=0.155 Sum_probs=109.6
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---------------------------hHHHHHHHHHHHccCCCCc
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------------------DQEFLAQVSMVSRLKNENV 123 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni 123 (245)
...||+|+||.||+|...+|+.||||++...... ...+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998654211 1123468889999999987
Q ss_pred ceEeEEEEeCCceEEEEEecCCCCHHHH-HhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCC
Q 025997 124 VELVGYYVDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKS 201 (245)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp 201 (245)
.....+... ..++||||++++++... +... .++......++.|++.++.++|+ ++ |+||||||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP 146 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSE 146 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCh
Confidence 554444333 24899999998765433 3321 16778889999999999999999 87 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCc
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
+|||++ ++.++|+|||++.....
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhEEEE-CCCEEEEEcccceecCC
Confidence 999998 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=200.98 Aligned_cols=165 Identities=22% Similarity=0.366 Sum_probs=135.5
Q ss_pred CCCCCeeccCCceEEEEEEEC-CC----cEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SG----RAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
....++||+|+||+||+|.+- .+ -+||+|++.... ....+++.|+-.|.+++|||++++++++..+. +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344678999999999999964 33 368999885443 33678999999999999999999999998765 88999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
+|++.|+|.++++.++.. +.....+.++.||++||.|||.+. +|||||..+|+|+.+...+||.|||++
T Consensus 777 q~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 999999999999987653 778889999999999999999996 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAP 244 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~AP 244 (245)
+.+.............-.+.|||=
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmal 869 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMAL 869 (1177)
T ss_pred hccCcccccccccccccCcHHHHH
Confidence 987655443322222224456653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=182.46 Aligned_cols=165 Identities=18% Similarity=0.335 Sum_probs=139.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCC--C----CcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--E----NVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~~~ 137 (245)
..+|.++..+|+|.||.|-.+..+ ++..||||+++.-..-.+..+-|+++|.++.+ | -++.+.++|...++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 577999999999999999999955 57889999998766667778889999999943 2 3678888898999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---------
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------- 208 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--------- 208 (245)
||+|.+ |-|+++++.++... .++...+..|+.|+++++.+||+.+ ++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred EEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 999988 45999999886543 3889999999999999999999997 999999999999942
Q ss_pred -----------CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 -----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 -----------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..++|+|||.|+...+.. ..++-|..|.|||
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPE 279 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPE 279 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCch
Confidence 2368999999987654433 4567899999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=176.11 Aligned_cols=163 Identities=23% Similarity=0.424 Sum_probs=134.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEE-EEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY-YVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e 141 (245)
.+.|.+.+.||+|.||.+.+++++ +.+.+++|.+........+|.+|...--.| .|.||+.-|+. |.+.+.+++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 466899999999999999999987 677899999988888889999998765555 58899987764 667788899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc--CCCceEEecccC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDL 219 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~--~~~~vkl~DfGl 219 (245)
|++.|+|..-+...+ +.+....+++.|++.|+.|+|+++ +||||||.+||||. +...|||||||+
T Consensus 103 ~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred cCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccc
Confidence 999999998876643 778888999999999999999998 99999999999995 345899999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+..+..... .--+..|.+||
T Consensus 170 t~k~g~tV~~-----~~~~~~y~~pe 190 (378)
T KOG1345|consen 170 TRKVGTTVKY-----LEYVNNYHAPE 190 (378)
T ss_pred ccccCceehh-----hhhhcccCCcH
Confidence 8766543322 12355677775
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=195.58 Aligned_cols=177 Identities=25% Similarity=0.427 Sum_probs=141.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----C----CcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
.++..+.+.||+|.||.|++|... . ...||||.++..... .+.+..|+++|+.+ .|+||+.+++++...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344556669999999999999843 1 457999998755443 56788999999999 599999999999998
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCC-C----CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGA-K----PG--PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~----~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
...++|+||+..|+|.+++...+..... . +. ..++..+.+.++.||+.|++||++.. +|||||-.+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 9999999999999999999987711100 0 11 24899999999999999999999997 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccc--cccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLG--TFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g--t~~y~APE 245 (245)
..+..+||+|||+|+............ -.| ...|||||
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApE 491 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPE 491 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHH
Confidence 999999999999998665444332111 122 24599998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=167.78 Aligned_cols=166 Identities=34% Similarity=0.499 Sum_probs=140.7
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
|.+.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++.+++++|+|++++++++...+..++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 556788999999999999976 488999999876544 35678889999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... +++..+..++.+++.++.+||.++ ++|+||+|.||+++.++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999865321 678889999999999999999997 9999999999999999999999999987665
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......++..|++||
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe 169 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPE 169 (225)
T ss_pred Ccccc-cccceeccCCcCCHh
Confidence 43211 112346788899997
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=193.43 Aligned_cols=166 Identities=29% Similarity=0.399 Sum_probs=128.8
Q ss_pred CCCCCeeccCCceE-EEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 68 FGTNSLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 68 ~~~~~~lG~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
|...+++|.|+-|+ ||+|.+. ++.||||++-.+ ...-..+|+..|..- .|||||++++.-.+..+.||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 44556788988775 8999987 689999988433 223456899998887 69999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---C--CceEEecccCC
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---D--DIAKISDFDLS 220 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~--~~vkl~DfGla 220 (245)
.+|.++++... ..... ..-...+.+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||++
T Consensus 587 ~sL~dlie~~~-~d~~~----~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 587 CSLQDLIESSG-LDVEM----QSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hhHHHHHhccc-cchhh----cccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 59999998741 11000 111345677889999999999987 999999999999975 3 47899999999
Q ss_pred CCCCcccccc-ccccccccccccCCC
Q 025997 221 NQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
+.+....... ......||-+|+|||
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHH
Confidence 9876543322 234467999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-25 Score=171.37 Aligned_cols=162 Identities=18% Similarity=0.332 Sum_probs=131.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeC--CceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 139 (245)
..++|++.+.+|+|.|++||.|. ..+.+.++||+++.- ....+.+|+.+|..|. ||||+++++...+. ....|+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45789999999999999999999 456788999998643 3457889999999996 99999999998765 356799
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEeccc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFD 218 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfG 218 (245)
+||..+.+...+... |+..++...+.+++.||.|+|+.| |+|||+||.|++|+. ...++|+|+|
T Consensus 114 FE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence 999999888776642 777788999999999999999998 999999999999985 4689999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|...-..... .-.+.+..|--||
T Consensus 179 LAEFYHp~~eY---nVRVASRyfKGPE 202 (338)
T KOG0668|consen 179 LAEFYHPGKEY---NVRVASRYFKGPE 202 (338)
T ss_pred hHhhcCCCcee---eeeeehhhcCCch
Confidence 99766443332 1123445555555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=185.92 Aligned_cols=161 Identities=22% Similarity=0.354 Sum_probs=133.3
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 141 (245)
..+.|.....+|.|+|+.|..+.+. +++..++|++.+.. .+..+|+.++... +|+||+++.+.+.++...|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3567888888999999999999965 77889999997652 2234466555554 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE-cCCCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill-~~~~~vkl~DfGla 220 (245)
.+.|+-+.+.+...+. .. .++..|+.+|+.++.|||++| +|||||||+|||+ ++.++++|+|||.+
T Consensus 397 ~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred hccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 9999988888766542 33 667789999999999999998 9999999999999 58999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+...... .+.+=|..|.|||
T Consensus 464 ~~~~~~~-----~tp~~t~~y~APE 483 (612)
T KOG0603|consen 464 SELERSC-----DTPALTLQYVAPE 483 (612)
T ss_pred hhCchhh-----cccchhhcccChh
Confidence 8876541 2234588999998
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=164.68 Aligned_cols=166 Identities=25% Similarity=0.362 Sum_probs=134.1
Q ss_pred hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCC-CCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.+.|.+++.||+|+||.+|.|. ..+|..||||.-.. ......+.-|..+.+.|++ ..|..+..+..+..+-.+||+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4679999999999999999999 56899999997543 3334567788889998875 6788888888888999999998
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEEecccC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDL 219 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl~DfGl 219 (245)
+ |.||.+++.-... .++..+++.++-|++.-++|+|.++ ++||||||+|+|..- ...+.++|||+
T Consensus 93 L-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred c-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccc
Confidence 8 5589888765432 2888999999999999999999998 999999999999864 35789999999
Q ss_pred CCCCCcccccc-----ccccccccccccC
Q 025997 220 SNQAPDAAARL-----HSTRVLGTFGYHA 243 (245)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~A 243 (245)
|+...+..... ......||..|.+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehh
Confidence 98775443321 2234678888864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=169.86 Aligned_cols=164 Identities=25% Similarity=0.371 Sum_probs=136.4
Q ss_pred CCCCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEecC
Q 025997 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.|.+.++||+|+||+++.|. .-+++.||||.- ..+....++..|....+.|. .++|...|-+...+-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 59999999999999999999 568999999964 33445567888998888884 689999998888888889999988
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-----CceEEecccC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAKISDFDL 219 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-----~~vkl~DfGl 219 (245)
|.||.|++.-... .++..++..++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+
T Consensus 107 GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 107 GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 5588888876543 2899999999999999999999997 9999999999999753 4688999999
Q ss_pred CCCCCccccccc-----cccccccccccC
Q 025997 220 SNQAPDAAARLH-----STRVLGTFGYHA 243 (245)
Q Consensus 220 a~~~~~~~~~~~-----~~~~~gt~~y~A 243 (245)
|+...+...... ...+.||.+||+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeE
Confidence 998766544321 234679999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-23 Score=160.24 Aligned_cols=159 Identities=34% Similarity=0.581 Sum_probs=135.0
Q ss_pred eccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHHH
Q 025997 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (245)
Q Consensus 74 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (245)
||+|++|.||++... +++.+++|+....... .+.+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999976 4889999998765442 5678999999999999999999999999899999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccCCCCCCccccc
Q 025997 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAAR 229 (245)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~~~ 229 (245)
++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 81 LLKENEG--------KLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 9976421 2788999999999999999999997 999999999999999 89999999999875543321
Q ss_pred cccccccccccccCCC
Q 025997 230 LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 230 ~~~~~~~gt~~y~APE 245 (245)
......+...|++||
T Consensus 149 -~~~~~~~~~~~~~pe 163 (215)
T cd00180 149 -LLKTIVGTPAYMAPE 163 (215)
T ss_pred -hhhcccCCCCccChh
Confidence 112245778899887
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=161.63 Aligned_cols=136 Identities=15% Similarity=0.145 Sum_probs=104.3
Q ss_pred CCCCeeccCCceEEEEEEECCCcEEEEEEcCCCC-CchHHHHHHHHHHHcc-----CCCCcceEeEEEEeCC---c-eEE
Q 025997 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRL-----KNENVVELVGYYVDGP---L-RVL 138 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~l 138 (245)
...+.||+|+||.||. +......+||++.... ...+.+.+|+.+++.+ .||||+++++++.++. . +.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999995 4433334789876542 2356789999999999 5799999999999874 3 347
Q ss_pred EEEe--cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCeEEcC----CCc
Q 025997 139 AYEH--ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL-EYLHEKAEPRIIHRNIKSSNVLLFD----DDI 211 (245)
Q Consensus 139 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~ivHrDlkp~Nill~~----~~~ 211 (245)
|+|| +.+++|.+++.... +++. ..++.+++.++ .|||+++ |+||||||+|||++. ++.
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence 8999 55799999996532 4444 34567888777 9999998 999999999999974 348
Q ss_pred eEEecccCCC
Q 025997 212 AKISDFDLSN 221 (245)
Q Consensus 212 vkl~DfGla~ 221 (245)
++|+||+.++
T Consensus 148 ~~LiDg~G~~ 157 (210)
T PRK10345 148 PVVCDNIGES 157 (210)
T ss_pred EEEEECCCCc
Confidence 9999954443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=166.09 Aligned_cols=153 Identities=34% Similarity=0.511 Sum_probs=132.4
Q ss_pred CceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHHHHHhc
Q 025997 78 SYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154 (245)
Q Consensus 78 ~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 154 (245)
+||.||+|... +++.+++|++...... .+.+.+|+..+++++|+||+++++++......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 5889999998655433 57889999999999999999999999998999999999999999999876
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccccccccc
Q 025997 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234 (245)
Q Consensus 155 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 234 (245)
... +++..++.++.+++.++.|||..+ ++|+||+|+||++++++.++|+|||++........ ...
T Consensus 81 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 145 (244)
T smart00220 81 RGR---------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTT 145 (244)
T ss_pred ccC---------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccc---ccc
Confidence 432 788899999999999999999997 99999999999999999999999999877654321 133
Q ss_pred ccccccccCCC
Q 025997 235 VLGTFGYHAPE 245 (245)
Q Consensus 235 ~~gt~~y~APE 245 (245)
..++..|++||
T Consensus 146 ~~~~~~~~~pE 156 (244)
T smart00220 146 FVGTPEYMAPE 156 (244)
T ss_pred ccCCcCCCCHH
Confidence 46888999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=167.81 Aligned_cols=167 Identities=22% Similarity=0.288 Sum_probs=130.3
Q ss_pred CCCCCCeeccCCceEEEEEEECCC--cEEEEEEcCCCCCc-hHHHHHHHHHHHccCC----CCcceEeEEE-EeCCceEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSG--RAAAIKKLDSSKQP-DQEFLAQVSMVSRLKN----ENVVELVGYY-VDGPLRVL 138 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~--~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 138 (245)
+|.+.+.||+|+||.||.+..... ..+|+|........ ...+..|+.++..+.. .++..+++.+ ....+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996643 47888876544222 2367788888888863 5889999988 47778899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-----CceE
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAK 213 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-----~~vk 213 (245)
||+.+ |.+|.++....... .++..+++.|+.|++.+|++||+.| ++||||||+|+++... ..+.
T Consensus 99 VM~l~-G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEecc-CccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 99987 56999988655422 3899999999999999999999998 9999999999999754 4699
Q ss_pred EecccCCC--CCCcccc---c---cccccccccccccCC
Q 025997 214 ISDFDLSN--QAPDAAA---R---LHSTRVLGTFGYHAP 244 (245)
Q Consensus 214 l~DfGla~--~~~~~~~---~---~~~~~~~gt~~y~AP 244 (245)
|.|||+++ ....... . .....+.||..|+++
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 99999998 3222111 1 111234599999876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=158.86 Aligned_cols=144 Identities=16% Similarity=0.154 Sum_probs=110.2
Q ss_pred CCCCCCeeccCCceEEEEEE--ECCCcEEEEEEcCCCCCc-------------------------hHHHHHHHHHHHccC
Q 025997 67 NFGTNSLIGEGSYGRVYFGV--LRSGRAAAIKKLDSSKQP-------------------------DQEFLAQVSMVSRLK 119 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~ 119 (245)
.|.+.+.||+|+||.||+|. ..+++.||+|.+...... ...+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58889999999999999998 468999999988643210 012457999999997
Q ss_pred CCC--cceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 025997 120 NEN--VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (245)
Q Consensus 120 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHr 197 (245)
+.. +.++++. ...++||||+.+.+|........ .+.......++.|++.++.+||+++ +|+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 532 3344432 23589999999988876542221 1455567789999999999999985 49999
Q ss_pred CCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 198 Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
||||+||+++ ++.++|+|||.+......
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999999 889999999998765443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=154.90 Aligned_cols=138 Identities=13% Similarity=0.171 Sum_probs=113.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHH----------HHHHHHHHHccCCCCcceEeEEEEeC-
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKNENVVELVGYYVDG- 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~~~~~~~~~- 133 (245)
.++|.+.++||+|+||.||++.. ++..+|+|.+.......+. +.+|+..+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 56899999999999999999766 5678999998654433222 57899999999999999999886643
Q ss_pred -------CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 -------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
...+++|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili 168 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV 168 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence 35789999999999988732 332 23558899999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCC
Q 025997 207 FDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~ 224 (245)
+.++ ++|+|||......
T Consensus 169 ~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred eCCC-EEEEECCCccccc
Confidence 9888 9999999886653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=150.23 Aligned_cols=132 Identities=17% Similarity=0.171 Sum_probs=105.6
Q ss_pred CCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchH-----HHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEe
Q 025997 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ-----EFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.....|++|+||+||++.. .+..++.+.+.......+ .+.+|+++|++|. |++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4566899999999997665 577888777765544322 4788999999995 5789999886 457999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeEEcCCCceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDl-kp~Nill~~~~~vkl~DfGla~ 221 (245)
+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.
T Consensus 80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 999998754321 11346778999999999998 999999 7999999999999999999998
Q ss_pred CCC
Q 025997 222 QAP 224 (245)
Q Consensus 222 ~~~ 224 (245)
...
T Consensus 141 ~~~ 143 (218)
T PRK12274 141 RGN 143 (218)
T ss_pred ecC
Confidence 544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=165.30 Aligned_cols=145 Identities=24% Similarity=0.370 Sum_probs=126.7
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
+......|.....||+|.|+.||++... ....||+|.+.... ....+.+|+++|..+ .+.||+++.+.+..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445667899999999999999999843 46789999986654 345689999999999 58999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKI 214 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl 214 (245)
..+|+||++..+..++... ++..++..+++.++.||.++|.+| ||||||||+|+|.+. .+.-.|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence 9999999999998888864 778889999999999999999998 999999999999975 467889
Q ss_pred ecccCCC
Q 025997 215 SDFDLSN 221 (245)
Q Consensus 215 ~DfGla~ 221 (245)
.|||+|.
T Consensus 175 vDFgLA~ 181 (418)
T KOG1167|consen 175 VDFGLAQ 181 (418)
T ss_pred EechhHH
Confidence 9999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=151.98 Aligned_cols=134 Identities=22% Similarity=0.335 Sum_probs=112.0
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.||+|++|.||+|.+ .+..+++|+....... ...+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5678889976432211 13467899999999999988777777777888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
++|++|.+++... .. ....++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 12 67788999999999999998 99999999999999 78899999999875
Q ss_pred C
Q 025997 223 A 223 (245)
Q Consensus 223 ~ 223 (245)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 4
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=161.60 Aligned_cols=161 Identities=25% Similarity=0.329 Sum_probs=129.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC---CCchHHHHHHHHHHHccCCCCcceEeEEEEeCC------c
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------L 135 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 135 (245)
.+|.-++.+|.|.- .|-.|... .++.||+|++... ........+|..++..++|+||++++.+|.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666777888877 55555533 6889999987433 233456778999999999999999999987543 4
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+|||+|.. +|.+++... ++-.....|..|++.|++|||+.+ |+||||||+||++..+..+||.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred HHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence 6999999964 899988732 677788899999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+|+..... ...+-.+.|..|.|||
T Consensus 161 dfg~ar~e~~~---~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 161 DFGLARTEDTD---FMMTPYVVTRYYRAPE 187 (369)
T ss_pred cchhhcccCcc---cccCchhheeeccCch
Confidence 99999765433 1224457889999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=167.35 Aligned_cols=166 Identities=21% Similarity=0.294 Sum_probs=136.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCC------CCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~l 138 (245)
..|.+....|+|-|+.|.+|... .++.||||+|.........=+.|+++|++|+. -++++|+..|...+++||
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 45777777899999999999955 57899999998776656666789999999963 378999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEEecc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDF 217 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl~Df 217 (245)
|+|.+. -+|.++|+..+...+ |.+..+..++.|+..||..|-..+ |+|.||||+|||+++. ..+|||||
T Consensus 512 VFE~Ls-lNLRevLKKyG~nvG------L~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 512 VFEPLS-LNLREVLKKYGRNVG------LHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred Eehhhh-chHHHHHHHhCcccc------eeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 999885 489999987654332 777888999999999999999998 9999999999999875 57899999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|.|.......-.+ .+-+-.|.|||
T Consensus 582 GSA~~~~eneitP----YLVSRFYRaPE 605 (752)
T KOG0670|consen 582 GSASFASENEITP----YLVSRFYRAPE 605 (752)
T ss_pred ccccccccccccH----HHHHHhccCcc
Confidence 9987776543221 22355688987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=148.31 Aligned_cols=137 Identities=16% Similarity=0.131 Sum_probs=107.8
Q ss_pred CCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc-----------------------hHHHHHHHHHHHccCCCC-
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----------------------DQEFLAQVSMVSRLKNEN- 122 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~n- 122 (245)
.|.+.+.||+|+||.||++...+++.+|||++...... ......|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 47788999999999999999888999999986543210 113566888888887774
Q ss_pred -cceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 123 -VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 123 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
+...++ ....+++|||+.+++|.++... .....++.+++.++.++|..+ |+|+||||
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 444443 2456899999999998765421 224567889999999999997 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCc
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-21 Score=168.15 Aligned_cols=137 Identities=22% Similarity=0.294 Sum_probs=110.3
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEE-cCCCCC--------chHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK-LDSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~-~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
..|...+.||+|+||.||++.+.... +++|+ +.+... ..+.+.+|+.+++.++|++++....++.+.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566789999999999999876443 33333 222111 124578899999999999999888777777788
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|+|
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 99999999999998874 23568889999999999998 9999999999999 678899999
Q ss_pred ccCCCCCC
Q 025997 217 FDLSNQAP 224 (245)
Q Consensus 217 fGla~~~~ 224 (245)
||+++...
T Consensus 471 FGla~~~~ 478 (535)
T PRK09605 471 FGLGKYSD 478 (535)
T ss_pred CcccccCC
Confidence 99997653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=147.04 Aligned_cols=131 Identities=24% Similarity=0.344 Sum_probs=105.3
Q ss_pred eeccCCceEEEEEEECCCcEEEEEEcCCCC-Cc--------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.||+|+||.||+|.+ ++..+++|...... .. ...+.+|+.++..+.|+++....-++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 46789999854321 11 144667999999998887655555556677789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875321 1 67889999999999998 99999999999999 889999999998764
Q ss_pred C
Q 025997 224 P 224 (245)
Q Consensus 224 ~ 224 (245)
.
T Consensus 140 ~ 140 (199)
T TIGR03724 140 D 140 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-20 Score=153.15 Aligned_cols=167 Identities=34% Similarity=0.526 Sum_probs=138.1
Q ss_pred CCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCC-CcceEeEEEEeCCceEEEEEe
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 142 (245)
|.+.+.||.|+|+.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999977 7889998865433 256788999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecccCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfGla~ 221 (245)
+.++++.+++...... ..+.......+..|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 9999999777654311 12788899999999999999999998 99999999999999988 79999999987
Q ss_pred CCCcccccc----ccccccccccccCCC
Q 025997 222 QAPDAAARL----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~----~~~~~~gt~~y~APE 245 (245)
......... ......||..|+|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPE 178 (384)
T ss_pred ecCCCCccccccccccccccccccCCHH
Confidence 554333211 124567999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=160.41 Aligned_cols=134 Identities=22% Similarity=0.385 Sum_probs=113.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-----C---CCcceEeEEEE----e
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----N---ENVVELVGYYV----D 132 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~----~ 132 (245)
.+|.+.++||.|.|++||+|... +.+.||+|+.+....-.+..+.||.+|++++ | ..||+|++.|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 57888899999999999999965 6778999998766666777889999999884 2 36999999987 3
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
+.++++|+|++ |.+|..+|....... ++...+..|+.||+.||.|||+.. +|||-||||+|||+...
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 56899999998 558999988765432 899999999999999999999976 69999999999999644
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=150.50 Aligned_cols=182 Identities=20% Similarity=0.289 Sum_probs=143.7
Q ss_pred HHHHhhCCCCCCCeeccCCceEEEEEEECC------CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEE
Q 025997 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV 131 (245)
Q Consensus 60 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~ 131 (245)
++.....++.+..++-+|.||.||+|.+++ .+.|.+|.++..... ...++.|..++..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 333345668888889999999999998663 345667776544333 346788999999999999999999876
Q ss_pred -eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
+....++++.++.-|+|..++.-.++.. ......++..+...++.|++.|+.|||+++ +||.||..+|++|++.-
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 4567889999999999999998655322 223345788888999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+|=.+++.+-...........--...||+||
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE 468 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE 468 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence 99999999999876665554433334467899987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=131.55 Aligned_cols=137 Identities=20% Similarity=0.228 Sum_probs=112.6
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCC--CCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.+++ .++++++.+....+..++++||+.+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35679999999999999765 7889998865543 5678899999999976 589999988887788999999998876
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+..+ +......++.+++.+|.++|.....+++|+|++|+||+++..+.++++|||.+....
T Consensus 80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 80 LDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 6543 234456678899999999998643459999999999999998999999999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=138.61 Aligned_cols=136 Identities=17% Similarity=0.222 Sum_probs=97.3
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCch---HHH----------------------HHHHHHHHccCCCC--c
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEF----------------------LAQVSMVSRLKNEN--V 123 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--i 123 (245)
.+.||+|+||.||+|...+++.||||++....... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999876432211 111 24555566654432 3
Q ss_pred ceEeEEEEeCCceEEEEEecCCCCHHH-HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCC
Q 025997 124 VELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKS 201 (245)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp 201 (245)
.+.++. ...+++|||++++++.. .+.... .. .....++.+++.++.++|. ++ |+|+||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSE 143 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence 444432 24689999999854321 111110 11 4567889999999999999 87 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCc
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
+||+++ ++.++|+|||.+.....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhEEEE-CCcEEEEECcccccccC
Confidence 999999 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-18 Score=136.40 Aligned_cols=135 Identities=16% Similarity=0.208 Sum_probs=103.0
Q ss_pred Ceec-cCCceEEEEEEECCCcEEEEEEcCCCC--------------CchHHHHHHHHHHHccCCCCc--ceEeEEEEeC-
Q 025997 72 SLIG-EGSYGRVYFGVLRSGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENV--VELVGYYVDG- 133 (245)
Q Consensus 72 ~~lG-~G~fg~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~- 133 (245)
..|| .|+.|+||.+... +..++||...... .....+.+|+.++.+|+|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 7889999988775 6778888764211 122457789999999998775 6666664332
Q ss_pred Cc---eEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 134 PL---RVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 134 ~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
.. .++|+|+++| .+|.+++.... ++.. .+.+|+.+|.+||++| |+||||||+|||++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~ 178 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD 178 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence 22 3599999997 68998886431 4433 3568899999999998 9999999999999988
Q ss_pred CceEEecccCCCCCC
Q 025997 210 DIAKISDFDLSNQAP 224 (245)
Q Consensus 210 ~~vkl~DfGla~~~~ 224 (245)
+.++|+|||.+....
T Consensus 179 ~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 179 GKFWLIDFDRGELRT 193 (239)
T ss_pred CCEEEEECCCcccCC
Confidence 899999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-19 Score=163.72 Aligned_cols=117 Identities=18% Similarity=0.194 Sum_probs=83.0
Q ss_pred ccCC-CCcceEeEEE-------EeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 025997 117 RLKN-ENVVELVGYY-------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188 (245)
Q Consensus 117 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 188 (245)
.+.| .||.++++++ .....+++++|++ +++|.+++..... .+++.+++.++.||+.||.|||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAAHS 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHHHh
Confidence 3445 5777777776 2234567778887 5599999974321 28899999999999999999999
Q ss_pred CCCCCeEecCCCCCCeEEcC-------------------CCceEEecccCCCCCCcccc-------c-------cccccc
Q 025997 189 KAEPRIIHRNIKSSNVLLFD-------------------DDIAKISDFDLSNQAPDAAA-------R-------LHSTRV 235 (245)
Q Consensus 189 ~~~~~ivHrDlkp~Nill~~-------------------~~~vkl~DfGla~~~~~~~~-------~-------~~~~~~ 235 (245)
++ |+||||||+|||++. ++.+|++|||+++....... . ......
T Consensus 99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 98 999999999999954 44566677777654211000 0 000124
Q ss_pred cccccccCCC
Q 025997 236 LGTFGYHAPE 245 (245)
Q Consensus 236 ~gt~~y~APE 245 (245)
+||+.|||||
T Consensus 176 ~gt~~Y~APE 185 (793)
T PLN00181 176 MEMSWYTSPE 185 (793)
T ss_pred CCCcceEChh
Confidence 6899999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=158.59 Aligned_cols=144 Identities=28% Similarity=0.361 Sum_probs=113.9
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..|.+...||+|+||.||+|...+++.||+|+-+....+. |.-=.+++.+|+ -+.|..+..++.-.+..+||+||
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 4566778899999999999998889999999865544332 211223445554 23455666666677888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-------CCceEEe
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------DDIAKIS 215 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-------~~~vkl~ 215 (245)
.+.|+|.+++...+ ..++..++.++.|++..+..||..+ |||+||||+|+||.. ..-++|+
T Consensus 776 ~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 776 SPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999998443 3888899999999999999999998 999999999999942 3468999
Q ss_pred cccCCCCC
Q 025997 216 DFDLSNQA 223 (245)
Q Consensus 216 DfGla~~~ 223 (245)
|||.|-.+
T Consensus 844 DfG~siDm 851 (974)
T KOG1166|consen 844 DFGRSIDM 851 (974)
T ss_pred ecccceee
Confidence 99998654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-18 Score=154.30 Aligned_cols=163 Identities=21% Similarity=0.313 Sum_probs=122.7
Q ss_pred CCCeeccCCceEEEEEEEC-CCcEEEEEEcC----CCCCch---HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~----~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
...++|.|++|.|+.+... ....++.|... ...... ..+..|+.+-..+.|+|++..+....+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999988877644 23333333322 111111 125567777888999999877776666555555599
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
||++ +|..++..... +...++-.++.|++.|+.|+|+.| |.|||||++|+++..+|.+||+|||.+.
T Consensus 402 ~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred cccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence 9999 99999987522 677788889999999999999998 9999999999999999999999999987
Q ss_pred CCCccccc--cccccccccccccCCC
Q 025997 222 QAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
........ .....++|+-.|+|||
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE 494 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPE 494 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcc
Confidence 55433332 3345678999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-18 Score=148.70 Aligned_cols=155 Identities=25% Similarity=0.322 Sum_probs=127.5
Q ss_pred eeccCCceEEEEEE----ECCCcEEEEEEcCCCCC---chHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEecC
Q 025997 73 LIGEGSYGRVYFGV----LRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 73 ~lG~G~fg~V~~~~----~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
++|+|.||.|++++ ...+..+|+|++++... .......|-.++..++ ||.++++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 23567788888754321 1224445777788886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+|+|...+..... +.+.....+...++.++.++|..+ |+|||+|++||+++.+|.+++.|||+++..-
T Consensus 81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 9999888766543 667777778889999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
.... .+||..|||||
T Consensus 149 ~~~~------~cgt~eymApE 163 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPE 163 (612)
T ss_pred hhhh------cccchhhhhhH
Confidence 4332 28999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-16 Score=134.53 Aligned_cols=141 Identities=22% Similarity=0.261 Sum_probs=98.0
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---------------------------h--------------HHHH
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------------------D--------------QEFL 109 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~~~~ 109 (245)
.+.||.|++|.||+|+.++|+.||||+....... . -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3579999999999999999999999997543110 0 0133
Q ss_pred HHHHHHHcc----CCCCcceEeEEEE-eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 025997 110 AQVSMVSRL----KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-GL 183 (245)
Q Consensus 110 ~E~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~-~l 183 (245)
+|+..+.++ +|.+-+.+...+. .....+|+|||+.|++|.++....... .. ...++..++. .+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------LD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------CC---HHHHHHHHHHHHH
Confidence 444444444 2333333333332 234578999999999998876532110 22 2345555554 46
Q ss_pred HHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 184 ~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
..+|..| ++|+|++|.||+++.++.++++|||++..+..
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7889887 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-14 Score=109.78 Aligned_cols=131 Identities=15% Similarity=0.072 Sum_probs=96.1
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCc-ceEeEEEEeCCceEEEEEecCCCCHHH
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSLHD 150 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (245)
+.|+.|.++.||++... +..+++|...........+.+|+..++.+.+.++ .+++.+. ....++||||++|.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999998865 6789999875543333456788988888865443 4555443 334589999999987754
Q ss_pred HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.. .. ...+..+++.+|..||..+ ...++|+|++|.||+++ ++.++++|||.+...
T Consensus 81 ~~--------------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 81 ED--------------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc--------------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 30 11 1234568899999999986 12359999999999998 678999999998643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=6e-15 Score=129.28 Aligned_cols=144 Identities=16% Similarity=0.239 Sum_probs=92.5
Q ss_pred CCCCCCCeeccCCceEEEEEEECC-CcEEEEEEcCCCCC---------------------------c--------hH---
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQ---------------------------P--------DQ--- 106 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---------------------------~--------~~--- 106 (245)
.+|+. +.||+|++|.||+|+.++ |+.||||++..... . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 689999999999999876 99999999864310 0 01
Q ss_pred ---HHHHHHHHHHcc----CCCCcceEeEEEEe-CCceEEEEEecCCCCHHHHH--hcCCCCCCCCCCCCCCHHHHHHHH
Q 025997 107 ---EFLAQVSMVSRL----KNENVVELVGYYVD-GPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIA 176 (245)
Q Consensus 107 ---~~~~E~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~ 176 (245)
++.+|+.-+.++ .+.+.+.+-.++.+ ....+|||||+.|+++.++- ...... ...+....+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHHHHHHH
Confidence 123344333333 24444444444432 45578999999999998753 221100 0002222222233
Q ss_pred HHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC----ceEEecccCCCCCCc
Q 025997 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPD 225 (245)
Q Consensus 177 ~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~----~vkl~DfGla~~~~~ 225 (245)
.| +...| ++|+|++|.||+++.++ .++++|||++..+..
T Consensus 274 ~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 34466 99999999999999887 999999999877654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-15 Score=119.38 Aligned_cols=158 Identities=24% Similarity=0.350 Sum_probs=123.0
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
+..+|.+...|+.|+|+++.+ .+++|++.... .-..+|..|.-.|+.+.||||+.+++.+.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 344678888999999999844 45557664432 33467888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe--cccCCCCCC
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS--DFDLSNQAP 224 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~--DfGla~~~~ 224 (245)
+|+.++++..+. +++..++++++.+++.|+.|||+.. +-|..--|....++||++.+++|+ |--++.+-.
T Consensus 273 slynvlhe~t~v-------vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~ 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV 344 (448)
T ss_pred HHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeecc
Confidence 999999987653 4788899999999999999999975 224444688999999999877764 443332211
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
...-.|.||+||
T Consensus 345 ---------gr~y~pawmspe 356 (448)
T KOG0195|consen 345 ---------GRAYSPAWMSPE 356 (448)
T ss_pred ---------ccccCcccCCHH
Confidence 112367899997
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.3e-15 Score=136.71 Aligned_cols=141 Identities=18% Similarity=0.186 Sum_probs=114.3
Q ss_pred CCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCC--CchHHHHH---HHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK--QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++...+.||++.|=+|.+|+++.|. |+||++-+.. .+.+.+.+ |++ ..-.++||++.+..+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999998876 8888774332 23344443 444 455689999998887777777888888
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|..+ +|+|.+.-+.. +...+.+-|+.||+.||.-+|..| |+|+|||.+||||..-..+.|+||..-+
T Consensus 102 yvkh-nLyDRlSTRPF---------L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF---------LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhh-hhhhhhccchH---------HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 8866 99999876542 667777779999999999999998 9999999999999999999999998765
Q ss_pred C
Q 025997 222 Q 222 (245)
Q Consensus 222 ~ 222 (245)
.
T Consensus 169 P 169 (1431)
T KOG1240|consen 169 P 169 (1431)
T ss_pred C
Confidence 3
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.8e-13 Score=102.03 Aligned_cols=136 Identities=17% Similarity=0.138 Sum_probs=97.1
Q ss_pred CCeeccCCceEEEEEEECC-------CcEEEEEEcCCCC----------------------Cc-hHHHH----HHHHHHH
Q 025997 71 NSLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSK----------------------QP-DQEFL----AQVSMVS 116 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~----------------------~~-~~~~~----~E~~~l~ 116 (245)
...||.|.=+.||.|...+ +..+|||+.+.+. .. ...+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3468999999999998543 4789999763210 00 12222 6888898
Q ss_pred ccCC--CCcceEeEEEEeCCceEEEEEecCCCCHHH-HHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCC
Q 025997 117 RLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEP 192 (245)
Q Consensus 117 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ 192 (245)
++.. -++...+.+ ..-+|||||+.+..+.. .++.. .++..+...+..+++.+|..+ |..+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g-- 145 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN-- 145 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 8853 466677754 45789999997654422 22211 144455667788999999998 7887
Q ss_pred CeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 193 ~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
|||+||++.|||+. ++.+.|+|||.+....
T Consensus 146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999997 4679999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.1e-15 Score=132.59 Aligned_cols=169 Identities=24% Similarity=0.331 Sum_probs=130.9
Q ss_pred CCCCCCCeeccCCceEEEEEEEC--CCcEEEEEEcCCCCC---chHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 139 (245)
..|.+.+.||+|+|+.|-..... ....+|.|.+..... .......|..+-+.+. |.|++.+++.....+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34777778999999999888753 344566666644332 2344455777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHH-hcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCeEEcCCC-ceEEec
Q 025997 140 YEHASKGSLHDIL-HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD-IAKISD 216 (245)
Q Consensus 140 ~e~~~~gsL~~~l-~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~~ivHrDlkp~Nill~~~~-~vkl~D 216 (245)
+++..++++.+.+ ..... ..+....-.+..|+..++.|+| ..+ +.|||+||+|.+++..+ .++++|
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCC
Confidence 9999999998887 33210 1444556678899999999999 887 99999999999999999 999999
Q ss_pred ccCCCCCCc-cccccccccccc-cccccCCC
Q 025997 217 FDLSNQAPD-AAARLHSTRVLG-TFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~-~~~~~~~~~~~g-t~~y~APE 245 (245)
||+|..... ..........+| ++.|+|||
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E 199 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPE 199 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcc
Confidence 999987765 333333344578 99999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.5e-14 Score=129.67 Aligned_cols=133 Identities=30% Similarity=0.476 Sum_probs=91.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..+|...+.|-.|+||.||..+++ +.+.+|+| +++... +++. ++....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee-------------------
Confidence 467999999999999999999977 56778884 433211 1110 22222333333
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
|+-...++..+. ++. +.+.+++|||+.+ |+|||+||+|.||..-|.+|++|||+++..
T Consensus 136 --gDc~tllk~~g~---------lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP---------LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --chhhhhcccCCC---------Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 566666654332 332 2256899999998 999999999999999999999999998753
Q ss_pred Ccc-------------ccccccccccccccccCCC
Q 025997 224 PDA-------------AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~-------------~~~~~~~~~~gt~~y~APE 245 (245)
... ........++||+.|.|||
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 211 1111223468999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-12 Score=103.41 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=105.9
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCC--chHHHHHHHHHHHccCC--CCcceEeEEEEeC---CceEEEEEecC
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKN--ENVVELVGYYVDG---PLRVLAYEHAS 144 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 144 (245)
+.|+.|.++.||++...++..+++|....... ....+..|+.+++.+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999877668899998765433 34578889999999875 3457777766543 25689999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 190 (245)
|.++.+.+... .++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 98877654311 1566666677777777787777521
Q ss_pred -------------------CCCeEecCCCCCCeEEcC--CCceEEecccCCCC
Q 025997 191 -------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQ 222 (245)
Q Consensus 191 -------------------~~~ivHrDlkp~Nill~~--~~~vkl~DfGla~~ 222 (245)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.45 E-value=2e-13 Score=110.42 Aligned_cols=166 Identities=20% Similarity=0.267 Sum_probs=95.8
Q ss_pred CCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCC----------CCcceEeEE----
Q 025997 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKN----------ENVVELVGY---- 129 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h----------~niv~~~~~---- 129 (245)
...+.||.|+|+.||.+.+. +++.+|+|+..... ...+++.+|.-....+.+ -.++--++.
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44668999999999999976 68999999863222 223455555533333221 112211221
Q ss_pred -----EEeCC--------ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 025997 130 -----YVDGP--------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 196 (245)
Q Consensus 130 -----~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 196 (245)
+.... ..+++|.-+. +||.+++......... ...+.....+.+..|+++.+++||+.| +||
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11111 2356666664 5888876531110000 011334445667789999999999998 999
Q ss_pred cCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 197 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 197 rDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||||+|++++.+|.+.|+||+.....+..... ...+..|.+||
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe 212 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPE 212 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChh
Confidence 999999999999999999999876655433221 12345677765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.7e-13 Score=111.69 Aligned_cols=113 Identities=24% Similarity=0.363 Sum_probs=82.8
Q ss_pred CCCCcceEeEEEEeC---------------------------CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHH
Q 025997 119 KNENVVELVGYYVDG---------------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171 (245)
Q Consensus 119 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~ 171 (245)
+|||||++..+|.+. ..+|+||..... +|.+++-.+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 599999999887642 235888877654 8999987654 56677
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc--CCC--ceEEecccCCCCCCcccccc----ccccccccccccC
Q 025997 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IAKISDFDLSNQAPDAAARL----HSTRVLGTFGYHA 243 (245)
Q Consensus 172 ~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~--~~~--~vkl~DfGla~~~~~~~~~~----~~~~~~gt~~y~A 243 (245)
...|+.|+++|+.|||.+| |.|||||.+|||+. +++ .+.|+|||.+-......-.. ..-..-|.-.-||
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 7888999999999999998 99999999999994 333 67899999864322111000 0112346777899
Q ss_pred CC
Q 025997 244 PE 245 (245)
Q Consensus 244 PE 245 (245)
||
T Consensus 420 PE 421 (598)
T KOG4158|consen 420 PE 421 (598)
T ss_pred hh
Confidence 98
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.7e-13 Score=116.51 Aligned_cols=100 Identities=31% Similarity=0.472 Sum_probs=88.8
Q ss_pred HHccCCCCcceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 025997 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (245)
Q Consensus 115 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 194 (245)
|+.+.|.|+.++++.+.+++..++|.+||..|+|.|.+....- .+++.....++++|+.||.|+|+.- -.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~s~--i~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHNSP--IG 70 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhcCc--ce
Confidence 4578999999999999999999999999999999999987432 2788888899999999999999874 23
Q ss_pred EecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 195 IHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 195 vHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
.|+.|+..|++++..+.+||+|||+.....
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhccccc
Confidence 999999999999999999999999986653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.8e-12 Score=93.09 Aligned_cols=130 Identities=20% Similarity=0.301 Sum_probs=96.0
Q ss_pred eeccCCceEEEEEEECCCcEEEEEE-cCCCCCc--------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 73 LIGEGSYGRVYFGVLRSGRAAAIKK-LDSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~~~~vavK~-~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.+++|+=+.+|.+.+. +..+++|. +.+.... ...-.+|+.++.++.--.|..-.=+..+.+...|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5788999999998765 33455664 3333222 134567899998886555554444556777889999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+|..|.+.+.... ..++..|-.-+.-||..+ |+|+||.++||++...+ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEAR----------------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhcc----------------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9988988886531 235566667788999998 99999999999997665 999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.2e-13 Score=100.24 Aligned_cols=74 Identities=28% Similarity=0.233 Sum_probs=62.3
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... .+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 689999975432 2899999999999999999999984 999999999999999 999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
. ...||+.|||||
T Consensus 62 ~-------~~~g~~~y~aPE 74 (176)
T smart00750 62 E-------QSRVDPYFMAPE 74 (176)
T ss_pred c-------cCCCcccccChH
Confidence 2 125899999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-11 Score=91.50 Aligned_cols=142 Identities=20% Similarity=0.249 Sum_probs=103.8
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEc-CCCCC--------chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKL-DSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~-~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
....|-+|+-+.|+++.+. |+...||.- .+... ......+|+..|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5667889999999998876 667777753 22211 1245677999998886555555555666777788999
Q ss_pred EecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC---ceEEec
Q 025997 141 EHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISD 216 (245)
Q Consensus 141 e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~---~vkl~D 216 (245)
||..| .++.+++....... ........++..|-+.+.-||.++ |+|+||..+||++..++ .+.++|
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 99976 47888887654321 111222567888888999999998 99999999999996554 568999
Q ss_pred ccCCCC
Q 025997 217 FDLSNQ 222 (245)
Q Consensus 217 fGla~~ 222 (245)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.1e-10 Score=91.18 Aligned_cols=140 Identities=16% Similarity=0.054 Sum_probs=96.3
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCC------------CchHHHHHHHHHHHccCCC--CcceEeEEEEe-----
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK------------QPDQEFLAQVSMVSRLKNE--NVVELVGYYVD----- 132 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~----- 132 (245)
+.+-.-....|++... .|+.+.||...... .....+.+|+..+.+|..- .++..+.+...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445666555 46788999653221 1112467888888777433 33444555543
Q ss_pred CCceEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---
Q 025997 133 GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--- 208 (245)
Q Consensus 133 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--- 208 (245)
....+||+|++++. +|.+++...... ..+......++.+++..+.-||..| |+|+||++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~ 176 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFP 176 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecccc
Confidence 23478999999886 799988532111 1445567788999999999999998 999999999999975
Q ss_pred ----CCceEEecccCCCC
Q 025997 209 ----DDIAKISDFDLSNQ 222 (245)
Q Consensus 209 ----~~~vkl~DfGla~~ 222 (245)
+..+.|+||+.+..
T Consensus 177 ~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 177 GREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCCceEEEEECCcccc
Confidence 46899999998854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.1e-13 Score=112.57 Aligned_cols=99 Identities=31% Similarity=0.434 Sum_probs=80.1
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
++|+.|++|.-.+|.+++.+.... ...++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~------e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG------EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc------cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 578999999999999999755432 126677788999999999999 65 999999999999999999999
Q ss_pred ecccCCCCCCccc----cccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAA----ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~----~~~~~~~~~gt~~y~APE 245 (245)
.|||+........ .....+..+||..||+||
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence 9999987654433 111224457999999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.5e-11 Score=90.68 Aligned_cols=125 Identities=19% Similarity=0.224 Sum_probs=81.0
Q ss_pred EEEEEEECCCcEEEEEEcCCCC--------------C--------c-----hHHHHHHHHHHHccCCC--CcceEeEEEE
Q 025997 81 RVYFGVLRSGRAAAIKKLDSSK--------------Q--------P-----DQEFLAQVSMVSRLKNE--NVVELVGYYV 131 (245)
Q Consensus 81 ~V~~~~~~~~~~vavK~~~~~~--------------~--------~-----~~~~~~E~~~l~~l~h~--niv~~~~~~~ 131 (245)
.||.|...++..+|+|...... . . .....+|+..|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999764211 0 0 02346699999999765 566776542
Q ss_pred eCCceEEEEEecC--CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCeEEcC
Q 025997 132 DGPLRVLAYEHAS--KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY-LHEKAEPRIIHRNIKSSNVLLFD 208 (245)
Q Consensus 132 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~~ivHrDlkp~Nill~~ 208 (245)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||+++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD 142 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence 3579999998 65555544322 1123345566777775555 57887 999999999999988
Q ss_pred CCceEEecccCCCCCC
Q 025997 209 DDIAKISDFDLSNQAP 224 (245)
Q Consensus 209 ~~~vkl~DfGla~~~~ 224 (245)
+ .+.|+|||.+....
T Consensus 143 ~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 143 G-KVYIIDFGQAVDSS 157 (188)
T ss_dssp T-CEEE--GTTEEETT
T ss_pred c-eEEEEecCcceecC
Confidence 7 89999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.3e-11 Score=101.93 Aligned_cols=168 Identities=23% Similarity=0.231 Sum_probs=127.1
Q ss_pred CCCCCCCeecc--CCceEEEEEEE---CCCcEEEEEEcCCCC---CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCce
Q 025997 66 DNFGTNSLIGE--GSYGRVYFGVL---RSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~--G~fg~V~~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (245)
..|.+...+|. |.+|.||.+.. .++..+|+|+-+.-. .....-.+|+...+++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667778999 99999999885 367788988732211 2223345677777777 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCeEEcCC-Cc
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GLEYLHEKAEPRIIHRNIKSSNVLLFDD-DI 211 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~ 211 (245)
++-+|++. .+|..+...... .++....+....+... ||.++|..+ ++|-|+||+||++..+ ..
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred eeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 99999986 588888876543 2566677777778888 999999997 9999999999999998 78
Q ss_pred eEEecccCCCCCCcccccc---ccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~---~~~~~~gt~~y~APE 245 (245)
.+++|||+...+....-.. ...+..|...|++||
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke 298 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE 298 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChh
Confidence 8999999987765443111 011224677799987
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.3e-10 Score=96.81 Aligned_cols=121 Identities=15% Similarity=0.200 Sum_probs=97.8
Q ss_pred ECCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCC
Q 025997 87 LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP 165 (245)
Q Consensus 87 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 165 (245)
..++.+|.|...+.+.. ..+...+.+..|+.++||||++++..+...+..|||+|-+. .|..+++.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----------- 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----------- 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------
Confidence 34677777777654443 23446677888999999999999999999999999999985 57777775
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 166 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 166 ~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+....+..-+.||+.||.|||+.+ .++|++|.-+.|+++..|..||++|-++...
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 334455667889999999999765 5999999999999999999999999876433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=100.70 Aligned_cols=147 Identities=22% Similarity=0.246 Sum_probs=116.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEEcCCCCCc-h--HHHHHHHHHHHcc-CCCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP-D--QEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~-~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (245)
...+|..+..||.|.|+.|+....+ ++..+++|.+...... . ..-..|+.+...+ .|.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3567888899999999999988744 6778899887554322 2 2224566666666 5889999988888888888
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEEec
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl~D 216 (245)
+-.|||.++++...+.-.. .+.....+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|
T Consensus 343 ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred CchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 9999999998876652211 2677778889999999999999987 9999999999999886 7889999
Q ss_pred ccCCCC
Q 025997 217 FDLSNQ 222 (245)
Q Consensus 217 fGla~~ 222 (245)
||..+.
T Consensus 411 ~~~~t~ 416 (524)
T KOG0601|consen 411 FGCWTR 416 (524)
T ss_pred cccccc
Confidence 998764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=84.94 Aligned_cols=135 Identities=16% Similarity=0.151 Sum_probs=96.7
Q ss_pred CCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-----------------------chHHHHHHHHHHHccCCC--C
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----------------------PDQEFLAQVSMVSRLKNE--N 122 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~--n 122 (245)
..+...||-|.=|.||.|....+.++|||.-..... ++....+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456678999999999999999999999996532110 112346788999998654 5
Q ss_pred cceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 025997 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (245)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~ 202 (245)
|.+.++ .+.-.+|||+..|-.|...-- .....-.++..|++-+.-+-..| +||+|+.+=
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~~~G---iVHGDlSef 231 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEF 231 (304)
T ss_pred CCCccc----cccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence 666554 367789999999866654321 12223344445555555555666 999999999
Q ss_pred CeEEcCCCceEEecccCCCCC
Q 025997 203 NVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 203 Nill~~~~~vkl~DfGla~~~ 223 (245)
||+++++|.+.++||--+...
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred eEEEecCCCEEEEeCcccccC
Confidence 999999999999999765544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.3e-08 Score=76.54 Aligned_cols=139 Identities=14% Similarity=0.060 Sum_probs=99.8
Q ss_pred eeccCCceEEEEEEECCCcEEEEEEcCC----C---CCchHHHHHHHHHHHccCCC--CcceEeEEEEeC----CceEEE
Q 025997 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDS----S---KQPDQEFLAQVSMVSRLKNE--NVVELVGYYVDG----PLRVLA 139 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lv 139 (245)
--|+||.+-|++-.+. |..+-+|.-.. + ......|.+|+..+.+|..- .+.+........ -..+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3577899999987665 34688887541 1 22457899999998888532 244444221111 235799
Q ss_pred EEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc--eEEec
Q 025997 140 YEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISD 216 (245)
Q Consensus 140 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~--vkl~D 216 (245)
+|-+.+ -||.+++...... ..+......+..+++..+.-||+.| +.|+|+-+.||+++.++. ++++|
T Consensus 104 Te~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 997764 5898888653211 1456666789999999999999998 999999999999986666 99999
Q ss_pred ccCCCC
Q 025997 217 FDLSNQ 222 (245)
Q Consensus 217 fGla~~ 222 (245)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-08 Score=80.19 Aligned_cols=108 Identities=25% Similarity=0.253 Sum_probs=82.1
Q ss_pred hHHHHHHHHHHHccCC--CCcceEeEEEEeCC----ceEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHH
Q 025997 105 DQEFLAQVSMVSRLKN--ENVVELVGYYVDGP----LRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177 (245)
Q Consensus 105 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ 177 (245)
.....+|...+..|.. -.+...+++..... ..++|+|++++. +|.+++..... .+......++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~ 125 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLR 125 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHH
Confidence 4567778877777743 33455666655422 358999999874 79999876321 34455678899
Q ss_pred HHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC---ceEEecccCCCCCC
Q 025997 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAP 224 (245)
Q Consensus 178 ~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~---~vkl~DfGla~~~~ 224 (245)
+++..+.-||.+| |+|+|+++.|||++.++ .+.++||+-++...
T Consensus 126 ~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 126 ALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999999998 99999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=89.37 Aligned_cols=140 Identities=21% Similarity=0.245 Sum_probs=91.6
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCC---------------------------chH--------------HHHH
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------------------------PDQ--------------EFLA 110 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------------------~~~--------------~~~~ 110 (245)
..|+.++-|.||+|++.+|+.||||+....-. ... ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999999999999999854211 000 1344
Q ss_pred HHHHHHcc----CCCCcceEeEEE-EeCCceEEEEEecCCCCHHHHH--hcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 025997 111 QVSMVSRL----KNENVVELVGYY-VDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (245)
Q Consensus 111 E~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 183 (245)
|..-+.++ .+..-+.+-..| .-...-.|+|||+.|..+.++. +... ++...+.....++. +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g----------~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG----------IDRKELAELLVRAF--L 278 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC----------CCHHHHHHHHHHHH--H
Confidence 54444444 222223343433 3356678999999999888874 3322 44323222222211 2
Q ss_pred HHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcc
Q 025997 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 184 ~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 226 (245)
.-+-..| +.|.|..|.||++..+|.+.+.|||+...+...
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2222345 999999999999999999999999998776543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.9e-08 Score=76.55 Aligned_cols=72 Identities=15% Similarity=0.126 Sum_probs=53.6
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC--cceEeEEEEeCCceEEEEEecCCCC
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
..||+|..+.||+. .+..+++|..... .......+|.+.++.+..-. +.+.+.+....+...++||++.|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 2456777876542 34456788999998886433 4677777777777889999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.8e-08 Score=85.17 Aligned_cols=143 Identities=14% Similarity=0.122 Sum_probs=106.9
Q ss_pred CceEEEEEEE-CCCcEEEEEEcCCCCCch-HHHHHHHHHHHccCCCCcceEeEEEEe----CCceEEEEEecCC-CCHHH
Q 025997 78 SYGRVYFGVL-RSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAYEHASK-GSLHD 150 (245)
Q Consensus 78 ~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~ 150 (245)
.-.+.|++.. .+|..|++|++...+... .....-+++++++.|.|||.+.+++.+ +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3456788884 488999999984332211 122334678999999999999998873 3468999999876 57887
Q ss_pred HHhcCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 151 ILHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 151 ~l~~~~~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+.-...... .......+++...|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+.-|+...+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 654433222 1122344788999999999999999999998 888999999999998888998877775544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.9e-09 Score=84.55 Aligned_cols=98 Identities=27% Similarity=0.394 Sum_probs=80.7
Q ss_pred HHHHccCCCCcceEeEEEEeC-----CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 025997 113 SMVSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187 (245)
Q Consensus 113 ~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH 187 (245)
.-+-.+-|.||++++.||.+. ....++.|||..|++.++|++.... ...+......+++-||+.||.|||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-----~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-----QKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-----hhhhhHHHHHHHHHHHHhhhhhhh
Confidence 335566799999999998754 3478899999999999999875432 223677777889999999999999
Q ss_pred cCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 188 ~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+. .|.|+|+++..+.|++..+|.+|+.-
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecc
Confidence 98 57799999999999999999888753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.9e-07 Score=72.68 Aligned_cols=136 Identities=15% Similarity=0.167 Sum_probs=87.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHH----------HHHHHHHHHccCCCC---cceEeEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKNEN---VVELVGYYV 131 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~n---iv~~~~~~~ 131 (245)
..+|...+++-......|.+-... ++.+++|.......-.+. ..+.+..+.+++... ...++-+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 456777788888777777766655 578888876443222211 223344344443322 222222222
Q ss_pred -----eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 132 -----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 132 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
-....+++|||++|..|.++.. ++. .+...+.+++.-+|..| ++|+|..|.|+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv 168 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV 168 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence 2234578999999988876542 322 23345677899999998 9999999999998
Q ss_pred cCCCceEEecccCCCC
Q 025997 207 FDDDIAKISDFDLSNQ 222 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~ 222 (245)
.+++ ++++||+..+.
T Consensus 169 ~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKRM 183 (229)
T ss_pred ECCc-EEEEECccccc
Confidence 8555 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.2e-07 Score=71.23 Aligned_cols=75 Identities=17% Similarity=0.091 Sum_probs=52.5
Q ss_pred eccCCc-eEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEecCCCCHHHH
Q 025997 74 IGEGSY-GRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151 (245)
Q Consensus 74 lG~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 151 (245)
|-.|.. +.||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|.+|.+.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444554 788988754 3678888765432 345677888888773 34566778877766678999999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.9e-07 Score=72.13 Aligned_cols=77 Identities=14% Similarity=0.186 Sum_probs=55.4
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC--CcceEeEEEEe---CCceEEEEEecCCC
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYVD---GPLRVLAYEHASKG 146 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~g 146 (245)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468899999999999887 68999986544 3446777888888887533 35566664432 33468999999998
Q ss_pred CHHH
Q 025997 147 SLHD 150 (245)
Q Consensus 147 sL~~ 150 (245)
++..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.1e-06 Score=64.29 Aligned_cols=133 Identities=15% Similarity=0.168 Sum_probs=93.0
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCC-----------------CchHHHHHHHHHHHccC------CCCcceEe
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSMVSRLK------NENVVELV 127 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~~~ 127 (245)
...||+|+.-.||. +......+||++.... ....+.++|+.....+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999988884 5555667888876544 12355677776665555 78899999
Q ss_pred EEEEeCCceEEEEEecCC------CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 128 GYYVDGPLRVLAYEHASK------GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
|+..++-..-+|+|.+.+ -+|.+++.... ++. .....+ -+-..||-+++ |+.+||+|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQAL---DEFKRYLLDHH---IVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHHH---HHHHHHHHHcC---CeecCCCc
Confidence 999999999999987643 36888885443 444 333333 33456777766 99999999
Q ss_pred CCeEEcCC--C--ceEEec-ccCCCC
Q 025997 202 SNVLLFDD--D--IAKISD-FDLSNQ 222 (245)
Q Consensus 202 ~Nill~~~--~--~vkl~D-fGla~~ 222 (245)
.||++... + .+.|+| ||-...
T Consensus 147 ~NIv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ccEEEEecCCCceEEEEEeCCCCccc
Confidence 99999643 2 577787 676544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.7e-06 Score=79.75 Aligned_cols=77 Identities=14% Similarity=0.168 Sum_probs=56.0
Q ss_pred CCeeccCCceEEEEEEECCC---cEEEEEEcCCCC--CchHHHHHHHHHHHccC-CCCc--ceEeEEEEeC---CceEEE
Q 025997 71 NSLIGEGSYGRVYFGVLRSG---RAAAIKKLDSSK--QPDQEFLAQVSMVSRLK-NENV--VELVGYYVDG---PLRVLA 139 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 139 (245)
.+.++.|.++.+|+.....+ ..+++|+..... .....+.+|+.+++.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999876543 367778764432 23457889999999995 6654 7777777654 467899
Q ss_pred EEecCCCC
Q 025997 140 YEHASKGS 147 (245)
Q Consensus 140 ~e~~~~gs 147 (245)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.5e-06 Score=68.62 Aligned_cols=147 Identities=17% Similarity=0.167 Sum_probs=93.0
Q ss_pred HHHHhhCCCCCCC---eeccCCceEEEEEEECCCcEEEEEEcCCCCCch--------------------HH-----HHHH
Q 025997 60 ELKEKTDNFGTNS---LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--------------------QE-----FLAQ 111 (245)
Q Consensus 60 ~~~~~~~~~~~~~---~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~-----~~~E 111 (245)
.+........+.. .|.+|.-+.||+|...++..+|+|+........ .. ..+|
T Consensus 39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE 118 (268)
T COG1718 39 TLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE 118 (268)
T ss_pred HHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence 3344444444444 455677788999998889999999875432111 11 1235
Q ss_pred HHHHHccC--CCCcceEeEEEEeCCceEEEEEecCCCC-HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 025997 112 VSMVSRLK--NENVVELVGYYVDGPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188 (245)
Q Consensus 112 ~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 188 (245)
+.-|+++. +-.+.+-+.+. .-.|+|||+.... -.-.|+.. .+...+...+..++++.+.-|-.
T Consensus 119 f~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----------~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 119 FRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----------PLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----------CcCchhHHHHHHHHHHHHHHHHH
Confidence 55566653 33344444432 3479999986531 11111111 12333566677778888877776
Q ss_pred -CCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 189 -KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 189 -~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
.+ +||+||+.=|||+. ++.+.|+|||-|....
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 55 99999999999999 8889999999886554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.3e-07 Score=77.92 Aligned_cols=139 Identities=17% Similarity=0.194 Sum_probs=88.5
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCch--------------------------------H------HHHHHH
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--------------------------------Q------EFLAQV 112 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------------------------------~------~~~~E~ 112 (245)
.+.||.-+.|.||+|+.++|+.||||+-...-... + +|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35799999999999999999999999865321110 0 133343
Q ss_pred H----HHHccCCCC------cceEeEEEEeCCceEEEEEecCCCCHHHH--HhcCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 025997 113 S----MVSRLKNEN------VVELVGYYVDGPLRVLAYEHASKGSLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180 (245)
Q Consensus 113 ~----~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~l~~~~~~~i~~~i~ 180 (245)
+ ..+.+.|-+ |.+++-.+ .....|+|||+.|..+.|. +.+.+ ++...+..-+.+..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAY 313 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHH
Confidence 2 222333444 33333322 3457899999999877664 33332 55444444333332
Q ss_pred HHHHHHhcCCCCCeEecCCCCCCeEEcC----CCceEEecccCCCCCCcc
Q 025997 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 181 ~~l~~lH~~~~~~ivHrDlkp~Nill~~----~~~vkl~DfGla~~~~~~ 226 (245)
.- -+-..| ++|.|-.|.||++.. ++.+.+.|||+...+...
T Consensus 314 ~~--qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 LE--QIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HH--HHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 21 222334 999999999999983 678999999998776543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-06 Score=65.03 Aligned_cols=129 Identities=19% Similarity=0.226 Sum_probs=87.7
Q ss_pred CCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcc-eEeEEEEeCCceEEEEEecCCCC
Q 025997 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
...+.|++|.+|.||+|.++. ..+|+|+- .....+..+..|+++|..++..++. +++.+. ..++.|||+.|-+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvr-r~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVR-RRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEe-cCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 345679999999999999884 58888864 3445677889999999998766553 444443 2345599999988
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC-CCCeEEcCCCceEEecccCCCC
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK-SSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlk-p~Nill~~~~~vkl~DfGla~~ 222 (245)
|.+..... .-.. ...+++.---|-..| |-|..|. |...++..++.+-|+||..|+.
T Consensus 99 L~~~~~~~------------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88765421 1112 223444433444455 8888774 5555666666899999998863
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.2e-06 Score=67.37 Aligned_cols=102 Identities=25% Similarity=0.205 Sum_probs=77.9
Q ss_pred HHHHHHHccCC-CCcceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 025997 110 AQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188 (245)
Q Consensus 110 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 188 (245)
.|.-+++.+++ +++++++|+|- .+++.||...+++....... ......+|..+.+|+.++++.+.++++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l------~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL------SQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc------ccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 47888888876 69999999982 36688999877654220000 000116899999999999999999998
Q ss_pred CCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 189 ~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
.-...+.-.|++++|+-+++++++|++|.....
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 544458889999999999999999999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=1e-05 Score=66.83 Aligned_cols=76 Identities=16% Similarity=0.030 Sum_probs=55.5
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCC---CCcceEeEEEEe---CCceEEEEEecC
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---ENVVELVGYYVD---GPLRVLAYEHAS 144 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~~ 144 (245)
.+.||.|..+.||+....++ .+.+|.. +.......+..|...|+.|.. -.+.++++++.. .+..++|||++.
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 45799999999999876555 4566663 332345678899999988843 367788877654 366899999999
Q ss_pred CCCH
Q 025997 145 KGSL 148 (245)
Q Consensus 145 ~gsL 148 (245)
+.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-05 Score=64.04 Aligned_cols=73 Identities=11% Similarity=0.062 Sum_probs=46.7
Q ss_pred CeeccCCceEEEEEEECC--CcEEEEEEcCCCCCchHHHHHHHHHHHccCC-CCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 72 SLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
+.|..|-.+.+|+....+ +..+++|..........+..+|+.+++.+.. .-..+++.... -.++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 456778888999987654 5788888765432222334468888887743 33445544332 2479999988654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-05 Score=64.45 Aligned_cols=72 Identities=14% Similarity=0.140 Sum_probs=44.0
Q ss_pred CeeccCCce-EEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC---CcceEeEEEEeC---CceEEEEEecC
Q 025997 72 SLIGEGSYG-RVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYVDG---PLRVLAYEHAS 144 (245)
Q Consensus 72 ~~lG~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~ 144 (245)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+.+..+... -+.+++...... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 356666655 58864 23566776443 33455788899988877532 344444443322 24588999998
Q ss_pred CCCH
Q 025997 145 KGSL 148 (245)
Q Consensus 145 ~gsL 148 (245)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 8665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.3e-07 Score=87.09 Aligned_cols=143 Identities=19% Similarity=0.178 Sum_probs=97.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+.+.+.+-+-+|.++.++.+.-. ++...++|...... ...+..+.+-.++-...+|.++...-.+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 455666777888899998887733 44444444332211 1112222333333334557666665556667788999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
++|+.+++|...++.... .+..-.......+.++++|||... ++|||++|.|+|+..++..+++|||+
T Consensus 883 ~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 999999999999887653 222223334456778999999986 89999999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-07 Score=83.65 Aligned_cols=153 Identities=18% Similarity=0.127 Sum_probs=104.8
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC-cceEeEEEEeCCceEEEEEecCCC-C
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKG-S 147 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-s 147 (245)
...-+++++++++++.+-...+....+.+... ....-++++|.+++||| .+..++-+...++.++.++++.++ +
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 33457899999999887443333335555332 44556889999999999 777777777778899999999876 2
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
........ ...+..-+...+.+.-++++.++|+.. -+||| ||+..+ +..+..||+....+....
T Consensus 322 ~~~~~~~s--------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 322 SALEMTVS--------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred ccccCChh--------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 22111100 011333344455666678899999864 48998 776654 678999999988776543
Q ss_pred cccccccccccccccCCC
Q 025997 228 ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~~~~~~gt~~y~APE 245 (245)
...+..+|+.|+|||
T Consensus 386 ---~~~t~~~~~~~~~pe 400 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPE 400 (829)
T ss_pred ---ccccCCCCCCCCCch
Confidence 235567999999997
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-05 Score=63.82 Aligned_cols=141 Identities=11% Similarity=0.059 Sum_probs=75.6
Q ss_pred eccCCceEEEEEEECCCcEEEEEEcCCCCCch-HHHHHHHHHHHccCCCCc-ceEeEEEEeCCceEEEEEecCCCCHHH-
Q 025997 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSLHD- 150 (245)
Q Consensus 74 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~- 150 (245)
+..|-.+.+|+... ++..+++|......... -+..+|..+++.+....+ .+++... . -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677788998773 45678888754332221 245678888888854333 3444332 2 368999998865431
Q ss_pred -------------HHhcCCCCCCCCCCCCCCHHH-HHHHHHH---------HHHHHHHHhcC-----CCCCeEecCCCCC
Q 025997 151 -------------ILHGKKGVKGAKPGPVLSWAQ-RVKIAVG---------AARGLEYLHEK-----AEPRIIHRNIKSS 202 (245)
Q Consensus 151 -------------~l~~~~~~~~~~~~~~l~~~~-~~~i~~~---------i~~~l~~lH~~-----~~~~ivHrDlkp~ 202 (245)
.+.+...... +...++... ......+ +...+..+-.. ....++|+|+.|.
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPR--FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1111111100 011122111 1111111 11112222111 1224899999999
Q ss_pred CeEEcCCCceEEecccCCCC
Q 025997 203 NVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 203 Nill~~~~~vkl~DfGla~~ 222 (245)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.1e-05 Score=63.74 Aligned_cols=75 Identities=17% Similarity=0.153 Sum_probs=53.6
Q ss_pred CCeeccCCceEEEEEEECCC-cEEEEEEcCCC--------CCchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEE
Q 025997 71 NSLIGEGSYGRVYFGVLRSG-RAAAIKKLDSS--------KQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l 138 (245)
.+.||.|.++.||++...++ +.++||.-... ....+....|.+.|..+. ...+.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998766 48999974311 123456677888777763 3457777776 4466789
Q ss_pred EEEecCCCC
Q 025997 139 AYEHASKGS 147 (245)
Q Consensus 139 v~e~~~~gs 147 (245)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.06 E-value=7.1e-05 Score=61.76 Aligned_cols=149 Identities=17% Similarity=0.163 Sum_probs=83.1
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC--CcceEeEE------EEeCCceEEEEEe
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY------YVDGPLRVLAYEH 142 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~ 142 (245)
.+.|..|....+|+....+ ..+++|.... .....+..|+.++..|.+. .+.+++.. ....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4456777778899877544 4688888754 3445667788887777432 24444331 1234567899999
Q ss_pred cCCCCHHH-----------HH---hcCC-CCCCC-CCCCCCCHHHHH----------HHHHHHHHHHHHHhc----CCCC
Q 025997 143 ASKGSLHD-----------IL---HGKK-GVKGA-KPGPVLSWAQRV----------KIAVGAARGLEYLHE----KAEP 192 (245)
Q Consensus 143 ~~~gsL~~-----------~l---~~~~-~~~~~-~~~~~l~~~~~~----------~i~~~i~~~l~~lH~----~~~~ 192 (245)
++|.++.. .+ +... ..... .......|.... .....+...+.++.. .-..
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98865421 11 1100 00000 000111221110 011112233444442 1112
Q ss_pred CeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 193 ~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 499999999999999887778999987654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.5e-05 Score=61.82 Aligned_cols=73 Identities=19% Similarity=0.153 Sum_probs=46.4
Q ss_pred eeccCCceEEEEEEECC-------CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC-cceEeEEEEeCCceEEEEEecC
Q 025997 73 LIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.|..|-...+|+....+ ++.+++|..........+..+|+.++..+.... ..+++.++. + .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence 45566677899887654 478888886554333345677888887774332 345555543 2 35789988
Q ss_pred CCCHH
Q 025997 145 KGSLH 149 (245)
Q Consensus 145 ~gsL~ 149 (245)
|.++.
T Consensus 81 G~~l~ 85 (302)
T cd05156 81 SRTLT 85 (302)
T ss_pred CCcCC
Confidence 76553
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00015 Score=55.96 Aligned_cols=124 Identities=27% Similarity=0.389 Sum_probs=84.4
Q ss_pred CCCCCCCeeccCCc-eEEEEEEECCCcEEEEEEcCC---C---------C----------CchHHHHHHHHHHHccC---
Q 025997 66 DNFGTNSLIGEGSY-GRVYFGVLRSGRAAAIKKLDS---S---------K----------QPDQEFLAQVSMVSRLK--- 119 (245)
Q Consensus 66 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~vavK~~~~---~---------~----------~~~~~~~~E~~~l~~l~--- 119 (245)
.+++..+.||.|.- |.||+++.. |+.+|+|.... . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56788899999999 999999887 67999998311 0 0 00124667877766664
Q ss_pred CCCc--ceEeEEEEeC------------------CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHH
Q 025997 120 NENV--VELVGYYVDG------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179 (245)
Q Consensus 120 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i 179 (245)
+.++ ++.+||..-. ....||-||.+... .+.... +.++
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~~~----~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQIRD----IPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccchhH----HHHH
Confidence 4455 8888886422 11245666654422 023233 3466
Q ss_pred HHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 180 ~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
..-+..+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 67788999998 999999999975 4589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00096 Score=55.66 Aligned_cols=161 Identities=16% Similarity=0.150 Sum_probs=81.9
Q ss_pred HHHHHhhCCCCC-----CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC--CcceEeE---
Q 025997 59 DELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVG--- 128 (245)
Q Consensus 59 ~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~--- 128 (245)
.++......|.+ .+.|+.|....+|+....++ .+++|+.. ....+.+..|+.++..|... .+.+.+.
T Consensus 10 ~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~ 86 (319)
T PRK05231 10 DELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRD 86 (319)
T ss_pred HHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCC
Confidence 344444444544 34566777788998876554 68888765 22344455566666555321 2333332
Q ss_pred ---EEEeCCceEEEEEecCCCCH-----------HHHHh---cCC-CCCCCC-CCCCCC-HHHHHH------------HH
Q 025997 129 ---YYVDGPLRVLAYEHASKGSL-----------HDILH---GKK-GVKGAK-PGPVLS-WAQRVK------------IA 176 (245)
Q Consensus 129 ---~~~~~~~~~lv~e~~~~gsL-----------~~~l~---~~~-~~~~~~-~~~~l~-~~~~~~------------i~ 176 (245)
+....+..+++++|++|..+ .+.+. ... ...... ....+. |..... ..
T Consensus 87 G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 166 (319)
T PRK05231 87 GAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALL 166 (319)
T ss_pred CCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHH
Confidence 11234567899999988642 11111 110 000000 000111 111111 11
Q ss_pred HH-HHHHHHHHhcC----CCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 177 VG-AARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 177 ~~-i~~~l~~lH~~----~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
.+ +...+..+... -...++|+|+.|.|||++.+...-|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 167 EAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 11 11112222211 112499999999999998766568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0015 Score=54.28 Aligned_cols=162 Identities=16% Similarity=0.196 Sum_probs=85.9
Q ss_pred HHHHHhhCCCCC-----CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC--CcceEeEE--
Q 025997 59 DELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY-- 129 (245)
Q Consensus 59 ~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-- 129 (245)
.++..-...|.+ .+.++.|.-..+|+....++ .+++|..... .....+..|++++..|... .+.+++..
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 344444444544 34567777788998875544 5778876442 2234556677777776422 23444332
Q ss_pred ----EEeCCceEEEEEecCCCCHH-----------HH---HhcCC-CCCCCCC--CCCCCHHHHH------------HHH
Q 025997 130 ----YVDGPLRVLAYEHASKGSLH-----------DI---LHGKK-GVKGAKP--GPVLSWAQRV------------KIA 176 (245)
Q Consensus 130 ----~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~-~~~~~~~--~~~l~~~~~~------------~i~ 176 (245)
....+..+++++|++|.++. .. ++... ....... ...-.|.... ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 11235678999999875431 11 11110 0000000 0001111110 001
Q ss_pred HHHHHHHHHHhc----CCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 177 VGAARGLEYLHE----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 177 ~~i~~~l~~lH~----~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
..+...+.++.. .-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 122334444432 1123499999999999999888778999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00037 Score=57.20 Aligned_cols=73 Identities=14% Similarity=0.090 Sum_probs=47.4
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
.+.++-|..+.+|+.. .+++.+.||.-. ......+..|.+-|+.|. --.+.+++++....+..+|++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999877 667889999865 333456778888887773 346778898888777889999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0012 Score=55.80 Aligned_cols=146 Identities=13% Similarity=0.183 Sum_probs=76.8
Q ss_pred eeccCCceEEEEEEECC-----CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCc-ceEeEEEEeCCceEEEEEecCCC
Q 025997 73 LIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 146 (245)
.|-.|-...+|+....+ ++.+++|.........-+..+|..+++.+..-++ .++++.+..+ .+.+|+.+.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45457788899987532 3578888775433222233568888777754333 3555655332 578888776
Q ss_pred CHHHH--------------HhcCCCCCCCCCCCCCCHHHHHHHHHH-----------------HHHHHHH----Hhc-CC
Q 025997 147 SLHDI--------------LHGKKGVKGAKPGPVLSWAQRVKIAVG-----------------AARGLEY----LHE-KA 190 (245)
Q Consensus 147 sL~~~--------------l~~~~~~~~~~~~~~l~~~~~~~i~~~-----------------i~~~l~~----lH~-~~ 190 (245)
+|... +................+..+.....+ +...+.. +.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 55321 111100000000000112222222111 1111111 121 11
Q ss_pred CCCeEecCCCCCCeEEcC-CCceEEecccCCCC
Q 025997 191 EPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (245)
Q Consensus 191 ~~~ivHrDlkp~Nill~~-~~~vkl~DfGla~~ 222 (245)
...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 234899999999999986 47899999988754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0017 Score=53.94 Aligned_cols=31 Identities=16% Similarity=0.433 Sum_probs=28.0
Q ss_pred CCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 192 ~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.++|+|+.+.|++++..+.+=|.||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4699999999999999988899999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00011 Score=60.58 Aligned_cols=131 Identities=16% Similarity=0.168 Sum_probs=90.4
Q ss_pred CCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCC-------------------Cc----hHHHHHHHHHHHccCCC--C
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-------------------QP----DQEFLAQVSMVSRLKNE--N 122 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-------------------~~----~~~~~~E~~~l~~l~h~--n 122 (245)
+.....||-|.-+.||.+-...|++.++|.-.... .+ +-...+|+..|+.|... -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56678999999999999999989998888532111 00 11234688888888431 2
Q ss_pred cceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 025997 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (245)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~ 202 (245)
|.+.+ +.++.++|||++.+-.|.+.-+-. . .-.+...+..-+.-|-.+| +||+|..-=
T Consensus 174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~------------d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEF 231 (465)
T KOG2268|consen 174 VPKPI----DHNRHCVVMELVDGYPLRQVRHVE------------D---PPTLYDDLMGLIVRLANHG---LIHGDFNEF 231 (465)
T ss_pred CCCcc----cccceeeHHHhhcccceeeeeecC------------C---hHHHHHHHHHHHHHHHHcC---ceecccchh
Confidence 33332 456788999999988877654321 1 1223333444455666777 999999999
Q ss_pred CeEEcCCCceEEecccCC
Q 025997 203 NVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 203 Nill~~~~~vkl~DfGla 220 (245)
||++.+++.++++||--.
T Consensus 232 Nimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred eeEEecCCCEEEeechHh
Confidence 999999999999999643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0028 Score=51.91 Aligned_cols=31 Identities=13% Similarity=0.357 Sum_probs=25.5
Q ss_pred CCeEecCCCCCCeEEcCCCc-eEEecccCCCC
Q 025997 192 PRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQ 222 (245)
Q Consensus 192 ~~ivHrDlkp~Nill~~~~~-vkl~DfGla~~ 222 (245)
+.++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0062 Score=51.44 Aligned_cols=72 Identities=21% Similarity=0.183 Sum_probs=47.2
Q ss_pred eeccCCceEEEEEEECCC-cEEEEEEcC----C----CCCchHHHHHHHHHHHccC--CC-CcceEeEEEEeCCceEEEE
Q 025997 73 LIGEGSYGRVYFGVLRSG-RAAAIKKLD----S----SKQPDQEFLAQVSMVSRLK--NE-NVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~~~-~~vavK~~~----~----~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 140 (245)
.||.|....||++....+ +.++||.-. . ...+.++..-|...|+... -| .+.+++.+ +.+...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997644 578998642 1 1223445556777776653 13 45555544 556677999
Q ss_pred EecCCC
Q 025997 141 EHASKG 146 (245)
Q Consensus 141 e~~~~g 146 (245)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0075 Score=51.84 Aligned_cols=72 Identities=13% Similarity=0.157 Sum_probs=48.3
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcC-----CCC---CchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEEE
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLD-----SSK---QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~-----~~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 139 (245)
.+.||.|....||+.... +..++||.-. .+. .+......|...|+.+. ...+.+++.+.. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 557899999999998764 4568888754 111 12333444566665553 347778887765 557888
Q ss_pred EEecCC
Q 025997 140 YEHASK 145 (245)
Q Consensus 140 ~e~~~~ 145 (245)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0065 Score=51.06 Aligned_cols=30 Identities=20% Similarity=0.364 Sum_probs=25.6
Q ss_pred CeEecCCCCCCeEEcC-CCceEEecccCCCC
Q 025997 193 RIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (245)
Q Consensus 193 ~ivHrDlkp~Nill~~-~~~vkl~DfGla~~ 222 (245)
-++|.||-+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 57899999988753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.058 Score=45.26 Aligned_cols=71 Identities=18% Similarity=0.186 Sum_probs=45.4
Q ss_pred CCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC--CcceEe---E--EEEeCCceEEEEEecCCCC
Q 025997 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELV---G--YYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 77 G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~gs 147 (245)
+.-..||+....++..+++|+..........+..|++.+..|... .++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345679998877788899998765555667777888877766321 122211 1 1223456788889988753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.003 Score=53.15 Aligned_cols=139 Identities=22% Similarity=0.240 Sum_probs=88.6
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-----------------------chHH--H--HHHHHHHHccCCCC
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----------------------PDQE--F--LAQVSMVSRLKNEN 122 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~--~--~~E~~~l~~l~h~n 122 (245)
+...|..|.-+.||.|.-.+|..+|||+.+.+-. ++.. . ..|+.=|+++....
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3445777888899999988999999998753210 1111 1 13555566666554
Q ss_pred cceEeEEEEeCCceEEEEEecCCCC-HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 123 VVELVGYYVDGPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
|.----... ..-.|||+|+.... ..-.|+. ..++...+..+-.+++.-+.-|-..+ ++||.||.-
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSE 293 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSE 293 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccccc----------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhh
Confidence 432211111 12478999986421 1112221 12666677777777777777776655 699999999
Q ss_pred CCeEEcCCCceEEecccCCCCC
Q 025997 202 SNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~ 223 (245)
=|+|+. +|.+.|+|.+-|...
T Consensus 294 fN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 294 FNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhheEE-CCEEEEEEccccccC
Confidence 998875 567999999876543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.015 Score=48.20 Aligned_cols=28 Identities=29% Similarity=0.447 Sum_probs=24.5
Q ss_pred CeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 193 ~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0014 Score=55.79 Aligned_cols=163 Identities=17% Similarity=0.194 Sum_probs=92.2
Q ss_pred CCCCeeccCCceEEEEEE-ECCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEE------EEe-CCceEEE
Q 025997 69 GTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY------YVD-GPLRVLA 139 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------~~~-~~~~~lv 139 (245)
...+.||+|+-+.+|-.- .+ .. +.|+........+. .-+..|.+. .||-+..=+.+ .-+ +...-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~--d~-VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR--DQ-VAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhh--ch-hheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345679999999988533 22 12 33544332222111 112233333 45533220111 011 2224566
Q ss_pred EEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 140 YEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 140 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|..+.+- .+..++.-.... .......|...+++++.++.+..-||..| -+-+|+.++|+|+.+++.|.|.|-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRR---qs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRR---QSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred cccCCCccchhhhcCchhhc---ccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccc
Confidence 6666553 233333221111 11234789999999999999999999998 7889999999999999999998743
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.-... ... . .....+|...|.+||
T Consensus 163 sfqi~-~ng-~-~~~cpVg~~eftPPE 186 (637)
T COG4248 163 SFQIN-ANG-T-LHLCPVGVSEFTPPE 186 (637)
T ss_pred ceeec-cCC-c-eEecccCccccCCHH
Confidence 21111 111 1 012246888999997
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.029 Score=47.04 Aligned_cols=146 Identities=20% Similarity=0.281 Sum_probs=81.6
Q ss_pred eccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC------cceEeEE----EEeCCceEEEEEec
Q 025997 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGY----YVDGPLRVLAYEHA 143 (245)
Q Consensus 74 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~----~~~~~~~~lv~e~~ 143 (245)
|.+ .-..+|+....+++. ++|+.... ....++..|...+..|.-.. +..+-|- .....+.+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456789888777666 88887766 66677777887777763211 1222111 11113778889999
Q ss_pred CCCCHHH------------HH---h-cCCCCC--CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHhcC---
Q 025997 144 SKGSLHD------------IL---H-GKKGVK--GAKPGPVLSWAQ-------------RVKIAVGAARGLEYLHEK--- 189 (245)
Q Consensus 144 ~~gsL~~------------~l---~-~~~~~~--~~~~~~~l~~~~-------------~~~i~~~i~~~l~~lH~~--- 189 (245)
+|..+.. ++ + ...... .........|.. -.....++...+..+.+.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9877662 11 1 011111 011111122320 011222333444444432
Q ss_pred ----CCCCeEecCCCCCCeEEcCCCc-eEEecccCCCC
Q 025997 190 ----AEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQ 222 (245)
Q Consensus 190 ----~~~~ivHrDlkp~Nill~~~~~-vkl~DfGla~~ 222 (245)
....+||+|+.|.||+++.+.. +.++||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1012899999999999998875 88999997653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0013 Score=58.98 Aligned_cols=46 Identities=26% Similarity=0.507 Sum_probs=40.1
Q ss_pred HHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 178 ~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
+++.|+.|+|+.. ++||++|.|++|.++..+..||+.|+++.....
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~ 152 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG 152 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCC
Confidence 4558999999875 699999999999999999999999998765544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.023 Score=48.70 Aligned_cols=73 Identities=15% Similarity=0.129 Sum_probs=49.0
Q ss_pred CCeeccCCceEEEEEEECC-CcEEEEEEc----CCC---CCchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEEE
Q 025997 71 NSLIGEGSYGRVYFGVLRS-GRAAAIKKL----DSS---KQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~-~~~vavK~~----~~~---~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 139 (245)
.+.||.|.-..||++...+ ++.++||.- ... ..+.++..-|.+.|+.+. -..+.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999753 567888854 211 233456666777777653 2356666654 55667788
Q ss_pred EEecCC
Q 025997 140 YEHASK 145 (245)
Q Consensus 140 ~e~~~~ 145 (245)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.031 Score=46.51 Aligned_cols=31 Identities=16% Similarity=0.223 Sum_probs=27.4
Q ss_pred CeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 193 ~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.++|+|+.+.|+|++.++.+-++||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 4999999999999999999999999877543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0068 Score=51.02 Aligned_cols=53 Identities=23% Similarity=0.261 Sum_probs=43.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 167 l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
-.++++..++.+.+.-+.-+..+- .+=||||.-.||||+ +|+|.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 467888888888776666665543 589999999999999 99999999999984
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.024 Score=44.85 Aligned_cols=73 Identities=14% Similarity=0.093 Sum_probs=46.7
Q ss_pred eccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHcc---CCCCcceEeEEEEeCCceEEEEEecCCCCHH
Q 025997 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (245)
Q Consensus 74 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (245)
+--|..-..|+... ...++.||.-. ....+.|..|+.-|+.+ +--.+.+++.+....++.|+|+||++-+.+.
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCNQ--REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEecc--hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 33343333443332 34678888643 22345677777665555 3456778888888899999999999875543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.069 Score=51.66 Aligned_cols=77 Identities=16% Similarity=0.118 Sum_probs=44.4
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC--CCC--cceEeE--------EEEe-CC--ce
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK--NEN--VVELVG--------YYVD-GP--LR 136 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~n--iv~~~~--------~~~~-~~--~~ 136 (245)
+.|+ |..-.+|+....++..+++|+..... .......|.+.|..|. ++. +.+++- .... ++ +.
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 3454 45678898887778889999987542 3334444555555442 122 222221 1111 11 46
Q ss_pred EEEEEecCCCCHHH
Q 025997 137 VLAYEHASKGSLHD 150 (245)
Q Consensus 137 ~lv~e~~~~gsL~~ 150 (245)
+.+++|++|..+.+
T Consensus 109 vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 109 LRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEeccCCCcHHh
Confidence 77899999877654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.03 Score=44.07 Aligned_cols=100 Identities=15% Similarity=0.168 Sum_probs=63.2
Q ss_pred EEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCC-ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCC
Q 025997 92 AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168 (245)
Q Consensus 92 ~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~ 168 (245)
...+|++....- ...-|.++..++.++. .|+++.. +.. .+-++.|.|-.... ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i------------------~~ 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI------------------NF 143 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc------------------ch
Confidence 344565543332 3455677888887764 4666652 333 35588888853211 11
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 169 ~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
..++..=+..|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.
T Consensus 144 ----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 ----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 111112246788889543 2599999999999999999999999764
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.039 Score=44.50 Aligned_cols=78 Identities=17% Similarity=0.084 Sum_probs=53.2
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec-CCCCHHH
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA-SKGSLHD 150 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~gsL~~ 150 (245)
..+-.|..+.|+.++..+|...++|..........+... ...|+..+-...|++++.- ...-.+++|.+ ++.+|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence 345678999999999999999999987544322222212 2447778878888998864 34566778888 4456665
Q ss_pred HH
Q 025997 151 IL 152 (245)
Q Consensus 151 ~l 152 (245)
+.
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 54
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.093 Score=45.07 Aligned_cols=74 Identities=16% Similarity=0.169 Sum_probs=42.3
Q ss_pred CeeccCCceEEEEEEECCC--cE-----EEEEEcCCCCCchHHHHHHHHHHHccCCC-CcceEeEEEEeCCceEEEEEec
Q 025997 72 SLIGEGSYGRVYFGVLRSG--RA-----AAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+.|..|-.+.+|++...++ .. |.++.........-+-.+|+.+++.+... .-.++++.+. -+++.||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 3455577889999875432 22 34333211111112335678888888544 3345666553 26889999
Q ss_pred CCCCHH
Q 025997 144 SKGSLH 149 (245)
Q Consensus 144 ~~gsL~ 149 (245)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 886653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.23 Score=43.50 Aligned_cols=29 Identities=17% Similarity=0.387 Sum_probs=24.1
Q ss_pred CeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 193 ~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
.++|.|+-+.|||..+++ ++|+||-.|..
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccccc
Confidence 489999999999876544 99999987753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.018 Score=44.12 Aligned_cols=28 Identities=11% Similarity=0.368 Sum_probs=24.9
Q ss_pred eEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 194 ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
.+|+|+.|.|+++.+++ ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 79999999999998777 89999998754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.11 Score=44.66 Aligned_cols=58 Identities=21% Similarity=0.157 Sum_probs=38.5
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH--HHhcCCCCCeEecCCCCCCeEEc
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE--YLHEKAEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~--~lH~~~~~~ivHrDlkp~Nill~ 207 (245)
..++=+|..|.++..+++... .++....+++.--..|+- ++-++ ++|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vDN----FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVDN----FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhhc----ceecccCCCcEEEE
Confidence 356667888889999887653 344444455544444442 23333 99999999999994
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.024 Score=47.36 Aligned_cols=51 Identities=29% Similarity=0.443 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHHhc---CCCCCeEecCCCCCCeEEcCCC------------------ceEEecccCCCCCC
Q 025997 172 RVKIAVGAARGLEYLHE---KAEPRIIHRNIKSSNVLLFDDD------------------IAKISDFDLSNQAP 224 (245)
Q Consensus 172 ~~~i~~~i~~~l~~lH~---~~~~~ivHrDlkp~Nill~~~~------------------~vkl~DfGla~~~~ 224 (245)
+..+..|++ |-|+-- .+...++|-||||+|||+-+.. .++|.||.+|+...
T Consensus 277 vkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 277 VKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 455667774 455221 1122499999999999995432 45788888876543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 245 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-24 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-75
Identities = 66/192 (34%), Positives = 112/192 (58%), Gaps = 10/192 (5%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
S+ EL+ +DNF +++G G +G+VY G L G A+K+L + ++ + +F +V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S + N++ L G+ + R+L Y + + GS+ L + + P L W +R +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
IA+G+ARGL YLH+ +P+IIHR++K++N+LL ++ A + DF L+ H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193
Query: 234 RVLGTFGYHAPE 245
V GT G+ APE
Sbjct: 194 AVRGTIGHIAPE 205
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-73
Identities = 73/192 (38%), Positives = 114/192 (59%), Gaps = 11/192 (5%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVSM 114
+ + +L+E T+NF LIG G +G+VY GVLR G A+K+ S Q +EF ++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S ++ ++V L+G+ + +L Y++ G+L L+G P +SW QR++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-----DLPTMSMSWEQRLE 143
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
I +GAARGL YLH +A IIHR++KS N+LL ++ + KI+DF +S + + + H ST
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE-LDQTHLST 199
Query: 234 RVLGTFGYHAPE 245
V GT GY PE
Sbjct: 200 VVKGTLGYIDPE 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-70
Identities = 78/215 (36%), Positives = 117/215 (54%), Gaps = 21/215 (9%)
Query: 42 EMKTVTVQPIAVPVISVDELKEKTDNF------GTNSLIGEGSYGRVYFGVLRSGRAAAI 95
E K++ V S ELK T+NF + +GEG +G VY G + + A+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 96 KKLDS-----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150
KKL + +++ Q+F ++ ++++ ++EN+VEL+G+ DG L Y + GSL D
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210
L G P LSW R KIA GAA G+ +LHE IHR+IKS+N+LL +
Sbjct: 120 RLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170
Query: 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
AKISDF L+ + A + ++R++GT Y APE
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-50
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 22/201 (10%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ + L ++ + G +G V+ L A+K + + +V +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 116 SRLKNENVVELVGYYVDGPLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+K+EN+++ +G G L KGSL D L V+SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122
Query: 172 RVKIAVGAARGLEYLHE-------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA ARGL YLHE +P I HR+IKS NVLL ++ A I+DF L+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 225 DAAARLHSTRVLGTFGYHAPE 245
+ + +GT Y APE
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPE 203
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-45
Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 28/195 (14%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQV 112
I +L T + E G ++ G + G +K L D S + ++F +
Sbjct: 7 IDFKQLNFLT-------KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
+ + NV+ ++G P GSL+++LH V+ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q VK A+ ARG+ +LH EP I + S +V++ +D A+IS D+
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163
Query: 231 HSTRVLGTFGYHAPE 245
S + + APE
Sbjct: 164 QSPGRMYAPAWVAPE 178
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-44
Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 23/191 (12%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
I E++ + ++G G++G V R + AIK+++S + + F+ ++ +
Sbjct: 5 IDYKEIEVE-------EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
SR+ + N+V+L G ++ P+ L E+A GSL+++LHG + P P + A +
Sbjct: 56 SRVNHPNIVKLYGACLN-PVC-LVMEYAEGGSLYNVLHGAE------PLPYYTAAHAMSW 107
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTR 234
+ ++G+ YLH +IHR++K N+LL + KI DF + H T
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTN 162
Query: 235 VLGTFGYHAPE 245
G+ + APE
Sbjct: 163 NKGSAAWMAPE 173
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-43
Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G V+ G A+K L D + EFL +V+++ RL++ N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
P + E+ S+GSL+ +LH L +R+ +A A+G+ YLH +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS------GAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
P I+HRN+KS N+L+ K+ DF LS S GT + APE
Sbjct: 158 -PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPE 209
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-43
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPD------ 105
+P ++ +E++ + IG+G +G V+ G L AIK L
Sbjct: 13 LPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 106 --QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
QEF +V ++S L + N+V+L G + P V+ E G L+ L K
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP----- 118
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ W+ ++++ + A G+EY+ + P I+HR+++S N+ L D AK++DF
Sbjct: 119 ---IKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245
LS Q+ + + +LG F + APE
Sbjct: 175 LSQQSVHS-----VSGLLGNFQWMAPE 196
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-41
Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 28/185 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----QEFLAQVSMVSRLKNENVVELVG 128
IG G +G+VY G A+K D + + + + LK+ N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ P L E A G L+ +L GK+ + V AV ARG+ YLH+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123
Query: 189 KAEPRIIHRNIKSSNVLL--------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+A IIHR++KSSN+L+ + I KI+DF L+ + G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYA 179
Query: 241 YHAPE 245
+ APE
Sbjct: 180 WMAPE 184
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 56/209 (26%), Positives = 76/209 (36%), Gaps = 32/209 (15%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLA--QVS 113
+ E DN LIG G YG VY G L R A+K S Q F+ +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIY 59
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-----LAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
V ++++N+ + L E+ GSL L
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SD 109
Query: 169 WAQRVKIAVGAARGLEYLHE------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-- 220
W ++A RGL YLH +P I HR++ S NVL+ +D ISDF LS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 221 ----NQAPDAAARLHSTRVLGTFGYHAPE 245
+ +GT Y APE
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-39
Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 24/185 (12%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G+G YG V+ G + G A+K S + ++ L++EN++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ GSL+D L L ++I + A GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ +Q+ + ++ RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182
Query: 241 YHAPE 245
Y APE
Sbjct: 183 YMAPE 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-39
Identities = 44/207 (21%), Positives = 83/207 (40%), Gaps = 29/207 (14%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFL 109
P+ V +++ IG+G YG V+ G R G A+K ++++
Sbjct: 28 PLLVQRTIAKQIQMV-------KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGP 165
++ +++EN++ + + G ++ GSL+D L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130
Query: 166 VLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L +K+A + GL +LH + +P I HR++KS N+L+ + I+D L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 221 --NQAPDAAARLHSTRVLGTFGYHAPE 245
+ + +GT Y PE
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPE 216
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-38
Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 24/185 (12%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ GSL D L+ ++ +K+A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ + A D + RV GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 241 YHAPE 245
Y APE
Sbjct: 217 YMAPE 221
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-38
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 25/186 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ-EFLAQVSMVSRLKNENVVELVGYYV 131
+G+G +G+ R +G +K+L + Q FL +V ++ L++ NV++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
E+ G+L I+ W+QRV A A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLS------------NQAPDAAARLHSTRVLGTF 239
IIHR++ S N L+ ++ ++DF L+ ++ R V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 240 GYHAPE 245
+ APE
Sbjct: 187 YWMAPE 192
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-37
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 20/178 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G +G+VY G AI+ +D + + + F +V + ++ENVV +G
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P + +L+ ++ K VL + +IA +G+ YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPE 245
I+H+++KS NV D+ I+DF L G + APE
Sbjct: 151 ---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-37
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G VY G A+K L + Q Q F +V ++ + ++ N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L ++ + SL+ LH + + IA ARG++YLH K
Sbjct: 90 TAPQLAIVT-QWCEGSSLYHHLH--------ASETKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IIHR++KS+N+ L +D+ KI DF L+ + + ++ G+ + APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 49/175 (28%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G+ G VY + + +G+ AI++++ +QP +E + + ++ KN N+V + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L V+ E+ + GSL D++ + Q + + LE+LH
Sbjct: 88 VGDELWVVM-EYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN- 135
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
++IHR+IKS N+LL D K++DF Q ++ + ++GT + APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPE 186
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-27
Identities = 58/175 (33%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IGEGS G V SGR A+K +D KQ +E L V ++ ++ NVVE+ Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L VL E G+L DI+ L+ Q + + L YLH +
Sbjct: 113 VGEELWVLM-EFLQGGALTDIV---------SQVR-LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPE 211
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 14/150 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K +FL + ++ + + N+V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L G L +++ AA G+EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--------TEGARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N L+ + ++ KISDF +S
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 44/184 (23%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
+ + +G+G++G+VY +G AA K +++ + + ++++ ++ +++ +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+V+L+G YY DG L ++ E G++ I+ L+ Q +
Sbjct: 78 IVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLE 128
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH K RIIHR++K+ NVL+ + +++DF +S + + S +GT +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYW 183
Query: 242 HAPE 245
APE
Sbjct: 184 MAPE 187
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 115 VSRLKN-ENVVELVGYYVDGPLRVLAY------EHASKGSLHDILHGKKGVKGAKPGPVL 167
+ + + N+ G ++ + E GS+ D+ +K K L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------IKNTKGNT-L 126
Query: 168 SWAQRVKIAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 225 DAAARLHSTRVLGTFGYHAPE 245
R ++ +GT + APE
Sbjct: 181 RTVGRRNT--FIGTPYWMAPE 199
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 21/191 (10%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
E +E+ +G GS+G V+ ++G A+KK+ +E + + L
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGL 107
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V L G +GP + E GSL ++ K L + +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---------KQMGCLPEDRALYYLGQ 158
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQ-APDAAARLHSTR-- 234
A GLEYLH + RI+H ++K+ NVLL D A + DF + PD + T
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 235 VLGTFGYHAPE 245
+ GT + APE
Sbjct: 216 IPGTETHMAPE 226
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 23/182 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG GS+ VY G+ + A +L K E F + M+ L++ N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 129 YYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ VL E + G+L L + + +GL+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK--------RFKV-MKIKVLRSWCRQILKGLQ 143
Query: 185 YLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+LH + P IIHR++K N+ + KI D L+ + A+ V+GT + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMA 198
Query: 244 PE 245
PE
Sbjct: 199 PE 200
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 16/177 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IGEGS+G+ GR IK+++ S+ +E +V++++ +K+ N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + + ++ G L ++ +KGV Q + V L+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ +I+HR+IKS N+ L D ++ DF ++ + +GT Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE 195
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 21/186 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
+GEG + V L G A+K++ +Q D+E + M + N++ LV Y
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 131 VDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ +G+L + + + G L+ Q + + +G RGLE +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-------GTF 239
H HR++K +N+LL D+ + D NQA L T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 240 GYHAPE 245
Y APE
Sbjct: 208 SYRAPE 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-25
Identities = 46/191 (24%), Positives = 81/191 (42%), Gaps = 35/191 (18%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYY 130
LIG G +G+V+ G+ IK++ + + ++E V +++L + N+V G +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 131 VDGPLRVLAY----------------EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
E KG+L + ++G K L ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALE 126
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ +G++Y+H K ++I+R++K SN+ L D KI DF L + R TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TR 180
Query: 235 VLGTFGYHAPE 245
GT Y +PE
Sbjct: 181 SKGTLRYMSPE 191
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-25
Identities = 56/183 (30%), Positives = 96/183 (52%), Gaps = 17/183 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+ F +GEGSYG VY + +G+ AIK++ QE + ++S++ + + +V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHV 86
Query: 124 VELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ G Y+ + L ++ E+ GS+ DI+ + L+ + I +G
Sbjct: 87 VKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT--------LTEDEIATILQSTLKG 137
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH R IHR+IK+ N+LL + AK++DF ++ Q D A+ ++ V+GT +
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWM 192
Query: 243 APE 245
APE
Sbjct: 193 APE 195
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-25
Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
++G+G+YG VY G L + AIK++ + L + +++ LK++N+V+ +G +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E GSL +L K G + + +++ GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLHDN- 141
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+I+HR+IK NVL+ + KISDF S + + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 42/199 (21%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGY 129
+G G +G V+ AIK++ + ++ + +V +++L++ +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 130 YVDGP---------LRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ +V Y + K +L D ++G+ ++ + L ++
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI---- 127
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----------NQAPDA 226
A +E+LH K ++HR++K SN+ DD+ K+ DF L P
Sbjct: 128 --AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 227 AARLHSTRVLGTFGYHAPE 245
A H+ +V GT Y +PE
Sbjct: 183 AYARHTGQV-GTKLYMSPE 200
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 34/178 (19%), Positives = 73/178 (41%), Gaps = 19/178 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 126 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-24
Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
++ R++HR++ + NVL+ KI+DF L+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-24
Identities = 44/194 (22%), Positives = 82/194 (42%), Gaps = 17/194 (8%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVS 116
+ + +++ IG GSYGR G+ K+LD + E +++V+++
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 117 RLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
LK+ N+V +D L Y E+ G L ++ KG K L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVL 114
Query: 174 KIAVGAARGLEYLHEKAEP--RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
++ L+ H +++ ++HR++K +NV L K+ DF L+ +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 232 STRVLGTFGYHAPE 245
+ +GT Y +PE
Sbjct: 175 T--FVGTPYYMSPE 186
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-24
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 49 QPIAVPVISVDELKEK-TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD- 105
P+ + + LK + F IG+GS+G V+ G+ R+ + AIK +D + D
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 106 -QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG 164
++ +++++S+ + V + G Y+ + E+ GS D+L +PG
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPG 114
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P L Q I +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q
Sbjct: 115 P-LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 225 DAAARLHSTRVLGTFGYHAPE 245
D + ++ +GT + APE
Sbjct: 171 DTQIKRNT--FVGTPFWMAPE 189
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-24
Identities = 34/178 (19%), Positives = 73/178 (41%), Gaps = 19/178 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 145 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 41/147 (27%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 252 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR+++++N+L+ ++ + K++DF L+
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLA 327
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-24
Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 15/178 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELV 127
IG G + VY L G A+KK+ D + A + ++ +L + NV++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+++ + E A G L ++ K K ++ K V LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ R++HR+IK +NV + + K+ D L HS ++GT Y +PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-24
Identities = 34/155 (21%), Positives = 65/155 (41%), Gaps = 20/155 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G++Y
Sbjct: 93 GICLRSEGSPLVV-LPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L K + +HR++ + N +L + K++DF L+
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 8e-24
Identities = 34/147 (23%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L E G L D L ++G + + + + + G+ YL E
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
+IHR++ + N L+ ++ + K+SDF ++
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 8e-24
Identities = 41/147 (27%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR+++++N+L+ ++ + K++DF L+
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLA 410
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 33/178 (18%), Positives = 71/178 (39%), Gaps = 19/178 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E L+ L KK + +R + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 172
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ I+H ++K +N L D + K+ DF ++NQ + +G Y PE
Sbjct: 173 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 17/152 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 78 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K +HR++ + NVLL + AKISDF LS
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 41/207 (19%), Positives = 82/207 (39%), Gaps = 37/207 (17%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+F +++G+G++G+V R AIKK+ +++ L++V +++ L ++ V
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 124 VELVGYYVDGPLRVLAY-------------EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
V +++ V E+ G+L+D++ +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLF 122
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
+++ L Y+H + IIHR++K N+ + + KI DF L+ + L
Sbjct: 123 RQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 231 HS------------TRVLGTFGYHAPE 245
T +GT Y A E
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-23
Identities = 33/147 (22%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L + G + + + A G+ ++ ++
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR+++++N+L+ + KI+DF L+
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLA 331
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-23
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 10/186 (5%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQ-VSMVSRLKNEN 122
D++ +IG G+ V AIK+++ Q + L + + +S+ + N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V +V L + S GS+ DI+ K G L + I G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 133
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR---VLGTF 239
LEYLH+ IHR++K+ N+LL +D +I+DF +S + +GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 240 GYHAPE 245
+ APE
Sbjct: 191 CWMAPE 196
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-23
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 17/152 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 404 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K +HRN+ + NVLL + AKISDF LS
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-23
Identities = 32/147 (21%), Positives = 61/147 (41%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V G + A+K + + EF + + +L + +V+ G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L G L +Q +++ G+ +L +
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N L+ D K+SDF ++
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-23
Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
++ R++HR++ + NVL+ KI+DF L+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-23
Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L FLA+ +++ +L+++ +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L G L+ + + +A A G+ ++ E+
Sbjct: 81 PIYIIT-EYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR+++++N+L+ D KI+DF L+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-23
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E A G L+ L + + +++ + G++YL
Sbjct: 85 GICEAESWMLVM-EMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
E +HR++ + NVLL AKISDF LS
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 21/152 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG--V 254
Query: 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR++ + NVL+ +D++AK+SDF L+
Sbjct: 308 N---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-23
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 17/151 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 285
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 286 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 337
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHRN+ + N L+ ++ + K++DF LS
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-23
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 19/191 (9%)
Query: 43 MKTVTVQPIAVPVISVDELKE-KTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AI 95
M +V + + + V + E + + +G+GS+G VY GV + AI
Sbjct: 1 MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 96 KKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHD 150
K + +S + EFL + S++ +VV L+G V P V+ E ++G L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVI-MELMTRGDLKS 117
Query: 151 ILHGKKGVKGAKP-GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209
L + P S ++ +++A A G+ YL+ + +HR++ + N ++ +D
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174
Query: 210 DIAKISDFDLS 220
KI DF ++
Sbjct: 175 FTVKIGDFGMT 185
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-23
Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 92 RPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR++ + N L+ D + K+SDF LS
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-23
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 24/165 (14%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L AIK L + +EF + + +RL++ NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
L+G V D PL ++ + + S G LH+ L + L V +
Sbjct: 77 LLG--VVTKDQPLSMI-FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+EYL ++H+++ + NVL++D KISD L
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-23
Identities = 38/228 (16%), Positives = 80/228 (35%), Gaps = 30/228 (13%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKT--DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
P MK + + ++ ++ +++ + +G + ++ + + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 97 KLD--------SSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGPLRV- 137
K + + + + ++ S KNE + G + V
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN-YDEVY 119
Query: 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197
+ YE+ S+ V + I Y+H + I HR
Sbjct: 120 IIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHR 176
Query: 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
++K SN+L+ + K+SDF S D ++ +R GT+ + PE
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPE 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-22
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 19/154 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G +G V+ GV + IK + S +Q Q + + L + ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G L+++ ++ GSL D + +G L + V A+G+ YL
Sbjct: 81 LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
E ++HRN+ + NVLL +++DF ++
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 38/164 (23%), Positives = 76/164 (46%), Gaps = 23/164 (14%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVKIA 176
G V PL ++ +E+ G L+ L + + L +Q + IA
Sbjct: 83 YG--VCGDGDPLIMV-FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+ YL + +HR++ + N L+ + + KI DF +S
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-22
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 32/198 (16%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
+ EK ++F +L+G+GS+ VY + +G AIK +D + + MV R+
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRV 58
Query: 119 KNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
+NE +++EL Y+ D V L E G ++ L +
Sbjct: 59 QNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKP--------F 109
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S + G+ YLH I+HR++ SN+LL + KI+DF L+ Q
Sbjct: 110 SENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 228 ARLHSTRVLGTFGYHAPE 245
+ ++ GT Y +PE
Sbjct: 167 EKHYTL--CGTPNYISPE 182
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 20/155 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G+++
Sbjct: 157 GICLRSEGSPLVVL-PYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 207
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L K + +HR++ + N +L + K++DF L+
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-22
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 24/157 (15%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + P + ++ ++ L +E++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G L+++ E+ GSL D L + AQ + A G+
Sbjct: 99 KGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGM 147
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YLH + IHR++ + NVLL +D + KI DF L+
Sbjct: 148 AYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-22
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAA 94
E K ++ Q V + D+ ++ S +G G+ G V+ + SG A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMA 62
Query: 95 IKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL 152
K + +P + + ++ ++ + +V G + + EH GSL +L
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 153 HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212
+ P +L K+++ +GL YL EK +I+HR++K SN+L+
Sbjct: 123 KKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 171
Query: 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
K+ DF +S Q D+ A + V GT Y +PE
Sbjct: 172 KLCDFGVSGQLIDSMAN---SFV-GTRSYMSPE 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-22
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 17/151 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 78
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 79 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 130
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
IHR++ + N L+ ++ + K++DF LS
Sbjct: 131 ---NFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-22
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L +K L A + A + L YL
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K R +HR+I + NVL+ +D K+ DF LS
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-22
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 20/155 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL----DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G V G + A+K L S + +F+ +V+ + L + N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L G + P++++ E A GSL D L +G + AV A G+ Y
Sbjct: 86 LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L K R IHR++ + N+LL D+ KI DF L
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-22
Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL------HGKKGVKGAKPGPVLSWAQRVKIAV 177
G V PL ++ +E+ G L+ L L Q + +A
Sbjct: 109 FG--VCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+ YL +HR++ + N L+ + KI DF +S
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 32/208 (15%)
Query: 54 PVISVDELKEKTD-------NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQP 104
P + D+ E+T +F ++G G+ G + + + R A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
D+E V ++ NV+ D + +A E + +L + + +
Sbjct: 65 DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ + + GL +LH I+HR++K N+L+ + A ISDF
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 219 LSNQ-APDAAARLHSTRVLGTFGYHAPE 245
L + A + + V GT G+ APE
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-22
Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 17/150 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+L+G V
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG--VIV 84
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR++ + NVL+ +D++AK+SDF L+
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-22
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L L A + A + L YL
Sbjct: 83 GVITENPVWIIM-ELCTLGELRSFLQ--------VRKYSLDLASLILYAYQLSTALAYLE 133
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
K R +HR+I + NVL+ +D K+ DF LS
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-22
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 18/154 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG+G +G VY G AIK + Q + FL + ++ L + NV+ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 128 GYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G + L + + G L + P + + + ARG+EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
E+ + +HR++ + N +L + K++DF L+
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-22
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G VY GV + + A+K K D + ++F+++ ++ L + ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P ++ E G L L + L V ++ + + YL
Sbjct: 80 GIIEEEPTWIIM-ELYPYGELGHYLE--------RNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR+I N+L+ + K+ DF LS
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-22
Identities = 39/156 (25%), Positives = 78/156 (50%), Gaps = 21/156 (13%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 109 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL K R IHR++ + N+L+ +++ KI DF L+
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-22
Identities = 39/156 (25%), Positives = 78/156 (50%), Gaps = 21/156 (13%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 78 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL K R IHR++ + N+L+ +++ KI DF L+
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-22
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + E V + +L++ N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ GS D+L K L + + GA +GL YLH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHS 172
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+IHR++K+ N+LL + + K+ DF ++
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 35/156 (22%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+K+L S ++F ++ ++ L ++ +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G LR++ E+ G L D L + L ++ + + +G+E
Sbjct: 91 GVSYGPGRQSLRLVM-EYLPSGCLRDFLQ--------RHRARLDASRLLLYSSQICKGME 141
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
YL + R +HR++ + N+L+ + KI+DF L+
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 48/186 (25%), Positives = 72/186 (38%), Gaps = 15/186 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+ +G G+YG V SG+ A+K++ ++ + L + + R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 121 -ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V G + E SL P +L KIAV
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LE+LH K +IHR++K SNVL+ K+ DF +S D A+ G
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 240 GYHAPE 245
Y APE
Sbjct: 174 PYMAPE 179
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-21
Identities = 38/157 (24%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L +S + ++ ++ L +EN+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G ++++ E GSL + L K ++ Q++K AV +G+
Sbjct: 89 KGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+YL + + +HR++ + NVL+ + KI DF L+
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-21
Identities = 47/162 (29%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 127 VGY-YVDGPLRVLAYEHASKGSLHDILHGKK-------GVKGAKPGPVLSWAQRVKIAVG 178
+G G L + E+A G+L D L + LS Q + A
Sbjct: 92 LGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 32/173 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IGEG++GRV+ A+K L ++S +F + ++++ N N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L+G V P+ +L +E+ + G L++ L + + P L
Sbjct: 115 LLG--VCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
S A+++ IA A G+ YL E+ + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-21
Identities = 51/187 (27%), Positives = 76/187 (40%), Gaps = 39/187 (20%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G+G +G VY +S A+K L ++ L + + +L+ E
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHP 69
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L GY+ D RV L E+A G+++ L K +
Sbjct: 70 NILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-----------TYITE 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L Y H K R+IHR+IK N+LL KI+DF S AP + + GT
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGT 170
Query: 239 FGYHAPE 245
Y PE
Sbjct: 171 LDYLPPE 177
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-21
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 14/176 (7%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
IG G+YG V V SG+ A+K++ S+ ++ L + +V R + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ E S + + P +L KI + + L +L E
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKEN 144
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IIHR+IK SN+LL K+ DF +S Q D+ A+ TR G Y APE
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 195
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-21
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G V G L+ A+K + +SS++ +EFL++ + + + NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 127 VG-------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+G + P+ +L G LH L + + +K V
Sbjct: 102 LGVCIEMSSQGIPKPMVIL--PFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDI 156
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+EYL + +HR++ + N +L DD ++DF LS
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-21
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G G V +G LR AIK L +++ ++FL++ S++ + + N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G L ++ E+ GSL L G + Q V + G G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLS 168
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ +HR++ + NVL+ + + K+SDF LS
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-21
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPD-QEFLAQVSMVSRLKNENVVEL 126
+G+G +G V L+ + A+K K D D +EFL + + + + +V +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 127 VG--------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
VG + P+ +L G LH L + + L V+ V
Sbjct: 91 VGVSLRSRAKGRLPIPMVIL--PFMKHGDLHAFL---LASRIGENPFNLPLQTLVRFMVD 145
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A G+EYL + IHR++ + N +L +D ++DF LS
Sbjct: 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-21
Identities = 45/185 (24%), Positives = 72/185 (38%), Gaps = 20/185 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRL-KN 120
+F S +G GSYG V+ GR A+K+ S + ++ LA+V ++ ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V L + +G + L E SL G L AQ
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L +LH + ++H ++K +N+ L K+ DF L + A A + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221
Query: 241 YHAPE 245
Y APE
Sbjct: 222 YMAPE 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-21
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 28/164 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ GV R +K L + + + F SM+S+L ++++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G +L E GSL L K ++ ++++A A +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK--------KNKNCINILWKLEVAKQLAAAMH 127
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD--------IAKISDFDLS 220
+L E +IH N+ + N+LL ++ K+SD +S
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-21
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQY 155
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLS 220
L E IHR+I + N LL +AKI DF ++
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 8e-21
Identities = 25/183 (13%), Positives = 61/183 (33%), Gaps = 21/183 (11%)
Query: 74 IGEG--SYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF---LAQVSMVSRLKNENVVELV 127
IG+G V +G +++++ ++ ++ + + N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
++ + + GS D++ ++ I G + L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYH 242
+HR++K+S++L+ D +S + R +
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 243 APE 245
+PE
Sbjct: 203 SPE 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-21
Identities = 48/232 (20%), Positives = 81/232 (34%), Gaps = 35/232 (15%)
Query: 26 PAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG 85
+PG V A +P + VD + +G+G + + +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 86 V-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGP 134
+ A K + S L + ++ E +VV G++ D
Sbjct: 61 SDADTKEVFAGKIVPKSL------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-N 113
Query: 135 LRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
V + E + SL ++ +K + + A+ G +YLH R
Sbjct: 114 DFVFVVLELCRRRSLLELHKRRKALTEPE-------ARY--YLRQIVLGCQYLHRN---R 161
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR++K N+ L +D KI DF L+ + R GT Y APE
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPE 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 24/196 (12%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-VSMVSRL 118
+ + +G G +G V + +G AIK+ P ++E + ++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 119 KNENVVELV------GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ NVV L +LA E+ G L L+ + G K GP+ +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAAR 229
+ + L YLHE RIIHR++K N++L I KI D + +
Sbjct: 130 I------SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GE 178
Query: 230 LHSTRVLGTFGYHAPE 245
L + V GT Y APE
Sbjct: 179 LCTEFV-GTLQYLAPE 193
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 40/202 (19%), Positives = 76/202 (37%), Gaps = 28/202 (13%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
+ + + ++G GS G V F GR A+K++ E + +++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESD 66
Query: 120 N-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV+ +A E + +L D++ K + + + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLRQ 123
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-------------FDDDIAKISDFDLSNQAPD 225
A G+ +LH +IIHR++K N+L+ ++ ISDF L +
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 226 AAARLHSTR--VLGTFGYHAPE 245
+ + GT G+ APE
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPE 202
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
IG G +G VY G+L++ AIK L +++ +FL + ++ + + N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L K G S Q V + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+HR++ + N+L+ + + K+SDF LS
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 17/153 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +G V G L+ AIK L +++ ++FL + S++ + + N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E+ GSL L K + Q V + G A G++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR--------KHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ +HR++ + N+L+ + + K+SDF L
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 44/205 (21%), Positives = 76/205 (37%), Gaps = 35/205 (17%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ 111
+P + VD + +G+G + + + + A K + S L +
Sbjct: 4 IPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL------LLK 55
Query: 112 VSMVSRLKNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKG 160
++ E +VV G++ D V + E + SL ++ +K +
Sbjct: 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTE 114
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+ G +YLH R+IHR++K N+ L +D KI DF L+
Sbjct: 115 PE-------ARY--YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPE 245
+ R GT Y APE
Sbjct: 163 TKVEYDGERKKVL--CGTPNYIAPE 185
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETR--PRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLS 220
L E IHR+I + N LL +AKI DF ++
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-20
Identities = 49/193 (25%), Positives = 77/193 (39%), Gaps = 27/193 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++ EG + VY + SGR A+K+L S+++ + Q V + +L N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 130 YVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
G L KG L + L K + LS +KI R
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL------KKMESRGPLSCDTVLKIFYQTCRA 148
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSNQAPDAAARLHS 232
++++H + +P IIHR++K N+LL + K+ DF D S A A
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 233 TRVLGTFGYHAPE 245
T Y PE
Sbjct: 208 ITRNTTPMYRTPE 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-20
Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELV 127
+G+G +G VY ++ A+K L S+ + Q+ + S L++ N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
Y+ D R+ L E A +G L+ L HG+ + + A L
Sbjct: 81 NYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-----------TFMEELADALH 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
Y HE+ ++IHR+IK N+L+ KI+DF S AP R + GT Y P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPP 181
Query: 245 E 245
E
Sbjct: 182 E 182
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-20
Identities = 35/173 (20%), Positives = 64/173 (36%), Gaps = 16/173 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELV 127
IG G +G V+ V G AIK+ Q L +V + L ++ +VV
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ + ++ E+ + GSL D + + L + + RGL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
++H +IK SN+ + I + + + + +G G
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK---IGDLG 179
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-20
Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 27/168 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-EN 122
+GEG++G+V A+K L D++++ + ++++ M+ + +N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P LS
Sbjct: 137 IINLLG--ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 45/166 (27%), Positives = 86/166 (51%), Gaps = 23/166 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG++G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 123 VVELVGY-YVDGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L P +++ V
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 45/168 (26%), Positives = 85/168 (50%), Gaps = 27/168 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P +++
Sbjct: 149 IINLLG--ACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
V ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 38/165 (23%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V + R A+K L ++ + ++++ ++ + + NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 125 ELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
L+G GPL V+ E G+L L K+ L+ +
Sbjct: 95 NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 1e-19
Identities = 41/218 (18%), Positives = 74/218 (33%), Gaps = 38/218 (17%)
Query: 53 VPVISVD-ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AIKKLDSSKQPD 105
+P I E + + + L+GEG++ +VY A +K +
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-- 108
Query: 106 QEFLAQVSMVSRLKNE---NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK 162
EF ++ RLK ++ ++ VL E S G+L + ++ K
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NT 164
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---------- 212
P V+ + A+ +E +H+ IIH +IK N +L + +
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 213 -KISDF----DLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ D D+ T T G+ E
Sbjct: 222 LALIDLGQSIDMKLFPKGTIF----TAKCETSGFQCVE 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 23/164 (14%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L EN+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 125 ELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIA 176
L+G GP+ V+ E+ G L + L K V A S + +
Sbjct: 114 NLLG--ACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A+G+ +L K IHR++ + NVLL + +AKI DF L+
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-19
Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 32/173 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GEG +G+V + A+K L ++S ++ L++ +++ ++ + +V++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L G DGPL ++ E+A GSL L L
Sbjct: 91 LYG--ACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ + A ++G++YL E +++HR++ + N+L+ + KISDF LS
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-19
Identities = 43/189 (22%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LY 176
Query: 237 GTFGYHAPE 245
GT Y P+
Sbjct: 177 GTEEYLHPD 185
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-19
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 18/176 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
+G G+ G+V+ ++G A+K++ S + + L + +V + + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++ +A E + + + P +L K+ V + L YL EK
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG-----KMTVAIVKALYYLKEK 143
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR++K SN+LL + K+ DF +S + D A+ R G Y APE
Sbjct: 144 H--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPE 194
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 7e-19
Identities = 29/241 (12%), Positives = 52/241 (21%), Gaps = 43/241 (17%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
+ A E T TV P L + + G V+ + A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 95 IKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELVGYY-------------------- 130
+K + + L ++ +RL E+ E
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 131 ------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L AS L + + R
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
L K ++H + N+ + D + D + +AP
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAP 259
Query: 245 E 245
Sbjct: 260 R 260
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 8e-19
Identities = 43/189 (22%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LY 176
Query: 237 GTFGYHAPE 245
GT Y P+
Sbjct: 177 GTEEYLHPD 185
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-19
Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 22/181 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
+G G VY AIK + + +E L S+L ++N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ + L E+ +L + + GP LS + G++
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ H+ RI+HR+IK N+L+ + KI DF ++ +A + + VLGT Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181
Query: 245 E 245
E
Sbjct: 182 E 182
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 9e-19
Identities = 27/241 (11%), Positives = 72/241 (29%), Gaps = 44/241 (18%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAI 95
++ A + + ++ P EL E+ +++G+ +G + +
Sbjct: 44 QSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEV 103
Query: 96 KKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVEL 126
+++P F+ +V + + ++ +
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 127 VGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
D R Y +L G+ + + L R+++ + R L
Sbjct: 164 RLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH ++H ++ +++L ++ F+ + + G+ P
Sbjct: 221 SLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGFEPP 271
Query: 245 E 245
E
Sbjct: 272 E 272
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-18
Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 28/187 (14%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
++G G V+ LR R A+K L + D F AQ + L + +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75
Query: 125 EL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ G + P L Y E+ +L DI+H + GP ++ + +++ A
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADA 125
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGT 238
+ L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T V+GT
Sbjct: 126 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 239 FGYHAPE 245
Y +PE
Sbjct: 183 AQYLSPE 189
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-18
Identities = 55/205 (26%), Positives = 81/205 (39%), Gaps = 49/205 (23%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSM 114
IG+GSYG V A+K L K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 115 VSRLKNE----------NVVELVGYYV-DGPLRVLAY---EHASKGSLHDILHGKKGVKG 160
+ ++ E NVV+L V D P Y E ++G + ++ K
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
LS Q +G+EYLH + +IIHR+IK SN+L+ +D KI+DF +S
Sbjct: 134 ------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPE 245
N+ + A L +T GT + APE
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPE 207
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 42/181 (23%), Positives = 66/181 (36%), Gaps = 22/181 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
L+G G G VY R A+K + + D F A+ RL+ +VV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + + + L +L + GP L+ + V I L+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR--------RQGP-LAPPRAVAIVRQIGSALD 148
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
H HR++K N+L+ DD A + DF ++ A +GT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 245 E 245
E
Sbjct: 205 E 205
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 25/244 (10%), Positives = 72/244 (29%), Gaps = 43/244 (17%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
++ A + + ++ P EL E+ +++G+ +G +
Sbjct: 48 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 107
Query: 95 IKKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVE 125
+ +++P F+ +V + + ++
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 126 LVG----YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+ +V + ++ + ++L + L R+++ + R
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQVIR 222
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L LH ++H ++ +++L ++ F+ A+A R
Sbjct: 223 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAPPET 278
Query: 242 HAPE 245
A
Sbjct: 279 TAER 282
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L N N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 125 ELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVK 174
L+G + GP V+ E+ G L + L K+ L +
Sbjct: 91 NLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+G+ +L K IHR++ + N+LL I KI DF L+
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V A+K L + + ++++ M+++L +EN+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 125 ELVGY-YVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSW 169
L+G + GP+ ++ E+ G L + L +K ++ + VL++
Sbjct: 113 NLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 39/188 (20%), Positives = 72/188 (38%), Gaps = 40/188 (21%)
Query: 72 SLIGEGSYGRVYFGV-LR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENV 123
I G G +Y + +GR +K L S D E Q ++ + + ++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQF--LAEVVHPSI 141
Query: 124 VEL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V++ + D + Y E+ SL K L A+ + +
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLE 190
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
L YLH +++ ++K N++L ++ K+ D A +R++S + G
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIML-TEEQLKLIDL-------GAVSRINSFGYLYG 239
Query: 238 TFGYHAPE 245
T G+ APE
Sbjct: 240 TPGFQAPE 247
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 37/193 (19%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + + A+K+++ + +++++ LK+ NV+ L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 131 VDGPLR--VLAYEHASKGSLHD---ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ R L +++A HD I+ + K K L + G+ Y
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARL---------HS 232
LH ++HR++K +N+L+ + KI+D ARL
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192
Query: 233 TRVLGTFGYHAPE 245
V+ TF Y APE
Sbjct: 193 DPVVVTFWYRAPE 205
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-14
Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 33/185 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE 245
Y APE
Sbjct: 173 YVAPE 177
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-14
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 29/190 (15%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
F ++G G++ V+ R G+ A+K + S L ++++ ++K+EN
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVG 178
+V L Y L + S G L D IL ++GV K A + ++ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDA--------SLVIQQVLS 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ++YLHE I+HR++K N+L ++ I+DF LS + +
Sbjct: 118 A---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STA 167
Query: 236 LGTFGYHAPE 245
GT GY APE
Sbjct: 168 CGTPGYVAPE 177
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 3e-14
Identities = 32/144 (22%), Positives = 58/144 (40%), Gaps = 22/144 (15%)
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ R+ + VG +V Y + K +L D ++ + ++ + G L
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSN 221
++ A +E+LH K ++HR++K SN+ DD+ K+ DF +
Sbjct: 172 QI------AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 222 QAPDAAARLHSTRVLGTFGYHAPE 245
A T +GT Y +PE
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPE 246
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-14
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 31/188 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++GEG++ RV + + + A+K ++ + + + V M+ + + NV+EL+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + L +E GS+ +H K+ A + V+ A L++L
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEA--------SVVVQDVASA---LDFL 127
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLS------NQAPDAAARLHSTRVLG 237
H K I HR++K N+L + KI DFDL + T G
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 238 TFGYHAPE 245
+ Y APE
Sbjct: 184 SAEYMAPE 191
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-14
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 20/182 (10%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+G + V + R G+ A+K K SS E L + S+ LK+ ++VEL
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ Y + + +E L + VK A G V S A L Y
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H+ IIHR++K VLL + + K+ F ++ Q ++ +GT + A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201
Query: 244 PE 245
PE
Sbjct: 202 PE 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-14
Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 33/185 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE 245
Y APE
Sbjct: 173 YVAPE 177
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-13
Identities = 49/214 (22%), Positives = 68/214 (31%), Gaps = 45/214 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+GSYG V + + AIK K+ D E + V ++ +L + N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG-------- 178
Y D L E G L D L+ K + Q
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 179 ----------------AAR-------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--K 213
+ L YLH + I HR+IK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 214 ISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPE 245
+ DF LS + T GT + APE
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 38/221 (17%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAA 93
P M + P ++ T F ++G+GS+G V + +G+
Sbjct: 2 PGSMMDHLHATPGMF-------VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC 54
Query: 94 AIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149
A+K + K + L +V ++ +L + N+++L ++ D L E + G L
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 150 D--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207
D I + A A+ ++ + + Y+H+ +I+HR++K N+LL
Sbjct: 115 DEIISRKRFSEVDA--------ARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLE 160
Query: 208 DDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+I DF LS + +GT Y APE
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 35/236 (14%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEK-----TDNFGTNSLIGEGS 78
++ +G G + T + P ++ + +D F S +G G+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 79 YGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
VY + + A+K L K D++ + + ++ RL + N+++L +
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 137 VLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
L E + G L D I+ +KG + A A VK + A + YLHE
Sbjct: 124 SLVLELVTGGELFDRIV--EKGYYSERDA--------ADAVKQILEA---VAYLHEN--- 167
Query: 193 RIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR++K N+L D KI+DF LS L T GT GY APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAPE 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 44/237 (18%), Positives = 91/237 (38%), Gaps = 20/237 (8%)
Query: 14 KASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSL 73
K + G + + + P + D++ +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G++G V+ R+ G A K + + + D+E + + + +S L++ +V L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
D V+ YE S G L + + + +S + V+ +GL ++HE
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN-- 274
Query: 192 PRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPE 245
+H ++K N++ + K+ DF L+ P + ++ GT + APE
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPE 326
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 55/199 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+GEGSYG+V + + A+K L K + + +K E
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKK-----LRRIPNGEANVKKEIQLLRRLRHK 66
Query: 122 NVVELVG-YYVDGPLRV-LAYEHASKGS--LHD-ILHGKKGVKGAKPGPVLSWAQRVKIA 176
NV++LV Y + ++ + E+ G + D + +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------------------FP 107
Query: 177 VGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
V A GLEYLH + I+H++IK N+LL KIS ++ AA
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 229 --RLHSTRVLGTFGYHAPE 245
+++ G+ + PE
Sbjct: 165 DDTCRTSQ--GSPAFQPPE 181
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 30/198 (15%)
Query: 61 LKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAAAIK---KLDSSKQPDQEFLAQV 112
+ K + +G G+YG V + + AIK K S + + L +V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWA 170
+++ L + N+++L ++ D L E G L D I K A A
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--------A 139
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAA 227
+K + + YLH+ I+HR++K N+LL + + KI DF LS +
Sbjct: 140 VIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 228 ARLHSTRVLGTFGYHAPE 245
LGT Y APE
Sbjct: 194 KM---KERLGTAYYIAPE 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-13
Identities = 38/186 (20%), Positives = 63/186 (33%), Gaps = 31/186 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------- 121
+G G V + + + A+K +D + + E
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
N+++L Y L ++ KG L D K + ++ +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--------RKIMRALLEV 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LH+ I+HR++K N+LL DD K++DF S Q GT
Sbjct: 137 ---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTP 187
Query: 240 GYHAPE 245
Y APE
Sbjct: 188 SYLAPE 193
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-13
Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 39/192 (20%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKN---ENV 123
IG G+YG VY SG A+K + + + +V+++ RL+ NV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L D ++V L +EH D+ + P P L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RGL++LH I+HR++K N+L+ K++DF L AR++S T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177
Query: 234 RVLGTFGYHAPE 245
V+ T Y APE
Sbjct: 178 PVVVTLWYRAPE 189
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-13
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 24/179 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG GS+G V V + + A KK+ D + Q + ++ L + N++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 132 DGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
D L E + G L + + A A+ +K + A + Y H+
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSA---VAYCHKL 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ HR++K N L D K+ DF L+ + ++ T+V GT Y +P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV-GTPYYVSPQ 178
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-13
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 52/194 (26%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V ++K E
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHP 71
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + E+ S G L D + + ++
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYI-----------------CKHGRVEEME 112
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
AR ++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 113 ARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 168
Query: 232 STRVLGTFGYHAPE 245
++ G+ Y APE
Sbjct: 169 TS--CGSPNYAAPE 180
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-13
Identities = 38/183 (20%), Positives = 74/183 (40%), Gaps = 29/183 (15%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V G+ A +++ K D + L + + LK+ N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + A + +
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADA--------SHCIQQILEA---VLH 125
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H+ ++HRN+K N+LL K++DF L+ + GT GY
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 243 APE 245
+PE
Sbjct: 181 SPE 183
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-13
Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 17/178 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVGYY 130
+G G++G V+ R SG IK ++ + A++ ++ L + N++++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D + E G L + + + LS ++ L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 191 EPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
++H+++K N+L D KI DF L+ + GT Y APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA-GTALYMAPE 196
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
D + +G G++G V+ V ++ GR K +++ D+ + +S++++L +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
++ L + D VL E S G L D + + +S A+ + A G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEG 161
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQA-PDAAARLHSTRVLGTF 239
L+++HE I+H +IK N++ + KI DF L+ + PD ++ T
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATA 214
Query: 240 GYHAPE 245
+ APE
Sbjct: 215 EFAAPE 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-12
Identities = 47/251 (18%), Positives = 82/251 (32%), Gaps = 36/251 (14%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN- 71
R+A + + N K A+ T + ++ F
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96
Query: 72 ---SLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------ 121
+IG G V V R+ G A+K ++ + + + + + E
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE-EVREATRRETHILRQ 155
Query: 122 -----NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 174
+++ L+ Y L ++ KG L D K ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET--------RSIMR 207
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A + +LH I+HR++K N+LL D+ ++SDF S
Sbjct: 208 SLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLREL 259
Query: 235 VLGTFGYHAPE 245
GT GY APE
Sbjct: 260 C-GTPGYLAPE 269
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 41/217 (18%)
Query: 43 MKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLRS-GRAAAIKK 97
M+TV V I +L + F IG GSY + ++ A+K
Sbjct: 1 MQTVGVHSIVQ------QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI 54
Query: 98 LDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGK 155
+D SK+ E ++ ++ R N++ L Y DG + E G L D IL +
Sbjct: 55 IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--R 109
Query: 156 KGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210
+ + A + + +EYLH + ++HR++K SN+L D+
Sbjct: 110 QKFFSEREA--------SAVLFTITKT---VEYLHAQ---GVVHRDLKPSNILYVDESGN 155
Query: 211 --IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+I DF + Q L T T + APE
Sbjct: 156 PESIRICDFGFAKQLRAENGLLM-TPC-YTANFVAPE 190
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 29/181 (16%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
+GEGS+ V + S +A A+K + + + + +++ + + N+V+L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 132 DGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D L E + G L + I KK A + ++ V A + ++H
Sbjct: 77 DQLHTFLVMELLNGGELFERIK--KKKHFSETEA--------SYIMRKLVSA---VSHMH 123
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ ++HR++K N+L D++ KI DF + P L + T Y AP
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 245 E 245
E
Sbjct: 179 E 179
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 34/190 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLA--QVSMVSRLKNENVVEL 126
IG+G++G V+ ++G+ A+KK +++ K+ P A ++ ++ LK+ENVV L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNL 81
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + KGS+ HD+ G+ + ++ ++
Sbjct: 82 IEICRTKASP----YNRCKGSIYLVFDFCEHDL----AGLLSNVLVK-FTLSEIKRVMQM 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRV 235
GL Y+H +I+HR++K++NVL+ D + K++DF L+ + A ++ ++ RV
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 236 LGTFGYHAPE 245
+ T Y PE
Sbjct: 190 V-TLWYRPPE 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 52/194 (26%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V +++ E
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHP 76
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+ S G L D + + ++
Sbjct: 77 HIIKL--YQVISTPSDIFMVMEYVSGGELFDYI-----------------CKNGRLDEKE 117
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+R G++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 118 SRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 173
Query: 232 STRVLGTFGYHAPE 245
++ G+ Y APE
Sbjct: 174 TS--CGSPNYAAPE 185
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 41/188 (21%), Positives = 68/188 (36%), Gaps = 35/188 (18%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------N 122
+G G+ G V R + AI+ + K + ++ E
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS-AREADPALNVETEIEILKKLNHPC 201
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
++++ ++ D + E G L D + + + K
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-----------LYFYQML 249
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLG 237
++YLHE IIHR++K NVLL + + KI+DF S + + L T G
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 303
Query: 238 TFGYHAPE 245
T Y APE
Sbjct: 304 TPTYLAPE 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 40/185 (21%), Positives = 78/185 (42%), Gaps = 22/185 (11%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVV 124
++G G +G+V+ + G A K + + D+E + +S++++L + N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
+L + VL E+ G L D I+ + L+ + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII--DESYN-------LTELDTILFMKQICEGI 200
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFG 240
++H+ I+H ++K N+L D KI DF L+ + P ++ GT
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV----NFGTPE 253
Query: 241 YHAPE 245
+ APE
Sbjct: 254 FLAPE 258
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 40/187 (21%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG G++G + A+K ++ D+ ++ L++ N+V V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84
Query: 132 -DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
P + + E+AS G L++ + + + AR
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-----------------CNAGRFSEDEARFFFQQLLS 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGT 238
G+ Y H +I HR++K N LL D A KI DF S + ++ ST +GT
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL-HSQPKST--VGT 180
Query: 239 FGYHAPE 245
Y APE
Sbjct: 181 PAYIAPE 187
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-12
Identities = 45/197 (22%), Positives = 79/197 (40%), Gaps = 30/197 (15%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK-----KLDSSKQPDQEFLAQV--- 112
E + + T S +G G++G V+ V + +K K+ + L +V
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 113 -SMVSRLKNENVVELVGYYVDGPLRVLAYE-HASKGSLHD--ILHGKKGVKGAKPGPVLS 168
+++SR+++ N+++++ + + L E H S L H + L
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----------LD 128
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
I + YL K IIHR+IK N+++ +D K+ DF +
Sbjct: 129 EPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--G 183
Query: 229 RLHSTRVLGTFGYHAPE 245
+L T GT Y APE
Sbjct: 184 KLFYTFC-GTIEYCAPE 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 33/203 (16%)
Query: 31 GGFYVKEAPAKEMKTVTVQP----IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV 86
G F + AP +K + I V +++ + +IG GS+G V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 87 LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY-YVDGPLRV-----LAY 140
L AIKK+ Q + ++ ++ +K+ NVV+L + Y +G + L
Sbjct: 61 LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRII 195
E+ + +++ +K P +K + R L Y+H I
Sbjct: 118 EYVPE-TVYRASRHYAKLKQTMP------MLLIKLYMYQL----LRSLAYIHSI---GIC 163
Query: 196 HRNIKSSNVLLF-DDDIAKISDF 217
HR+IK N+LL + K+ DF
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDF 186
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 7e-12
Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY G A+KK L+ + P + ++S++ LK+ N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
VL +EH D+ K + G L + G+ Y H++
Sbjct: 69 IHTKKRLVLVFEHLD----QDL----KKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
R++HR++K N+L+ + KI+DF L+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 39/181 (21%), Positives = 76/181 (41%), Gaps = 26/181 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ L ++ + G L + + A + ++ + + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCIQQILES---IAYCH 145
Query: 188 EKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
I+HRN+K N+LL K++DF L+ + D + GT GY +P
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYLSP 199
Query: 245 E 245
E
Sbjct: 200 E 200
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-12
Identities = 44/190 (23%), Positives = 78/190 (41%), Gaps = 26/190 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKN 120
+ + ++G+GS+G V R + A+K ++ + D + + V ++ +L +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+++L D + E + G L D I + A A+ +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRV 235
+ Y+H+ I+HR++K N+LL + KI DF LS R+
Sbjct: 133 G---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184
Query: 236 LGTFGYHAPE 245
GT Y APE
Sbjct: 185 -GTAYYIAPE 193
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
IG+G++ +V + +GR AIK +D ++ + L + V ++ L + N+V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 130 YV-DGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
V + + L E+AS G + D L HG+ + + ++Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR-----------MKEKEARSKFRQIVSAVQY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
H+K RI+HR++K+ N+LL D KI+DF SN+ G Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 17/151 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
+GEG+YG VY GR A+K+ LD+ + P + ++S++ L + N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E D+ K V L +Q RG+ + H+
Sbjct: 88 IHSERCLTLVFEFME----KDL----KKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH 138
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
RI+HR++K N+L+ D K++DF L+
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-12
Identities = 44/200 (22%), Positives = 72/200 (36%), Gaps = 35/200 (17%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
K D + + +G G+ G V R + AIK + K + ++
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS-AREADPALNVET 64
Query: 121 E----------NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLS 168
E ++++ ++ D + E G L D + + +
Sbjct: 65 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC------- 116
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225
+ A ++YLHE IIHR++K NVLL + + KI+DF S +
Sbjct: 117 -KLYFYQMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 226 AAARLHSTRVLGTFGYHAPE 245
L T GT Y APE
Sbjct: 170 --TSLMRTLC-GTPTYLAPE 186
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 38/190 (20%), Positives = 62/190 (32%), Gaps = 38/190 (20%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+G G +G VY G+ + AIK ++ + D ++ +R+ E
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW---GELPNGTRVPMEVVLLKKVSSG 106
Query: 122 --NVVELVGYYVDGPLRVLAYEHAS-KGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIA 176
V+ L+ ++ VL E L D G L
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----------LQEELARSFF 155
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQAPDAAARLHSTRV 235
+ + H ++HR+IK N+L+ + K+ DF D
Sbjct: 156 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-- 208
Query: 236 LGTFGYHAPE 245
GT Y PE
Sbjct: 209 DGTRVYSPPE 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-11
Identities = 40/183 (21%), Positives = 78/183 (42%), Gaps = 30/183 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + + + Y
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADA--------SHCIQQILES---IAY 120
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H I+HRN+K N+LL K++DF L+ + D + GT GY
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYL 174
Query: 243 APE 245
+PE
Sbjct: 175 SPE 177
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 43/234 (18%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SG 90
+ + + Q IA+ +++K G + +G G+YG V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 91 RAAAIKKLD--------------SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136
AIK + + ++ +E ++S++ L + N+++L + D
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 137 VLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194
L E G L + I K A A +K + + YLH+ I
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDA--------ANIMKQILSG---ICYLHKH---NI 167
Query: 195 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+HR+IK N+LL + + KI DF LS+ +L LGT Y APE
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRD--RLGTAYYIAPE 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 26/181 (14%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+GS+G V R + + A+K ++ + D + + V ++ +L + N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D + E + G L D I + A A+ +K + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSG---ITYMH 138
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ I+HR++K N+LL + KI DF LS ++ +GT Y AP
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD--RIGTAYYIAP 192
Query: 245 E 245
E
Sbjct: 193 E 193
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 42/210 (20%), Positives = 76/210 (36%), Gaps = 44/210 (20%)
Query: 56 ISVDELKEKTDNFG-----TNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL 109
+ + K + ++G G G+V R G+ A+K L S + QE
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-- 71
Query: 110 AQVSMVSRLKN-ENVVELVGYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG--- 160
V + ++V ++ Y + E G L I ++G +
Sbjct: 72 --VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTE 127
Query: 161 --AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKIS 215
A A+ ++ A +++LH I HR++K N+L + + K++
Sbjct: 128 REA--------AEIMRDIGTA---IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
DF + + A + T T Y APE
Sbjct: 174 DFGFAKETTQNALQ---TPC-YTPYYVAPE 199
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY +G A+KK LD+ + P + ++S++ L + N+V+L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHPNIVKLLD 69
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L +E D+ K A + +GL + H
Sbjct: 70 VIHTENKLYLVFEFLH----QDL----KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
R++HR++K N+L+ + K++DF L+
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 36/189 (19%), Positives = 62/189 (32%), Gaps = 34/189 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR-----------LKN 120
L+G+G +G V+ G L AIK + ++ L+ +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGS-LHD--ILHGKKGVKGAKPGPVLSWAQRVKIAV 177
V+ L+ ++ +L E L D G G ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-----------CFFG 146
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVL 236
+++ H + ++HR+IK N+L+ AK+ DF D
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDF--D 199
Query: 237 GTFGYHAPE 245
GT Y PE
Sbjct: 200 GTRVYSPPE 208
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 3e-11
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 45/180 (25%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQV 112
++K + + +GEG + VY + + AIKK L + L ++
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG- 160
++ L + N++ L D K + +
Sbjct: 64 KLLQELSHPNIIGL----------------------LDAFGHKSNISLVFDFMETDLEVI 101
Query: 161 -AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
VL+ + + +GLEYLH+ I+HR++K +N+LL ++ + K++DF L
Sbjct: 102 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 53/194 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+GEGS+G+V ++ + A+K + L + M R++ E
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHP 69
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+A G L D + ++ ++
Sbjct: 70 HIIKL--YDVITTPTDIVMVIEYAG-GELFDYI-----------------VEKKRMTEDE 109
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R +EY H +I+HR++K N+LL D+ KI+DF LSN D L
Sbjct: 110 GRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLK 165
Query: 232 STRVLGTFGYHAPE 245
++ G+ Y APE
Sbjct: 166 TS--CGSPNYAAPE 177
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 33/176 (18%), Positives = 67/176 (38%), Gaps = 19/176 (10%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ V S + K + ++S+++ ++ N++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
V+ +E S + + ++ L+ + V L++LH
Sbjct: 73 MEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 193 RIIHRNIKSSNVLLFDDDIA--KISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPE 245
I H +I+ N++ + KI +F + Q P RL + Y+APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPE 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-11
Identities = 19/151 (12%), Positives = 41/151 (27%), Gaps = 19/151 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS----MVSRLKNENVVEL 126
G + + + R A+ +D + L + +SR+ V +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ ++ E GSL ++ P P ++ A +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217
H + S V + D ++
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVVLAYP 173
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-11
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 22/156 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE------FLAQVSMVSRLKNENVVEL 126
+G G+Y VY G+ +G A+K++ + D E + ++S++ LK+EN+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 127 VGYYVDGPLRVLAYEHASK--GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L +E D +G + V + ++ +GL
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQGLA 122
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ HE +I+HR++K N+L+ K+ DF L+
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 38/208 (18%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVY 83
P+ ++ ++ TV P P + + ++ +IG GS+G VY
Sbjct: 18 QQPSAFGSMKVSRDKDGSKVTTVVATPGQGP------DRPQEVSYTDTKVIGNGSFGVVY 71
Query: 84 FGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY-YVDGPLRV--- 137
L SG AIKK+ D+ F ++ ++ +L + N+V L + Y G +
Sbjct: 72 QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 138 --LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKA 190
L ++ + +++ + + + + PV+ VK + R L Y+H
Sbjct: 128 LNLVLDYVPE-TVYRVA--RHYSRAKQTLPVI----YVKLYMYQL----FRSLAYIHSF- 175
Query: 191 EPRIIHRNIKSSNVLLFDD-DIAKISDF 217
I HR+IK N+LL D + K+ DF
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-10
Identities = 36/165 (21%), Positives = 65/165 (39%), Gaps = 44/165 (26%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG V+ + A+K+ LD + P L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSWAQRVKI 175
HD+LH K + K L
Sbjct: 67 --------------------HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF 106
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+GL + H + ++HR++K N+L+ + K+++F L+
Sbjct: 107 LFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 39/191 (20%)
Query: 74 IGEGSYGRVYFG--VLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN---ENVV 124
IGEG+YG+V+ + GR A+K+ + + ++ P + +V+++ L+ NVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 77
Query: 125 EL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L D ++ L +EH D+ P P + +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMFQL 129
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TR 234
RGL++LH R++HR++K N+L+ K++DF L AR++S T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTS 178
Query: 235 VLGTFGYHAPE 245
V+ T Y APE
Sbjct: 179 VVVTLWYRAPE 189
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-10
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 18/151 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVGY 129
IGEGSYG V+ +G+ AIKK S+ L ++ M+ +LK+ N+V L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 130 YVDGPLRVLAYEHASKGSLHDILHG-KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E+ H +LH + +G V S + + + + H+
Sbjct: 71 FRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCHK 120
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
IHR++K N+L+ + K+ DF
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 36/194 (18%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNE- 121
++F + +IG G +G VY +G+ A+K LD K E LA NE
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--------LNER 240
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGA 179
++ LV D P V ++Y + L IL G G + + +
Sbjct: 241 IMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNG------GDLHYHLSQHGVFSEAD 293
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R GLE++H + +++R++K +N+LL + +ISD L+
Sbjct: 294 MRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 348
Query: 232 STRVLGTFGYHAPE 245
V GT GY APE
Sbjct: 349 -ASV-GTHGYMAPE 360
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 43/196 (21%), Positives = 81/196 (41%), Gaps = 43/196 (21%)
Query: 66 DNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ + +GEG+Y VY G + A+K+ L+ + + +VS++ LK+ N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSW 169
+V L HDI+H +K + K G +++
Sbjct: 62 IVTL----------------------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINM 99
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
RGL Y H + +++HR++K N+L+ + K++DF L+ +A +
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTK 155
Query: 230 LHSTRVLGTFGYHAPE 245
+ V+ T Y P+
Sbjct: 156 TYDNEVV-TLWYRPPD 170
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 52/251 (20%), Positives = 87/251 (34%), Gaps = 41/251 (16%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDN---FG 69
+ S PF P P + PA+ Q V S ++K+
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
T+ ++G G G+V + + A+K L + +E V + R ++V +V
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIV 121
Query: 128 GYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG-----AKPGPVLSWAQRVKIAV 177
Y + E G L I +G + A ++ +K
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREA--------SEIMKSIG 171
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTR 234
A ++YLH I HR++K N+L I K++DF + + +T
Sbjct: 172 EA---IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTP 223
Query: 235 VLGTFGYHAPE 245
T Y APE
Sbjct: 224 C-YTPYYVAPE 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-10
Identities = 44/184 (23%), Positives = 70/184 (38%), Gaps = 27/184 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LH K +I H ++K N++L D +I K+ DF L+++ D + GT +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 242 HAPE 245
APE
Sbjct: 185 VAPE 188
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-10
Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSR 117
+ + + L+GEGSYG V +GR AIKK S D+ + ++ ++ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQ 80
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L++EN+V L+ L +E ++ D L G V + ++
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQI---- 133
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
G+ + H IIHR+IK N+L+ + K+ DF +
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 41/188 (21%), Positives = 75/188 (39%), Gaps = 35/188 (18%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V + G+ A K + + + R +++ N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAAR 181
L + + VL E S G L D + +K A Q +K +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLA--EKESLTEDEA--------TQFLKQILD--- 119
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLG 237
G+ YLH K RI H ++K N++L D ++ K+ DF ++++ +A + + G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKN--IFG 173
Query: 238 TFGYHAPE 245
T + APE
Sbjct: 174 TPEFVAPE 181
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 41/195 (21%), Positives = 72/195 (36%), Gaps = 31/195 (15%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR------ 117
D + T +G G + V +S G A K + + + R
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 118 -LKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 174
+++ NV+ L Y + +L E + G L D + A + +K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------TEFLK 121
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARL 230
+ + YLH +I H ++K N++L D ++ KI DF L+++ D
Sbjct: 122 QILNG---VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF 174
Query: 231 HSTRVLGTFGYHAPE 245
+ GT + APE
Sbjct: 175 --KNIFGTPEFVAPE 187
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 29/185 (15%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQ-APDAAARLHSTRVLGTFG 240
LH K +I H ++K N++L D +I K+ DF L+++ + + GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGTPE 183
Query: 241 YHAPE 245
+ APE
Sbjct: 184 FVAPE 188
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-09
Identities = 43/197 (21%), Positives = 73/197 (37%), Gaps = 56/197 (28%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY + + AIK+ L+ ++ P + +VS++ L++ N++EL
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIEL-- 98
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQRVKIA 176
++H + K P +S
Sbjct: 99 --------------------KSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL 138
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDL--SNQAPDAAA 228
G+ + H + R +HR++K N LL A KI DF L + P
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPI--- 191
Query: 229 RLHSTRVLGTFGYHAPE 245
R + ++ T Y PE
Sbjct: 192 RQFTHEII-TLWYRPPE 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 31/185 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLK-NENVVELVG 128
+G G + V + +S G+ A K L + Q + + ++++ K V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 129 YYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GL 183
Y + +L E+A+ G + L + ++S + + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVS----ENDVIRLIKQILEGV 144
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFG 240
YLH+ I+H ++K N+LL KI DF +S + A L ++GT
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE--IMGTPE 198
Query: 241 YHAPE 245
Y APE
Sbjct: 199 YLAPE 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 32/179 (17%), Positives = 59/179 (32%), Gaps = 42/179 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGYYV 131
+G GS+G V SG+ A+KK+ D + ++ ++ L + N+++LV Y+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWA----------------QRVKI 175
K V + +K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 176 AVGAA----------------RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDF 217
+ + R + ++H I HR+IK N+L+ D+ K+ DF
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDF 186
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 43/191 (22%), Positives = 73/191 (38%), Gaps = 36/191 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQ-----VSMVSRLKNE 121
I GSYG V GV G AIK++ ++ FL + + +++ +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 122 NVVELVGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
N++ L + L E L ++H ++ V+S
Sbjct: 90 NILGL--RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--------IVISPQHIQY 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
GL LHE ++HR++ N+LL D++ I DF+L+ + A + T
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTH 192
Query: 235 VLGTFGYHAPE 245
+ Y APE
Sbjct: 193 YVTHRWYRAPE 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 1e-08
Identities = 36/195 (18%), Positives = 61/195 (31%), Gaps = 41/195 (21%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---------DSSKQPDQEFLAQVSMV 115
T+ IGEG +G V+ + AIK + S ++ +E L ++ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 116 SRLKN---------ENVVELVGYY-VDGP-----LRVLAYEHASKGSLHDILHGKKGVKG 160
L E + L + V G L+ + +++KGS +D K +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 161 --------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206
+ S A I L R HR++ NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195
Query: 207 FDDDIAKISDFDLSN 221
+ K+
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 34/194 (17%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK 97
P M +++ D F + G+G++G V G + +G + AIKK
Sbjct: 2 PGSMMSLNAAAAADERS------RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK 55
Query: 98 LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--------VLAYEHASKGSLH 149
+ + L + ++ L + N+V+L Y + E+ +LH
Sbjct: 56 VIQDPRFRNRELQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLH 113
Query: 150 DILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204
+ A P +K + R + LH + + HR+IK NV
Sbjct: 114 RCCRNYYRRQVAPP------PILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNV 162
Query: 205 LLFDDD-IAKISDF 217
L+ + D K+ DF
Sbjct: 163 LVNEADGTLKLCDF 176
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 25/190 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
D F ++G G +G V+ ++ +G+ A KKL+ ++ L + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN------KKRLKKRKGYQGAMVEKKI 238
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
+ V V LAY +K L ++ G + P + +
Sbjct: 239 LAKV----HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GLE+LH++ II+R++K NVLL DD +ISD L+ + +
Sbjct: 295 TAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA 350
Query: 236 LGTFGYHAPE 245
GT G+ APE
Sbjct: 351 -GTPGFMAPE 359
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 36/194 (18%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
+ F ++G+G +G V +R +G+ A KKL+ ++ + + + NE +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE------KKRIKKRKGEAMALNEKQI 237
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GA 179
+E V + V LAY + +K +L +L G G + + A
Sbjct: 238 LEKV----NSRFVVSLAYAYETKDALCLVLTLMNG------GDLKFHIYHMGQAGFPEAR 287
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
A GLE LH + RI++R++K N+LL D +ISD L+ P+ +
Sbjct: 288 AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTI 342
Query: 232 STRVLGTFGYHAPE 245
RV GT GY APE
Sbjct: 343 KGRV-GTVGYMAPE 355
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 7e-08
Identities = 37/241 (15%), Positives = 71/241 (29%), Gaps = 71/241 (29%)
Query: 34 YVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGS-YGRVY--FGVLRSG 90
+V K+ VQ + ++S +E+ +I F L S
Sbjct: 29 FVDNFDCKD-----VQDMPKSILSKEEIDH---------IIMSKDAVSGTLRLFWTLLSK 74
Query: 91 RAAAIKK-LDSSKQPDQEFLAQ----------------VSMVSRLKNENVVELVGYYVDG 133
+ ++K ++ + + +FL + RL N+N V Y V
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSR 133
Query: 134 P-----LRVLAYEHASKGSLHDILHGKKG---------------VKGAKPGPVLSWAQRV 173
LR E ++ ++ G G V+ + W
Sbjct: 134 LQPYLKLRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W---- 186
Query: 174 KIAVGAARG-------LEYLHEKAEPRIIHRNIKSSNV-LLFDDDIAKISDFDLSNQAPD 225
+ + L+ L + +P R+ SSN+ L A++ S +
Sbjct: 187 -LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 226 A 226
Sbjct: 246 C 246
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-08
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 34/191 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYV 131
+G G G V+ V + AIKK+ + + L ++ ++ RL ++N+V++ + +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--FEI 76
Query: 132 DGPLRVLAYEHASKGS---------------LHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
GP + + L ++L L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----------LLEEHARLFM 126
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS-NQAPDAAARLHSTR 234
RGL+Y+H ++HR++K +N+ + +D + KI DF L+ P + + H +
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 235 VLGTFGYHAPE 245
L T Y +P
Sbjct: 184 GLVTKWYRSPR 194
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 33/204 (16%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLA 110
+ + +L+ K +++ +IG G++G V ++R + + A+K L + +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFE------MI 108
Query: 111 QVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ S + E + + + + P V L Y L+ ++ G G +++
Sbjct: 109 KRSDSAFFWEERDI-MA--FANSPWVVQLFYAFQDDRYLYMVMEYMPG------GDLVNL 159
Query: 170 AQRVKIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ AR L+ +H IHR++K N+LL K++DF
Sbjct: 160 MSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 222 QAPDAAARLHSTRVLGTFGYHAPE 245
+ T V GT Y +PE
Sbjct: 217 KMNKEGMVRCDTAV-GTPDYISPE 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
K++ ++F ++GEGS+ V + R AIK L+ + + + + V +
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE------KRHIIKENKVPYVTR 79
Query: 121 ENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVG 178
E V + +D P V L + L+ L K G +L + +++
Sbjct: 80 ERDV-MS--RLDHPFFVKLYFTFQDDEKLYFGLSYAKN------GELLKYIRKIGSFDET 130
Query: 179 AAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
R LEYLH K IIHR++K N+LL +D +I+DF + + +
Sbjct: 131 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 231 HSTRVLGTFGYHAPE 245
+ +GT Y +PE
Sbjct: 188 RANSFVGTAQYVSPE 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 35/185 (18%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V ++G A+KKL S+ A+ + ++ +K+ENV+ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGL- 93
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P R L H L++I+ +K L+ +
Sbjct: 94 -LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQIL 142
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 241 YHAPE 245
Y APE
Sbjct: 195 YRAPE 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 6/64 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YL + RIIHR++K N+LL + I+DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 242 HAPE 245
APE
Sbjct: 181 MAPE 184
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-07
Identities = 16/58 (27%), Positives = 32/58 (55%), Gaps = 3/58 (5%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-05
Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 12/95 (12%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL--DSSKQPDQEFLAQVS-MVSRLKNENVV 124
+G G++G+V + R A+K L ++ + ++++ ++ + NVV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 125 ELVGYY--VDGPLRVLAYEHASKGSLHDILHGKKG 157
L+G GPL V+ E G+L L K+
Sbjct: 90 NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRN 123
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 18/163 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G + +G AIK + K + + + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G V+ E SL D L K S + +A +EY+H K
Sbjct: 76 EGDYNVMVMELLGP-SLED-LFNFCSRK-------FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 192 PRIIHRNIKSSNVLLFDDDIAK---ISDFDLSNQAPDAAARLH 231
IHR++K N L+ I DF L+ + DA H
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-07
Identities = 33/164 (20%), Positives = 59/164 (35%), Gaps = 34/164 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV 131
+G G G+V + + A+K L + +E V + R + ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81
Query: 132 DGPLRVLAY----EHASKGSLHDILHGKKGV----KGAKPGPVLSWAQRVKIAVGAARGL 183
+ E G L + + + A ++ +K A +
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA--------SEIMKSIGEA---I 130
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAP 224
+YLH I HR++K N+L I K++DF A
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AK 168
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 49/185 (26%), Positives = 74/185 (40%), Gaps = 35/185 (18%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V V R+G AIKKL + E A+ + ++ +++ENV+ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGL- 89
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L L ++ +K L + +
Sbjct: 90 -LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQML 138
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL Y+H IIHR++K N+ + +D KI DF L+ QA TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 241 YHAPE 245
Y APE
Sbjct: 191 YRAPE 195
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-07
Identities = 28/162 (17%), Positives = 59/162 (36%), Gaps = 22/162 (13%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN- 120
D++ +G G Y V+ + + + +K L K ++ ++ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90
Query: 121 ENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R A EH + + L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDL 219
+ L+Y H I+HR++K NV++ + ++ D+ L
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 8e-07
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 30/160 (18%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG V R AIKK+ + + + +++++RL +++VV++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV- 117
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ P V + E A + + L+ +
Sbjct: 118 -LDIVIPKDVEKFDELYVVLEIADS-DFKKLF---------RTPVYLTELHIKTLLYNLL 166
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
G++Y+H I+HR++K +N L+ D K+ DF L+
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 36/186 (19%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISL- 126
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + L E +L ++ + L + +
Sbjct: 127 -LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 173
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L+ A + T + T
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTR 227
Query: 240 GYHAPE 245
Y APE
Sbjct: 228 YYRAPE 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 44/186 (23%), Positives = 73/186 (39%), Gaps = 36/186 (19%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGL- 89
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + + E +L ++ + L + +
Sbjct: 90 -LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L A A T + T
Sbjct: 137 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTR 190
Query: 240 GYHAPE 245
Y APE
Sbjct: 191 YYRAPE 196
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 35/187 (18%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-----VSMVSRLKNENVVEL 126
IGEG+YG V + AIKK+ P + + Q + ++ R ++EN++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS----PFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 127 VGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + L+ +L + LS
Sbjct: 91 --NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGT 238
RGL+Y+H A ++HR++K SN+LL KI DF L+ PD T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 239 FGYHAPE 245
Y APE
Sbjct: 195 RWYRAPE 201
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 36/185 (19%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V + RSG AIKKL S+ E A+ + ++ +++ENV+ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGL- 88
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L + L I+ K S + +
Sbjct: 89 -LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------FSEEKIQYLVYQML 136
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H ++HR++K N+ + +D KI DF L+ A TR
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 241 YHAPE 245
Y APE
Sbjct: 189 YRAPE 193
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 41/203 (20%), Positives = 84/203 (41%), Gaps = 35/203 (17%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVS 113
V +++ ++F +IG G++G V V++ + + A+K L +K + + +
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVA--VVKLKNADKVFAMKIL--NKW----EMLKRA 116
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ + E V LV D L Y +L+ ++ G G +L+ +
Sbjct: 117 ETACFREERDV-LV--NGDSKWITTLHYAFQDDNNLYLVMDYYVG------GDLLTLLSK 167
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
++ AR ++ +H+ +HR+IK N+L+ + +++DF +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 223 APDAAARLHSTRVLGTFGYHAPE 245
+ S V GT Y +PE
Sbjct: 225 LMEDGTVQSSVAV-GTPDYISPE 246
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-06
Identities = 37/215 (17%), Positives = 72/215 (33%), Gaps = 46/215 (21%)
Query: 35 VKEAPAKEMKTVT---VQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR 91
VK A A + + AV I D + IG+G +G +Y + S
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---WKVGLPIGQGGFGCIYLADMNSSE 60
Query: 92 AAAIK-----KLDSSKQPDQEF-------LAQVSMVSRLKNENVVELVG----------Y 129
+ K++ S A+ + + ++ +G
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 130 YVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
R + + L I + K+ S +++++ LEY+H
Sbjct: 121 KNGKSYRFMIMDRFGS-DLQKIYEANAKR----------FSRKTVLQLSLRILDILEYIH 169
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLS 220
E +H +IK+SN+LL + ++ D+ L+
Sbjct: 170 EH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-06
Identities = 44/203 (21%), Positives = 85/203 (41%), Gaps = 31/203 (15%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVS 113
V+ + E++ + D+F +IG G++ V ++ +G+ A+K + +K + +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--NKW----DMLKRG 103
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
VS + E V LV D L + + L+ ++ G G +L+ +
Sbjct: 104 EVSCFREERDV-LV--NGDRRWITQLHFAFQDENYLYLVMEYYVG------GDLLTLLSK 154
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+I AR ++ +H +HR+IK N+LL +++DF +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 223 APDAAARLHSTRVLGTFGYHAPE 245
A + S +GT Y +PE
Sbjct: 212 L-RADGTVRSLVAVGTPDYLSPE 233
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 36/167 (21%), Positives = 62/167 (37%), Gaps = 24/167 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK-LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEGS+G ++ G L + + AIK S P + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76
Query: 132 DGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G VL + SL D+L G+K S A ++ +HEK
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHEK 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAK-----ISDFDLSNQAPDAAARLH 231
+ +++R+IK N L+ + + DF + D + H
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 169
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 35/201 (17%), Positives = 70/201 (34%), Gaps = 40/201 (19%)
Query: 44 KTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK--KLDS 100
+ + Q + P V + E + + IG G +G +Y A K++
Sbjct: 16 ENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY 74
Query: 101 SKQP--DQEF-----LAQVSMVSRLKNENVVELVG----------YYVDGPLRVLAYEHA 143
+ E +A+ + + ++ +G + R + E
Sbjct: 75 QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL 134
Query: 144 SKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201
L I +G VL ++ + LEY+HE +H +IK+
Sbjct: 135 GI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIHEN---EYVHGDIKA 179
Query: 202 SNVLLFDDDIAKI--SDFDLS 220
+N+LL + ++ +D+ LS
Sbjct: 180 ANLLLGYKNPDQVYLADYGLS 200
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 11/73 (15%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++ LH +IHR++K SN+L+ + K+ DF L+ ++AA +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 241 --------YHAPE 245
Y APE
Sbjct: 180 VEFVATRWYRAPE 192
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 35/166 (21%), Positives = 61/166 (36%), Gaps = 22/166 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG G++G + G L + AIK + Q L + + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 133 GPLRVLAYEHASKGSLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
G + E SL D+ L + S + IA+ +EY+H K
Sbjct: 77 GKYNAMVLELLGP-SLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHSKN 125
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH 231
+I+R++K N L+ + I DF L+ + D + H
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 4/64 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH + +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 242 HAPE 245
APE
Sbjct: 316 LAPE 319
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 25/66 (37%), Positives = 39/66 (59%), Gaps = 9/66 (13%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 239
L++LH II+R++K N+LL D++ I K++DF LS ++ D + +S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILL-DEEGHI-KLTDFGLSKESIDHEKKAYS--FCGTV 190
Query: 240 GYHAPE 245
Y APE
Sbjct: 191 EYMAPE 196
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 8e-05
Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 242 HAPE 245
APE
Sbjct: 172 LAPE 175
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 21/64 (32%), Positives = 32/64 (50%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 242 HAPE 245
APE
Sbjct: 177 IAPE 180
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 21/64 (32%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH+K II+R++K N++L K++DF L ++ H+ GT Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 242 HAPE 245
APE
Sbjct: 188 MAPE 191
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 40/165 (24%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG VY + + AIKK+ ++ + + +++++RLK++ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL- 90
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----I 175
Y + P + + E A L + L+ + +K +
Sbjct: 91 -YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI---------FLT-EEHIKTILYNL 138
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+G ++HE + IIHR++K +N LL D K+ DF L+
Sbjct: 139 LLG----ENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 18/163 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G +++ AIK ++ K + L + + L+ + + + V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G VL + SL D L K LS + +A +E++H K+
Sbjct: 74 EGDYNVLVMDLLGP-SLED-LFNFCSRK-------LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 192 PRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLH 231
+HR+IK N L+ + I DF L+ + D + H
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 21/64 (32%), Positives = 32/64 (50%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 242 HAPE 245
APE
Sbjct: 220 IAPE 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 21/64 (32%), Positives = 32/64 (50%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH+K II+R++K NVLL + K++DF + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDY 190
Query: 242 HAPE 245
APE
Sbjct: 191 IAPE 194
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 4e-04
Identities = 23/64 (35%), Positives = 36/64 (56%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 242 HAPE 245
APE
Sbjct: 185 IAPE 188
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 4e-04
Identities = 19/64 (29%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLH I++R++K N+LL ++DF L + + + + GT Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 242 HAPE 245
APE
Sbjct: 206 LAPE 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 21/64 (32%), Positives = 31/64 (48%), Gaps = 5/64 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 508
Query: 242 HAPE 245
APE
Sbjct: 509 IAPE 512
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 10/67 (14%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQA-PDAAARLHSTRVLGT 238
LE+LH+ II+R+IK N+LL D + + ++DF LS + D R + GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILL-DSNGHV-VLTDFGLSKEFVADETERAYD--FCGT 223
Query: 239 FGYHAPE 245
Y AP+
Sbjct: 224 IEYMAPD 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.91 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.83 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.62 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.72 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.49 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.87 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.73 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.85 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.17 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.15 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.06 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=313.27 Aligned_cols=168 Identities=26% Similarity=0.359 Sum_probs=150.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|+.+|++|+|||||++++++.+.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 7899999998643 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|||.||+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 112 Ey~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 99999999999986542 899999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+..........+.+||+.|||||
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPE 204 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPE 204 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHH
T ss_pred eecCCCCCcccccCcccCcccCCHH
Confidence 8775443333345678999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=314.70 Aligned_cols=169 Identities=24% Similarity=0.413 Sum_probs=143.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||+||+|++. +++.||||++...... .+.+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999965 7899999999765433 357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|||+||+|.+++...... .+++.+++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 103 Ey~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp ECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred eCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccc
Confidence 999999999999765432 2788999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ ....+||+.|||||
T Consensus 173 ~~~~~~~~~--~~~~~GT~~YmAPE 195 (350)
T 4b9d_A 173 RVLNSTVEL--ARACIGTPYYLSPE 195 (350)
T ss_dssp SCCCHHHHH--HHHHHSCCTTCCHH
T ss_pred eeecCCccc--ccccCCCccccCHH
Confidence 987644322 23468999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=311.82 Aligned_cols=165 Identities=32% Similarity=0.487 Sum_probs=147.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+.|++.+.||+|+||+||+|+++ +++.||||++.... ...+.+.+|+.+|++++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45889999999999999999976 78999999986443 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
+||+|.+++.... +++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999997643 899999999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ..+.+||+.|||||
T Consensus 221 ~~~~~~--~~~~~GTp~YmAPE 240 (346)
T 4fih_A 221 SKEVPR--RKSLVGTPYWMAPE 240 (346)
T ss_dssp CSSSCC--BCCCCSCGGGCCHH
T ss_pred CCCCCc--ccccccCcCcCCHH
Confidence 543322 24578999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=320.84 Aligned_cols=165 Identities=32% Similarity=0.487 Sum_probs=147.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+.|++.+.||+|+||.||+|+++ +++.||||++..... ..+.+.+|+.+|++++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 45899999999999999999975 789999999965443 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.||+|.+++.... +++.++..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999997643 899999999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ..+.+||+.|||||
T Consensus 298 ~~~~~~--~~~~~GTp~YmAPE 317 (423)
T 4fie_A 298 SKEVPR--RKSLVGTPYWMAPE 317 (423)
T ss_dssp CSSCCC--BCCCEECTTTCCHH
T ss_pred CCCCcc--ccccccCcCcCCHH
Confidence 543322 24578999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=300.27 Aligned_cols=167 Identities=28% Similarity=0.434 Sum_probs=138.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.+++.+.+.||+|+||+||+|+++. .||||+++..... .+.|.+|+.++++++|||||++++++. .+.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 4577888999999999999998763 6999998755433 357889999999999999999999875 466899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
||++|+|.+++..... .+++.+++.|+.||+.||.|||+++ ||||||||+|||+++++.+||+|||+|+
T Consensus 112 y~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp CCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred cCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence 9999999999976432 2899999999999999999999997 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..............+||+.|||||
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE 204 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPE 204 (307)
T ss_dssp C------------CCCCTTSCCHH
T ss_pred ecccCCcceeecccccCCCccCHH
Confidence 765433333334568999999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=296.82 Aligned_cols=165 Identities=25% Similarity=0.380 Sum_probs=132.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||+||+|++. +++.||||++.+.. .....+.+|+.++++++|||||++++++.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999965 78999999986543 2245788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+ +|+|.+++..... +++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 92 mEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp EECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred EeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 9999 6799999976542 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+....... ..+.+||+.|||||
T Consensus 159 a~~~~~~~~---~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 159 SNIMTDGNF---LKTSCGSPNYAAPE 181 (275)
T ss_dssp C------------------CTTSCHH
T ss_pred CeecCCCCc---cCCeeECcccCChh
Confidence 987654332 24568999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=303.25 Aligned_cols=177 Identities=23% Similarity=0.415 Sum_probs=145.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
++|.+.+.||+|+||+||+|++. ++..||||+++.... ..++|.+|+.+|++|+|||||++++++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 467899999975432 24679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 139 AYEHASKGSLHDILHGKKGV----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~----~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
|||||++|+|.++|...... ........+++.+++.++.||+.||.|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999764310 00011224999999999999999999999997 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+|+...............||+.|||||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 200 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 200 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHH
Confidence 9999998655443333334457999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=303.38 Aligned_cols=177 Identities=21% Similarity=0.362 Sum_probs=139.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
++|.+.+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|+.+|++|+|||||++++++.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999864 477899999975432 24679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 139 AYEHASKGSLHDILHGKKGVKG------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
|||||++|+|.+++........ ......+++.+++.++.||+.||.|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999986542210 011234899999999999999999999997 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+|+...............||+.|||||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 230 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChh
Confidence 999999998765444333334567999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=299.19 Aligned_cols=177 Identities=27% Similarity=0.373 Sum_probs=147.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
+++++.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.++++++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566788999999999999863 467899999965432 3578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 138 LAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
||||||++|+|.++|........ ......+++.+++.++.||+.||.|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975432110 011234899999999999999999999997 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||+|+..............+||+.|||||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 217 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE 217 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHH
Confidence 99999999998765544333344568999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=301.95 Aligned_cols=165 Identities=27% Similarity=0.333 Sum_probs=140.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.+.|.+.+.||+|+||.||+|+++ +++.||||+++..... .+|+.++++|+|||||++++++.+++.+|||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 355777889999999999999975 7899999999654332 46999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecccCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfGla~~ 222 (245)
+||+|.+++..... +++..+..++.||+.||.|||+++ ||||||||+|||++.+| .+||+|||+|+.
T Consensus 133 ~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp TTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred CCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999986542 899999999999999999999998 99999999999999987 699999999987
Q ss_pred CCccccc---cccccccccccccCCC
Q 025997 223 APDAAAR---LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~---~~~~~~~gt~~y~APE 245 (245)
+...... .....++||+.|||||
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE 226 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPE 226 (336)
T ss_dssp C------------CCCCCCGGGCCHH
T ss_pred ccCCCcccceecCCccccCccccCHH
Confidence 6433211 1223468999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=302.33 Aligned_cols=166 Identities=23% Similarity=0.303 Sum_probs=138.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
++|++.+.||+|+||+||+|+.. +++.||||++.+... ....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999863 467899999865432 23467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|||||+||+|.+++..... +++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 vmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 9999999999999986542 899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+........ ..+.+||+.|||||
T Consensus 172 la~~~~~~~~~--~~~~~GT~~YmAPE 196 (304)
T 3ubd_A 172 LSKESIDHEKK--AYSFCGTVEYMAPE 196 (304)
T ss_dssp EEEC-----CC--CCSCCCCGGGCCHH
T ss_pred cceeccCCCcc--ccccccCcccCCHH
Confidence 99865443322 24568999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=296.44 Aligned_cols=172 Identities=22% Similarity=0.411 Sum_probs=134.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCC-------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP------- 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 134 (245)
.++|++.+.||+|+||+||+|+++ +++.||||++...... .+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356899999999999999999975 7899999998654432 357889999999999999999999987544
Q ss_pred -----ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
++|++||||.+|+|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 3799999999999999998654321 1456678899999999999999998 9999999999999999
Q ss_pred CceEEecccCCCCCCcccccc----------ccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~APE 245 (245)
+.+||+|||+|+......... .....+||+.|||||
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE 200 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence 999999999998765432211 123457999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=292.11 Aligned_cols=163 Identities=28% Similarity=0.406 Sum_probs=138.6
Q ss_pred CCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe----CCceEEEE
Q 025997 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAY 140 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 140 (245)
++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+|++|+|||||+++++|.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55667999999999999975 7889999998644332 3568899999999999999999999875 34589999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGl 219 (245)
|||++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||||+|||++. ++.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcC
Confidence 9999999999998653 2899999999999999999999974 34999999999999985 78999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+...... ..+.+||+.|||||
T Consensus 179 a~~~~~~~----~~~~~GTp~YmAPE 200 (290)
T 3fpq_A 179 ATLKRASF----AKAVIGTPEFMAPE 200 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGG
T ss_pred CEeCCCCc----cCCcccCccccCHH
Confidence 97543321 24568999999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=293.62 Aligned_cols=169 Identities=27% Similarity=0.397 Sum_probs=134.8
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCC----ceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 141 (245)
.+|.+.+.||+|+||+||+|+++ ++.||||++.........+..|+..+.+++|||||++++++.+.+ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 34677889999999999999984 889999999654322223334666677899999999999998654 5799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCeEEcCCCceEEec
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
||++|+|.++++... +++..++.++.|++.||.|||++. .++||||||||+|||++.++++||+|
T Consensus 82 y~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999998653 899999999999999999999861 22499999999999999999999999
Q ss_pred ccCCCCCCccccc--cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
||+|+........ ......+||+.|||||
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE 182 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHH
T ss_pred CCCCccccCCCCceeeecccccccccccCHH
Confidence 9999765332221 1123457999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=292.10 Aligned_cols=186 Identities=20% Similarity=0.328 Sum_probs=151.9
Q ss_pred eHHHHHHhhCCCCCCCeeccCCceEEEEEEECC------CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCC-CCcceEe
Q 025997 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKN-ENVVELV 127 (245)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h-~niv~~~ 127 (245)
+.+++....++|++.+.||+|+||+||+|.+.. ++.||||.+...... .+.+.+|+.+|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 445555567889999999999999999998642 357999999765443 3578999999999976 8999999
Q ss_pred EEEEeC-CceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 025997 128 GYYVDG-PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (245)
Q Consensus 128 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDl 199 (245)
+++... +.++||||||++|+|.++|+...... .......+++.+++.++.||+.||.|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 998764 56899999999999999997643211 0011234899999999999999999999997 999999
Q ss_pred CCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 200 kp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++++.+||+|||+|+.+.............||+.|||||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE 257 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 257 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHH
Confidence 9999999999999999999998775544433345567999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=293.59 Aligned_cols=167 Identities=26% Similarity=0.419 Sum_probs=142.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe------CCc
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD------GPL 135 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 135 (245)
++|++.+.||+|+||+||+|+++ +++.||||++...... .+.+.+|+.+|+.|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 7999999999765443 3467889999999999999999998764 357
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
+|||||||. |+|.+++..... +++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEe
Confidence 899999996 689999976542 899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCcccc--ccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAA--RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~--~~~~~~~~gt~~y~APE 245 (245)
|||+|+.+..... .....+.+||+.|||||
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APE 232 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHH
Confidence 9999987643221 11234578999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=300.05 Aligned_cols=165 Identities=27% Similarity=0.364 Sum_probs=142.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHH---HHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|++.++||+|+||+||+|+++ +++.||||++.+.. .....+.+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 578999999999999999999976 78999999985431 22233333 46677788999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|+||||+.||+|.+++..... +++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecc
Confidence 999999999999999986542 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|+...... ..+.+||+.|||||
T Consensus 336 FGlA~~~~~~~----~~t~~GTp~YmAPE 360 (689)
T 3v5w_A 336 LGLACDFSKKK----PHASVGTHGYMAPE 360 (689)
T ss_dssp CTTCEECSSCC----CCSCCSCGGGCCHH
T ss_pred cceeeecCCCC----CCCccCCcCccCHH
Confidence 99998765432 24568999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=281.69 Aligned_cols=166 Identities=24% Similarity=0.366 Sum_probs=140.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (245)
..+.|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+|+++|+.+ +||||+++++++.+.+.+|+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4578999999999999999999853 46789999986543 445688999999998 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEEecc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDF 217 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl~Df 217 (245)
||||+++|+|.+++.. +++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 98 vmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 98 AMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999842 889999999999999999999998 9999999999999876 89999999
Q ss_pred cCCCCCCccccc--------------------------cccccccccccccCCC
Q 025997 218 DLSNQAPDAAAR--------------------------LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~--------------------------~~~~~~~gt~~y~APE 245 (245)
|+|+........ ......+||+.|||||
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 999754322110 0113357999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=293.56 Aligned_cols=167 Identities=23% Similarity=0.358 Sum_probs=146.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||+|+++ +++.||+|++..... ..+.+.+|+.+|+.|+|||||+++++|.+.+.+|++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999975 789999999865443 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC--CceEEecccCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLS 220 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~--~~vkl~DfGla 220 (245)
|.||+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 236 ~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 236 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp CCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred cCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 999999999965432 2899999999999999999999998 9999999999999854 89999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+...... ...+||+.|||||
T Consensus 305 ~~~~~~~~~---~~~~GT~~y~APE 326 (573)
T 3uto_A 305 AHLDPKQSV---KVTTGTAEFAAPE 326 (573)
T ss_dssp EECCTTSEE---EEECSSGGGCCHH
T ss_pred eEccCCCce---eeeEECccccCHH
Confidence 877543322 3468999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=256.74 Aligned_cols=167 Identities=28% Similarity=0.372 Sum_probs=146.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
..++|.+.+.||+|+||.||+|.+ .+++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999997 58899999998654333 35678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred EECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999976432 889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++....... ....+||+.|+|||
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 161 SNEFTVGGK---LDAFCGAPPYAAPE 183 (328)
T ss_dssp CGGGSSSCG---GGTTSSSGGGCCHH
T ss_pred ceecCCCCc---cccccCCcceeCcc
Confidence 976543322 24567999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=254.90 Aligned_cols=167 Identities=25% Similarity=0.341 Sum_probs=146.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999976 7899999998642 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 999999999999976432 889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....+||+.|||||
T Consensus 152 a~~~~~~~~~--~~~~~gt~~y~aPE 175 (337)
T 1o6l_A 152 CKEGISDGAT--MKTFCGTPEYLAPE 175 (337)
T ss_dssp CBCSCCTTCC--BCCCEECGGGCCGG
T ss_pred hhhcccCCCc--ccccccChhhCChh
Confidence 9864332221 24568999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.12 Aligned_cols=171 Identities=20% Similarity=0.311 Sum_probs=147.6
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
+....++|.+.+.||+|+||.||+|+++ +++.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999976 6889999998542 2233457889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 999999999999999997643 889999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ ...+.+||+.|||||
T Consensus 211 DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE 239 (410)
T 3v8s_A 211 DFGTCMKMNKEGMV-RCDTAVGTPDYISPE 239 (410)
T ss_dssp CCTTCEECCTTSEE-ECCSCCSCGGGCCHH
T ss_pred ccceeEeeccCCcc-cccCCcCCccccCHH
Confidence 99999766443221 224568999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=264.60 Aligned_cols=173 Identities=19% Similarity=0.266 Sum_probs=147.7
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
+....++|++.+.||+|+||+||+|+++ +++.||+|++.+. ......+.+|+.++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3344678999999999999999999976 5788999998542 1223347889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++||||+.+|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999986322 2899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ .....+||+.|||||
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE 246 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPE 246 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChH
Confidence 99999766443222 223468999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.14 Aligned_cols=166 Identities=27% Similarity=0.437 Sum_probs=146.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999995 478999999985433 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp CTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999997643 889999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 166 ~~~~~~~--~~~~~gt~~y~aPE 186 (297)
T 3fxz_A 166 ITPEQSK--RSTMVGTPYWMAPE 186 (297)
T ss_dssp CCSTTCC--BCCCCSCGGGCCHH
T ss_pred cCCcccc--cCCccCCcCccChh
Confidence 6543322 23457999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.82 Aligned_cols=170 Identities=24% Similarity=0.364 Sum_probs=145.8
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
....++|.+.+.||+|+||.||+|+++ +++.||+|++.+. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345788999999999999999999976 6889999998643 23456678899998877 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999976432 899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ ....+||+.|+|||
T Consensus 161 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE 188 (345)
T 1xjd_A 161 DFGMCKENMLGDAK--TNTFCGTPDYIAPE 188 (345)
T ss_dssp CCTTCBCCCCTTCC--BCCCCSCGGGCCHH
T ss_pred EChhhhhcccCCCc--ccCCCCCcccCChh
Confidence 99999865332221 24568999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=256.43 Aligned_cols=168 Identities=24% Similarity=0.349 Sum_probs=141.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (245)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.+. ....+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4678999999999999999999976 6889999998643 22345678899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccc
Confidence 99999999999999976532 899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++....... .....+||+.|||||
T Consensus 169 G~a~~~~~~~~--~~~~~~gt~~y~aPE 194 (353)
T 3txo_A 169 GMCKEGICNGV--TTATFCGTPDYIAPE 194 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHH
T ss_pred cceeecccCCc--cccccCCCcCeEChh
Confidence 99986433222 124568999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=250.09 Aligned_cols=167 Identities=18% Similarity=0.217 Sum_probs=146.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 467899999999999999999976 6889999998766555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC--CCceEEecccCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSN 221 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--~~~vkl~DfGla~ 221 (245)
.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 84 SGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp CCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred CCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 99999999975432 2899999999999999999999998 999999999999987 7899999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....||+.|+|||
T Consensus 153 ~~~~~~~~---~~~~gt~~y~aPE 173 (321)
T 1tki_A 153 QLKPGDNF---RLLFTAPEYYAPE 173 (321)
T ss_dssp ECCTTCEE---EEEESCGGGSCHH
T ss_pred ECCCCCcc---ccccCChhhcCcH
Confidence 76443221 3357999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=253.12 Aligned_cols=166 Identities=27% Similarity=0.400 Sum_probs=145.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-------chHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.+.|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999976 688999999854332 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC----ce
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~----~v 212 (245)
++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCE
T ss_pred EEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCE
Confidence 99999999999999997543 2899999999999999999999998 99999999999998776 79
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++....... ....+||+.|+|||
T Consensus 159 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 188 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188 (361)
T ss_dssp EECCCSSCEECCTTCC---CCCCCSCGGGCCHH
T ss_pred EEEecCCceEcCCCCc---cccCCCCccEECch
Confidence 9999999986654322 23457999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=256.91 Aligned_cols=166 Identities=23% Similarity=0.355 Sum_probs=146.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999965 6889999998542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp ECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 999999999999986532 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++....... ....+||+.|+|||
T Consensus 162 a~~~~~~~~---~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 162 AAMLPRETQ---ITTMAGTKPYMAPE 184 (384)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCGG
T ss_pred eeeccCCCc---eeccCCCccccCCe
Confidence 986643322 24568999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=257.53 Aligned_cols=168 Identities=22% Similarity=0.315 Sum_probs=144.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (245)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.+... ..+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4578999999999999999999976 678899999865322 234578899999887 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 130 lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999976532 899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++....... .....+||+.|||||
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE 223 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPE 223 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHH
T ss_pred ceeeecccCCC--ccccccCCcccCCch
Confidence 99986432222 124568999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=249.61 Aligned_cols=164 Identities=28% Similarity=0.397 Sum_probs=145.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 567999999999999999999975 7899999998543 23456778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 999999999999986542 889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...... ...+||+.|+|||
T Consensus 153 a~~~~~~~-----~~~~gt~~y~aPE 173 (318)
T 1fot_A 153 AKYVPDVT-----YTLCGTPDYIAPE 173 (318)
T ss_dssp CEECSSCB-----CCCCSCTTTCCHH
T ss_pred ceecCCcc-----ccccCCccccCHh
Confidence 97654321 3467999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=250.53 Aligned_cols=175 Identities=39% Similarity=0.644 Sum_probs=150.0
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
...++|.+.+.||+|+||.||+|.+++++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 35688999999999999999999988899999999865543 35678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp CCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred cCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999998654321 123899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...............||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPE 211 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHH
T ss_pred ccccccccccccccCCCccccCHH
Confidence 654332222223456999999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=251.97 Aligned_cols=169 Identities=30% Similarity=0.421 Sum_probs=145.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999976 788999999854432 24568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (323)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccc
Confidence 999999999987543 2899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...............||+.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE 177 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPE 177 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHH
T ss_pred eeccCCcccccCCCccCcCccCcH
Confidence 654333222234567999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=260.96 Aligned_cols=174 Identities=20% Similarity=0.245 Sum_probs=148.1
Q ss_pred HHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCC
Q 025997 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (245)
Q Consensus 60 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 134 (245)
+.....++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ...+.+.+|..++..++|+||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33345678999999999999999999975 78999999985422 12235788999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..|+||||+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence 99999999999999999976431 2899999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++........ .....+||+.|||||
T Consensus 204 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE 233 (412)
T 2vd5_A 204 ADFGSCLKLRADGTV-RSLVAVGTPDYLSPE 233 (412)
T ss_dssp CCCTTCEECCTTSCE-ECSSCCSCGGGCCHH
T ss_pred eechhheeccCCCcc-ccceeccccCcCCHH
Confidence 999999766443221 123468999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=245.89 Aligned_cols=170 Identities=26% Similarity=0.449 Sum_probs=144.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999975 68899999885433 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp CTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 999999999987432 2899999999999999999999998 99999999999999999999999999976
Q ss_pred CCcccccc------------ccccccccccccCCC
Q 025997 223 APDAAARL------------HSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~------------~~~~~~gt~~y~APE 245 (245)
........ ......||+.|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHH
T ss_pred cccccccccccccccccccccccccCCCcceeCHH
Confidence 54332211 011457999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=252.26 Aligned_cols=167 Identities=32% Similarity=0.411 Sum_probs=143.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCC----ceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|++. ++.||||++............|+.++++++||||+++++++.... .+++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 457899999999999999999876 789999999765444556667899999999999999999998754 369999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCeEecCCCCCCeEEcCCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK----------AEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------~~~~ivHrDlkp~Nill~~~~ 210 (245)
||+++|+|.+++.... +++..++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 102 e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred ecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence 9999999999997643 89999999999999999999998 7 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||+++...............||+.|+|||
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE 203 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHH
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHh
Confidence 99999999997654433222233457999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.88 Aligned_cols=186 Identities=35% Similarity=0.640 Sum_probs=156.3
Q ss_pred ceeeHHHHHHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEE
Q 025997 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV 131 (245)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 131 (245)
..++..++....++|.+.+.||+|+||.||+|...+++.||||++..... ....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45667788888999999999999999999999988899999999865432 2346889999999999999999999999
Q ss_pred eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
+.+..++||||+.+|+|.+++...... ...+++..+..++.|++.||.|||++..++|+||||||+|||++.++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred cCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999875432 123899999999999999999999991112999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++......... .....||+.|+|||
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE 205 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPE 205 (326)
T ss_dssp EEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHH
T ss_pred EEeccCccccccCcccccc-cccccCCcCccCHH
Confidence 9999999997654332221 23456999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=241.81 Aligned_cols=169 Identities=23% Similarity=0.442 Sum_probs=149.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|+.++++++||||+++++++.+.+..+++|||+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35788899999999999999999888999999998777777889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999976543 2889999999999999999999998 9999999999999999999999999997654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......||+.|+|||
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE 177 (269)
T 4hcu_A 158 DDQYT-SSTGTKFPVKWASPE 177 (269)
T ss_dssp CHHHH-STTSTTCCGGGCCHH
T ss_pred ccccc-cccCcccccccCCHH
Confidence 43222 123345788999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=252.46 Aligned_cols=166 Identities=23% Similarity=0.288 Sum_probs=139.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||.||+++.. +++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999976 7899999999776666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc--eEEecccCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISDFDLSN 221 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~--vkl~DfGla~ 221 (245)
.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 99 ~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 99 SGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp CSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 99999999875432 899999999999999999999998 999999999999987765 9999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 167 ~~~~~~~---~~~~~gt~~y~aPE 187 (361)
T 3uc3_A 167 SSVLHSQ---PKSTVGTPAYIAPE 187 (361)
T ss_dssp -----------------CTTSCHH
T ss_pred cccccCC---CCCCcCCCCcCChh
Confidence 5432221 13457999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=250.53 Aligned_cols=167 Identities=23% Similarity=0.320 Sum_probs=144.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... .+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467899999999999999999976 6889999998654322 34577899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999976432 899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++....... .....+||+.|+|||
T Consensus 156 ~a~~~~~~~~--~~~~~~gt~~y~aPE 180 (345)
T 3a8x_A 156 MCKEGLRPGD--TTSTFCGTPNYIAPE 180 (345)
T ss_dssp GCBCSCCTTC--CBCCCCSCGGGCCHH
T ss_pred ccccccCCCC--cccccCCCccccCcc
Confidence 9976432221 124568999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=251.73 Aligned_cols=164 Identities=24% Similarity=0.308 Sum_probs=145.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999976 7899999998543 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 999999999999976432 889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...... ...+||+.|+|||
T Consensus 188 a~~~~~~~-----~~~~gt~~y~aPE 208 (350)
T 1rdq_E 188 AKRVKGRT-----WTLCGTPEALAPE 208 (350)
T ss_dssp CEECSSCB-----CCCEECGGGCCHH
T ss_pred ceeccCCc-----ccccCCccccCHH
Confidence 98664322 3467999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=251.12 Aligned_cols=178 Identities=25% Similarity=0.415 Sum_probs=145.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
.++|.+.+.||+|+||.||+|++. ++..||||++...... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 3457999999765332 35688999999999 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
+..|+||||+.+|+|.+++....... ...+...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999998654210 0011234889999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............||+.|||||
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 275 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 275 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence 999999999999998654433222223346789999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=245.07 Aligned_cols=167 Identities=26% Similarity=0.393 Sum_probs=142.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||+|...+++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4779999999999999999999988999999998654332 3678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+ +|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 100 FMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence 9985 88888876542 2889999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....||+.|+|||
T Consensus 168 ~~~~~~~~--~~~~~~t~~y~aPE 189 (311)
T 3niz_A 168 AFGIPVRS--YTHEVVTLWYRAPD 189 (311)
T ss_dssp ETTSCCC-----CCCCCCTTCCHH
T ss_pred ecCCCccc--ccCCcccCCcCCHH
Confidence 65433221 13357899999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=243.57 Aligned_cols=168 Identities=23% Similarity=0.356 Sum_probs=140.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|++. +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999965 7889999988543322 35678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999976532 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ......||+.|+|||
T Consensus 158 ~~~~~~~~~~-~~~~~~gt~~y~aPE 182 (294)
T 4eqm_A 158 AKALSETSLT-QTNHVLGTVQYFSPE 182 (294)
T ss_dssp STTC--------------CCSSCCHH
T ss_pred cccccccccc-ccCccccCccccCHh
Confidence 9876543222 123457999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.94 Aligned_cols=172 Identities=22% Similarity=0.408 Sum_probs=141.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCC-------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------- 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 134 (245)
.++|++.+.||+|+||.||+|+++ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457889999999999999999976 78999999986433 23567899999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEEecCCCCHHHHHhcCCCCCCCCCC
Q 025997 135 --------------------------------------------------LRVLAYEHASKGSLHDILHGKKGVKGAKPG 164 (245)
Q Consensus 135 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 164 (245)
..+++|||+.+++|.+++.......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~----- 159 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE----- 159 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG-----
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc-----
Confidence 3799999999999999998754321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccc----------ccccc
Q 025997 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR----------LHSTR 234 (245)
Q Consensus 165 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~----------~~~~~ 234 (245)
...+..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .....
T Consensus 160 -~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 160 -DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp -GSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred -chhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 2566778999999999999999998 999999999999999999999999999866543211 11233
Q ss_pred ccccccccCCC
Q 025997 235 VLGTFGYHAPE 245 (245)
Q Consensus 235 ~~gt~~y~APE 245 (245)
..||+.|+|||
T Consensus 236 ~~gt~~y~aPE 246 (332)
T 3qd2_B 236 QVGTKLYMSPE 246 (332)
T ss_dssp CC-CGGGSCHH
T ss_pred cCCCcCccChH
Confidence 57999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=251.00 Aligned_cols=169 Identities=23% Similarity=0.286 Sum_probs=145.6
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCce
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (245)
...++|.+.+.||+|+||.||+|+.. +++.||+|++.+. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 35678999999999999999999976 5788999998643 23456778899999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|+||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999976432 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++....... .....+||+.|||||
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE 191 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPE 191 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHH
T ss_pred CCcccccccCCc--ccccccCCccccChh
Confidence 999986432221 124568999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.41 Aligned_cols=167 Identities=25% Similarity=0.362 Sum_probs=136.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEE----CCCcEEEEEEcCCCC-----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999996 478899999987543 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 999999999999999997643 2788999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ .....||+.|+|||
T Consensus 164 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE 191 (327)
T 3a62_A 164 DFGLCKESIHDGTV--THTFCGTIEYMAPE 191 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHH
T ss_pred eCCcccccccCCcc--ccccCCCcCccCHh
Confidence 99998764332221 23457999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=243.28 Aligned_cols=163 Identities=32% Similarity=0.458 Sum_probs=143.0
Q ss_pred CCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+.+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 556678999999999999976 78999999986543 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 127 ~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 127 GALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp CBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 99999987532 899999999999999999999998 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... .....||+.|+|||
T Consensus 194 ~~~~--~~~~~gt~~y~aPE 211 (321)
T 2c30_A 194 DVPK--RKSLVGTPYWMAPE 211 (321)
T ss_dssp SSCC--BCCCCSCGGGCCHH
T ss_pred Cccc--cccccCCccccCHh
Confidence 3221 23457999999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=245.59 Aligned_cols=165 Identities=25% Similarity=0.389 Sum_probs=143.9
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-------chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
+.|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888999999999999999976 688999998854321 3567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC----ceE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAK 213 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~----~vk 213 (245)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 91 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEE
T ss_pred EEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEE
Confidence 9999999999999997543 2899999999999999999999998 99999999999998877 899
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++....... .....||+.|+|||
T Consensus 159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 187 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPE 187 (326)
T ss_dssp ECCCTTCEECCTTSC---CCCCCSCTTTCCHH
T ss_pred EEECCCCeECCCCCc---cccccCCcCcCCce
Confidence 999999976643222 13457999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.41 Aligned_cols=173 Identities=21% Similarity=0.223 Sum_probs=142.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEE------ECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC---CCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGV------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||.||+|. ..+++.||+|++... ...++..|+.+++.++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 34668888999999999999994 446889999998643 4567788888888886 899999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC------
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD------ 208 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~------ 208 (245)
..++||||+.+|+|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred CcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 999999999999999999753211 0123899999999999999999999998 999999999999998
Q ss_pred -----CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 -----DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 -----~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.+||+|||+|+..............+||+.|||||
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 255 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHH
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChH
Confidence 8999999999996543222222234567999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=243.85 Aligned_cols=166 Identities=31% Similarity=0.443 Sum_probs=138.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---------------------------chHHHHHHHHHHH
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------------------------PDQEFLAQVSMVS 116 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~ 116 (245)
.++|.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 578999999999999999999965 688999999854321 1246889999999
Q ss_pred ccCCCCcceEeEEEEe--CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 025997 117 RLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (245)
Q Consensus 117 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 194 (245)
+++||||+++++++.+ .+..++||||+.+++|.+++... .+++..+..++.||+.||.|||+++ |
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQK---I 158 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 9999999999999986 56789999999999998765332 2899999999999999999999998 9
Q ss_pred EecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 195 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 195 vHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||||||+|||++.++.+||+|||+++........ .....||+.|+|||
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPE 207 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGG
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChh
Confidence 99999999999999999999999999766543222 13457999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=248.02 Aligned_cols=165 Identities=26% Similarity=0.381 Sum_probs=144.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57899999999999999999996 47889999998532 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+ +|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 88 ~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred EECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecc
Confidence 9999 6799998875432 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+......... ...+||+.|+|||
T Consensus 155 s~~~~~~~~~---~~~~gt~~y~aPE 177 (336)
T 3h4j_B 155 SNIMTDGNFL---KTSCGSPNYAAPE 177 (336)
T ss_dssp TBTTTTSBTT---CCCTTSTTTSCGG
T ss_pred ceeccCCccc---ccccCCcCcCCHH
Confidence 9876543322 3457999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=248.64 Aligned_cols=166 Identities=25% Similarity=0.412 Sum_probs=144.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999975 6889999998655433 356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---CceEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~~vkl~Df 217 (245)
||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 108 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp CCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeec
Confidence 9999999999997643 2899999999999999999999998 9999999999999865 45999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++........ .....||+.|+|||
T Consensus 176 G~a~~~~~~~~---~~~~~gt~~y~aPE 200 (362)
T 2bdw_A 176 GLAIEVNDSEA---WHGFAGTPGYLSPE 200 (362)
T ss_dssp TTCBCCTTCCS---CCCSCSCTTTCCHH
T ss_pred CcceEecCCcc---cccCCCCccccCHH
Confidence 99987654322 13457999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=238.76 Aligned_cols=170 Identities=22% Similarity=0.331 Sum_probs=149.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..++|.+.+.||+|+||.||+|...++..||+|++.......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34678899999999999999999988889999999877777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 86 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp TTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999976432 2889999999999999999999998 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....+|+.|+|||
T Consensus 155 ~~~~~~~-~~~~~~~~~y~aPE 175 (268)
T 3sxs_A 155 LDDQYVS-SVGTKFPVKWSAPE 175 (268)
T ss_dssp CTTCEEE-CCSCCCCGGGCCHH
T ss_pred chhhhhc-ccCCCcCcccCCHH
Confidence 4432221 12345778899998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=240.42 Aligned_cols=166 Identities=21% Similarity=0.363 Sum_probs=141.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999975 6889999998654332 3678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+ +|.+.+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9986 66666654322 2899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....||+.|+|||
T Consensus 150 ~~~~~~~~--~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 150 AFGIPVRC--YSAEVVTLWYRPPD 171 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHH
T ss_pred ecCCcccc--ccCCccccCCcChH
Confidence 65433221 23457899999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=252.94 Aligned_cols=167 Identities=22% Similarity=0.329 Sum_probs=136.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHH-HHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999976 67899999986432 223455667666 577899999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 117 v~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence 9999999999999976432 888999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++....... .....+||+.|||||
T Consensus 185 ~a~~~~~~~~--~~~~~~gt~~y~aPE 209 (373)
T 2r5t_A 185 LCKENIEHNS--TTSTFCGTPEYLAPE 209 (373)
T ss_dssp BCGGGBCCCC--CCCSBSCCCCCCCHH
T ss_pred cccccccCCC--ccccccCCccccCHH
Confidence 9975332221 224568999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=253.97 Aligned_cols=167 Identities=22% Similarity=0.308 Sum_probs=143.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|... +++.+|+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467999999999999999999965 7889999998665433 356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc---CCCceEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~---~~~~vkl~Df 217 (245)
||+.+|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 90 E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 90 DLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp CCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccC
Confidence 99999999999986542 899999999999999999999998 99999999999998 4578999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++........ .....||+.|||||
T Consensus 158 G~a~~~~~~~~~--~~~~~gt~~Y~APE 183 (444)
T 3soa_A 158 GLAIEVEGEQQA--WFGFAGTPGYLSPE 183 (444)
T ss_dssp SSCBCCCTTCCB--CCCSCSCGGGCCHH
T ss_pred ceeEEecCCCce--eecccCCcccCCHH
Confidence 999876543322 13457999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=240.15 Aligned_cols=169 Identities=24% Similarity=0.385 Sum_probs=146.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|.+.++..||+|++.......+.+.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 45788899999999999999999988899999998777777889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 103 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp TCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999976332 2899999999999999999999998 9999999999999999999999999997654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......+|+.|+|||
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE 191 (283)
T 3gen_A 172 DDEYT-SSVGSKFPVRWSPPE 191 (283)
T ss_dssp CHHHH-STTSTTSCGGGCCHH
T ss_pred ccccc-cccCCccCcccCCHH
Confidence 43222 122345788999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=260.20 Aligned_cols=168 Identities=27% Similarity=0.395 Sum_probs=146.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999975 7899999998542 23456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 263 mEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence 9999999999999765321 2889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ...+||+.|||||
T Consensus 333 a~~~~~~~~~---~~~~GT~~Y~APE 355 (576)
T 2acx_A 333 AVHVPEGQTI---KGRVGTVGYMAPE 355 (576)
T ss_dssp CEECCTTCCE---ECCCSCGGGCCHH
T ss_pred ceecccCccc---cccCCCccccCHH
Confidence 9876543221 3458999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=241.80 Aligned_cols=166 Identities=27% Similarity=0.435 Sum_probs=140.5
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|.+.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578899999999999999999988999999998654332 36788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+ +|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 986 99999876432 2889999999999999999999998 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE 170 (288)
T 1ob3_A 150 FGIPVRK--YTHEIVTLWYRAPD 170 (288)
T ss_dssp HCC-----------CCCTTCCHH
T ss_pred cCccccc--cccccccccccCch
Confidence 4322111 13346899999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=246.07 Aligned_cols=170 Identities=25% Similarity=0.356 Sum_probs=143.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC------CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
+.|++.+.||+|+||.||+|..+ +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46899999999999999999965 7899999988421 2245778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc---eEEe
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKIS 215 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~---vkl~ 215 (245)
||||+.+++|.+.+...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 104 v~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence 99999999998887643211 113789999999999999999999998 999999999999986654 9999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ ....+||+.|+|||
T Consensus 176 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE 203 (351)
T 3c0i_A 176 GFGVAIQLGESGLV--AGGRVGTPHFMAPE 203 (351)
T ss_dssp CCTTCEECCTTSCB--CCCCCSCGGGCCHH
T ss_pred cCcceeEecCCCee--ecCCcCCcCccCHH
Confidence 99999766543221 23457999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=253.64 Aligned_cols=164 Identities=22% Similarity=0.330 Sum_probs=131.5
Q ss_pred hCCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHc-cCCCCcceEeEEEEe----CCceE
Q 025997 65 TDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSR-LKNENVVELVGYYVD----GPLRV 137 (245)
Q Consensus 65 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~ 137 (245)
.++|.+. +.||+|+||.||+|.+. +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ...+|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 4567665 68999999999999975 788999999853 3567788888744 589999999999875 56789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl 214 (245)
+||||+.+|+|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEE
Confidence 999999999999999865321 2899999999999999999999998 999999999999997 789999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++....... ....+||+.|+|||
T Consensus 206 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 233 (400)
T 1nxk_A 206 TDFGFAKETTSHNS---LTTPCYTPYYVAPE 233 (400)
T ss_dssp CCCTTCEECC--------------CTTCCGG
T ss_pred EecccccccCCCCc---cccCCCCCCccCHh
Confidence 99999986543322 23457999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=242.81 Aligned_cols=170 Identities=28% Similarity=0.473 Sum_probs=141.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|.+.+.||+|+||.||+|.+. .+..||||++...... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888999999999999999974 3446999999764333 4578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 128 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence 9999999999999975432 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCcccccc-ccccccccccccCCC
Q 025997 219 LSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
+++......... ......+|+.|+|||
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE 224 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPE 224 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHH
T ss_pred cccccccCccceeeccCCCCcccccCHh
Confidence 998664432211 112234688899998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.58 Aligned_cols=167 Identities=25% Similarity=0.338 Sum_probs=136.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999965 7889999998532 22345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 227 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp ECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence 999999999999976442 8999999999999999999998 87 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++........ ....+||+.|||||
T Consensus 295 ~a~~~~~~~~~--~~~~~gt~~y~aPE 319 (446)
T 4ejn_A 295 LCKEGIKDGAT--MKTFCGTPEYLAPE 319 (446)
T ss_dssp CCCTTCC-------CCSSSCGGGCCHH
T ss_pred CceeccCCCcc--cccccCCccccCHh
Confidence 99865433222 24568999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.70 Aligned_cols=171 Identities=25% Similarity=0.432 Sum_probs=144.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..++|.+.+.||+|+||.||+|.+. +++.||||.+...... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3456888899999999999999976 7889999998754322 246788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 192 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 99999999999975432 2889999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+...............+|+.|+|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE 285 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPE 285 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHH
T ss_pred eecCCCceeecCCCCCCCcCcCCHh
Confidence 7654332221112234678899998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=255.30 Aligned_cols=166 Identities=25% Similarity=0.375 Sum_probs=146.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999976 78999999985432 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccc
Confidence 99999999999997543 2899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++....... ....+||+.|+|||
T Consensus 163 a~~~~~~~~---~~~~~gt~~y~aPE 185 (476)
T 2y94_A 163 SNMMSDGEF---LRTSCGSPNYAAPE 185 (476)
T ss_dssp CEECCTTCC---BCCCCSCSTTCCHH
T ss_pred hhhcccccc---ccccCCCcCeEChh
Confidence 976644322 23457999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=235.10 Aligned_cols=183 Identities=41% Similarity=0.634 Sum_probs=153.8
Q ss_pred cceeeHHHHHHhhCCCCCC------CeeccCCceEEEEEEECCCcEEEEEEcCCCC-----CchHHHHHHHHHHHccCCC
Q 025997 53 VPVISVDELKEKTDNFGTN------SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNE 121 (245)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~ 121 (245)
.+.++..++...+++|... +.||+|+||.||+|.. +++.||+|++.... ...+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4556777888888887766 8999999999999987 47899999986432 2246788999999999999
Q ss_pred CcceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
||+++++++.+.+..+++|||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp 161 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 9999999999999999999999999999999753211 13889999999999999999999998 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+++.++.+||+|||+++...............||+.|+|||
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE 205 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHH
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChH
Confidence 99999999999999999987654332222234457999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=254.30 Aligned_cols=160 Identities=21% Similarity=0.218 Sum_probs=133.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC---------chHHHHHHHHHHHccC---------CCCcceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLK---------NENVVEL 126 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------h~niv~~ 126 (245)
.++|.+.+.||+|+||.||+|++ +++.||||++..... ..+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45689999999999999999998 679999999864421 2367889999988886 7777777
Q ss_pred eEEEE------------------------------eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHH
Q 025997 127 VGYYV------------------------------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176 (245)
Q Consensus 127 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~ 176 (245)
.+.+. ..+..++||||+.+|++.+.+... .+++..++.++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence 76643 267899999999999776666432 28999999999
Q ss_pred HHHHHHHHHHh-cCCCCCeEecCCCCCCeEEcCCC--------------------ceEEecccCCCCCCccccccccccc
Q 025997 177 VGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD--------------------IAKISDFDLSNQAPDAAARLHSTRV 235 (245)
Q Consensus 177 ~~i~~~l~~lH-~~~~~~ivHrDlkp~Nill~~~~--------------------~vkl~DfGla~~~~~~~~~~~~~~~ 235 (245)
.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~ 237 (336)
T 2vuw_A 168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence 99999999999 887 99999999999999887 999999999976532 234
Q ss_pred cccccccCCC
Q 025997 236 LGTFGYHAPE 245 (245)
Q Consensus 236 ~gt~~y~APE 245 (245)
+||+.|||||
T Consensus 238 ~gt~~y~aPE 247 (336)
T 2vuw_A 238 VFCDVSMDED 247 (336)
T ss_dssp ECCCCTTCSG
T ss_pred EEeecccChh
Confidence 7999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=253.46 Aligned_cols=168 Identities=25% Similarity=0.370 Sum_probs=130.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC-----Cc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (245)
.++|.+.+.||+|+||.||+|++. +++.||||++...... .+.+.+|+.+|++++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999965 7889999998654333 35688999999999999999999998543 56
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccc-cchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 899999985 69999997643 2899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccc-------------------------cccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAAR-------------------------LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~-------------------------~~~~~~~gt~~y~APE 245 (245)
|||+++........ ......+||+.|||||
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 99999875422110 0123457899999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=255.81 Aligned_cols=170 Identities=26% Similarity=0.412 Sum_probs=147.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||.||+|.+. ++..||||.+.......+.+.+|+.+|++++||||+++++++...+..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 456778889999999999999976 4789999999877777888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 299 ~~g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 299 TYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp TTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999864322 2889999999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......+|+.|+|||
T Consensus 369 ~~~~~~-~~~~~~~~~~y~aPE 389 (495)
T 1opk_A 369 TGDTYT-AHAGAKFPIKWTAPE 389 (495)
T ss_dssp TTCCEE-CCTTCCCCGGGCCHH
T ss_pred cCCcee-ecCCCcCCcceeCHh
Confidence 433222 112335678999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=256.74 Aligned_cols=171 Identities=25% Similarity=0.369 Sum_probs=147.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|+.+ +++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 7899999998543 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.||+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 264 mE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecce
Confidence 9999999999999764321 123899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....+||+.|||||
T Consensus 336 a~~~~~~~~~--~~~~~GT~~Y~APE 359 (543)
T 3c4z_A 336 AVELKAGQTK--TKGYAGTPGFMAPE 359 (543)
T ss_dssp CEECCTTCCC--BCCCCSCTTTSCHH
T ss_pred eeeccCCCcc--cccccCCccccChh
Confidence 9866443221 23458999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=246.80 Aligned_cols=167 Identities=25% Similarity=0.338 Sum_probs=144.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 788999999865432 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC--CCceEEecccCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLS 220 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--~~~vkl~DfGla 220 (245)
+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++
T Consensus 130 ~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 130 LSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp CCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccc
Confidence 999999999875432 2899999999999999999999998 999999999999974 478999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ ....||+.|+|||
T Consensus 199 ~~~~~~~~~---~~~~gt~~y~aPE 220 (387)
T 1kob_A 199 TKLNPDEIV---KVTTATAEFAAPE 220 (387)
T ss_dssp EECCTTSCE---EEECSSGGGCCHH
T ss_pred eecCCCcce---eeeccCCCccCch
Confidence 866443221 2347999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=254.54 Aligned_cols=170 Identities=21% Similarity=0.402 Sum_probs=146.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
..++|.+.+.||+|+||.||+|.+.++..||||++.......+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 34567888899999999999999988889999999877667889999999999999999999999985 66789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 265 ~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp TTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999754221 2788899999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....+|+.|+|||
T Consensus 335 ~~~~~~~-~~~~~~~~~y~aPE 355 (454)
T 1qcf_A 335 EDNEYTA-REGAKFPIKWTAPE 355 (454)
T ss_dssp CCHHHHT-TCSSSSCGGGSCHH
T ss_pred CCCceec-cCCCcccccccCHH
Confidence 4432211 12335788999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.59 Aligned_cols=170 Identities=24% Similarity=0.431 Sum_probs=133.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|.+.+.||+|+||.||+|++. ++..||||.+...... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 5678999999765432 3578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence 9999999999999976532 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCcccccc-ccccccccccccCCC
Q 025997 219 LSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
+++......... ......+|+.|+|||
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE 220 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPE 220 (373)
T ss_dssp ---------------------CTTSCHH
T ss_pred cccccccCCccceeccCCCcCCCccChh
Confidence 998765432211 111224578899998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=239.83 Aligned_cols=168 Identities=23% Similarity=0.376 Sum_probs=143.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCC--ceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 140 (245)
++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999976 68899999986533 33567889999999999999999999998665 789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----cCCCceEEec
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISD 216 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill----~~~~~vkl~D 216 (245)
||+.+++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 89 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp ECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred eCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEcc
Confidence 999999999999865321 12889999999999999999999998 9999999999999 7788899999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++........ ....||+.|+|||
T Consensus 160 fg~a~~~~~~~~~---~~~~gt~~y~aPE 185 (319)
T 4euu_A 160 FGAARELEDDEQF---VSLYGTEEYLHPD 185 (319)
T ss_dssp CTTCEECCTTCCB---CCCCSCGGGCCHH
T ss_pred CCCceecCCCCce---eecccCCCccCHH
Confidence 9999766543322 3457999999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.19 Aligned_cols=166 Identities=19% Similarity=0.351 Sum_probs=139.3
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccC--CCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 140 (245)
.+|.+.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.++++++ |+||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999888999999998654433 356889999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
| +.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 136 E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp E-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred e-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9 567899999986542 788899999999999999999998 99999999999995 588999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..............+||+.|||||
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE 226 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPE 226 (390)
T ss_dssp CCC---------CCSCCCGGGCCHH
T ss_pred ccccCCCccccCCCCCcCCCccChH
Confidence 8775443322234567999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=243.11 Aligned_cols=167 Identities=20% Similarity=0.350 Sum_probs=139.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCC--CCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 139 (245)
.+.|.+.+.||+|+||.||++...+++.||||++...... .+.+.+|+.++++++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568999999999999999999888999999998655443 2567899999999987 9999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|| +.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 88 ~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EC-CCSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred Ee-CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccc
Confidence 99 567899999987542 889999999999999999999998 99999999999997 67899999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++..............+||+.|+|||
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE 179 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPE 179 (343)
T ss_dssp SCCC------------CCCCSSCCHH
T ss_pred ccccCcccccccCCCCcCCcCcCCHH
Confidence 98775443332234567999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=245.34 Aligned_cols=179 Identities=28% Similarity=0.413 Sum_probs=147.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 132 (245)
..++|.+.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999853 2357999998765433 35688999999999 99999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nil 205 (245)
.+..++||||+.+|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998654211 0011234899999999999999999999998 999999999999
Q ss_pred EcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 206 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.++.+||+|||+++...............||+.|+|||
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 263 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHH
Confidence 9999999999999998765433322233456889999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=243.46 Aligned_cols=180 Identities=26% Similarity=0.383 Sum_probs=146.0
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCC
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 134 (245)
...++|.+.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999974 3478999999765433 356889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDl 199 (245)
..++||||+.+++|.+++........ ......+++.+++.++.||+.||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999986431100 000134899999999999999999999998 999999
Q ss_pred CCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 200 kp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||++.++.+||+|||+++...............||+.|+|||
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence 9999999999999999999987554332222223456899999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.47 Aligned_cols=168 Identities=28% Similarity=0.422 Sum_probs=140.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC-----Cc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999965 6889999999754333 35788999999999999999999998766 56
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEc
Confidence 899999987 59999997643 2899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccc--------------------cccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAAR--------------------LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~--------------------~~~~~~~gt~~y~APE 245 (245)
|||+++........ ......+||+.|+|||
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 99999866433211 1124567999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=244.16 Aligned_cols=165 Identities=28% Similarity=0.387 Sum_probs=129.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 467899999999999999999976 67899999986543 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEEecccCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLS 220 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl~DfGla 220 (245)
.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 131 ~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 131 TGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp CSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999997643 2889999999999999999999998 999999999999975 889999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+....... .....||+.|+|||
T Consensus 199 ~~~~~~~~---~~~~~gt~~y~aPE 220 (349)
T 2w4o_A 199 KIVEHQVL---MKTVCGTPGYCAPE 220 (349)
T ss_dssp -----------------CGGGSCHH
T ss_pred cccCcccc---cccccCCCCccCHH
Confidence 86643321 13457999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=238.23 Aligned_cols=172 Identities=23% Similarity=0.352 Sum_probs=130.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999965 68899999885433 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+. ++|.+++....... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~-~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp CCC-CBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred ecC-CCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence 998 59999887542111 1123889999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....||+.|+|||
T Consensus 157 ~~~~~~~~--~~~~~~t~~y~aPE 178 (317)
T 2pmi_A 157 AFGIPVNT--FSSEVVTLWYRAPD 178 (317)
T ss_dssp ETTSCCCC--CCCCCSCCTTCCHH
T ss_pred ecCCCccc--CCCCcccccccCch
Confidence 65432221 13457899999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=244.25 Aligned_cols=167 Identities=23% Similarity=0.361 Sum_probs=144.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---------chHHHHHHHHHHHccCCCCcceEeEEEEeC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 133 (245)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567999999999999999999965 788999999865432 223567899999999999999999999999
Q ss_pred CceEEEEEecCCC-CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 134 PLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 134 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
+..++||||+.+| +|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcE
Confidence 9999999999776 99999986542 899999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++........ ....||+.|+|||
T Consensus 170 kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE 199 (335)
T 3dls_A 170 KLIDFGSAAYLERGKLF---YTFCGTIEYCAPE 199 (335)
T ss_dssp EECCCTTCEECCTTCCB---CEECSCGGGCCHH
T ss_pred EEeecccceECCCCCce---eccCCCccccChh
Confidence 99999999766443221 3457999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.62 Aligned_cols=165 Identities=27% Similarity=0.297 Sum_probs=137.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch---HHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||+||+|+.. +++.||||++....... .....|+..+.++ +|+||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56899999999999999999976 78999999986554332 3445566655555 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 137 e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp ECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred ecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceee
Confidence 999 6699998876432 2899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ .....||+.|+|||
T Consensus 205 ~~~~~~~~---~~~~~gt~~y~aPE 226 (311)
T 3p1a_A 205 VELGTAGA---GEVQEGDPRYMAPE 226 (311)
T ss_dssp EECC---------CCCCCGGGCCGG
T ss_pred eecccCCC---CcccCCCccccCHh
Confidence 76644322 23456999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=242.20 Aligned_cols=169 Identities=21% Similarity=0.370 Sum_probs=135.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCc----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPL---- 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 135 (245)
.++|++.+.||+|+||.||+|++ .+++.||||++...... ...+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 47889999999765433 2467889999999999999999999876543
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 158 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 158 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEEC
T ss_pred cEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEe
Confidence 499999999999999997643 2899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccc-cccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
|||+++........ .......||+.|+|||
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 189 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189 (311)
T ss_dssp CCSCC------------------CCTTCCHH
T ss_pred eccCcccccccccccccccccCcCcccCCHH
Confidence 99999866443221 1123356999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=237.99 Aligned_cols=172 Identities=32% Similarity=0.468 Sum_probs=136.8
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCch---HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..++|.+.+.||+|+||.||+|.. +++.||||++....... +.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788999999999999999987 47889999987655433 46889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++...... ..+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||++
T Consensus 114 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp ECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999764311 12788999999999999999999984 23999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+....... ......||+.|+|||
T Consensus 187 ~~~~~~~~--~~~~~~gt~~y~aPE 209 (309)
T 3p86_A 187 RLKASTFL--SSKSAAGTPEWMAPE 209 (309)
T ss_dssp -----------------CCTTSCHH
T ss_pred cccccccc--ccccCCCCccccChh
Confidence 75543221 123457999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=247.80 Aligned_cols=176 Identities=25% Similarity=0.381 Sum_probs=143.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999943 4668999999654333 34688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC---ceE
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~---~vk 213 (245)
++||||+.+|+|.+++....... .....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999998654211 11224899999999999999999999998 99999999999999554 599
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++...............||+.|+|||
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE 256 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHH
Confidence 99999987543222222223456899999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=245.94 Aligned_cols=185 Identities=21% Similarity=0.329 Sum_probs=148.7
Q ss_pred HHHHHHhhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeE
Q 025997 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVG 128 (245)
Q Consensus 58 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~ 128 (245)
...+....++|.+.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3445556788999999999999999999842 4578999999765433 35688999999999 7899999999
Q ss_pred EEEeCC-ceEEEEEecCCCCHHHHHhcCCCCCC-----------------------------------------------
Q 025997 129 YYVDGP-LRVLAYEHASKGSLHDILHGKKGVKG----------------------------------------------- 160 (245)
Q Consensus 129 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~----------------------------------------------- 160 (245)
++.+.+ ..+++|||+.+|+|.+++........
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998755 48999999999999999987543100
Q ss_pred ----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCcccccc
Q 025997 161 ----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230 (245)
Q Consensus 161 ----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 230 (245)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 000122889999999999999999999998 9999999999999999999999999998664433332
Q ss_pred ccccccccccccCCC
Q 025997 231 HSTRVLGTFGYHAPE 245 (245)
Q Consensus 231 ~~~~~~gt~~y~APE 245 (245)
......||+.|+|||
T Consensus 251 ~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 251 RKGDARLPLKWMAPE 265 (359)
T ss_dssp EC--CEECGGGCCHH
T ss_pred hccccCCCceeEChh
Confidence 334457899999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=242.52 Aligned_cols=166 Identities=22% Similarity=0.320 Sum_probs=144.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-----CCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----NENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~ 137 (245)
..++|.+.+.||+|+||.||+|++. +++.||||++.........+..|+.+++.++ |+||+++++++...+..+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 3578999999999999999999974 7889999999765545567788999999986 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---------
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------- 208 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--------- 208 (245)
+||||+ +++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccc
Confidence 999999 88999999875432 2889999999999999999999998 999999999999975
Q ss_pred ----------------CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 ----------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 ----------------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.+||+|||+++...... ....||+.|+|||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE 229 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPE 229 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHH
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcH
Confidence 7899999999997644322 3457999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=247.50 Aligned_cols=161 Identities=23% Similarity=0.328 Sum_probs=134.2
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999965 78899999986544 2356788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE--cCCCceEEecccCCCCCCcc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDA 226 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill--~~~~~vkl~DfGla~~~~~~ 226 (245)
.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 174 ~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 998875432 2889999999999999999999998 9999999999999 56789999999999866543
Q ss_pred ccccccccccccccccCCC
Q 025997 227 AARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 227 ~~~~~~~~~~gt~~y~APE 245 (245)
... ....||+.|+|||
T Consensus 243 ~~~---~~~~gt~~y~aPE 258 (373)
T 2x4f_A 243 EKL---KVNFGTPEFLAPE 258 (373)
T ss_dssp CBC---CCCCSSCTTCCHH
T ss_pred ccc---ccccCCCcEeChh
Confidence 222 3346999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.21 Aligned_cols=168 Identities=21% Similarity=0.292 Sum_probs=142.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 36799999999999999999996 478899999986443 234688999999999 999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc-----eEEecc
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~-----vkl~Df 217 (245)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 87 ~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 87 L-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred C-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9 8999999986422 2899999999999999999999998 999999999999998887 999999
Q ss_pred cCCCCCCcccccc-----ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
|+++......... ......||+.|+|||
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 187 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChH
Confidence 9998654332211 123467999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=262.40 Aligned_cols=169 Identities=23% Similarity=0.286 Sum_probs=145.3
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCce
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (245)
...++|++.+.||+|+||.||+|+.. +++.||||++.+. ....+.+..|..++..+ +|++|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34678999999999999999999965 6788999998642 23446678899999888 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|+||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECC
T ss_pred EEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEee
Confidence 999999999999999986532 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++....... .....+||+.|||||
T Consensus 486 FGla~~~~~~~~--~~~~~~GT~~Y~APE 512 (674)
T 3pfq_A 486 FGMCKENIWDGV--TTKTFCGTPDYIAPE 512 (674)
T ss_dssp CTTCEECCCTTC--CBCCCCSCSSSCCHH
T ss_pred cceeeccccCCc--ccccccCCCcccCHh
Confidence 999975432222 224568999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=244.48 Aligned_cols=171 Identities=15% Similarity=0.224 Sum_probs=145.1
Q ss_pred hCCCCCCCeeccC--CceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+| +||.||+|+.. +++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999976 7899999998654333 3567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence 99999999999999865322 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccc-----cccccccccccccCCC
Q 025997 219 LSNQAPDAAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~-----~~~~~~~gt~~y~APE 245 (245)
++......... .......||+.|+|||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred cceeeccccccccccccccccccccccccCHH
Confidence 98654322111 0112347999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=237.43 Aligned_cols=178 Identities=23% Similarity=0.357 Sum_probs=145.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467888999999999999999852 3478999999755432 35688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
+++|||+.+++|.+++........ ......+++.+++.++.||+.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986542100 001123889999999999999999999998 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++.++.+||+|||+++...............+|+.|+|||
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 99999999999999999997664433322223446789999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=235.95 Aligned_cols=167 Identities=25% Similarity=0.402 Sum_probs=139.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367899999999999999999976 6899999998665443 356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 99999999998875432 889999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....||+.|+|||
T Consensus 150 ~~~~~~~~~--~~~~~~~~~y~aPE 172 (311)
T 4agu_A 150 RLLTGPSDY--YDDEVATRWYRSPE 172 (311)
T ss_dssp EECC--------------GGGCCHH
T ss_pred hhccCcccc--cCCCcCCccccChH
Confidence 766533222 13357999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=232.91 Aligned_cols=169 Identities=23% Similarity=0.428 Sum_probs=148.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||+|.+.+++.||+|.+.......+.+.+|+.++++++||||+++++++.+.+..+++|||+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35688889999999999999999888899999998777677889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999976532 2889999999999999999999998 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......||+.|+|||
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE 175 (267)
T 3t9t_A 156 DDQYT-SSTGTKFPVKWASPE 175 (267)
T ss_dssp CHHHH-STTSTTCCGGGCCHH
T ss_pred ccccc-ccccccccccccChh
Confidence 33221 122345788999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=243.98 Aligned_cols=168 Identities=25% Similarity=0.393 Sum_probs=131.8
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccC-CCCcceEeEEEEeCC--ce
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGP--LR 136 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~ 136 (245)
..++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.+. |+||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999965 7899999998654332 356778999999997 999999999998554 68
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|+||||+. ++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 87 ~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp EEEEECCS-EEHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEecccC-cCHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecC
Confidence 99999998 59999997642 889999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccc-------------------cccccccccccccccCCC
Q 025997 217 FDLSNQAPDAA-------------------ARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~-------------------~~~~~~~~~gt~~y~APE 245 (245)
||+++...... ........+||+.|+|||
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE 200 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence 99997543210 011123457999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=251.53 Aligned_cols=167 Identities=27% Similarity=0.402 Sum_probs=142.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--------------CchHHHHHHHHHHHccCCCCcceEeE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENVVELVG 128 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~ 128 (245)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567999999999999999999975 67899999986532 23467889999999999999999999
Q ss_pred EEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC
Q 025997 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (245)
Q Consensus 129 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~ 208 (245)
++.+....++||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLEN 181 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEec
Confidence 99999999999999999999998876432 899999999999999999999998 999999999999987
Q ss_pred CC---ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 DD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 ~~---~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++ .+||+|||+++....... ....+||+.|+|||
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 218 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE 218 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHH
T ss_pred CCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHH
Confidence 75 699999999976644322 13457999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=234.26 Aligned_cols=167 Identities=29% Similarity=0.412 Sum_probs=138.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCC------CchHHHHHHHHHHHccC---CCCcceEeEEEEeCC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGP 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 134 (245)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999996 478899999985322 22356778888777765 999999999998765
Q ss_pred -----ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
..+++|||+. ++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSG 156 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTT
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC
Confidence 4799999997 5999999865432 2899999999999999999999998 9999999999999999
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+||+|||+++........ ....||+.|+|||
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE 189 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPE 189 (308)
T ss_dssp SCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHH
T ss_pred CCEEEeeCccccccCCCccc---CCccccccccCch
Confidence 99999999999866433222 3457999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=251.75 Aligned_cols=169 Identities=26% Similarity=0.461 Sum_probs=140.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||+|.+..+..||||++.......+.+.+|+.++++++||||+++++++.+ +..++||||+.
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45677888999999999999999888889999998776677889999999999999999999999865 67899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 262 ~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 262 KGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp TCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999753211 2889999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......+|+.|+|||
T Consensus 332 ~~~~~-~~~~~~~~~~y~aPE 351 (452)
T 1fmk_A 332 DNEYT-ARQGAKFPIKWTAPE 351 (452)
T ss_dssp ------------CCGGGSCHH
T ss_pred CCcee-cccCCcccccccCHh
Confidence 33221 112335788999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=237.69 Aligned_cols=166 Identities=28% Similarity=0.410 Sum_probs=144.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-------chHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356889999999999999999976 688999998854322 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC----ce
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~----~v 212 (245)
++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCE
T ss_pred EEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCE
Confidence 99999999999999997643 2889999999999999999999998 99999999999999887 79
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||++........ .....||+.|+|||
T Consensus 159 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE 188 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188 (321)
T ss_dssp EECCCTTCEECCTTCC---CCCCCSCGGGCCHH
T ss_pred EEccCccceecCcccc---ccccCCCCCccCcc
Confidence 9999999976654322 13457999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=245.05 Aligned_cols=168 Identities=23% Similarity=0.326 Sum_probs=144.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEE----CCCcEEEEEEcCCCC-----CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +|+||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999997 378899999986432 2345677899999999 6999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++||||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 99999999999999999976432 889999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++........ .....+||+.|+|||
T Consensus 201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE 230 (355)
T 1vzo_A 201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPD 230 (355)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHH
T ss_pred eeCCCCeecccCCCC-cccCcccCcCccChh
Confidence 999999765433222 123457999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=246.94 Aligned_cols=166 Identities=26% Similarity=0.401 Sum_probs=133.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---------CchHHHHHHHHHHHccCCCCcceEeEEEEeC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---------QPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 133 (245)
..++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999965 68899999985421 11234788999999999999999999975 4
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---C
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---D 210 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~ 210 (245)
+..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcc
Confidence 56899999999999999886543 2899999999999999999999998 9999999999999754 4
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||+++....... ....+||+.|+|||
T Consensus 280 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 311 (419)
T 3i6u_A 280 LIKITDFGHSKILGETSL---MRTLCGTPTYLAPE 311 (419)
T ss_dssp CEEECCSSTTTSCC--------------CTTCCTT
T ss_pred eEEEeecccceecCCCcc---ccccCCCCCccCce
Confidence 599999999987654322 23467999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=239.37 Aligned_cols=179 Identities=23% Similarity=0.380 Sum_probs=144.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCC--CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3467889999999999999999962 45679999986542 2346789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlk 200 (245)
..++||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 9999999999999999998654210 0001123789999999999999999999998 9999999
Q ss_pred CCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 201 p~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++.++.+||+|||++................||+.|+|||
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 999999999999999999998665433322233456889999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=232.43 Aligned_cols=167 Identities=22% Similarity=0.340 Sum_probs=145.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC-CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
..++|.+.+.||+|+||.||+|... ++..+|+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3456899999999999999999976 5778999988553 3346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEeccc
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~DfG 218 (245)
|+.+++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 87 ~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp CCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred ccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999998876432 889999999999999999999998 9999999999999 778999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... ....||+.|+|||
T Consensus 155 ~~~~~~~~~~~---~~~~~t~~y~aPE 178 (277)
T 3f3z_A 155 LAARFKPGKMM---RTKVGTPYYVSPQ 178 (277)
T ss_dssp TCEECCTTSCB---CCCCSCTTTCCHH
T ss_pred cceeccCccch---hccCCCCCccChH
Confidence 98765433221 3457999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=235.84 Aligned_cols=159 Identities=24% Similarity=0.339 Sum_probs=125.0
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
.+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+.+|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999975 6889999998532 4567788999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC---ceEEecccCCCCCCc
Q 025997 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225 (245)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~---~vkl~DfGla~~~~~ 225 (245)
.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 94 ~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 94 FERIKKKKH---------FSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp HHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999987542 899999999999999999999998 99999999999998765 899999999976543
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....+||+.|+|||
T Consensus 162 ~~~~--~~~~~~t~~y~aPE 179 (325)
T 3kn6_A 162 DNQP--LKTPCFTLHYAAPE 179 (325)
T ss_dssp --------------------
T ss_pred CCCc--ccccCCCcCccCHH
Confidence 3222 23457899999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=240.25 Aligned_cols=165 Identities=26% Similarity=0.382 Sum_probs=140.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 141 (245)
..++|++.+.||+|+||.||+|..+ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 3467999999999999999999976 6889999999655432 35688888887 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC----CceEEecc
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIAKISDF 217 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~----~~vkl~Df 217 (245)
|+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+||
T Consensus 97 ~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 97 LMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp CCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred CCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999999976542 899999999999999999999998 9999999999998543 35999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++........ ....+||+.|+|||
T Consensus 165 g~a~~~~~~~~~--~~~~~gt~~y~aPE 190 (342)
T 2qr7_A 165 GFAKQLRAENGL--LMTPCYTANFVAPE 190 (342)
T ss_dssp TTCEECBCTTCC--BCCSSCCSSCCCHH
T ss_pred CCcccCcCCCCc--eeccCCCccccCHH
Confidence 999866443222 23457999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=247.22 Aligned_cols=164 Identities=30% Similarity=0.502 Sum_probs=140.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCC-ceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||.||+|.+. ++.||||.++... ..+.+.+|+.++++++||||+++++++...+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 456888899999999999999986 6799999997654 5678999999999999999999999987665 789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 270 ~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp TTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999865321 2788999999999999999999998 999999999999999999999999998754
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....+|+.|+|||
T Consensus 340 ~~~~-----~~~~~~~~y~aPE 356 (450)
T 1k9a_A 340 SSTQ-----DTGKLPVKWTAPE 356 (450)
T ss_dssp C-----------CCCTTTSCHH
T ss_pred cccc-----cCCCCCcceeCHH
Confidence 3221 2235788999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=235.90 Aligned_cols=165 Identities=26% Similarity=0.418 Sum_probs=136.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHc--cCCCCcceEeEEEEeC----CceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDG----PLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~l 138 (245)
.++|.+.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46799999999999999999988 5889999998643 34556667776666 7999999999986643 45899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecCCCCCCeEEcCCC
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
||||+.+|+|.+++.... +++..++.++.||+.||.||| +++ |+||||||+|||++.++
T Consensus 84 v~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTS
T ss_pred ehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCC
Confidence 999999999999996432 899999999999999999999 776 99999999999999999
Q ss_pred ceEEecccCCCCCCccccc--cccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
.+||+|||+++........ .......||+.|+|||
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 187 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChh
Confidence 9999999998654322211 1123347999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=235.30 Aligned_cols=171 Identities=26% Similarity=0.408 Sum_probs=148.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..++|.+.+.||+|+||.||+|.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3467888899999999999999976 578899999987766778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++...... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp CTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999864432 2899999999999999999999998 99999999999999999999999999986
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... ......+|+.|+|||
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE 182 (288)
T 3kfa_A 161 MTGDTYT-AHAGAKFPIKWTAPE 182 (288)
T ss_dssp SCSSSSE-EETTEEECGGGCCHH
T ss_pred ccCCccc-cccCCccccCcCChh
Confidence 6543322 123345788999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=236.11 Aligned_cols=170 Identities=25% Similarity=0.394 Sum_probs=138.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEe--CCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 136 (245)
.++|++.+.||+|+||.||+|++ .+++.||||++...... .+.+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999984 26789999998754332 3578899999999999999999999864 3568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 999999999999999986543 2889999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
||+++......... ......||+.|+|||
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 187 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcH
Confidence 99998764432211 112345788899998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=233.39 Aligned_cols=172 Identities=28% Similarity=0.442 Sum_probs=135.5
Q ss_pred HHHhhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 61 LKEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 61 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
+....++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 344567899999999999999999996 478999999985321 234678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~ 154 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIA 154 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEE
Confidence 9999999999999999986432 2899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++......... .....||+.|+|||
T Consensus 155 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 182 (278)
T 3cok_A 155 DFGLATQLKMPHEK--HYTLCGTPNYISPE 182 (278)
T ss_dssp CCTTCEECC---------------------
T ss_pred eecceeeccCCCCc--ceeccCCCCcCCcc
Confidence 99998765432221 12356999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=232.53 Aligned_cols=169 Identities=24% Similarity=0.423 Sum_probs=145.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++||||+++++++. .+..+++|||+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 3568889999999999999999888889999999877667788999999999999999999999876 456899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+++|.+++...... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999753211 2889999999999999999999998 9999999999999999999999999997665
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......+|+.|+|||
T Consensus 161 ~~~~~-~~~~~~~~~~y~aPE 180 (279)
T 1qpc_A 161 DNEYT-AREGAKFPIKWTAPE 180 (279)
T ss_dssp SSCEE-CCTTCCCCTTTSCHH
T ss_pred Ccccc-cccCCCCccCccChh
Confidence 43222 112345788999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=255.13 Aligned_cols=169 Identities=26% Similarity=0.461 Sum_probs=145.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|.+.+.||+|+||.||+|.+..+..||||++.......+.+.+|+.+|++++|+||+++++++.+ +..++||||+.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45577788999999999999999888889999998776677889999999999999999999999865 67899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+|+|.+++...... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 345 ~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 345 KGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp TEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred CCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999753211 2889999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......+|+.|||||
T Consensus 415 ~~~~~-~~~~~~~~~~y~aPE 434 (535)
T 2h8h_A 415 DNEYT-ARQGAKFPIKWTAPE 434 (535)
T ss_dssp CHHHH-TTCSTTSCGGGSCHH
T ss_pred CCcee-cccCCcCcccccCHH
Confidence 43221 112345788999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=238.39 Aligned_cols=162 Identities=32% Similarity=0.504 Sum_probs=140.6
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
+.|.+.+.||+|+||.||+|+. .+++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3488889999999999999996 47889999998654332 246789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+. |+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 134 e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 9997 588888864322 2899999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..... ....||+.|+|||
T Consensus 202 ~~~~~~------~~~~gt~~y~aPE 220 (348)
T 1u5q_A 202 SIMAPA------NSFVGTPYWMAPE 220 (348)
T ss_dssp BSSSSB------CCCCSCGGGCCHH
T ss_pred eecCCC------CcccCCcceeCHh
Confidence 766432 3457999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=238.23 Aligned_cols=167 Identities=23% Similarity=0.360 Sum_probs=144.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999999999999976 678899998854321 245688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccC
Confidence 99999999999987643 2899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+......... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~--~~~~~gt~~y~aPE 211 (335)
T 2owb_A 188 ATKVEYDGER--KKVLCGTPNYIAPE 211 (335)
T ss_dssp CEECCSTTCC--BCCCCSCCSSCCHH
T ss_pred ceecccCccc--ccccCCCccccCHH
Confidence 9765432221 23457999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=249.64 Aligned_cols=166 Identities=27% Similarity=0.411 Sum_probs=143.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC---CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456999999999999999999976 7899999998432 334678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc---CCCceEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~---~~~~vkl~Df 217 (245)
||+.+++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 101 e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp CCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred EcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEEC
Confidence 99999999998876432 899999999999999999999998 99999999999995 4568999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++....... ....+||+.|+|||
T Consensus 169 g~a~~~~~~~~---~~~~~gt~~y~aPE 193 (486)
T 3mwu_A 169 GLSTCFQQNTK---MKDRIGTAYYIAPE 193 (486)
T ss_dssp SCTTTBCCC-------CCTTGGGGCCGG
T ss_pred CcCeECCCCCc---cCCCcCCCCCCCHH
Confidence 99986644322 13457999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=238.97 Aligned_cols=169 Identities=24% Similarity=0.420 Sum_probs=138.3
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc------hHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
...++|.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999965 6899999998653221 2467899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 9999999986 89998876432 2778889999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ .....||+.|+|||
T Consensus 155 Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE 182 (346)
T 1ua2_A 155 DFGLAKSFGSPNRA--YTHQVVTRWYRAPE 182 (346)
T ss_dssp CCGGGSTTTSCCCC--CCCSCCCCTTCCHH
T ss_pred ecccceeccCCccc--CCcccccccccCch
Confidence 99999876543222 23457999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=234.95 Aligned_cols=178 Identities=22% Similarity=0.363 Sum_probs=147.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
.++|.+.+.||+|+||.||+|.+ .+++.||+|.+...... .+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999985 25678999999765432 46788999999999 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKG---------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
.++||||+.+|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999986542100 001123899999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||++................||+.|+|||
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 217 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence 999999999999998765543332233456889999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=249.08 Aligned_cols=166 Identities=27% Similarity=0.415 Sum_probs=140.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.+.|.+.+.||+|+||.||+|+.. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346899999999999999999976 78899999986542 33567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---CceEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~~vkl~Df 217 (245)
||+.+|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+||
T Consensus 116 e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 183 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDF 183 (494)
T ss_dssp ECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEEC
Confidence 99999999998876432 889999999999999999999998 9999999999999764 56999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++....... ....+||+.|+|||
T Consensus 184 G~a~~~~~~~~---~~~~~gt~~y~aPE 208 (494)
T 3lij_A 184 GLSAVFENQKK---MKERLGTAYYIAPE 208 (494)
T ss_dssp TTCEECBTTBC---BCCCCSCTTTCCHH
T ss_pred CCCeECCCCcc---ccccCCCcCeeCHH
Confidence 99976654322 23457999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=239.22 Aligned_cols=169 Identities=25% Similarity=0.392 Sum_probs=138.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcE----EEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... .....+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467888999999999999999965 4443 7888775432 22356778999999999999999999885 56689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSC
T ss_pred EEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCC
Confidence 99999999999999976532 2788899999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............||+.|+|||
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE 187 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALE 187 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHH
T ss_pred CcccccCcccccccccCCCCcccccChH
Confidence 9998765443333334456888999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=231.27 Aligned_cols=169 Identities=30% Similarity=0.424 Sum_probs=145.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999976 78899999985432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 999999999886542 2889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...............||+.|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE 177 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPE 177 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGG
T ss_pred ccCCCcchhcccCCccccCccChH
Confidence 654332222224457999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=239.86 Aligned_cols=169 Identities=24% Similarity=0.415 Sum_probs=135.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|.+.+.||+|+||.||+|++. +++ .||+|.+.... ...+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456889999999999999999965 444 36888875433 34567899999999999999999999998754 78
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+++||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 99999999999999986543 2899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............||+.|+|||
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHH
T ss_pred cceeEccCCcccccccCCCccccccChH
Confidence 9987554333222223345788999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=243.34 Aligned_cols=168 Identities=23% Similarity=0.376 Sum_probs=143.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCC--ceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 140 (245)
++|.+.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56889999999999999999976 68999999986533 33567889999999999999999999998755 789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----cCCCceEEec
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISD 216 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill----~~~~~vkl~D 216 (245)
||+.+|+|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 89 e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp CCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred ecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEec
Confidence 999999999999764321 12889999999999999999999998 9999999999999 7778899999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++........ ....||+.|+|||
T Consensus 160 FG~a~~~~~~~~~---~~~~gt~~y~aPE 185 (396)
T 4eut_A 160 FGAARELEDDEQF---VSLYGTEEYLHPD 185 (396)
T ss_dssp GGGCEECCCGGGS---SCSSSCCTTCCHH
T ss_pred CCCceEccCCCcc---ccccCCccccCHH
Confidence 9999876543322 3457999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=239.32 Aligned_cols=169 Identities=26% Similarity=0.417 Sum_probs=145.9
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---------hHHHHHHHHHHHcc-CCCCcceEeEEE
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRL-KNENVVELVGYY 130 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~~~~~~ 130 (245)
....++|.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334567999999999999999999976 7899999998654321 24577899999999 799999999999
Q ss_pred EeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 131 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
......++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 99999999999999999999997543 2899999999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.+||+|||++........ .....||+.|+|||
T Consensus 238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE 269 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269 (365)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred CEEEEecCcccccCCCcc---cccCCCCCCccChh
Confidence 999999999876654322 13457999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=232.33 Aligned_cols=169 Identities=24% Similarity=0.391 Sum_probs=137.8
Q ss_pred hCCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.+.|.+. +.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999954 78999999986543 3457789999999885 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc---eEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~---vkl~Df 217 (245)
||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 91 e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp ECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 99999999999976432 889999999999999999999998 999999999999988765 999999
Q ss_pred cCCCCCCcccc-----ccccccccccccccCCC
Q 025997 218 DLSNQAPDAAA-----RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~-----~~~~~~~~gt~~y~APE 245 (245)
|++........ ........||+.|+|||
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 191 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191 (316)
T ss_dssp TCCC-------------------CCSGGGCCHH
T ss_pred cCccccccCCccccccccccccccCCcCccChH
Confidence 99876532211 11112346999999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=229.77 Aligned_cols=166 Identities=31% Similarity=0.523 Sum_probs=132.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|.+. ++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467889999999999999999976 78999999865432 236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC--------CCc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------DDI 211 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--------~~~ 211 (245)
|||+.+++|.+++.... +++..++.++.|++.||.|||+++..+|+||||||+|||++. ++.
T Consensus 85 ~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999999996432 899999999999999999999986445889999999999986 678
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++....... ....||+.|+|||
T Consensus 155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE 184 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPE 184 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHH
T ss_pred eEEccCCcccccccccc----cCCCCccceeCHH
Confidence 99999999976543322 2346999999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.18 Aligned_cols=163 Identities=25% Similarity=0.318 Sum_probs=133.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999965 688999999865422 2456789999999999999999999997553
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..|+||||+.+ +|.+.+... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEE
Confidence 46999999976 577777532 788999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++....... ....+||+.|+|||
T Consensus 206 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 233 (464)
T 3ttj_A 206 LDFGLARTAGTSFM---MTPYVVTRYYRAPE 233 (464)
T ss_dssp CCCCCC-----CCC---C----CCCTTCCHH
T ss_pred EEEEeeeecCCCcc---cCCCcccccccCHH
Confidence 99999986643321 24467999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.57 Aligned_cols=178 Identities=25% Similarity=0.411 Sum_probs=144.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
.++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467889999999999999999863 4678999999765432 35688999999999 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
+..++||||+.+++|.+++......... .....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999865421100 01223889999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............+|+.|+|||
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 229 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence 999999999999997665433222223345788999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=232.92 Aligned_cols=169 Identities=24% Similarity=0.376 Sum_probs=141.0
Q ss_pred CCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeC--Cce
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (245)
..|++.+.||+|+||.||+|++ .+++.||+|++.... ...+.+.+|+.++++++|+||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 368899999986543 3347789999999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECc
Confidence 999999999999999965432 2899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
||++......... .......||..|+|||
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 199 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCe
Confidence 9999766443221 1123456889999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=239.98 Aligned_cols=162 Identities=28% Similarity=0.382 Sum_probs=134.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367899999999999999999974 7899999998654333 356789999999999999999999997653
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.+|+||||+ +++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 469999999 789999997642 889999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++..... ....+||+.|+|||
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE 195 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPE 195 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTH
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHH
Confidence 999999765432 13457999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=251.45 Aligned_cols=166 Identities=28% Similarity=0.479 Sum_probs=144.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356889999999999999999976 7899999998543 23457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEec
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISD 216 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~D 216 (245)
|||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 105 ~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 999999999999976542 899999999999999999999998 9999999999999 4678999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+++....... ....+||+.|+|||
T Consensus 173 fg~a~~~~~~~~---~~~~~gt~~y~aPE 198 (484)
T 3nyv_A 173 FGLSTHFEASKK---MKDKIGTAYYIAPE 198 (484)
T ss_dssp TTHHHHBCCCCS---HHHHTTGGGTCCHH
T ss_pred eeeeEEcccccc---cccCCCCccccCce
Confidence 999875543322 13357999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=231.72 Aligned_cols=170 Identities=24% Similarity=0.383 Sum_probs=139.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|... ++..+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356888999999999999999965 68899999885433 345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEeccc
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~DfG 218 (245)
|+.+++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 101 ~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 101 TCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp CCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred eCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 99999999988543110 012899999999999999999999998 9999999999999 446789999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... ....||+.|+|||
T Consensus 173 ~a~~~~~~~~~---~~~~~t~~y~aPE 196 (285)
T 3is5_A 173 LAELFKSDEHS---TNAAGTALYMAPE 196 (285)
T ss_dssp CCCC-------------CTTGGGCCHH
T ss_pred cceecCCcccC---cCcccccCcCChH
Confidence 99766543222 3457999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=237.63 Aligned_cols=175 Identities=23% Similarity=0.344 Sum_probs=128.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC-C---cEEEEEEcCCCC---CchHHHHHHHHHHHccCCCCcceEeEEEEeCCce-
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS-G---RAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR- 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~-~---~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 136 (245)
.++|.+.+.||+|+||.||+|.+.. + ..||||++.... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4679999999999999999999653 3 279999986543 2346788999999999999999999999877655
Q ss_pred -----EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 137 -----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 137 -----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
+++|||+.+++|.+++....... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 99999999999999986543211 0113889999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++...............+|+.|+|||
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHH
T ss_pred EEEeeccccccccccccccccccccCcccccCch
Confidence 9999999998765433322223345788999997
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=238.01 Aligned_cols=168 Identities=26% Similarity=0.434 Sum_probs=137.7
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHc--cCCCCcceEeEEEEeC----Cc
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDG----PL 135 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~ 135 (245)
....++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|.+++.. ++|+||+++++++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 334568999999999999999999986 889999998533 23445555555554 4899999999999887 67
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCeEecCCCCCCeEEc
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--------AEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~~~~ivHrDlkp~Nill~ 207 (245)
.++||||+.+|+|.+++.... +++..++.++.|++.||.|||++ + |+||||||+|||++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVK 176 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEEC
T ss_pred eEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEEC
Confidence 899999999999999997643 89999999999999999999998 7 99999999999999
Q ss_pred CCCceEEecccCCCCCCcccccc--ccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
.++.+||+|||+++......... ......||+.|+|||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 216 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChh
Confidence 99999999999997654332221 112457999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=238.59 Aligned_cols=166 Identities=22% Similarity=0.372 Sum_probs=135.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch--HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|.+.+.||+|+||.||+|... +++.||+|++....... ..+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999976 78899999986543221 2455799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+. ++|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CS-EEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred cc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 97 499999876542 2889999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE 170 (324)
T 3mtl_A 150 KSIPTKT--YDNEVVTLWYRPPD 170 (324)
T ss_dssp C--------------CGGGCCHH
T ss_pred ccCCccc--cccccCcccccChh
Confidence 5433222 13347899999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=229.92 Aligned_cols=166 Identities=25% Similarity=0.403 Sum_probs=143.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++...+..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 6889999998654333 356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc---eEEecc
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISDF 217 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~---vkl~Df 217 (245)
||+.+++|.+.+..... +++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+||
T Consensus 85 e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp CCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred ecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 99999999998876532 899999999999999999999998 999999999999986654 999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++......... ....||+.|+|||
T Consensus 153 g~~~~~~~~~~~---~~~~~~~~y~aPE 177 (284)
T 3kk8_A 153 GLAIEVNDSEAW---HGFAGTPGYLSPE 177 (284)
T ss_dssp TTCEECCSSCBC---CCSCSCGGGCCHH
T ss_pred eeeEEcccCccc---cCCCCCcCCcCch
Confidence 999765443221 3457999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=233.65 Aligned_cols=164 Identities=26% Similarity=0.417 Sum_probs=141.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CC-------cEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-------RAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
.++|.+.+.||+|+||.||+|... ++ ..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457888999999999999999965 33 469999986543 335678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc----
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~---- 211 (245)
.++||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence 9999999999999999986542 2888999999999999999999998 999999999999998876
Q ss_pred ----eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 ----AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 ----vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||++...... ....||+.|+|||
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE 187 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPE 187 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHH
T ss_pred ccceeeeccCcccccccCc------cccCCcCcccCHH
Confidence 999999998766433 2235899999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=234.88 Aligned_cols=179 Identities=23% Similarity=0.386 Sum_probs=145.7
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.++++++|+||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 3467899999999999999999854 3678999999755433 3468899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.++||||+.+++|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 999999999999999987532100 0000012688999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...............||+.|+|||
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CcCccccccccccccccccCCCCCCCccChh
Confidence 9999998664433322223446789999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=231.69 Aligned_cols=167 Identities=29% Similarity=0.510 Sum_probs=131.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|.... .+|+|++...... .+.+.+|+.++++++|+||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4579999999999999999998653 5999998765443 35688999999999999999999965 5667899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 100 WCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 9999999999965432 2899999999999999999999998 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...............||+.|+|||
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE 192 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPE 192 (289)
T ss_dssp ---------------CCCTTCCHH
T ss_pred ccccccccccccccCCCccccCch
Confidence 654332222224457999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=230.43 Aligned_cols=168 Identities=27% Similarity=0.399 Sum_probs=130.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4578889999999999999999653 456999998654332 35688999999999999999999997 4567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence 9999999999999976532 2889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++........ ......+|+.|+|||
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE 187 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPE 187 (281)
T ss_dssp ------------------CCGGGCCHH
T ss_pred cccccCccccc-ccccCCCcccccChh
Confidence 99876543221 112335788999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=231.32 Aligned_cols=166 Identities=30% Similarity=0.452 Sum_probs=141.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|.+.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567999999999999999999966 67789999885322 234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999976432 889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....||+.|+|||
T Consensus 155 ~~~~~~~~~~----~~~~~~~~y~aPE 177 (279)
T 3fdn_A 155 WSVHAPSSRR----TDLCGTLDYLPPE 177 (279)
T ss_dssp EESCC------------CCCCTTCCHH
T ss_pred ccccCCcccc----cccCCCCCccCHh
Confidence 9866543321 3457999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=237.44 Aligned_cols=170 Identities=31% Similarity=0.499 Sum_probs=142.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEe------CCc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD------GPL 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~ 135 (245)
..++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++++ +||||+++++++.. .+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 4577999999999999999999974 788999999977666678899999999999 79999999999987 467
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.++||||+.+++|.+++...... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 89999999999999999865321 2889999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++......... .....||+.|+|||
T Consensus 172 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 199 (326)
T 2x7f_A 172 DFGVSAQLDRTVGR--RNTFIGTPYWMAPE 199 (326)
T ss_dssp CCTTTC---------------CCGGGCCHH
T ss_pred eCcCceecCcCccc--cccccCCccccChh
Confidence 99998766432221 13457999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=238.26 Aligned_cols=167 Identities=24% Similarity=0.389 Sum_probs=135.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
..++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4578999999999999999999965 7889999999654432 34577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-----CCCceEE
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-----DDDIAKI 214 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~-----~~~~vkl 214 (245)
|||+.+ +|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 112 ~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp EECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred EecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 999985 99999987542 889999999999999999999998 99999999999994 4556999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++........ .....||+.|+|||
T Consensus 179 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE 207 (329)
T 3gbz_A 179 GDFGLARAFGIPIRQ--FTHEIITLWYRPPE 207 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHH
T ss_pred CcCCCccccCCcccc--cCCCcCCccccCHH
Confidence 999998754322221 13346899999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.33 Aligned_cols=165 Identities=24% Similarity=0.415 Sum_probs=140.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-------chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999976 789999998854321 3567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC----ceE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAK 213 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~----~vk 213 (245)
++|||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEE
T ss_pred EEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceE
Confidence 9999999999999997543 2899999999999999999999998 99999999999998877 899
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++......... ....||+.|+|||
T Consensus 153 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE 181 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNEF---KNIFGTPEFVAPE 181 (283)
T ss_dssp ECCCTTCEECC-----------CCCGGGCCHH
T ss_pred EEecccceeccCCCcc---cccCCCcCccCcc
Confidence 9999999766433221 3346999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=237.48 Aligned_cols=173 Identities=26% Similarity=0.400 Sum_probs=138.4
Q ss_pred HHHHHHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc------------hHHHHHHHHHHHccCCCCcce
Q 025997 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVE 125 (245)
Q Consensus 58 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~ 125 (245)
..++....++|.+.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 34566678899999999999999999999888999999988543221 267889999999999999999
Q ss_pred EeEEEEeC-----CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 025997 126 LVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (245)
Q Consensus 126 ~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlk 200 (245)
+++++... ...++||||+. |+|.+++..... .+++..+..++.||+.||.|||+++ |+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence 99998543 35799999998 589888875432 2899999999999999999999998 9999999
Q ss_pred CCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 201 p~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++.++.+||+|||+++........ ....||+.|+|||
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE 203 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPE 203 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHH
T ss_pred hHHEEEcCCCCEEEEecCccccccccccc---ceecccceecCcH
Confidence 99999999999999999999755433222 3457999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=238.48 Aligned_cols=166 Identities=33% Similarity=0.488 Sum_probs=133.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHH--HHccCCCCcceEeEEEEe-----CCce
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSM--VSRLKNENVVELVGYYVD-----GPLR 136 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~~ 136 (245)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++|+||+++++.+.. ...+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc--chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 457899999999999999999977 5789999998543 23444444444 556899999999986542 2357
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCeEecCCCCCCeEEc
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---------AEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------~~~~ivHrDlkp~Nill~ 207 (245)
++||||+++|+|.+++.... .++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK 154 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence 89999999999999997654 68889999999999999999998 7 99999999999999
Q ss_pred CCCceEEecccCCCCCCcccc------ccccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAA------RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~------~~~~~~~~gt~~y~APE 245 (245)
.++.+||+|||+++....... ........||+.|+|||
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHH
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCch
Confidence 999999999999976543211 11123457999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=239.55 Aligned_cols=169 Identities=21% Similarity=0.312 Sum_probs=135.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC------CcEEEEEEcCCCCCc------------hHHHHHHHHHHHccCCCCcceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVEL 126 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~ 126 (245)
.++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999999764 478999998654321 1123445666778889999999
Q ss_pred eEEEEeC----CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 025997 127 VGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (245)
Q Consensus 127 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~ 202 (245)
++++... ...++||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~ 181 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS 181 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH
Confidence 9998764 4589999999 9999999986532 2899999999999999999999998 999999999
Q ss_pred CeEEc--CCCceEEecccCCCCCCcccccc-----ccccccccccccCCC
Q 025997 203 NVLLF--DDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 203 Nill~--~~~~vkl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
|||++ .++.+||+|||+++......... ......||+.|||||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 231 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID 231 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence 99999 88999999999997665432211 112345999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=227.95 Aligned_cols=167 Identities=25% Similarity=0.351 Sum_probs=141.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456889999999999999999976 789999999865432 245678899999999 999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-----------
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----------- 208 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~----------- 208 (245)
|||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred EEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccc
Confidence 9999999999999764210 012899999999999999999999998 999999999999984
Q ss_pred --------CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 --------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 --------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...+||+|||++...... ....||+.|+|||
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE 200 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANE 200 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHH
T ss_pred ccccccCCceEEEEcccccccccCCc------cccCCCccccChh
Confidence 447999999998766432 2235999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.57 Aligned_cols=167 Identities=27% Similarity=0.423 Sum_probs=139.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467899999999999999999976 6889999988554433 345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp ECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence 99999999888765432 899999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ .....||+.|+|||
T Consensus 172 ~~~~~~~~~--~~~~~~t~~y~aPE 194 (331)
T 4aaa_A 172 RTLAAPGEV--YDDEVATRWYRAPE 194 (331)
T ss_dssp --------------CCCCCTTCCHH
T ss_pred eeecCCccc--cCCCcCCccccCcc
Confidence 765443222 13357999999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=230.32 Aligned_cols=165 Identities=28% Similarity=0.508 Sum_probs=141.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe-----------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD----------- 132 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------- 132 (245)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 356889999999999999999976 78999999986543 457789999999999999999998864
Q ss_pred -----CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc
Q 025997 133 -----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 133 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~ 207 (245)
....+++|||+.+++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLV 156 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEc
Confidence 34579999999999999999754321 2889999999999999999999998 99999999999999
Q ss_pred CCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.++.+||+|||++......... ....||+.|+|||
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE 191 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPE 191 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHH
T ss_pred CCCCEEECcchhheeccccccc---cccCCcccccChh
Confidence 9999999999998766543221 3346999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=228.63 Aligned_cols=165 Identities=29% Similarity=0.449 Sum_probs=144.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888999999999999999965 78899999985443 3457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++.... +++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 102 ~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 102 LGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 168 (303)
T ss_dssp CTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeeccccee
Confidence 99999999997532 899999999999999999999998 99999999999999999999999999976
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 169 ~~~~~~~--~~~~~~~~~y~aPE 189 (303)
T 3a7i_A 169 LTDTQIK--RNTFVGTPFWMAPE 189 (303)
T ss_dssp CBTTBCC--BCCCCSCGGGCCHH
T ss_pred cCccccc--cCccCCCcCccCHH
Confidence 5433221 23457999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=238.60 Aligned_cols=180 Identities=26% Similarity=0.307 Sum_probs=140.6
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC------CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
...++|.+.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 34567999999999999999999965 7889999988532 2345678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHHHHH
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKG-------------------------------AKPGPVLSWAQRVKIAVGAARGLE 184 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~~i~~~l~ 184 (245)
.++||||+.+|+|.+++........ ......+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999999853111000 000112456778889999999999
Q ss_pred HHhcCCCCCeEecCCCCCCeEEcCCC--ceEEecccCCCCCCcccc--ccccccccccccccCCC
Q 025997 185 YLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 185 ~lH~~~~~~ivHrDlkp~Nill~~~~--~vkl~DfGla~~~~~~~~--~~~~~~~~gt~~y~APE 245 (245)
|||+++ |+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 999998 99999999999998766 899999999975432111 11123457999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=229.54 Aligned_cols=167 Identities=28% Similarity=0.386 Sum_probs=144.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----------chHHHHHHHHHHHccC-CCCcceEeEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----------PDQEFLAQVSMVSRLK-NENVVELVGYYV 131 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 131 (245)
..++|.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999975 688999999865431 1245778999999995 999999999999
Q ss_pred eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
..+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 9999999999999999999997643 2899999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||++........ .....||+.|+|||
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 193 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE 193 (298)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred EEEecccchhhcCCCcc---cccccCCccccCHH
Confidence 99999999876543322 13457999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=232.18 Aligned_cols=170 Identities=22% Similarity=0.312 Sum_probs=138.3
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
...++|.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34688999999999999999999975 7889999998654322 256888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 111 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSC
T ss_pred EEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecC
Confidence 9999999999999997643 2889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++......... ......||+.|+|||
T Consensus 179 g~~~~~~~~~~~-~~~~~~~~~~y~aPE 205 (309)
T 2h34_A 179 GIASATTDEKLT-QLGNTVGTLYYMAPE 205 (309)
T ss_dssp CC-----------------CCGGGCCGG
T ss_pred ccCccccccccc-cccccCCCcCccCHH
Confidence 998765443221 113456999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=233.87 Aligned_cols=169 Identities=25% Similarity=0.397 Sum_probs=140.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEe--------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 132 (245)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999974 789999999855432 24578899999999999999999999887
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
.+..++||||+.+ +|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 3468999999985 88888765432 2899999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCcccc--ccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~APE 245 (245)
||+|||+++....... ........||+.|+|||
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCch
Confidence 9999999976542211 11123457899999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=226.00 Aligned_cols=165 Identities=32% Similarity=0.547 Sum_probs=139.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch--------HHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--------QEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
.++|.+.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367889999999999999999975 78899999986543221 57889999999999999999999986554
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc----
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~---- 211 (245)
+++|||+.+++|.+.+..... .+++..++.++.|++.||.|||+++ ++|+||||||+|||++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSC
T ss_pred -eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCce
Confidence 799999999999998875432 2899999999999999999999984 23999999999999988776
Q ss_pred -eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 -vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++...... ....||+.|+|||
T Consensus 167 ~~kl~Dfg~~~~~~~~~-----~~~~g~~~y~aPE 196 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHSV-----SGLLGNFQWMAPE 196 (287)
T ss_dssp CEEECCCTTCBCCSSCE-----ECCCCCCTTSCGG
T ss_pred eEEeCCCCccccccccc-----cccCCCccccCch
Confidence 9999999997654322 3457999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=229.07 Aligned_cols=166 Identities=28% Similarity=0.449 Sum_probs=144.4
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3567999999999999999999976 6778999988532 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999976432 889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++....... .....||+.|+|||
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE 182 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPE 182 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHH
T ss_pred ccccCcccc----cccccCCCCcCCHH
Confidence 986554322 13457999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=232.68 Aligned_cols=170 Identities=24% Similarity=0.390 Sum_probs=138.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe-----------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD----------- 132 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------- 132 (245)
.++|++.+.||+|+||.||+|... +++.||||.+.......+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 456889999999999999999965 78999999986544445678899999999999999999998865
Q ss_pred --CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC
Q 025997 133 --GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 133 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~ 210 (245)
.+..+++|||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTS
T ss_pred ccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCC
Confidence 3567999999999999999975432 2788899999999999999999998 99999999999999999
Q ss_pred ceEEecccCCCCCCcccc------------ccccccccccccccCCC
Q 025997 211 IAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 211 ~vkl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~APE 245 (245)
.+||+|||++........ ........||+.|+|||
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence 999999999976542210 11113456999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=230.93 Aligned_cols=161 Identities=17% Similarity=0.339 Sum_probs=140.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEe--CCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|.. .+++.||+|++.. ...+.+.+|+.++++++ |+||+++++++.+ ....+++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36799999999999999999996 4788999999864 34577899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfGl 219 (245)
||+.+++|.+++.. +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 113 e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 99999999999853 788899999999999999999998 99999999999999776 899999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....||+.|+|||
T Consensus 178 a~~~~~~~~~---~~~~~~~~y~aPE 200 (330)
T 3nsz_A 178 AEFYHPGQEY---NVRVASRYFKGPE 200 (330)
T ss_dssp CEECCTTCCC---CSCCSCGGGCCHH
T ss_pred ceEcCCCCcc---ccccccccccChh
Confidence 9765433221 3457999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=229.16 Aligned_cols=167 Identities=23% Similarity=0.360 Sum_probs=144.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|... +++.+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 456888999999999999999976 678899998854322 245678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccC
Confidence 99999999999987643 2899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+......... .....||+.|+|||
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~y~aPE 185 (294)
T 2rku_A 162 ATKVEYDGER--KKVLCGTPNYIAPE 185 (294)
T ss_dssp CEECCSTTCC--BCCCCSCCSSCCHH
T ss_pred ceecccCccc--cccccCCCCcCCcc
Confidence 8765432221 13457999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=228.53 Aligned_cols=170 Identities=25% Similarity=0.363 Sum_probs=140.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC-----CCchHHHHHHHHHHHccCCCCcceEeEEEE--eCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.++++++|+||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999964 7889999998643 233567889999999999999999999984 45678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++||||+.++ |.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeec
Confidence 9999999876 77777654322 2899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||++................||+.|+|||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE 181 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPE 181 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHH
T ss_pred cccccccCccccccccccCCCCCCCcChh
Confidence 99997654322222223456999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=229.60 Aligned_cols=165 Identities=27% Similarity=0.429 Sum_probs=139.7
Q ss_pred CCCCCeeccCCceEEEEEEEC-----CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 138 (245)
|++.+.||+|+||.||++.+. +++.||||++...... .+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 6788999999765432 35688999999999999999999999874 57899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+++|.+++.... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcc
Confidence 999999999999997643 889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccc-cccccccccccccCCC
Q 025997 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
++......... .......||+.|+|||
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPE 207 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHH
T ss_pred ccccccccccccccccCCCCCceeeChH
Confidence 99766543221 1123346889999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=233.57 Aligned_cols=169 Identities=24% Similarity=0.412 Sum_probs=134.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcE----EEEEEcCCC--CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999965 4443 577777543 234678899999999999999999999998654 78
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++++++.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence 99999999999999986543 2889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++...............||+.|+|||
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE 189 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALE 189 (327)
T ss_dssp TC----------------CCCGGGSCHH
T ss_pred cceeEccCccccccccCCCccccccCHH
Confidence 9998765443332223345788999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=234.83 Aligned_cols=167 Identities=27% Similarity=0.353 Sum_probs=142.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeC-----Cce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 136 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357999999999999999999965 7888999998754433 36788999999999999999999998755 368
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+.+ +|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 999999974 9999997643 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
||+++......... ......||+.|+|||
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 201 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPE 201 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCH
Confidence 99998665432221 123457999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.21 Aligned_cols=179 Identities=26% Similarity=0.407 Sum_probs=145.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECC-C-----cEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCC
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-G-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 134 (245)
..++|.+.+.||+|+||.||+|.... + ..||+|.+...... .+.+.+|+.+++++ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35678999999999999999999652 2 47999998765432 35688999999999 8999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
..++||||+.+|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999875321000 000123789999999999999999999998 9999999999999999
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+||+|||+++...............||+.|+|||
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 236 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 236 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHH
Confidence 999999999998654433222223446788999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=226.45 Aligned_cols=167 Identities=23% Similarity=0.356 Sum_probs=138.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3578999999999999999999976 7899999998532 2334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecc
Confidence 9999999999999976432 889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++......... ....||+.|+|||
T Consensus 157 ~~~~~~~~~~~---~~~~~~~~y~aPE 180 (276)
T 2h6d_A 157 LSNMMSDGEFL---RTSCGSPNYAAPE 180 (276)
T ss_dssp GGGCCCC----------------CCTG
T ss_pred cccccCCCcce---ecccCCccccCHH
Confidence 99776543221 3346899999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=227.68 Aligned_cols=168 Identities=20% Similarity=0.235 Sum_probs=142.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++......+++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46799999999999999999996 578899999885432 335678899999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc-----eEEecc
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~-----vkl~Df 217 (245)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 88 ~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9 8999999986532 2899999999999999999999998 999999999999987765 999999
Q ss_pred cCCCCCCccccc-----cccccccccccccCCC
Q 025997 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~-----~~~~~~~gt~~y~APE 245 (245)
|+++........ .......||+.|+|||
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 188 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCch
Confidence 999765433221 1123457999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=233.32 Aligned_cols=165 Identities=27% Similarity=0.406 Sum_probs=137.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---------chHHHHHHHHHHHccCCCCcceEeEEEEeCC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 134 (245)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ....+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 356899999999999999999975 678999999865321 1235788999999999999999999987654
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc---
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--- 211 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~--- 211 (245)
.++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCC
T ss_pred -eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCe
Confidence 899999999999999987543 2889999999999999999999998 999999999999987654
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++........ ....||+.|+|||
T Consensus 156 ~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE 186 (322)
T 2ycf_A 156 IKITDFGHSKILGETSLM---RTLCGTPTYLAPE 186 (322)
T ss_dssp EEECCCTTCEECCCCHHH---HHHHSCCTTCCHH
T ss_pred EEEccCccceeccccccc---ccccCCcCccCch
Confidence 999999999766433211 2346999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=238.74 Aligned_cols=165 Identities=27% Similarity=0.437 Sum_probs=142.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457889999999999999999976 7889999998655332 3578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
|+.+++|.+++..... +++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 112 ~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp CCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999976532 88999999999999999999985 6 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 180 ~~~~~~~----~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 180 GQLIDSM----ANSFVGTRSYMSPE 200 (360)
T ss_dssp HHHHHHC--------CCCCTTCCHH
T ss_pred ccccccc----ccCCCCCCCeECHH
Confidence 6543221 23457999999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=228.19 Aligned_cols=170 Identities=22% Similarity=0.346 Sum_probs=139.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEE-eCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 137 (245)
..+|.+.+.||+|+||.||+|.... ...+|+|.+...... .+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3458888999999999999999642 235899988754432 356889999999999999999999865 456789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++|||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSC
T ss_pred EEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcc
Confidence 99999999999999976432 2789999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCcccccc--ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
|+++......... ......||+.|+|||
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALE 202 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHH
T ss_pred cccccccccchhccccccCCCCCccccChH
Confidence 9998765433211 123346788999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=229.46 Aligned_cols=165 Identities=26% Similarity=0.429 Sum_probs=141.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456889999999999999999975 789999999865433 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEecccC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~DfGl 219 (245)
+.+++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 88 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 88 VSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp CCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred CCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 999999999875432 889999999999999999999998 9999999999999 7788999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...... .....||+.|+|||
T Consensus 156 ~~~~~~~~----~~~~~~~~~y~aPE 177 (304)
T 2jam_A 156 SKMEQNGI----MSTACGTPGYVAPE 177 (304)
T ss_dssp TCCCCCBT----THHHHSCCCBCCTT
T ss_pred ceecCCCc----cccccCCCCccChH
Confidence 87654321 12346999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=232.47 Aligned_cols=170 Identities=22% Similarity=0.363 Sum_probs=142.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEE--eCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 136 (245)
.++|++.+.||+|+||.||+|++ .+++.||||++...... .+.+.+|+.++++++|+||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788899999999999999984 36789999998765432 356889999999999999999999887 45668
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcc
Confidence 999999999999999976432 2899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
||++......... .......||+.|+|||
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred cccceecccCCccceeeccCCccccccCHH
Confidence 9999765433221 1123346889999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=232.02 Aligned_cols=184 Identities=21% Similarity=0.337 Sum_probs=147.8
Q ss_pred HHHHHhhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEE
Q 025997 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGY 129 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~ 129 (245)
..+....++|.+.+.||+|+||.||+|.+ .+++.||||.+...... .+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444567899999999999999999984 25678999999765433 34688999999999 78999999999
Q ss_pred EEeCC-ceEEEEEecCCCCHHHHHhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 130 YVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 130 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
+...+ ..+++|||+.+++|.+++......... .....+++..++.++.||+.||.|||+++ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 87654 589999999999999999865431000 00123789999999999999999999998 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+++.++.+||+|||+++...............||+.|+|||
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence 99999999999999999998765433322233456899999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=226.78 Aligned_cols=168 Identities=30% Similarity=0.459 Sum_probs=140.0
Q ss_pred CCCCCCC-eeccCCceEEEEEEEC---CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
++|.+.+ .||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999854 577899999976533 245788999999999999999999999 56679999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence 999999999999975432 2899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccc-ccccccccccccCCC
Q 025997 220 SNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
+.......... ......||+.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPE 183 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHH
T ss_pred eeeeccCcceeeccccccccccccCHH
Confidence 97664332211 112335789999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=239.78 Aligned_cols=165 Identities=22% Similarity=0.295 Sum_probs=141.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHcc------CCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL------KNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~ 137 (245)
..+|++.+.||+|+||.||+|... +++.||||++.........+.+|+.+++.+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 456999999999999999999965 688999999976554456777888888877 5679999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc--eEEe
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKIS 215 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~--vkl~ 215 (245)
++|||+. ++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred EEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence 9999996 5999999875432 2889999999999999999999998 999999999999999887 9999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++....... ...+||+.|||||
T Consensus 245 DFG~a~~~~~~~-----~~~~gt~~y~aPE 269 (429)
T 3kvw_A 245 DFGSSCYEHQRV-----YTYIQSRFYRAPE 269 (429)
T ss_dssp CCTTCEETTCCC-----CSSCSCGGGCCHH
T ss_pred ecccceecCCcc-----cccCCCCCccChH
Confidence 999986543221 3457999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=228.67 Aligned_cols=168 Identities=32% Similarity=0.498 Sum_probs=140.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3567999999999999999999976 68999999986543 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 106 ~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 106 CGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp CTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 999999999874321 2899999999999999999999998 99999999999999999999999999976
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 175 ~~~~~~~--~~~~~~~~~y~aPE 195 (314)
T 3com_A 175 LTDTMAK--RNTVIGTPFWMAPE 195 (314)
T ss_dssp CBTTBSC--BCCCCSCGGGCCHH
T ss_pred hhhhccc--cCccCCCCCccChh
Confidence 5433221 23457999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=234.59 Aligned_cols=163 Identities=25% Similarity=0.312 Sum_probs=131.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 6889999998654333 356788999999999999999999997654
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++||||+.+ +|.+.+... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence 68999999975 888888632 788999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++....... .....||+.|+|||
T Consensus 169 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 196 (371)
T 2xrw_A 169 LDFGLARTAGTSFM---MTPYVVTRYYRAPE 196 (371)
T ss_dssp CCCCC-------------------CTTCCHH
T ss_pred EEeecccccccccc---cCCceecCCccCHH
Confidence 99999986643221 13457999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=232.45 Aligned_cols=174 Identities=22% Similarity=0.307 Sum_probs=131.9
Q ss_pred HHHHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCc---
Q 025997 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--- 135 (245)
Q Consensus 60 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 135 (245)
......++|.+.+.||+|+||.||+|.+. +++.||||++...........+++..++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 44566789999999999999999999975 78899999986665556677888888999999999999999875433
Q ss_pred ----eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEecCCCCCCeEEcC-
Q 025997 136 ----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--EKAEPRIIHRNIKSSNVLLFD- 208 (245)
Q Consensus 136 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~~~~ivHrDlkp~Nill~~- 208 (245)
.++||||+.+ +|.+.+...... ...+++..+..++.|++.||.||| +++ |+||||||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETT
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCC
Confidence 7899999986 555544321110 113788999999999999999999 887 999999999999996
Q ss_pred CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.+||+|||+++........ ....||+.|+|||
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE 201 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPE 201 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHH
T ss_pred CCcEEEeeCCCceecCCCCCc---ccccCCcceeCHH
Confidence 899999999999876543322 3457899999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=236.13 Aligned_cols=168 Identities=22% Similarity=0.331 Sum_probs=134.8
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe---------
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--------- 132 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 132 (245)
...++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3457899999999999999999996 47899999988544322 2369999999999999999999844
Q ss_pred -----------------------------CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 025997 133 -----------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (245)
Q Consensus 133 -----------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 183 (245)
..+.++||||+++ +|.+.+...... ...+++..+..++.||+.||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHH
Confidence 3348899999984 887777532110 11389999999999999999
Q ss_pred HHHhcCCCCCeEecCCCCCCeEEc-CCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 184 EYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 184 ~~lH~~~~~~ivHrDlkp~Nill~-~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
.|||+++ |+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||
T Consensus 155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE 211 (383)
T 3eb0_A 155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPE 211 (383)
T ss_dssp HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHH
T ss_pred HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHH
Confidence 9999998 99999999999998 6889999999999865433222 3457899999998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=228.21 Aligned_cols=168 Identities=24% Similarity=0.384 Sum_probs=141.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..+++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 467899999999999999999976 789999999865432 2367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+. ++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 82 e~~~-~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~ 150 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 150 (299)
T ss_dssp ECCS-EEHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHH
T ss_pred Eccc-CCHHHHHHhhhcc-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhh
Confidence 9998 5999999765422 2788999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... .....||+.|+|||
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE 173 (299)
T 2r3i_A 151 RAFGVPVRT--YTHEVVTLWYRAPE 173 (299)
T ss_dssp HHHCCCSBC--TTSCBCCCTTCCHH
T ss_pred hhccCCccc--cCcccccccccCcH
Confidence 654322111 13346899999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=230.37 Aligned_cols=168 Identities=27% Similarity=0.435 Sum_probs=142.1
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHc--cCCCCcceEeEEEEeCC----c
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP----L 135 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~ 135 (245)
....++|.+.+.||+|+||.||+|.+. ++.||||++... ....+.+|++++.. ++||||+++++++...+ .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 334567999999999999999999985 889999998533 45667888888877 79999999999998776 7
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecCCCCCCeEEc
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivHrDlkp~Nill~ 207 (245)
.++||||+.+|+|.+++.... +++..++.++.|++.||.||| +++ |+||||||+|||++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred eEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 899999999999999997643 899999999999999999999 776 99999999999999
Q ss_pred CCCceEEecccCCCCCCcccccc--ccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
.++.+||+|||++.......... ......||+.|+|||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 221 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHH
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHh
Confidence 99999999999986543322111 123457999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-33 Score=223.06 Aligned_cols=165 Identities=24% Similarity=0.337 Sum_probs=142.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC--CceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|.+. ++.||+|++...... .+.+.+|+.++++++||||+++++++.+. +..+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467899999999999999999986 789999999765433 35688999999999999999999999877 788999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++|+|.+++...... .+++..++.++.||+.||.|||+++ +.|+||||||+|||++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccc
Confidence 9999999999999865432 3899999999999999999999974 2399999999999999999999999998
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+..... ....||+.|+|||
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE 178 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPE 178 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHH
T ss_pred eeeecc-------cCccCCccccChh
Confidence 754322 2346899999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=252.37 Aligned_cols=156 Identities=15% Similarity=0.121 Sum_probs=121.9
Q ss_pred eeccCCceEEEEEE-ECCCcEEEEEEcCCCCC-----------chHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEE
Q 025997 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-----------PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 73 ~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (245)
..+.|++|.+..++ ...|+.+++|.+.+... ..+++.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666665 34688999999854321 124688999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||++|++|.++|..... ++.. .|+.||+.||.|+|++| ||||||||+|||++++|.+||+|||+
T Consensus 321 MEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence 999999999999986542 5543 57899999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+........ ..+.+||+.|||||
T Consensus 386 Ar~~~~~~~~--~~t~vGTp~YmAPE 409 (569)
T 4azs_A 386 IVTTPQDCSW--PTNLVQSFFVFVNE 409 (569)
T ss_dssp EESCC---CC--SHHHHHHHHHHHHH
T ss_pred CeeCCCCCcc--ccCceechhhccHH
Confidence 9877544322 24468999999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=247.63 Aligned_cols=161 Identities=30% Similarity=0.461 Sum_probs=132.2
Q ss_pred eeccCCceEEEEEEEC---CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 73 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.+|++++||||+++++++.. +..++||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 45679999997643 345789999999999999999999999876 56999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccc
Q 025997 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (245)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 227 (245)
|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 422 L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 422 LHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp HHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred HHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999975432 2899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccc-cccccccccccCCC
Q 025997 228 ARLH-STRVLGTFGYHAPE 245 (245)
Q Consensus 228 ~~~~-~~~~~gt~~y~APE 245 (245)
.... .....+|+.|||||
T Consensus 491 ~~~~~~~~~~~~~~y~APE 509 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPE 509 (613)
T ss_dssp -----------CCTTSCHH
T ss_pred ceeeeccCCCCccceeCHh
Confidence 2111 12234678999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=230.71 Aligned_cols=169 Identities=27% Similarity=0.442 Sum_probs=135.4
Q ss_pred CCCCCCCeeccCCceEEEEEEECC-----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.+|.+.+.||+|+||.||+|.... +..||+|.+...... ...+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778899999999999998652 235999998755433 3468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence 9999999999999976432 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCcccccc-ccccccccccccCCC
Q 025997 219 LSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
+++......... ......+|+.|+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE 220 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPE 220 (333)
T ss_dssp C-----------------CCCGGGSCHH
T ss_pred cchhhccccccccccCCCCccccccCch
Confidence 998764332211 112234688999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=236.59 Aligned_cols=162 Identities=29% Similarity=0.427 Sum_probs=122.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeC------C
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------P 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 134 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367999999999999999999964 7889999999654333 35678999999999999999999998754 5
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..++++|++ +++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence 679999998 679999886532 899999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...... ....||+.|+|||
T Consensus 174 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE 199 (367)
T 2fst_X 174 LDFGLARHTADEM-----TGYVATRWYRAPE 199 (367)
T ss_dssp CC--------------------CCCTTCCHH
T ss_pred eeccccccccccC-----CCcCcCcCccChH
Confidence 9999998654321 3457999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=224.90 Aligned_cols=167 Identities=23% Similarity=0.347 Sum_probs=138.4
Q ss_pred CCCCCeeccCCceEEEEEEEC-CC---cEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce-EEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR-VLAY 140 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~ 140 (245)
|.+.+.||+|+||.||+|.+. ++ ..+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+.. +++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 555688999999999999854 22 36999998754432 35788999999999999999999999876655 9999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp CCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred ecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 99999999999976432 2789999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccc--cccccccccccccCCC
Q 025997 221 NQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
+........ .......||+.|+|||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 198 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALE 198 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHH
T ss_pred ccccCCcccccccCcCCCCCccccChh
Confidence 866443221 1123346889999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=235.58 Aligned_cols=167 Identities=22% Similarity=0.373 Sum_probs=128.4
Q ss_pred CCCCCeeccCCceEEEEEEEC--CC--cEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEe-CCceEEEE
Q 025997 68 FGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAY 140 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 140 (245)
|.+.+.||+|+||.||+|.+. ++ ..||+|.+...... .+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556688999999999999864 22 36899998654332 4678899999999999999999998754 45789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 171 e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp ECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence 99999999999976432 2788999999999999999999998 999999999999999999999999999
Q ss_pred CCCCcccccc--ccccccccccccCCC
Q 025997 221 NQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
+......... ......+|+.|+|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE 266 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALE 266 (373)
T ss_dssp ------------------CCGGGSCHH
T ss_pred ccccccccccccccCCCCCcccccChH
Confidence 8654322111 112345788999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=230.22 Aligned_cols=168 Identities=23% Similarity=0.403 Sum_probs=139.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467899999999999999999976 68899999986543 3457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.+++|.+++..... .+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 98 CPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred CCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999998875322 2899999999999999999999998 99999999999999999999999998753
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ......||+.|+|||
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE 187 (302)
T 2j7t_A 167 NLKTLQ--KRDSFIGTPYWMAPE 187 (302)
T ss_dssp HHHHHH--C-----CCGGGCCHH
T ss_pred cccccc--ccccccCChhhcCCe
Confidence 321111 113357999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-32 Score=221.91 Aligned_cols=169 Identities=30% Similarity=0.450 Sum_probs=140.2
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
++|.....||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44566669999999999999964 68899999986543 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceEEecccCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vkl~DfGla~~ 222 (245)
++++|.+++...... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||++..
T Consensus 102 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 102 PGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp SEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred CCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999865321 12678888999999999999999998 999999999999987 89999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE 193 (295)
T 2clq_A 173 LAGINPC--TETFTGTLQYMAPE 193 (295)
T ss_dssp SCC-------CCCCCCGGGCCHH
T ss_pred cCCCCCc--ccccCCCccccChh
Confidence 5432211 23457999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=228.02 Aligned_cols=175 Identities=22% Similarity=0.338 Sum_probs=131.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC---
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP--- 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 134 (245)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.++++++||||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 456888889999999999999854 3458999998765433 356889999999999999999999988654
Q ss_pred --ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
..+++|||+.+++|.+++....... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3599999999999999985432111 1123899999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+++...............+|+.|+|||
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 219 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCch
Confidence 999999998765433222223345788999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=228.92 Aligned_cols=171 Identities=22% Similarity=0.376 Sum_probs=133.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++|+||+++++++...+..+++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999964 789999999865322 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred EecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 9999999999998642111 112889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+......... .....||+.|+|||
T Consensus 183 ~~~~~~~~~~--~~~~~~~~~y~aPE 206 (310)
T 2wqm_A 183 GRFFSSKTTA--AHSLVGTPYYMSPE 206 (310)
T ss_dssp ------------------CCSSCCHH
T ss_pred eeeecCCCcc--ccccCCCeeEeChH
Confidence 8765433221 13356899999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=233.96 Aligned_cols=168 Identities=17% Similarity=0.259 Sum_probs=134.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCCCc------------hHHHHHHHHHHHccCCCCcceEeE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVELVG 128 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~ 128 (245)
.++|.+.+.||+|+||.||+|... ++..+|+|++...... ...+.+|+..++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999975 5678999998655322 123567888899999999999999
Q ss_pred EEEe----CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 025997 129 YYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (245)
Q Consensus 129 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Ni 204 (245)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 182 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL 182 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence 9987 77899999999 899999997654 2899999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEecccCCCCCCcccccc-----ccccccccccccCCC
Q 025997 205 LLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 205 ll~~~~--~vkl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
|++.++ .+||+|||+++......... ......||+.|+|||
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 230 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD 230 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHH
Confidence 999877 99999999997664332111 113457999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.20 Aligned_cols=175 Identities=28% Similarity=0.437 Sum_probs=139.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcE--EEEEEcCCCC--CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA--AAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~--vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (245)
.++|.+.+.||+|+||.||+|+.. ++.. +|+|.+.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367899999999999999999965 5554 4889875432 2346788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 139 AYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
||||+++++|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 9999999999999976530000 000113899999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++....... .....+|+.|+|||
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE 211 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIE 211 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHH
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChh
Confidence 99999999875433221 12335788999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=227.06 Aligned_cols=168 Identities=26% Similarity=0.408 Sum_probs=137.2
Q ss_pred hCCCCCCC-eeccCCceEEEEEEEC---CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 65 TDNFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
.++|.+.+ .||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 8999999999999642 4678999998754332 46788999999999999999999998 667789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 99999999999999986532 889999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCcccccc-ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
|++.......... ......||+.|+|||
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE 190 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPE 190 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChH
Confidence 9997654332211 112234678999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=240.55 Aligned_cols=168 Identities=13% Similarity=0.181 Sum_probs=133.1
Q ss_pred CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCC----CCchHHHHHHH---HHHHccCCCCcceEe-------EEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSS----KQPDQEFLAQV---SMVSRLKNENVVELV-------GYY 130 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~ 130 (245)
++|.+.+.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+ .++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5678889999999999999995 57899999998532 22346788999 556666899999998 666
Q ss_pred EeCC-----------------ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 025997 131 VDGP-----------------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (245)
Q Consensus 131 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 193 (245)
.+.+ ..+++|||+ +|+|.+++....... .....+++..++.++.||+.||.|||+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5543 278999999 579999998643211 00112446788889999999999999998
Q ss_pred eEecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 194 ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE 272 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPE 272 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChh
Confidence 999999999999999999999999999864332 134568 9999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=228.26 Aligned_cols=170 Identities=25% Similarity=0.394 Sum_probs=141.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCC--ce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 136 (245)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 36889999998764433 457889999999999999999999987543 78
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 999999999999999986532 2889999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
||++.......... ......+|..|+|||
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 218 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHH
T ss_pred CcchhhccccccccccccCCCCceeEECch
Confidence 99997664432211 112345788899998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=228.17 Aligned_cols=166 Identities=28% Similarity=0.492 Sum_probs=132.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 356888899999999999999986 688999998643 34567899999999999999999999876 45899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc-eEEecccCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQA 223 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~-vkl~DfGla~~~ 223 (245)
+++|.+++...... ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++...
T Consensus 83 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 83 GGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp TCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999865321 12688899999999999999999932123999999999999998886 799999999765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....||+.|+|||
T Consensus 157 ~~~~-----~~~~gt~~y~aPE 173 (307)
T 2eva_A 157 QTHM-----TNNKGSAAWMAPE 173 (307)
T ss_dssp -------------CCTTSSCHH
T ss_pred cccc-----ccCCCCCceEChh
Confidence 4322 2346999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=231.07 Aligned_cols=176 Identities=25% Similarity=0.381 Sum_probs=139.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|.+ .++..||||.+...... ...+.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999984 25678999999654332 35688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceE
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vk 213 (245)
++||||+.+++|.+++....... .....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+|
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999998754221 11123889999999999999999999998 999999999999984 45699
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++................||+.|+|||
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 215 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHh
Confidence 99999986432222211223346899999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=234.60 Aligned_cols=166 Identities=21% Similarity=0.331 Sum_probs=143.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc------------------hHHHHHHHHHHHccCCCCcceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP------------------DQEFLAQVSMVSRLKNENVVEL 126 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~h~niv~~ 126 (245)
.++|.+.+.||+|+||.||+|.. +++.||+|.+...... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999998532111 1788999999999999999999
Q ss_pred eEEEEeCCceEEEEEecCCCCHHHH------HhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCC
Q 025997 127 VGYYVDGPLRVLAYEHASKGSLHDI------LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNI 199 (245)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDl 199 (245)
++++.+.+..++||||+.+++|.++ +..... ..+++..++.++.||+.||.|||+ ++ |+||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl 178 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT-------CFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV 178 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC-------CCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc-------cCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence 9999999999999999999999998 443211 238999999999999999999999 87 999999
Q ss_pred CCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 200 kp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||++.++.+||+|||++....... .....||+.|+|||
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE 220 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPE 220 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGG
T ss_pred ChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCch
Confidence 9999999999999999999997654331 23457999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=229.84 Aligned_cols=179 Identities=26% Similarity=0.348 Sum_probs=128.2
Q ss_pred HhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 63 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999954 78899999886543 2345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+++|.+++....... ......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999987421100 001123899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccc---ccccccccccccccCCC
Q 025997 220 SNQAPDAAA---RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~---~~~~~~~~gt~~y~APE 245 (245)
+........ ........||+.|+|||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPE 196 (303)
T ss_dssp HHHCC---------------CCCTTCCHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHH
Confidence 865432211 11113356999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=230.18 Aligned_cols=169 Identities=24% Similarity=0.347 Sum_probs=139.5
Q ss_pred hhCCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccC-CCCcceEeEEEEeCCceE
Q 025997 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRV 137 (245)
Q Consensus 64 ~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 137 (245)
..+.|.+. +.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34456666 78999999999999976 689999999865332 3567889999999994 699999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl 214 (245)
+||||+.+++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred EEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999998654221 3899999999999999999999998 999999999999987 789999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++........ ....||+.|+|||
T Consensus 176 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE 203 (327)
T 3lm5_A 176 VDFGMSRKIGHACEL---REIMGTPEYLAPE 203 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHH
T ss_pred eeCccccccCCcccc---ccccCCcCccCCe
Confidence 999999866443221 3457999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=235.88 Aligned_cols=165 Identities=23% Similarity=0.309 Sum_probs=138.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC--------CCCcceEeEEEE----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK--------NENVVELVGYYV---- 131 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~---- 131 (245)
.++|.+.+.||+|+||.||+|+.. +++.||||++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 367999999999999999999965 6889999999765444577889999999986 788999999987
Q ss_pred eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCC
Q 025997 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDD 210 (245)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~ 210 (245)
.....++||||+ +++|.+.+...... .+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 456789999999 55777766544321 289999999999999999999998 7 99999999999998775
Q ss_pred -------------------------------------------------ceEEecccCCCCCCccccccccccccccccc
Q 025997 211 -------------------------------------------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (245)
Q Consensus 211 -------------------------------------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y 241 (245)
.+||+|||++....... ....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcc
Confidence 79999999997654321 345799999
Q ss_pred cCCC
Q 025997 242 HAPE 245 (245)
Q Consensus 242 ~APE 245 (245)
+|||
T Consensus 260 ~aPE 263 (397)
T 1wak_A 260 RSLE 263 (397)
T ss_dssp CCHH
T ss_pred cCCh
Confidence 9998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=228.97 Aligned_cols=165 Identities=18% Similarity=0.349 Sum_probs=141.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-C-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC------cceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-R-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~ 136 (245)
.++|++.+.||+|+||.||+|.. . +++.||+|++.......+.+.+|+.+++.++|++ ++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46799999999999999999996 3 6789999999765444567888999999887654 99999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC--------
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------- 208 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-------- 208 (245)
++||||+ +++|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence 9999999 78999999865432 2789999999999999999999998 999999999999987
Q ss_pred -----------CCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 209 -----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 209 -----------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.+||+|||+++...... ....||+.|+|||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 204 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPE 204 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHH
T ss_pred CccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChH
Confidence 6689999999987644321 3457999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=249.40 Aligned_cols=160 Identities=20% Similarity=0.348 Sum_probs=136.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCc-----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 135 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 6889999998654332 3467899999999999999999999987665
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 7999999999999987754 1899999999999999999999998 9999999999999875 89999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++..... ....||+.|||||
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE 247 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPE 247 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTT
T ss_pred ecccchhcccC------CccCCCccccCHH
Confidence 99999766432 3457999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=229.41 Aligned_cols=167 Identities=27% Similarity=0.410 Sum_probs=139.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeC-----Cce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 136 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999976 7889999999654332 35678999999999999999999987654 678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
+++|||+. ++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 155 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCD 155 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred EEEEeccC-ccHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEe
Confidence 99999997 59999987642 899999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCcccccc--------ccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARL--------HSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~--------~~~~~~gt~~y~APE 245 (245)
||+++......... ......||+.|+|||
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCe
Confidence 99997654322110 112357899999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=236.03 Aligned_cols=174 Identities=23% Similarity=0.373 Sum_probs=126.0
Q ss_pred CCCC-CCeeccCCceEEEEEEEC---CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe--CCceEEEE
Q 025997 67 NFGT-NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAY 140 (245)
Q Consensus 67 ~~~~-~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 140 (245)
.|.+ .++||+|+||.||+|+++ +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 4655 458999999999999965 57889999997543 33568899999999999999999999964 66899999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----cCCCceEEec
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISD 216 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill----~~~~~vkl~D 216 (245)
||+.+ +|.+++..............+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99975 88888763321110111123889999999999999999999998 9999999999999 6778999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
||+++........ ......+||+.|+|||
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPE 205 (405)
T ss_dssp TTCCC----------------CCCTTCCHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCch
Confidence 9999876432211 1123457999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=226.08 Aligned_cols=169 Identities=26% Similarity=0.310 Sum_probs=128.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch--HH-HHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QE-FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~-~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|... +++.||+|++....... .. +.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999974 78899999987654332 22 334455578889999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||+.+ +|.+++...... ...+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 86 e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp ECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred ehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence 99975 888877542110 11389999999999999999999997 7 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....||+.|+|||
T Consensus 157 ~~~~~~~~~~---~~~~~t~~y~aPE 179 (290)
T 3fme_A 157 SGYLVDDVAK---DIDAGCKPYMAPE 179 (290)
T ss_dssp ----------------CCCCCCSCHH
T ss_pred cccccccccc---cccCCCccccChh
Confidence 9776543322 3346999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=222.98 Aligned_cols=168 Identities=23% Similarity=0.370 Sum_probs=137.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998542 33699999876533 24678899999999999999999999864 55789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 90 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence 9999999999999976432 2889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++.......... .....+|+.|+|||
T Consensus 159 ~~~~~~~~~~~~-~~~~~~~~~y~aPE 184 (281)
T 3cc6_A 159 LSRYIEDEDYYK-ASVTRLPIKWMSPE 184 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHH
T ss_pred CCcccccccccc-cccCCCCcceeCch
Confidence 998765432211 12345788999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=231.45 Aligned_cols=161 Identities=26% Similarity=0.412 Sum_probs=135.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCce----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR---- 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 136 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 367899999999999999999965 7889999999765433 35678999999999999999999999877654
Q ss_pred --EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 137 --VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 137 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
++||||+. ++|.+++... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEcccc-ccHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEE
Confidence 99999997 5898887432 889999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...... ....||+.|+|||
T Consensus 186 ~Dfg~a~~~~~~~-----~~~~~t~~y~aPE 211 (371)
T 4exu_A 186 LDFGLARHADAEM-----TGYVVTRWYRAPE 211 (371)
T ss_dssp CSTTCC-------------CTTCCCTTSCHH
T ss_pred EecCcccccccCc-----CCcccCccccCHH
Confidence 9999997654322 3457899999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=222.28 Aligned_cols=165 Identities=27% Similarity=0.387 Sum_probs=138.6
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe----CCceEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVL 138 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 138 (245)
.|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677788999999999999965 6788999988644322 3568899999999999999999999875 356899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-CCCceEEecc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDF 217 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~-~~~~vkl~Df 217 (245)
||||+.+++|.+++..... +++..++.++.||+.||.|||+++ ++|+||||||+|||++ .++.+||+||
T Consensus 107 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 9999999999999976432 889999999999999999999984 2399999999999997 7899999999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|++........ ....||+.|+|||
T Consensus 177 g~~~~~~~~~~----~~~~~t~~y~aPE 200 (290)
T 1t4h_A 177 GLATLKRASFA----KAVIGTPEFMAPE 200 (290)
T ss_dssp TGGGGCCTTSB----EESCSSCCCCCGG
T ss_pred CCccccccccc----ccccCCcCcCCHH
Confidence 99865443221 3356999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=226.30 Aligned_cols=167 Identities=20% Similarity=0.350 Sum_probs=136.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---hHHHHHHHHHHHccC--CCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 139 (245)
.++|.+.+.||+|+||.||++...+++.||+|++...... .+.+.+|+.++++++ |+||+++++++...+..+++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4568999999999999999999888999999998654433 356889999999997 59999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|| +.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 107 ~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~ 172 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI 172 (313)
T ss_dssp EC-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred Ee-cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccc
Confidence 99 567899999986542 889999999999999999999998 99999999999996 48999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++...............||+.|+|||
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPE 198 (313)
T ss_dssp SCC--------------CCGGGCCHH
T ss_pred cccccCccccccccCCCCCCCcCCHH
Confidence 98765443322223457999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=236.82 Aligned_cols=165 Identities=25% Similarity=0.341 Sum_probs=132.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeC------CceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 138 (245)
.+|.+.+.||+|+||.||+|++. +++.||||++..... ...+|++++++++|+||+++++++... .++++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35888999999999999999975 689999999854432 234699999999999999999988542 23679
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-CceEEecc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDF 217 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-~~vkl~Df 217 (245)
||||+.+ +|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 131 v~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence 9999986 677666431100 113899999999999999999999998 9999999999999955 67899999
Q ss_pred cCCCCCCccccccccccccccccccCCC
Q 025997 218 DLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+++........ ...+||+.|+|||
T Consensus 202 G~a~~~~~~~~~---~~~~~t~~y~aPE 226 (420)
T 1j1b_A 202 GSAKQLVRGEPN---VSYICSRYYRAPE 226 (420)
T ss_dssp TTCEECCTTCCC---CSCCSCTTSCCHH
T ss_pred hhhhhcccCCCc---eeeeeCCCcCCHH
Confidence 999865433221 3457999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-33 Score=233.36 Aligned_cols=166 Identities=17% Similarity=0.242 Sum_probs=138.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC---------CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcce----------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE---------- 125 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 125 (245)
.++|.+.+.||+|+||.||+|.... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3679999999999999999999763 789999998644 46889999999999999987
Q ss_pred -----EeEEEEe-CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 025997 126 -----LVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (245)
Q Consensus 126 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDl 199 (245)
+++++.. ++..++||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 185 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHENE---YVHGNV 185 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5677765 67889999999 89999999865211 2899999999999999999999998 999999
Q ss_pred CCCCeEEcCCC--ceEEecccCCCCCCcccccc-----ccccccccccccCCC
Q 025997 200 KSSNVLLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 200 kp~Nill~~~~--~vkl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
||+|||++.++ .+||+|||+++......... ......||+.|+|||
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 238 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHH
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHH
Confidence 99999999988 99999999998765433211 112347999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=247.39 Aligned_cols=161 Identities=27% Similarity=0.413 Sum_probs=131.4
Q ss_pred CeeccCCceEEEEEEEC---CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|+.++++++||||+++++++. .+..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 36999999999999753 467899999875432 2467999999999999999999999986 4568899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 454 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999976542 889999999999999999999998 99999999999999999999999999976543
Q ss_pred cccc-cccccccccccccCCC
Q 025997 226 AAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~APE 245 (245)
.... .......||+.|+|||
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE 542 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPE 542 (635)
T ss_dssp -------------CGGGSCHH
T ss_pred CccccccccCCCCceeeeChh
Confidence 3221 1112335788999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-33 Score=225.18 Aligned_cols=164 Identities=30% Similarity=0.500 Sum_probs=133.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeC-CceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-PLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 143 (245)
.++|++.+.||+|+||.||+|... ++.||+|.+.... ..+.+.+|+.++++++||||+++++++... +..+++|||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 467889999999999999999875 7899999986543 457789999999999999999999987654 4789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.+++|.+++...... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 98 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 999999999754321 2688889999999999999999998 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....+|+.|+|||
T Consensus 168 ~~~~-----~~~~~~~~y~aPE 184 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPE 184 (278)
T ss_dssp -------------CCTTTSCHH
T ss_pred cccc-----cCCCccccccCHH
Confidence 4322 2235788999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=233.81 Aligned_cols=165 Identities=23% Similarity=0.299 Sum_probs=131.9
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCC------ceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------LRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv 139 (245)
.+|.+.+.||+|+||.||+|+...+..+|+|++...... ..+|+.+++.++||||+++++++.... ..++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 468999999999999999999887777999988543322 236899999999999999999986543 37899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-CCCceEEeccc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~-~~~~vkl~DfG 218 (245)
|||+.++ +.+.+...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 117 ~e~~~~~-l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EECCSEE-HHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeccCcc-HHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 9999874 44433311000 012889999999999999999999998 99999999999999 79999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++........ ....||+.|+|||
T Consensus 188 ~a~~~~~~~~~---~~~~~t~~y~aPE 211 (394)
T 4e7w_A 188 SAKILIAGEPN---VSYICSRYYRAPE 211 (394)
T ss_dssp TCEECCTTCCC---CSSCSCGGGCCHH
T ss_pred CcccccCCCCC---cccccCcCccCHH
Confidence 99765433222 3457899999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=227.94 Aligned_cols=173 Identities=25% Similarity=0.322 Sum_probs=139.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEe----CCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 138 (245)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45799999999999999999997 578999999885432 234678899999999999999999999873 347899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.+++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 99999999999998763211 113899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCcccccc-------ccccccccccccCCC
Q 025997 219 LSNQAPDAAARL-------HSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~-------~~~~~~gt~~y~APE 245 (245)
++.......... ......||+.|+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred cchhcccccccccccccccccccccCCcccCCHh
Confidence 987654221110 011235799999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=224.23 Aligned_cols=167 Identities=26% Similarity=0.398 Sum_probs=138.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEEcCCCC---CchHHHHHHHHHHHcc---CCCCcceEeEEEE-----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL---KNENVVELVGYYV----- 131 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~----- 131 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 467999999999999999999973 67889999885322 2234566777777666 8999999999987
Q ss_pred eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
.....+++|||+. |+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCC
Confidence 4567899999998 5999999765432 2889999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++....... .....||+.|+|||
T Consensus 159 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE 189 (326)
T 1blx_A 159 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPE 189 (326)
T ss_dssp EEECSCCSCCCCCGGGG---GCCCCCCCTTCCHH
T ss_pred EEEecCcccccccCCCC---ccccccccceeCHH
Confidence 99999999987654332 23457999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=245.43 Aligned_cols=168 Identities=27% Similarity=0.397 Sum_probs=138.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4568888999999999999999752 457999998654333 367889999999999999999999984 567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 468 v~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp EEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 9999999999999986532 2889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++........ ......||+.|||||
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE 562 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPE 562 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHH
T ss_pred CCeecCCCcce-eccCCCCCcceeCHH
Confidence 99876543322 112345788999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=227.31 Aligned_cols=166 Identities=22% Similarity=0.308 Sum_probs=135.0
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc-------hHHHHHHHHHHHcc----CCCCcceEeEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRL----KNENVVELVGYYV 131 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l----~h~niv~~~~~~~ 131 (245)
..++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+|+.+++++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4577999999999999999999964 7889999999654321 23455789999888 8999999999999
Q ss_pred eCCceEEEEEe-cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-CC
Q 025997 132 DGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DD 209 (245)
Q Consensus 132 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~-~~ 209 (245)
..+..++++|+ +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++ .+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 99999999999 78899999997643 2899999999999999999999998 99999999999999 88
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+||+|||++........ ....||+.|+|||
T Consensus 177 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE 208 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPE 208 (312)
T ss_dssp TEEEECCCSSCEECCSSCB----CCCCSCTTTSCHH
T ss_pred CeEEEEEcchhhhcccCcc----cccCCcccccCce
Confidence 9999999999876654321 3456999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=221.70 Aligned_cols=167 Identities=26% Similarity=0.393 Sum_probs=143.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC---CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
..++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4567999999999999999999976 7889999998543 23457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC---CceEEec
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISD 216 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~---~~vkl~D 216 (245)
+||+.+++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|
T Consensus 100 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (287)
T ss_dssp ECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred EEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEec
Confidence 999999999998865432 889999999999999999999998 9999999999999754 4799999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||++......... ....||+.|+|||
T Consensus 168 fg~~~~~~~~~~~---~~~~~~~~y~aPE 193 (287)
T 2wei_A 168 FGLSTCFQQNTKM---KDRIGTAYYIAPE 193 (287)
T ss_dssp TTGGGTBCCCSSC---SCHHHHHTTCCHH
T ss_pred cCcceeecCCCcc---ccccCcccccChH
Confidence 9998765433211 2346899999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=228.14 Aligned_cols=168 Identities=21% Similarity=0.340 Sum_probs=142.2
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-------chHHHHHHHHHHHccC--CCCcceEeEEEE
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLK--NENVVELVGYYV 131 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 131 (245)
....++|.+.+.||+|+||.||+|... +++.||||.+..... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334577999999999999999999964 788999999854322 2245678999999996 599999999999
Q ss_pred eCCceEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-CC
Q 025997 132 DGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DD 209 (245)
Q Consensus 132 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~-~~ 209 (245)
..+..++++|++.+ ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 99999999999976 89999997643 2889999999999999999999998 99999999999999 78
Q ss_pred CceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+||+|||+++...... .....||+.|+|||
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE 218 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 218 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHH
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChH
Confidence 999999999987665332 13457999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=233.06 Aligned_cols=168 Identities=24% Similarity=0.384 Sum_probs=139.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccCC-CCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.+++.|+| ++|..+..++...+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46899999999999999999996 4789999998754432 3457889999999987 5666666777788889999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEecccC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~DfGl 219 (245)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred C-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9 8899999975432 2899999999999999999999998 9999999999999 5889999999999
Q ss_pred CCCCCcccccc-----ccccccccccccCCC
Q 025997 220 SNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
++......... ......||+.|+|||
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 183 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVN 183 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ceeccCCccccccccccccccCCCccccCHH
Confidence 98664432211 112467999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=223.68 Aligned_cols=175 Identities=22% Similarity=0.349 Sum_probs=141.1
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe--CCceE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRV 137 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 137 (245)
..++|++.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3567999999999999999999976 7889999998654433 3568899999999999999999998754 56789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeEEcCCCceEEe
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
++|||+++++|.+++...... ...+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 999999999999999753211 123889999999999999999999974 1239999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+++........ .....||+.|+|||
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 159 DFGLARILNHDTSF--AKTFVGTPYYMSPE 186 (279)
T ss_dssp CCCHHHHC---CHH--HHHHHSCCTTCCHH
T ss_pred cCchheeecccccc--ccccCCCccccChH
Confidence 99998765432211 12346899999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=223.15 Aligned_cols=167 Identities=23% Similarity=0.325 Sum_probs=131.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEE-----------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYV----------- 131 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~----------- 131 (245)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999976 588999998865432 2467889999999999999999999873
Q ss_pred ---eCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-
Q 025997 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (245)
Q Consensus 132 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~- 207 (245)
..+..+++|||+. |+|.+++.... +++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 3467899999998 59999996532 889999999999999999999998 99999999999997
Q ss_pred CCCceEEecccCCCCCCccccc-cccccccccccccCCC
Q 025997 208 DDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ~~~~vkl~DfGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
+++.+||+|||+++........ .......||+.|+|||
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcH
Confidence 5679999999999866432111 1112346799999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-33 Score=235.01 Aligned_cols=163 Identities=12% Similarity=0.056 Sum_probs=119.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHcc--CCCCcceEe-------EEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL--KNENVVELV-------GYYV 131 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l--~h~niv~~~-------~~~~ 131 (245)
.+|.+.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34888899999999999999965 7889999999765432 34566775444444 699988755 4444
Q ss_pred eC-----------------CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhc
Q 025997 132 DG-----------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR------VKIAVGAARGLEYLHE 188 (245)
Q Consensus 132 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~lH~ 188 (245)
.. ...++||||+. ++|.+++...... +.+..+ +.++.||+.||.|||+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 33 23799999999 7999999864221 333344 6777999999999999
Q ss_pred CCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 189 ~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++ |+||||||+|||++.++.+||+|||+++...... ....||+.|+|||
T Consensus 213 ~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE 261 (371)
T 3q60_A 213 KG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPRE 261 (371)
T ss_dssp TT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHH
T ss_pred CC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChh
Confidence 98 9999999999999999999999999998664332 1345779999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=219.53 Aligned_cols=168 Identities=23% Similarity=0.365 Sum_probs=135.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEE-EeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++.++|++++..+..+ ...+..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 46799999999999999999996 578899999864432 224578899999999988766665554 677788999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEecccC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~DfGl 219 (245)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp C-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred c-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9 8899999975432 2899999999999999999999998 9999999999999 7889999999999
Q ss_pred CCCCCccccc-----cccccccccccccCCC
Q 025997 220 SNQAPDAAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~-----~~~~~~~gt~~y~APE 245 (245)
++........ .......||+.|+|||
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchH
Confidence 9765443221 1123457999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=227.29 Aligned_cols=161 Identities=26% Similarity=0.402 Sum_probs=135.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCc-----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 135 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367899999999999999999975 7889999998664433 3567889999999999999999999987654
Q ss_pred -eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.+++|||+. ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 499999997 588877642 1889999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++...... ....||+.|+|||
T Consensus 168 ~Dfg~~~~~~~~~-----~~~~~t~~y~aPE 193 (353)
T 3coi_A 168 LDFGLARHADAEM-----TGYVVTRWYRAPE 193 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHH
T ss_pred eecccccCCCCCc-----cccccCcCcCCHH
Confidence 9999997654321 3357899999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=222.20 Aligned_cols=170 Identities=29% Similarity=0.379 Sum_probs=125.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHH-HHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|.+.+.||+|+||.||+|... +++.||||++...... ...+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999975 7889999998655332 234556665 677789999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||+.+ +|.+++...... ....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 101 e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp CCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99985 888877631100 011388999999999999999999998 8 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
++........ ....||+.|+|||
T Consensus 173 ~~~~~~~~~~---~~~~gt~~y~aPE 195 (327)
T 3aln_A 173 SGQLVDSIAK---TRDAGCRPYMAPE 195 (327)
T ss_dssp SCC-----------------------
T ss_pred ceeccccccc---ccCCCCccccCce
Confidence 9876543221 3346999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=225.73 Aligned_cols=165 Identities=18% Similarity=0.334 Sum_probs=139.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CC-cEEEEEEcCCCCCchHHHHHHHHHHHccCCCC------cceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|... ++ ..||+|++.......+.+.+|+.++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 467999999999999999999975 44 68999999765445567888999999998765 89999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE----------
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---------- 206 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---------- 206 (245)
++||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEecc-CCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 9999999 56777777654321 2889999999999999999999998 9999999999999
Q ss_pred ---------cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 ---------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ---------~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...... ....||+.|+|||
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 209 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPE 209 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHH
T ss_pred ccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCe
Confidence 567899999999997543322 3457999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=218.27 Aligned_cols=168 Identities=23% Similarity=0.366 Sum_probs=138.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEE-EeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 142 (245)
.++|.+.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ...+..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 46799999999999999999996 578999999885443 335688999999999988766555544 567788999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE---cCCCceEEecccC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill---~~~~~vkl~DfGl 219 (245)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred c-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9 8899999975432 2899999999999999999999998 9999999999999 4788999999999
Q ss_pred CCCCCcccccc-----ccccccccccccCCC
Q 025997 220 SNQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
++......... ......||+.|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHH
T ss_pred cccccccccccccccccccccccccccCChh
Confidence 97654432211 123457999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=227.71 Aligned_cols=165 Identities=27% Similarity=0.316 Sum_probs=138.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CC-----CcceEeEEEEeCCceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NE-----NVVELVGYYVDGPLRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~ 137 (245)
.++|.+.+.||+|+||.||+|... +++.||||++.........+..|+.+++.++ |+ +|+++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 578999999999999999999966 6789999999755444566778888888875 44 4999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCCeEecCCCCCCeEEc--CCCceE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE--KAEPRIIHRNIKSSNVLLF--DDDIAK 213 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~~~ivHrDlkp~Nill~--~~~~vk 213 (245)
+||||+. ++|.+++...... .+++..+..++.||+.||.|||. .+ |+||||||+|||++ .++.+|
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred EEEecCC-CCHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 9999996 4999999865422 28899999999999999999995 45 99999999999995 478899
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++...... ....||+.|+|||
T Consensus 202 L~DFG~a~~~~~~~-----~~~~~t~~y~aPE 228 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI-----YQYIQSRFYRSPE 228 (382)
T ss_dssp ECCCTTCEETTCCC-----CSSCSCGGGCCHH
T ss_pred EEeccCceeccccc-----ccccCCccccChH
Confidence 99999997664321 3457999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=222.70 Aligned_cols=163 Identities=23% Similarity=0.349 Sum_probs=120.5
Q ss_pred hCCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHH-HHHHccCCCCcceEeEEEEe----CCceE
Q 025997 65 TDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV-SMVSRLKNENVVELVGYYVD----GPLRV 137 (245)
Q Consensus 65 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~----~~~~~ 137 (245)
.++|.+. +.||+|+||.||+|.+. +++.||||++... ....+|+ ..++.++|+||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678885 46999999999999976 7899999998543 2233333 34667799999999999876 44589
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl 214 (245)
+||||+.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 999999999999999865432 3899999999999999999999998 999999999999976 456999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++....... ....||+.|+|||
T Consensus 173 ~Dfg~~~~~~~~~~----~~~~~t~~y~aPE 199 (336)
T 3fhr_A 173 TDFGFAKETTQNAL----QTPCYTPYYVAPE 199 (336)
T ss_dssp CCCTTCEEC----------------------
T ss_pred eccccceecccccc----ccCCCCcCccChh
Confidence 99999976543221 3457899999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=221.50 Aligned_cols=169 Identities=30% Similarity=0.470 Sum_probs=130.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC--CCc--EEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGR--AAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~--~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|++.+.||+|+||.||+|.+. +++ .||+|++..... ..+.+.+|+.++++++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999853 333 689998865422 2467889999999999999999999997654 8
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
++++||+.+++|.+++..... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence 899999999999999976432 2889999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccc-cccccccccccccCCC
Q 025997 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
||++......... .......+|+.|+|||
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHH
T ss_pred ccccccccccccchhhhccCCCCceeeCch
Confidence 9998766433221 1122345788999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=229.29 Aligned_cols=165 Identities=19% Similarity=0.277 Sum_probs=139.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-----------CCCcceEeEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD 132 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 132 (245)
.++|.+.+.||+|+||.||+|... +++.||||++.......+.+.+|+.++++++ |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 467999999999999999999964 7889999999765545667888999988886 7899999999886
Q ss_pred CC----ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEc
Q 025997 133 GP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLF 207 (245)
Q Consensus 133 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~ 207 (245)
.+ ..+++||++ +++|.+++...... .+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 166 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEe
Confidence 54 789999999 88999999865432 288999999999999999999998 8 99999999999994
Q ss_pred ------CCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 208 ------DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 208 ------~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..+.+||+|||++....... ....||+.|+|||
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE 205 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE 205 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH
T ss_pred ccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcH
Confidence 34589999999997654321 3347999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=223.38 Aligned_cols=168 Identities=27% Similarity=0.381 Sum_probs=136.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..++|++.+.||+|+||.||+|.... .+|+|++..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999999764 599999865432 2356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 109 e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp BCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999976432 2888999999999999999999998 99999999999998 679999999998
Q ss_pred CCCCcccc---ccccccccccccccCCC
Q 025997 221 NQAPDAAA---RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~---~~~~~~~~gt~~y~APE 245 (245)
........ ........||+.|+|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE 204 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPE 204 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHH
T ss_pred cccccccccccccccccCCCcccccChH
Confidence 75432111 11112346999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=221.78 Aligned_cols=172 Identities=24% Similarity=0.335 Sum_probs=127.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccC-CCCcceEeEEEEe--------CC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLK-NENVVELVGYYVD--------GP 134 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--------~~ 134 (245)
.+|.+.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46888999999999999999965 788999998854332 2456889999999996 9999999999853 33
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..+++|||+. |+|.+++...... ..+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred eEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 4799999996 6999988652211 12899999999999999999999973 23999999999999999999999
Q ss_pred ecccCCCCCCcccccc----------ccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~----------~~~~~~gt~~y~APE 245 (245)
+|||+++......... ......||+.|+|||
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp CCCTTCBCCSSCC----------------------------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence 9999998765332210 011346999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=230.22 Aligned_cols=166 Identities=23% Similarity=0.302 Sum_probs=130.1
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.+|...+.||+|+||.|+.....+++.||||++.... ...+.+|+.+++.+ +||||+++++++.+....++||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 3578888999999999776556678999999986532 23356899999999 79999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-----CCceEEecccC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-----DDIAKISDFDL 219 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-----~~~vkl~DfGl 219 (245)
|+|.+++...... +....++.++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+
T Consensus 102 -g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 102 -ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp -EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred -CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 5999999865421 333456789999999999999998 999999999999953 23688999999
Q ss_pred CCCCCccccc-cccccccccccccCCC
Q 025997 220 SNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
++........ .......||+.|+|||
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE 196 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPE 196 (432)
T ss_dssp EECC------------CCSCTTSCCGG
T ss_pred eeeccCCCcceeeccccCCCcCccChh
Confidence 9876533211 1123457999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=230.14 Aligned_cols=170 Identities=24% Similarity=0.301 Sum_probs=126.8
Q ss_pred CCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEEEEEecCCC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASKG 146 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (245)
|.+.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+. |
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4456789999999998777778999999988542 245678899999886 89999999999999999999999996 5
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC-------------CceE
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-------------DIAK 213 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~-------------~~vk 213 (245)
+|.+++........ .....++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+|
T Consensus 94 sL~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 94 NLQDLVESKNVSDE--NLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp EHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred CHHHHHhccCCCch--hhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 99999986542210 0011233345789999999999999998 9999999999999754 4899
Q ss_pred EecccCCCCCCcccccc--ccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~APE 245 (245)
|+|||+++......... ......||+.|+|||
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 202 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence 99999998765432211 113457999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=236.52 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=140.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEe------CCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD------GPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 135 (245)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999964 6889999998654332 4568899999999999999999998765 667
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc---e
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---A 212 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~---v 212 (245)
.++||||+.+|+|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEE
T ss_pred EEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeE
Confidence 89999999999999999865421 12778889999999999999999998 999999999999997664 9
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||++......... ....||+.|+|||
T Consensus 164 KL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE 193 (676)
T 3qa8_A 164 KIIDLGYAKELDQGELC---TEFVGTLQYLAPE 193 (676)
T ss_dssp EECSCCCCCBTTSCCCC---CCCCSCCTTCSSC
T ss_pred EEccccccccccccccc---ccccCCcccCChH
Confidence 99999999876543322 3457999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=217.94 Aligned_cols=166 Identities=25% Similarity=0.400 Sum_probs=123.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch--HH-HHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QE-FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~-~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||.||+|... +++.||||++....... .. +.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 78999999986554332 22 334455678889999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||+ ++.+..+...... .+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 104 e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp CCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCC
Confidence 999 4566665543221 288999999999999999999985 7 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+......... ....||+.|+|||
T Consensus 172 ~~~~~~~~~~---~~~~~~~~y~aPE 194 (318)
T 2dyl_A 172 SGRLVDDKAK---DRSAGCAAYMAPE 194 (318)
T ss_dssp C-----------------CCTTCCHH
T ss_pred chhccCCccc---cccCCCccccChh
Confidence 9765443221 3346999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=209.50 Aligned_cols=143 Identities=14% Similarity=0.066 Sum_probs=127.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch----HHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|.+.+.||+|+||.||+|++. +++.||||++....... +.+.+|+..+++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999976 58999999997654432 67889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+++|.+++... ....++..++.||+.||.|||+++ |+||||||+|||++.++.+||+++|..
T Consensus 111 e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp ECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999542 344568889999999999999998 999999999999999999999988765
Q ss_pred CC
Q 025997 221 NQ 222 (245)
Q Consensus 221 ~~ 222 (245)
..
T Consensus 177 ~~ 178 (286)
T 3uqc_A 177 PD 178 (286)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=230.47 Aligned_cols=153 Identities=17% Similarity=0.158 Sum_probs=118.9
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc---------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..+.||+|+||.||+|.. .++.+++|+....... .+.+.+|+.++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999944 4678899876443221 234789999999999999996666666778889999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||++
T Consensus 419 E~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp ECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred ECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccC
Confidence 99999999999864 3468899999999999998 999999999999998 9999999999
Q ss_pred CCCCcccccc-----ccccccccccccCCC
Q 025997 221 NQAPDAAARL-----HSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~-----~~~~~~gt~~y~APE 245 (245)
+......... ......||+.|||||
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE 506 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDE 506 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHH
Confidence 8776543221 123567999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=204.24 Aligned_cols=147 Identities=20% Similarity=0.346 Sum_probs=127.3
Q ss_pred hCCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHH-HccCCCCcceEeEEEEe----CCceE
Q 025997 65 TDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV-SRLKNENVVELVGYYVD----GPLRV 137 (245)
Q Consensus 65 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~ 137 (245)
.++|.+. +.||+|+||.||+|... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 4567776 77999999999999964 788999999853 35677888887 55699999999999886 67789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl 214 (245)
+||||+.+++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999999875422 2899999999999999999999998 999999999999998 789999
Q ss_pred ecccCCCCCCc
Q 025997 215 SDFDLSNQAPD 225 (245)
Q Consensus 215 ~DfGla~~~~~ 225 (245)
+|||++.....
T Consensus 162 ~Dfg~a~~~~~ 172 (299)
T 3m2w_A 162 TDFGFAKETTG 172 (299)
T ss_dssp CCCTTCEECTT
T ss_pred ecccccccccc
Confidence 99999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=211.55 Aligned_cols=167 Identities=13% Similarity=0.193 Sum_probs=121.8
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC----chHHHHHHHHHHHccCC-CCcc----------------
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKN-ENVV---------------- 124 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h-~niv---------------- 124 (245)
+|...+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++| .|..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4667789999999999999954 789999999873322 24678899999999977 2211
Q ss_pred -----eEeEEEEe-----CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 025997 125 -----ELVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (245)
Q Consensus 125 -----~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 194 (245)
.+..++.. ....+++|+++ +++|.+++....... .....+++..++.++.||+.||.|||+++ |
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111111 12356666655 579999885211000 00112778889999999999999999998 9
Q ss_pred EecCCCCCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 195 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 195 vHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||||||+|||++.++.+||+|||+++..... ....+| +.|||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE 277 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPE 277 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCch
Confidence 99999999999999999999999998766543 234578 9999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=194.94 Aligned_cols=136 Identities=14% Similarity=0.113 Sum_probs=110.2
Q ss_pred hhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-------------------chHHHHHHHHHHHccCCCCcc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------------------PDQEFLAQVSMVSRLKNENVV 124 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv 124 (245)
....|.+.+.||+|+||.||+|.+.+++.||+|.+..... ....+.+|+.++++++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 3445666699999999999999997789999999864321 2346789999999998 4 5
Q ss_pred eEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 025997 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (245)
Q Consensus 125 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Ni 204 (245)
++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+++ |+||||||+||
T Consensus 165 ~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 165 AVPKVYA-WEGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp SSCCEEE-EETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred CcCeEEe-ccceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 5666543 356799999999999988 421 123468999999999999998 99999999999
Q ss_pred EEcCCCceEEecccCCCCC
Q 025997 205 LLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 205 ll~~~~~vkl~DfGla~~~ 223 (245)
|++ ++.+||+|||+++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEV 242 (282)
T ss_dssp EEE-TTEEEECCCTTCEET
T ss_pred EEE-CCcEEEEECCCCeEC
Confidence 999 999999999998654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=174.67 Aligned_cols=136 Identities=16% Similarity=0.160 Sum_probs=105.9
Q ss_pred CCCCCeeccCCceEEEEEEE-CCCcE--EEEEEcCCCCCc-------------------------hHHHHHHHHHHHccC
Q 025997 68 FGTNSLIGEGSYGRVYFGVL-RSGRA--AAIKKLDSSKQP-------------------------DQEFLAQVSMVSRLK 119 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~ 119 (245)
|.+.+.||+|+||.||+|.. .+++. ||||++...... ...+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 999986543211 125778999999998
Q ss_pred CCCc--ceEeEEEEeCCceEEEEEecCC-C----CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCC
Q 025997 120 NENV--VELVGYYVDGPLRVLAYEHASK-G----SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAE 191 (245)
Q Consensus 120 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~ 191 (245)
|+++ ..++.. +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +++
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 8754 344432 357899999942 3 77776532 223356788999999999999 887
Q ss_pred CCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 192 ~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
|+||||||+|||++. .++|+|||+|....
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999999988 89999999997654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=7.7e-22 Score=165.68 Aligned_cols=139 Identities=12% Similarity=0.155 Sum_probs=99.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC---------------chHHH--------HHHHHHHHccCCC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------------PDQEF--------LAQVSMVSRLKNE 121 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------~~~~~--------~~E~~~l~~l~h~ 121 (245)
..-|.+...||+|+||.||+|...+|+.||||+++.... ..... .+|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 334888999999999999999998999999998753210 01111 2356666666544
Q ss_pred CcceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
++....-+.. ...+|||||+.|++|.++.. . .....++.||+.+|.|||++| ||||||||
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------------V--PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhcc-------------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 4322111111 23479999999988865432 1 124567899999999999998 99999999
Q ss_pred CCeEEcCCC----------ceEEecccCCCCC
Q 025997 202 SNVLLFDDD----------IAKISDFDLSNQA 223 (245)
Q Consensus 202 ~Nill~~~~----------~vkl~DfGla~~~ 223 (245)
.|||+++++ .+.|+||+-+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998776 3899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-15 Score=121.03 Aligned_cols=145 Identities=17% Similarity=0.098 Sum_probs=112.9
Q ss_pred HHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCC-CchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEE
Q 025997 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 62 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 139 (245)
....+.|.+...++.|+.+.||++... ++.+++|...... .....+.+|+.+++.+. +..+.++++++...+..|++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 445677888888888999999998754 6789999986421 23346888999999884 67788999999888899999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA----------------------------- 190 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------- 190 (245)
||+++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~--------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EECCSSEEHHHHCCT--------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred EEecCCeehhhccCC--------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 999999999876421 1123467788999999999810
Q ss_pred ---------------------------CCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 191 ---------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 191 ---------------------------~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=110.33 Aligned_cols=137 Identities=12% Similarity=0.038 Sum_probs=98.5
Q ss_pred CCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC--cceEeEEEEeCCceEEEEEecC
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~ 144 (245)
++.+....+.|..+.||++...++..+++|..... ....+.+|+.+++.+.+.+ +.+++.+...++..+++|||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34443333456679999998777788999987543 3345778999998885444 5678888887788999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 190 (245)
|.+|. ... .. ...++.+++..|..||+..
T Consensus 99 G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 99 GQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp SEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 98874 211 11 1245666777777777642
Q ss_pred ---------------------CCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 191 ---------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 191 ---------------------~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
...++|+|++|.|||+++++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=109.70 Aligned_cols=141 Identities=17% Similarity=0.183 Sum_probs=103.5
Q ss_pred CCCeeccCCceEEEEEEECCCcEEEEEEcC--CCC--CchHHHHHHHHHHHccC--CCCcceEeEEEEeC---CceEEEE
Q 025997 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSK--QPDQEFLAQVSMVSRLK--NENVVELVGYYVDG---PLRVLAY 140 (245)
Q Consensus 70 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 140 (245)
..+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.|. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988654 678888775 332 22456788999999986 45678888888766 3489999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------------------------------ 190 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------ 190 (245)
||++|.++.+... ..++..+...++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp ECCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 9999877643111 01677788888999999999999731
Q ss_pred -------------------------CCCeEecCCCCCCeEEcCCCc--eEEecccCCCC
Q 025997 191 -------------------------EPRIIHRNIKSSNVLLFDDDI--AKISDFDLSNQ 222 (245)
Q Consensus 191 -------------------------~~~ivHrDlkp~Nill~~~~~--vkl~DfGla~~ 222 (245)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 235999999999999987653 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=9e-10 Score=90.02 Aligned_cols=135 Identities=21% Similarity=0.240 Sum_probs=95.3
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCC--cceEeEEEEeCC---ceEEEEEecC
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NEN--VVELVGYYVDGP---LRVLAYEHAS 144 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~ 144 (245)
.+.++.|..+.||+.. ..+++|..... .....+.+|+.+++.+. +.. +.+++......+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999753 56888875422 23467888999998883 332 445554433333 3588999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------- 190 (245)
|.+|.+..... ++..+...++.+++..|..||+..
T Consensus 100 G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 100 GVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred CeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 98887533221 566677777788888888887511
Q ss_pred ---------------------CCCeEecCCCCCCeEEcC--CCceEEecccCCC
Q 025997 191 ---------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSN 221 (245)
Q Consensus 191 ---------------------~~~ivHrDlkp~Nill~~--~~~vkl~DfGla~ 221 (245)
.+.++|+|++|.||++++ ...+.|+||+.+.
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 134899999999999998 4567899999864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=1.7e-08 Score=80.75 Aligned_cols=134 Identities=12% Similarity=0.065 Sum_probs=95.1
Q ss_pred eeccCCce-EEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEecCCCCHH
Q 025997 73 LIGEGSYG-RVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (245)
Q Consensus 73 ~lG~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (245)
.+..|..+ .||+.... .+..+++|.-... ....+.+|...|+.|. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445444 68987754 4567888875422 3456788999998884 334778888888889999999999998887
Q ss_pred HHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 025997 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--------------------------------------- 190 (245)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------- 190 (245)
+...... .....++.++...|..||...
T Consensus 109 ~~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 109 QVLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp HHHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 7654321 122345566666677777521
Q ss_pred ----------------CCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 191 ----------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 191 ----------------~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0137999999999999987777799998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.5e-08 Score=81.57 Aligned_cols=135 Identities=17% Similarity=0.131 Sum_probs=90.0
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC---CcceEeEEEE-eCCceEEEEEecCCC
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYV-DGPLRVLAYEHASKG 146 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g 146 (245)
.+.++.|....||+. +..+++|+.. .......+.+|+.+|+.|.+. .+.+++.+.. ..+..+++||+++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 346788888899987 5678888742 112245788999999998642 3566666664 345678999999998
Q ss_pred CHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 025997 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK------------------------------------- 189 (245)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------------------------------------- 189 (245)
+|.+..-.. ++..+...++.++...|..||+.
T Consensus 99 ~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 99 ILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred ECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 877632111 33334444444444444444432
Q ss_pred --------------------CCCCeEecCCCCCCeEEcC---CCc-eEEecccCCC
Q 025997 190 --------------------AEPRIIHRNIKSSNVLLFD---DDI-AKISDFDLSN 221 (245)
Q Consensus 190 --------------------~~~~ivHrDlkp~Nill~~---~~~-vkl~DfGla~ 221 (245)
..+.++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1224799999999999987 455 4899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=4.1e-08 Score=81.84 Aligned_cols=78 Identities=9% Similarity=0.001 Sum_probs=54.0
Q ss_pred Cee-ccCCceEEEEEEEC-------CCcEEEEEEcCCCC---C-chHHHHHHHHHHHccCC---CCcceEeEEEEeC---
Q 025997 72 SLI-GEGSYGRVYFGVLR-------SGRAAAIKKLDSSK---Q-PDQEFLAQVSMVSRLKN---ENVVELVGYYVDG--- 133 (245)
Q Consensus 72 ~~l-G~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~--- 133 (245)
+.| +.|..+.+|+.... ++..+++|...... . ....+.+|+.+++.|.. -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78889999987754 25678888765432 1 23467788888888742 3567788776554
Q ss_pred CceEEEEEecCCCCHH
Q 025997 134 PLRVLAYEHASKGSLH 149 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~ 149 (245)
+..+++||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-06 Score=74.35 Aligned_cols=74 Identities=20% Similarity=0.100 Sum_probs=49.6
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC--------CchHHHHHHHHHHHccCC--C-CcceEeEEEEeCCceEE
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------QPDQEFLAQVSMVSRLKN--E-NVVELVGYYVDGPLRVL 138 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 138 (245)
.+.||.|.++.||++... +++.+++|...... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 46789999764321 123456778888887742 3 34456543 4556789
Q ss_pred EEEecCCC
Q 025997 139 AYEHASKG 146 (245)
Q Consensus 139 v~e~~~~g 146 (245)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.49 E-value=3.2e-06 Score=69.58 Aligned_cols=146 Identities=19% Similarity=0.284 Sum_probs=78.3
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC--CCCcceEeE------EEEeCCceEEEEEec
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK--NENVVELVG------YYVDGPLRVLAYEHA 143 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~~ 143 (245)
+.|+.|..+.||+....++ .+++|.... ....+..|+.+++.|. .-.+.+++. +....+..+++++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3465677889999887654 588998864 2344445556555553 112333332 123456789999999
Q ss_pred CCCCHH--------------HHHhcC-CCC--C-CCC-CCCCCCHHHH-------------------------------H
Q 025997 144 SKGSLH--------------DILHGK-KGV--K-GAK-PGPVLSWAQR-------------------------------V 173 (245)
Q Consensus 144 ~~gsL~--------------~~l~~~-~~~--~-~~~-~~~~l~~~~~-------------------------------~ 173 (245)
+|.++. ..++.. ... . ... ....-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986431 111111 100 0 000 0011122211 0
Q ss_pred HHHHHHHHHHHHHhc----------CCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 174 KIAVGAARGLEYLHE----------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 174 ~i~~~i~~~l~~lH~----------~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
.+..++..++.+|+. .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345566652 012349999999999999878889999999864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.5e-05 Score=67.87 Aligned_cols=72 Identities=17% Similarity=0.180 Sum_probs=44.2
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCC-----CCC-----chHHHHHHHHHHH-ccCCCCcceEeEEEEeCCceEEE
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-----SKQ-----PDQEFLAQVSMVS-RLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~-----~~~-----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.+.||.|..+.||++.. +++.++||.... ... ....+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45789999999999864 467899994321 111 2223333433222 22234566777664 5678999
Q ss_pred EEec-CC
Q 025997 140 YEHA-SK 145 (245)
Q Consensus 140 ~e~~-~~ 145 (245)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.2e-05 Score=65.75 Aligned_cols=144 Identities=20% Similarity=0.205 Sum_probs=91.1
Q ss_pred CCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC---CCCcceEeEEEEeCCceEEEEEecCCCC
Q 025997 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
.+.|+.|....+|+... ++..+++|..... ....+..|+..|+.|. ...+.+++.+....+..+++||++++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45689999999999875 4668888876432 3566888988888874 3568888888877788999999999875
Q ss_pred HH--------H---HHhcCCC-CC-CCC-----------CCCCCCHHHHH---HHHH----------------HHHHHH-
Q 025997 148 LH--------D---ILHGKKG-VK-GAK-----------PGPVLSWAQRV---KIAV----------------GAARGL- 183 (245)
Q Consensus 148 L~--------~---~l~~~~~-~~-~~~-----------~~~~l~~~~~~---~i~~----------------~i~~~l- 183 (245)
+. + .++.... .. +.. ....-+|.... ++.. .++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 41 1 2222211 00 000 00012454332 1111 111112
Q ss_pred HHHhc-CCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 184 EYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 184 ~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23432 2245699999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.15 E-value=4.7e-05 Score=61.32 Aligned_cols=75 Identities=23% Similarity=0.230 Sum_probs=54.2
Q ss_pred CCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC-chHHHHHHHHHHHccCC---CCcceEeEEEEeCCceEEEEEecC
Q 025997 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKN---ENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
...+.+|.|..+.||+....+|+.+++|+...... ....+..|+..|+.|.. --+.+++.+ + ..+++||++.
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeec
Confidence 33567899999999999999999999998754332 34567889999888842 234555554 2 3478999987
Q ss_pred CCC
Q 025997 145 KGS 147 (245)
Q Consensus 145 ~gs 147 (245)
++.
T Consensus 94 ~~~ 96 (288)
T 3f7w_A 94 ERP 96 (288)
T ss_dssp CCC
T ss_pred ccC
Confidence 654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.03 E-value=3.9e-05 Score=62.19 Aligned_cols=74 Identities=8% Similarity=0.007 Sum_probs=44.6
Q ss_pred CCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCc-ceEeEEEEeCCceEEEEEec-CC
Q 025997 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA-SK 145 (245)
Q Consensus 68 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~ 145 (245)
+.-.+.|+.|....+|+. ..+++|+.........+..+|+..++.+...++ .+++.. +.+.-++++||+ ++
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 333677888999999998 567888765432221223457777766642222 455543 344467899999 65
Q ss_pred CCH
Q 025997 146 GSL 148 (245)
Q Consensus 146 gsL 148 (245)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.03 E-value=0.00013 Score=59.70 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=50.2
Q ss_pred CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCC--CcceEeEE-----EEeCCceEEEEEecC
Q 025997 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY-----YVDGPLRVLAYEHAS 144 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~ 144 (245)
..++ |....||+....+++.+++|...........+..|..+++.|... .+++++.. ....+..++++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 3466 788899987766677899999865444566777888887777422 23444432 122455688999998
Q ss_pred CCC
Q 025997 145 KGS 147 (245)
Q Consensus 145 ~gs 147 (245)
|.+
T Consensus 111 G~~ 113 (328)
T 1zyl_A 111 GRQ 113 (328)
T ss_dssp CEE
T ss_pred CCC
Confidence 743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.98 E-value=4.2e-05 Score=62.49 Aligned_cols=164 Identities=13% Similarity=0.168 Sum_probs=85.1
Q ss_pred eeHHHHHHhhCCCCCC-----CeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC--cceEeE
Q 025997 56 ISVDELKEKTDNFGTN-----SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVG 128 (245)
Q Consensus 56 ~~~~~~~~~~~~~~~~-----~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~ 128 (245)
++..++......|.+. +.|+.|....+|+....++ .+++|..... ...+.+..|+.+++.|...+ +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 3445555555666652 3466788889999886655 6788887642 22345666777777663212 333332
Q ss_pred E------EEeCCceEEEEEecCCCCHH-----------H---HHhcC-CCCCCCC--CCCCCCHHHHHH-----------
Q 025997 129 Y------YVDGPLRVLAYEHASKGSLH-----------D---ILHGK-KGVKGAK--PGPVLSWAQRVK----------- 174 (245)
Q Consensus 129 ~------~~~~~~~~lv~e~~~~gsL~-----------~---~l~~~-~~~~~~~--~~~~l~~~~~~~----------- 174 (245)
. ....+..++++++++|..+. + .++.. ....... ......|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 12345678999999875431 0 11111 1100000 000011221100
Q ss_pred -HHHHHHHHHHHHhcC----CCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 175 -IAVGAARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 175 -i~~~i~~~l~~lH~~----~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
+...+...+.++... ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133344444421 12249999999999999877666899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00028 Score=57.92 Aligned_cols=77 Identities=12% Similarity=0.105 Sum_probs=39.3
Q ss_pred eeccCCceE-EEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCC--CCcceEeEEEEeCCceEEEEEecCCCCHH
Q 025997 73 LIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (245)
Q Consensus 73 ~lG~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (245)
.|+.|.... +|+....++..+++|...... ...+..|+.+++.+.. -.+.+++.+.... -+++||++.+.++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 455554444 666654336677777654332 1234456666666532 2355666653222 37899999876776
Q ss_pred HHHh
Q 025997 150 DILH 153 (245)
Q Consensus 150 ~~l~ 153 (245)
+.+.
T Consensus 101 ~~l~ 104 (333)
T 3csv_A 101 EVIN 104 (333)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 5543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=61.71 Aligned_cols=145 Identities=16% Similarity=0.175 Sum_probs=79.1
Q ss_pred CCeeccCCceEEEEEEEC--------CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEE
Q 025997 71 NSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 141 (245)
.+.|..|-...+|++... +++.+++|+.-..........+|..+++.|. +.-..++++.+.+ .+|+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 345767888889998864 2468888886332334566778998888874 3233566665532 28999
Q ss_pred ecCCCCHH--------------HH---HhcCCCCCCCCCCCCCCHHHHHHHHHHHH-------------------HHHHH
Q 025997 142 HASKGSLH--------------DI---LHGKKGVKGAKPGPVLSWAQRVKIAVGAA-------------------RGLEY 185 (245)
Q Consensus 142 ~~~~gsL~--------------~~---l~~~~~~~~~~~~~~l~~~~~~~i~~~i~-------------------~~l~~ 185 (245)
|++|.+|. +. ++.....-+ .. ...-+.++.++..++. ..+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~-~~-~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFT-KE-PHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSC-CS-CCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCC-CC-cccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99875432 11 111111000 00 0001233333332221 11222
Q ss_pred ----HhcC-CCCCeEecCCCCCCeEEcCC----CceEEecccCCC
Q 025997 186 ----LHEK-AEPRIIHRNIKSSNVLLFDD----DIAKISDFDLSN 221 (245)
Q Consensus 186 ----lH~~-~~~~ivHrDlkp~Nill~~~----~~vkl~DfGla~ 221 (245)
|... ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 12349999999999999876 789999998865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00013 Score=62.75 Aligned_cols=72 Identities=11% Similarity=-0.015 Sum_probs=44.9
Q ss_pred CeeccCCceEEEEEEECC-CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCc-ceEeEEEEeCCceEEEEEecCCCC
Q 025997 72 SLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGS 147 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 147 (245)
+.|+.|-...+|+....+ +..+++|+........-+..+|..+++.|...++ .++++.+. + .+++||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 457778889999988764 4678888764322221122578888888854444 56777652 2 35999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00012 Score=62.51 Aligned_cols=71 Identities=13% Similarity=0.122 Sum_probs=47.5
Q ss_pred CCeeccCCceEEEEEEECC--------CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC-cceEeEEEEeCCceEEEEE
Q 025997 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 141 (245)
.+.|+.|....+|++...+ +..+++|+.... .....+.+|+.+++.|...+ ..++++.+. + .+++|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 3467888889999998653 467888877332 22256668988888874333 356666543 2 38899
Q ss_pred ecCCC
Q 025997 142 HASKG 146 (245)
Q Consensus 142 ~~~~g 146 (245)
|++|.
T Consensus 153 ~l~G~ 157 (429)
T 1nw1_A 153 YIPSR 157 (429)
T ss_dssp CCCEE
T ss_pred EeCCc
Confidence 99763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00012 Score=61.01 Aligned_cols=72 Identities=7% Similarity=0.019 Sum_probs=41.9
Q ss_pred CeeccCCceEEEEEEECC---------CcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC-cceEeEEEEeCCceEEEEE
Q 025997 72 SLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 141 (245)
..|+.|....+|+....+ +..+++|+.........+...|..+++.+...+ +.++++.. . -++++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457778888999988653 267888876432211112356777777774333 44666543 2 368999
Q ss_pred ecCCCC
Q 025997 142 HASKGS 147 (245)
Q Consensus 142 ~~~~gs 147 (245)
|++|.+
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0028 Score=52.16 Aligned_cols=30 Identities=27% Similarity=0.357 Sum_probs=26.2
Q ss_pred CCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 192 ~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 359999999999999988889999997654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0013 Score=55.93 Aligned_cols=72 Identities=6% Similarity=-0.025 Sum_probs=45.7
Q ss_pred CeeccCCceEEEEEEECC--------CcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEe
Q 025997 72 SLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.|..|-...+|+....+ +..+++++........-+..+|..+++.+. +.-..++++.+ . -++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456678888999988653 577888886433222223456777777774 22345566533 2 3788999
Q ss_pred cCCCC
Q 025997 143 ASKGS 147 (245)
Q Consensus 143 ~~~gs 147 (245)
++|.+
T Consensus 152 I~G~~ 156 (424)
T 3mes_A 152 IDGEP 156 (424)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 99854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.17 E-value=0.47 Score=36.26 Aligned_cols=86 Identities=6% Similarity=-0.038 Sum_probs=61.0
Q ss_pred CCCCcceEeEEEEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEec
Q 025997 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE-YLHEKAEPRIIHR 197 (245)
Q Consensus 119 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~~ivHr 197 (245)
.||.+ -..+-.+.+.+.+.++.-+++-=...+.. ++..+.++++.+|+.... +++. -+|-
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~tf 108 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLIF 108 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------------cCHHHHHHHHHHHHHHHHHhhhC-----ceeE
Confidence 57777 34444667777777776544332333432 677888888888877665 4544 5788
Q ss_pred CCCCCCeEEcCCCceEEecccCCCCC
Q 025997 198 NIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 198 Dlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
-|.|+||+++.++.+++.-.|+-..+
T Consensus 109 ~l~P~NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 109 IVCPENLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp CCCGGGEEECTTCCEEESCCEETTTB
T ss_pred EEeCceEEEeCCCcEEEEEcCCcccC
Confidence 89999999999999999999985544
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.81 E-value=0.35 Score=36.83 Aligned_cols=86 Identities=6% Similarity=0.058 Sum_probs=61.2
Q ss_pred CCCCcceEeEEEEeCCceEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 025997 119 KNENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (245)
Q Consensus 119 ~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHr 197 (245)
.||+.+.. .+-.+.+.+.+.++.-.. -++.. +.. ++....++++.+|+....+++. =+|-
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------------~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------------FTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------------SCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------------cCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 57877765 455566666666655432 23333 222 6788899999998887765554 3788
Q ss_pred CCCCCCeEEcCCCceEEecccCCCCC
Q 025997 198 NIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 198 Dlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
-|.|+||+++.++.+++.-.|+-..+
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV 129 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB
T ss_pred EEecceEEEcCCCCEEEEEccCccCC
Confidence 89999999999999999999985544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.15 E-value=0.11 Score=43.72 Aligned_cols=29 Identities=24% Similarity=0.434 Sum_probs=24.4
Q ss_pred eEecCCCCCCeEE------cCCCceEEecccCCCC
Q 025997 194 IIHRNIKSSNVLL------FDDDIAKISDFDLSNQ 222 (245)
Q Consensus 194 ivHrDlkp~Nill------~~~~~vkl~DfGla~~ 222 (245)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3467899999988753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.06 E-value=0.028 Score=48.37 Aligned_cols=60 Identities=5% Similarity=-0.001 Sum_probs=17.9
Q ss_pred CCCCeeccCCceEEEEEEECC-CcEEEE------EEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEE
Q 025997 69 GTNSLIGEGSYGRVYFGVLRS-GRAAAI------KKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYV 131 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~~-~~~vav------K~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 131 (245)
.+.+.|| ||.||+|.+.. ..+||+ |....... ....+.+|..+++.++|+|+++.+++-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3455666 99999999763 457888 65543222 2245778888899999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 245 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-44
Identities = 42/179 (23%), Positives = 78/179 (43%), Gaps = 12/179 (6%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
+ +G G +G V+ G A+K L FLA+ +++ +L+++ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L P+ + E+ GSL D L G+K L+ + + +A A G+ +
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ E+ IHR+++++N+L+ D KI+DF L+ D + AP
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 179
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-43
Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 18/185 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+F S +G G+ G V+ + SG A K + +P + + ++ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G + + EH GSL +L + K+++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVI 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ + +GT
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 168
Query: 241 YHAPE 245
Y +PE
Sbjct: 169 YMSPE 173
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-42
Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVV 124
IG GS+G VY G A + + + + Q Q F +V ++ + ++ N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+GY L + + SL+ LH + + + IA A+G++
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMD 118
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH K IIHR++KS+N+ L +D KI DF L+ + ++ G+ + AP
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 245 E 245
E
Sbjct: 176 E 176
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-42
Identities = 40/172 (23%), Positives = 70/172 (40%), Gaps = 12/172 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+HR++ + N L+ D + K+SDF LS D S + PE
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPE 171
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-39
Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L + + + + + G+ YL E
Sbjct: 73 APICLVFEFMEHGCLSDYLR--------TQRGLFAAETLLGMCLDVCEGMAYLEEA---C 121
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR++ + N L+ ++ + K+SDF ++ D ST + +PE
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPE 172
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-39
Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 134 PLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L ++ GSL D L+ ++ +K+A+ A GL +LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119
Query: 190 A-----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYH 242
+P I HR++KS N+L+ + I+D L+ + A + +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 243 APE 245
APE
Sbjct: 180 APE 182
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-39
Identities = 42/203 (20%), Positives = 83/203 (40%), Gaps = 26/203 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N ++G G++G+V A+K L + ++++ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 118 LKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG--------------VKGAK 162
L + EN+V L+G L +E+ G L + L K+ ++ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
VL++ + A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 223 APDAAARLHSTRVLGTFGYHAPE 245
+ + + APE
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPE 236
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-39
Identities = 40/190 (21%), Positives = 74/190 (38%), Gaps = 21/190 (11%)
Query: 73 LIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENV 123
+G G++G+V + A+K L S + ++++ ++S L N N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG---------VKGAKPGPVLSWAQRVK 174
V L+G G ++ E+ G L + L K+ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ + + +
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 235 VLGTFGYHAP 244
+ AP
Sbjct: 207 ARLPVKWMAP 216
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 8e-39
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 26/203 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N IGEG++GRV+ A+K L D +F + ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAK 162
N N+V+L+G G L +E+ + G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P LS A+++ IA A G+ YL E + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 223 APDAAARLHSTRVLGTFGYHAPE 245
A + PE
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPE 212
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-38
Identities = 40/183 (21%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
D + +G+G++G+VY + + AA K +D+ + + ++++ ++ +++ + N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L+ + + E + G++ ++ + L+ +Q +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ +IIHR++K+ N+L D K++DF +S + R S +GT +
Sbjct: 123 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWM 177
Query: 243 APE 245
APE
Sbjct: 178 APE 180
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 2e-38
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ + + KK L + + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHS 133
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+IHR++K+ N+LL + + K+ DF ++ + +GT + APE
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPE 181
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-38
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+++ +GEG+YG V V R + A A+K +D + D + ++ + L +EN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
VV+ G+ +G ++ L E+ S G L D + G + + G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YLH I HR+IK N+LL + D KISDF L+ ++ GT Y
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 243 APE 245
APE
Sbjct: 173 APE 175
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-38
Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 21/185 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
++F +G+G +G VY + S A+K L ++ + +V + S L++
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L GY+ D L E+A G+++ L + A
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L Y H K R+IHR+IK N+LL KI+DF S AP + T + GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169
Query: 241 YHAPE 245
Y PE
Sbjct: 170 YLPPE 174
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 8e-38
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 12/189 (6%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ D+ + + + +G G YG VY GV + A+K L +EFL + +++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+K+ N+V+L+G P + E + G+L D L + +S + +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYM 120
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A + +EYL +K IHR++ + N L+ ++ + K++DF LS H
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGA 176
Query: 236 LGTFGYHAP 244
+ AP
Sbjct: 177 KFPIKWTAP 185
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-37
Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 12/189 (6%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++ D + ++ +G+G +G V+ G AIK L + FL + ++
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+L++E +V+L + P+ + E+ SKGSL D L G+ G L Q V +
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDM 118
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 119 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 174
Query: 236 LGTFGYHAP 244
+ AP
Sbjct: 175 KFPIKWTAP 183
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-37
Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 19/192 (9%)
Query: 60 ELKEKTDNFG-TNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD--QEFLAQVS 113
+L K DN + +G G++G V GV R AIK L + +E + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
++ +L N +V L+G L +L E A G LH L GK+ + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSNVA 112
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHS 232
++ + G++YL EK +HR++ + NVLL + AKISDF LS D +
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 233 TRVLGTFGYHAP 244
+ ++AP
Sbjct: 170 SAGKWPLKWYAP 181
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-37
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 18/181 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQ 64
Query: 126 LVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G V+ + + E+ +KGSL D L + VL +K ++ +E
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAME 117
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL +HR++ + NVL+ +D++AK+SDF L+ +A + AP
Sbjct: 118 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAP 169
Query: 245 E 245
E
Sbjct: 170 E 170
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-37
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQP 104
P PV+ +++K + +IGEG++G+V ++ AAIK++ +SK
Sbjct: 1 PTIYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---- 159
++F ++ ++ +L + N++ L+G LA E+A G+L D L + ++
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 160 ---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216
LS Q + A ARG++YL +K + IHR++ + N+L+ ++ +AKI+D
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170
Query: 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
F LS + T + A E
Sbjct: 171 FGLSRGQEV---YVKKTMGRLPVRWMAIE 196
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-37
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 15/190 (7%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK 119
+ +++ IG GSYGR + G+ K+LD + E +++V+++ LK
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 120 NENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+ N+V +D L E+ G L ++ KG K L +++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMT 116
Query: 178 GAARGLEYLHEK--AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
L+ H + ++HR++K +NV L K+ DF L+ + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAF 174
Query: 236 LGTFGYHAPE 245
+GT Y +PE
Sbjct: 175 VGTPYYMSPE 184
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 9e-37
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 29/206 (14%)
Query: 57 SVDELKEKTDNFGTN---------SLIGEGSYGRVYFGVLRS----GRAAAIKKLDS--S 101
+ ++ E F +IG G +G V G L+ AIK L S +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 102 KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
++ ++FL++ S++ + + NV+ L G ++ E GSL L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ Q V + G A G++YL + +HR++ + N+L+ + + K+SDF LS
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 222 QAPDAAARLHSTRVLG---TFGYHAP 244
D + T LG + AP
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAP 202
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-35
Identities = 45/181 (24%), Positives = 72/181 (39%), Gaps = 23/181 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG GS+ VY G+ + A +L +K Q F + M+ L++ N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 130 YVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ VL E + G+L L K V+ +GL++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH + P IIHR++K N+ + KI D L+ + + V+GT + AP
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 245 E 245
E
Sbjct: 183 E 183
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-34
Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLD--SSKQ 103
A V DE + + + +G+GS+G VY GV + AIK ++ +S +
Sbjct: 6 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 65
Query: 104 PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
EFL + S++ +VV L+G G ++ E ++G L L + P
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 164 -GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
S ++ +++A A G+ YL+ + +HR++ + N ++ +D KI DF ++
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 223 APDAAARLHSTRVLGTFGYHAPE 245
+ + L + +PE
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPE 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-34
Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 17/191 (8%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSM 114
S+ + + + IG+G+ G VY + + +G+ AI++++ +QP +E + ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ KN N+V + Y+ G + E+ + GSL D++ Q
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ + LE+LH ++IHR+IKS N+LL D K++DF Q + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 175
Query: 235 VLGTFGYHAPE 245
++GT + APE
Sbjct: 176 MVGTPYWMAPE 186
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-34
Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 20/179 (11%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G +L E A G L+ L + + +++ + G++YL
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPE 245
E +HR++ + NVLL AKISDF LS D T ++APE
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-34
Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 19/189 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPD--QEFLAQVSMVS 116
K F ++G G++G VY G+ AIK+L + P +E L + +++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWC 117
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 237 GTFGYHAPE 245
+ A E
Sbjct: 175 VPIKWMALE 183
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-33
Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 19/186 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD--QEFLAQVSMVSRLK 119
+ IGEG +G V+ G+ S A AIK + ++FL + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++V+L+G + P+ ++ E + G L L +K L A + A
Sbjct: 67 HPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRKYS--------LDLASLILYAYQL 117
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K R +HR+I + NVL+ +D K+ DF LS D+ +++
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 173
Query: 240 GYHAPE 245
+ APE
Sbjct: 174 KWMAPE 179
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-33
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 19/188 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
+IG G +G VY G+L++ AIK L + Q +FL + ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ N++ L G ++ E+ G+L L K G S Q V + G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRG 118
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
A G++YL +HR++ + N+L+ + + K+SDF LS D ++T
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 238 TFGYHAPE 245
+ APE
Sbjct: 176 PIRWTAPE 183
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-33
Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 17/189 (8%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVS 116
K++ ++F ++GEGS+ V L + R AIK L+ + + V ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
RL + V+L + D +A G L +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
LEYLH IIHR++K N+LL +D +I+DF + + + + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 237 GTFGYHAPE 245
GT Y +PE
Sbjct: 172 GTAQYVSPE 180
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 9e-33
Identities = 38/196 (19%), Positives = 78/196 (39%), Gaps = 20/196 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSR 117
D +G G++G+V + R A+K L ++ + ++++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 118 LKNE-NVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLS 168
+ + NVV L+G G ++ E G+L L K+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 229 RLHSTRVLGTFGYHAP 244
+ + AP
Sbjct: 190 YVRKGDARLPLKWMAP 205
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-32
Identities = 49/188 (26%), Positives = 78/188 (41%), Gaps = 21/188 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLD----SSKQPDQEFLAQVSMVSR 117
+ +G+GS+G V G + + A+K L S + +F+ +V+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L + N++ L G + P++ + E A GSL D L +G + AV
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAV 118
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVL 236
A G+ YL K R IHR++ + N+LL D+ KI DF L P
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 237 GTFGYHAP 244
F + AP
Sbjct: 176 VPFAWCAP 183
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-32
Identities = 39/200 (19%), Positives = 78/200 (39%), Gaps = 25/200 (12%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQ--EF 108
VI L +F +IG G +G VY G L A+K L+ + +F
Sbjct: 21 VIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
L + ++ + NV+ L+G + + + G L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------P 127
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-- 225
+ + + A+G+++L K + +HR++ + N +L + K++DF L+ D
Sbjct: 128 TVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 226 AAARLHSTRVLGTFGYHAPE 245
+ + T + A E
Sbjct: 185 FDSVHNKTGAKLPVKWMALE 204
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-32
Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKL--DSSKQPDQEFLAQVSMV 115
D +GEG++G+V A+K L D++++ + ++++ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 116 SRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVL 167
+ +N++ L+G + E+ASKG+L + L ++ P L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 228 ARLHSTRVLGTFGYHAPE 245
+T + APE
Sbjct: 190 YYKKTTNGRLPVKWMAPE 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 9e-32
Identities = 45/192 (23%), Positives = 83/192 (43%), Gaps = 20/192 (10%)
Query: 60 ELKEKT--DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMV 115
E+K+ + D + +G G++G V+ V +GR K +++ D+ ++S++
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++L + ++ L + D VL E S G L D + +S A+ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--------AEDYKMSEAEVINY 132
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDAAARLHST 233
A GL+++HE I+H +IK N++ KI DF L+ + +T
Sbjct: 133 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189
Query: 234 RVLGTFGYHAPE 245
T + APE
Sbjct: 190 ---ATAEFAAPE 198
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 115 bits (289), Expect = 4e-31
Identities = 41/184 (22%), Positives = 80/184 (43%), Gaps = 18/184 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENV 123
D++ + +G G++G V+ R +G A K + + + D+E ++ +S L++ +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V L + D V+ YE S G L + + + +S + V+ +GL
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGL 137
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HE +H ++K N++ K+ DF L+ + +T GT +
Sbjct: 138 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEF 191
Query: 242 HAPE 245
APE
Sbjct: 192 AAPE 195
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (277), Expect = 6e-30
Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 27/192 (14%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----------QEFLAQVSM 114
+N+ ++G G V + + + A+K +D + + L +V +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 115 VSRLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+ ++ N+++L Y L ++ KG L D L K LS +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KI + LH+ I+HR++K N+LL DD K++DF S Q
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167
Query: 234 RVLGTFGYHAPE 245
V GT Y APE
Sbjct: 168 EVCGTPSYLAPE 179
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-29
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 21/182 (11%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V + AIKK+ + Q L ++ ++ R ++EN++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 129 YYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + H L+ +L + LS RGL+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLK 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTFGYHA 243
Y+H ++HR++K SN+LL KI DF L+ A PD T + T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 244 PE 245
PE
Sbjct: 181 PE 182
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-29
Identities = 32/187 (17%), Positives = 68/187 (36%), Gaps = 17/187 (9%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
KE + + +G G +G V+ V S + K + ++S+++ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L + V+ +E S + + ++ L+ + V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGT 238
L++LH I H +I+ N++ KI +F + Q + +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 239 FGYHAPE 245
Y+APE
Sbjct: 167 PEYYAPE 173
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (274), Expect = 6e-29
Identities = 44/188 (23%), Positives = 75/188 (39%), Gaps = 24/188 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKN 120
++F + +IG G +G VY +G+ A+K LD KQ + L + M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 121 ---ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+V + + + + G LH L A A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD L+ +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167
Query: 238 TFGYHAPE 245
T GY APE
Sbjct: 168 THGYMAPE 175
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-29
Identities = 37/186 (19%), Positives = 74/186 (39%), Gaps = 20/186 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV-----SMVSRLK 119
++F + ++G+GS+G+V+ + + + AIK L + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + E+ + G L + ++ A
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167
Query: 240 GYHAPE 245
Y APE
Sbjct: 168 DYIAPE 173
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 107 bits (267), Expect = 1e-28
Identities = 42/191 (21%), Positives = 82/191 (42%), Gaps = 22/191 (11%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK 119
+D + ++G G V+ LR R A+K L + D F + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 120 NENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+ +V + GPL + E+ +L DI+H + ++ + +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEV 116
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-R 234
A + L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T
Sbjct: 117 IADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 235 VLGTFGYHAPE 245
V+GT Y +PE
Sbjct: 174 VIGTAQYLSPE 184
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 2e-27
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 21/186 (11%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNE 121
D + ++G G++ V R+ + AIK + +E +++++ ++K+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V L Y G L + S G L D + K + ++
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLD 118
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
++YLH + I+HR++K N+L + +D ISDF LS + + GT
Sbjct: 119 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGT 172
Query: 239 FGYHAP 244
GY AP
Sbjct: 173 PGYVAP 178
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 103 bits (257), Expect = 4e-27
Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNEN 122
+ + IGEG+YG VY G A+KK+ K+ + + ++S++ LK+ N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L VL +EH + + + G L + G
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNG 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ Y H++ R++HR++K N+L+ + KI+DF L+ + + T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYR 167
Query: 243 APE 245
AP+
Sbjct: 168 APD 170
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-25
Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD------QEFLAQVSMVSRLKNENVVE 125
+GEG + VY + + + AIKK+ + + + L ++ ++ L + N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+ + L ++ I L+ + + +GLEY
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH+ I+HR++K +N+LL ++ + K++DF L+ T + T Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPE 170
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.8 bits (248), Expect = 2e-25
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 22/185 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
+F +G GS+GRV+ R +GR A+K L + + M+S + +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
++ + G + D + ++ G L +L + A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD + + GT
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 166
Query: 241 YHAPE 245
Y APE
Sbjct: 167 YIAPE 171
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 3e-25
Identities = 47/202 (23%), Positives = 77/202 (38%), Gaps = 25/202 (12%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL 109
+A P D +E ++ +IG GS+G VY L SG AIKK+ K+
Sbjct: 7 VATPGQGPDRPQE--VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKN 61
Query: 110 AQVSMVSRLKNENVVELVGYYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
++ ++ +L + N+V L ++ D L ++ + H +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222
L R L Y+H I HR+IK N+LL D + K+ DF + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 223 APDAAARLHSTRVLGTFGYHAP 244
+ + + Y AP
Sbjct: 173 LVRGE---PNVSYICSRYYRAP 191
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 5e-25
Identities = 37/197 (18%), Positives = 73/197 (37%), Gaps = 27/197 (13%)
Query: 60 ELKEKT--DNFG-TNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++K+ D++ T+ ++G G G+V R+ A+K L + +E
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HW 59
Query: 116 SRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ ++V +V Y + ++ E G L + + + +
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTERE 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAA 228
+I ++YLH I HR++K N+L + I K++DF + + +
Sbjct: 113 ASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 229 RLHSTRVLGTFGYHAPE 245
T Y APE
Sbjct: 170 LTTPCY---TPYYVAPE 183
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-24
Identities = 40/184 (21%), Positives = 74/184 (40%), Gaps = 17/184 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNE 121
+NF IGEG+YG VY + +G A+KK+ + + + ++S++ L +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E + + + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ T + T Y
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWY 168
Query: 242 HAPE 245
APE
Sbjct: 169 RAPE 172
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 4e-24
Identities = 36/184 (19%), Positives = 64/184 (34%), Gaps = 26/184 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSRLKN--EN 122
L+G G +G VY G+ + AIK ++ + D +V ++ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ L+ ++ VL E ++G L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H ++HR+IK N+L+ + K+ DF D T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
Query: 242 HAPE 245
PE
Sbjct: 176 SPPE 179
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 4e-24
Identities = 39/184 (21%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKN 120
++F L+G+G++G+V +GR A+K L ++ + + ++ ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ L + E+A+ G L L ++ + +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH + +++R+IK N++L D KI+DF L + A + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170
Query: 241 YHAP 244
Y AP
Sbjct: 171 YLAP 174
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-24
Identities = 43/187 (22%), Positives = 75/187 (40%), Gaps = 27/187 (14%)
Query: 72 SLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQEFLAQV------SMVSRLKNENV 123
+ IGEG+YG+V+ GR A+K++ + L+ + + ++ NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 124 VELVGYYVDGPLR-----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L L +EH + + P P + +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------VPEPGVPTETIKDMMFQ 124
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL++LH R++HR++K N+L+ K++DF L+ ++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 239 FGYHAPE 245
Y APE
Sbjct: 179 LWYRAPE 185
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.9 bits (235), Expect = 8e-24
Identities = 36/183 (19%), Positives = 65/183 (35%), Gaps = 23/183 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY- 130
IG GS+G +Y G + +G AIK + + + + ++ + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G V+ E + S + +A +EY+H K
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122
Query: 191 EPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH-----STRVLGTFGYH 242
IHR++K N L+ + I DF L+ + DA H + + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 243 APE 245
+
Sbjct: 181 SIN 183
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.5 bits (234), Expect = 1e-23
Identities = 33/185 (17%), Positives = 62/185 (33%), Gaps = 25/185 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYY 130
IGEGS+G ++ G L + + AIK + + L + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G VL + + G S A ++ +HEK
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+++R+IK N L+ + ++ + DF + D + H + GT
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 241 YHAPE 245
Y +
Sbjct: 179 YMSIN 183
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 3e-23
Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 22/185 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
D F +G GS+GRV SG A+K LD K + L + ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + D + E+ + G + L S A
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIV 151
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
EYLH +I+R++K N+L+ +++DF + + + + GT
Sbjct: 152 LTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPE 203
Query: 241 YHAPE 245
APE
Sbjct: 204 ALAPE 208
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.7 bits (227), Expect = 1e-22
Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 27/192 (14%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSR 117
D + T +G G + V +G A K + + ++ +VS++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ NV+ L Y + +L E + G L D L K+ L+ + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLK 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHST 233
G+ YLH +I H ++K N++L D ++ KI DF L+++
Sbjct: 121 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFK 174
Query: 234 RVLGTFGYHAPE 245
+ GT + APE
Sbjct: 175 NIFGTPEFVAPE 186
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 1e-22
Identities = 41/178 (23%), Positives = 79/178 (44%), Gaps = 10/178 (5%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IG+G++G V+ R +G+ A+KK+ + + L ++ ++ LK+ENVV L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + H G+ + ++ ++ GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHR- 135
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPE 245
+I+HR++K++NVL+ D + K++DF L+ + T + T Y PE
Sbjct: 136 --NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 4e-22
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 17/177 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
+G G+YG V V R+G AIKKL Q + + ++ ++ +++ENV+ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + GK L + + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA 139
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
IIHR++K N+ + +D KI DF L+ QA T + T Y APE
Sbjct: 140 A---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPE 188
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 87.6 bits (216), Expect = 5e-21
Identities = 30/188 (15%), Positives = 67/188 (35%), Gaps = 25/188 (13%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N 120
D++ +G G Y V+ + + + +K L K+ ++ ++ ++ L+
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGG 89
Query: 121 ENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R L +EH + + L+
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYE 137
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLG 237
+ L+Y H I+HR++K NV++ + ++ D+ L+ +
Sbjct: 138 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVA 191
Query: 238 TFGYHAPE 245
+ + PE
Sbjct: 192 SRYFKGPE 199
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 6e-21
Identities = 33/176 (18%), Positives = 68/176 (38%), Gaps = 17/176 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K++ + L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E + + +GL + H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
++HR++K N+L+ + K+++F L+ +A R +S V+ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDV 172
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 2e-18
Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 27/192 (14%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL 118
E + + S +G G+YG V ++G A+KKL Q + ++ ++ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 KNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
K+ENV+ L+ + V H L++I+ +K L+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +T
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 234 RVLGTFGYHAPE 245
R Y APE
Sbjct: 182 R-----WYRAPE 188
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.2 bits (199), Expect = 2e-18
Identities = 31/182 (17%), Positives = 67/182 (36%), Gaps = 11/182 (6%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G G + V+ + + A+K + K + ++ ++ R+ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 132 DGPLRVLAY--EHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLE 184
+ L++L + G ++ G + +I+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 185 YLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
Y+H + IIH +IK NVL+ D + +++ H T + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 244 PE 245
PE
Sbjct: 198 PE 199
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-18
Identities = 39/190 (20%), Positives = 75/190 (39%), Gaps = 23/190 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPD-----QEFLAQVSMVS 116
+NF ++G G+YG+V+ +G+ A+K L + + + ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 117 RLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++ +V L + L ++ + G L L ++ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
LE+LH+ II+R+IK N+LL + ++DF LS + A +
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDF 190
Query: 236 LGTFGYHAPE 245
GT Y AP+
Sbjct: 191 CGTIEYMAPD 200
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (191), Expect = 2e-17
Identities = 40/183 (21%), Positives = 66/183 (36%), Gaps = 28/183 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG G+ G V R AIKKL Q + ++ ++ + ++N++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 129 YYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+ + L E I + + G
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------DHERMSYLLYQMLCG 131
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+++LH IIHR++K SN+++ D KI DF L+ A T + T Y
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 243 APE 245
APE
Sbjct: 186 APE 188
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 1e-13
Identities = 26/160 (16%), Positives = 46/160 (28%), Gaps = 27/160 (16%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------QPDQEFLAQVSMVSRLKN 120
L+GEG V+ +K D F +R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L G V P +A L D + ++
Sbjct: 66 RALQKLQGLAV--PKVYAWEGNAVLMELIDAKELYRVR----------VENPDEVLDMIL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ + + I+H ++ NVL+ ++ I I DF S
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.97 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=298.19 Aligned_cols=169 Identities=30% Similarity=0.421 Sum_probs=147.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|++.+.||+|+||+||+|+++ +++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 568999999999999999999975 789999999865432 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+.+|+|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 999999999987543 2899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..............+||+.|||||
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTH
T ss_pred eeccCCccccccceeeCcCccCHh
Confidence 765443333335578999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=289.97 Aligned_cols=165 Identities=27% Similarity=0.437 Sum_probs=146.8
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
++|++.+.||+|+||+||+|+++ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 78999999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.+++.... +++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 100 ~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 100 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999999887643 899999999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ....+||+.|||||
T Consensus 167 ~~~~~~--~~~~~gt~~Y~aPE 186 (293)
T d1yhwa1 167 TPEQSK--RSTMVGTPYWMAPE 186 (293)
T ss_dssp CSTTCC--BCCCCSCGGGCCHH
T ss_pred cccccc--ccccccCCCccChh
Confidence 543222 24567999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-44 Score=293.26 Aligned_cols=170 Identities=26% Similarity=0.408 Sum_probs=150.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|++.+.||+|+||+||+|.++ +++.||||+++.+....+++.+|+.+|++++|||||++++++.+.+..+++|||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 456888899999999999999976 6889999999887777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 96 ~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 96 TYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp TTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred cCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999764322 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|||||
T Consensus 166 ~~~~~~~-~~~~~g~~~y~aPE 186 (287)
T d1opja_ 166 TGDTYTA-HAGAKFPIKWTAPE 186 (287)
T ss_dssp CSSSSEE-ETTEEECGGGCCHH
T ss_pred CCCCcee-eccccccccccChH
Confidence 5433222 23346899999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=285.86 Aligned_cols=165 Identities=30% Similarity=0.452 Sum_probs=146.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||+||+|+++ +++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 567999999999999999999975 7889999998532 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 mEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999976542 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+....... ....||+.|||||
T Consensus 153 a~~~~~~~~----~~~~Gt~~Y~APE 174 (263)
T d2j4za1 153 SVHAPSSRR----TTLCGTLDYLPPE 174 (263)
T ss_dssp CSCCCCCCC----EETTEEGGGCCHH
T ss_pred eeecCCCcc----cccCCCCcccCHH
Confidence 987654322 3457999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=285.64 Aligned_cols=168 Identities=23% Similarity=0.444 Sum_probs=140.9
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|++.+.||+|+||.||+|.+.+++.||||++.......+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57888999999999999999998888999999988777788999999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 85 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence 999999876542 3889999999999999999999998 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ......||+.|||||
T Consensus 154 ~~~~-~~~~~~gt~~y~aPE 172 (263)
T d1sm2a_ 154 DQYT-SSTGTKFPVKWASPE 172 (263)
T ss_dssp ------------CTTSCCHH
T ss_pred CCce-eecceecCcccCChH
Confidence 3322 123357999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=289.71 Aligned_cols=168 Identities=26% Similarity=0.359 Sum_probs=144.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 7899999998542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 88 Ey~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence 99999999999876542 899999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.+............+||+.|||||
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE 180 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPE 180 (288)
T ss_dssp EECC----------CCCCGGGCCHH
T ss_pred eecccCCcccccccccCCccccCce
Confidence 8775443333334568999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=283.74 Aligned_cols=167 Identities=29% Similarity=0.467 Sum_probs=138.4
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.++|.+.+.||+|+||.||+|+++ ..||||+++.... ..+.+.+|+.++++++||||+++++++. .+.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467999999999999999999865 3699999865432 3467889999999999999999999864 567899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
|+++|+|.+++..... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999975432 2899999999999999999999997 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
............+..||+.|||||
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE 176 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPE 176 (276)
T ss_dssp C------------CCCCGGGCCHH
T ss_pred eccccCCcccccccccCcccCCHH
Confidence 765443333335568999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=288.11 Aligned_cols=167 Identities=23% Similarity=0.406 Sum_probs=146.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
+.|++.+.||+|+||.||+|+++ +++.||||++.... ...+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 78899999986543 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 92 ~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 92 AGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999998765332 2899999999999999999999998 999999999999999999999999999766
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... .....||+.|||||
T Consensus 161 ~~~~~~--~~~~~Gt~~y~APE 180 (288)
T d2jfla1 161 TRTIQR--RDSFIGTPYWMAPE 180 (288)
T ss_dssp HHHHHH--HTCCCSCCTTCCHH
T ss_pred CCCccc--ccccccccccCCHH
Confidence 433222 24568999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=284.86 Aligned_cols=169 Identities=24% Similarity=0.423 Sum_probs=147.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||.||+|.+++++.||||+++......+.+.+|+.++++++|||||++++++. ++..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 3568888999999999999999998889999999887777889999999999999999999999875 456799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 91 ~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 99999987654322 2899999999999999999999997 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......||+.|||||
T Consensus 161 ~~~~~-~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 161 DNEYT-AREGAKFPIKWTAPE 180 (272)
T ss_dssp SSCEE-CCTTCCCCTTTSCHH
T ss_pred CCccc-cccccCCcccccChH
Confidence 43322 223457999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=295.57 Aligned_cols=166 Identities=27% Similarity=0.415 Sum_probs=144.6
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
..++|++.+.||+|+||+||+|++. +++.||+|+++.... ..+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 788999999865432 3467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
||+.+|+|.+++.+... +++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+
T Consensus 84 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp ECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999976532 8999999999999999999997 46 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+...... ..+.+||+.|||||
T Consensus 152 a~~~~~~~----~~~~~GT~~Y~APE 173 (322)
T d1s9ja_ 152 SGQLIDSM----ANSFVGTRSYMSPE 173 (322)
T ss_dssp CHHHHHHT----C---CCSSCCCCHH
T ss_pred ccccCCCc----cccccCCccccCch
Confidence 98653321 24568999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=276.22 Aligned_cols=169 Identities=24% Similarity=0.385 Sum_probs=151.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (245)
.++|++.+.||+|+||+||+|++++++.||||+++......+++.+|+.++++++||||+++++++.+++.+++||||+.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 36899999999999999999999988899999998877788899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCC
Q 025997 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (245)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~ 224 (245)
+|+|.+++..... .+++..++.++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 83 ~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp TEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred CCcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheecc
Confidence 9999999776543 2889999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCCC
Q 025997 225 DAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ......||+.|||||
T Consensus 152 ~~~~~-~~~~~~~t~~y~aPE 171 (258)
T d1k2pa_ 152 DDEYT-SSVGSKFPVRWSPPE 171 (258)
T ss_dssp SSSCC-CCCCSCCCGGGCCHH
T ss_pred CCCce-eecccCCCCCcCCcH
Confidence 43322 223457999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=287.93 Aligned_cols=167 Identities=25% Similarity=0.341 Sum_probs=148.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|+.+ +++.||||++.+. ....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 578999999999999999999975 7899999998643 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999999987543 889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+........ ....+||+.|||||
T Consensus 152 a~~~~~~~~~--~~~~~GT~~Y~aPE 175 (337)
T d1o6la_ 152 CKEGISDGAT--MKTFCGTPEYLAPE 175 (337)
T ss_dssp CBCSCCTTCC--BCCCEECGGGCCGG
T ss_pred ccccccCCcc--cccceeCHHHhhhh
Confidence 9876543322 24568999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=284.50 Aligned_cols=174 Identities=22% Similarity=0.345 Sum_probs=133.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe--CCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 138 (245)
.++|++.+.||+|+||+||+|+.+ +++.||||.+...... .+.+.+|++++++++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 467999999999999999999975 7899999999766543 3468899999999999999999999864 456899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeEEcCCCceEEec
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 99999999999998643211 113899999999999999999999854 13499999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|+........ ....+||+.|||||
T Consensus 158 FG~a~~~~~~~~~--~~~~~gt~~Y~APE 184 (269)
T d2java1 158 FGLARILNHDTSF--AKAFVGTPYYMSPE 184 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHH
T ss_pred ccceeecccCCCc--cccCCCCcccCCHH
Confidence 9999876543322 23468999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-42 Score=284.36 Aligned_cols=161 Identities=30% Similarity=0.449 Sum_probs=142.4
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.|+..+.||+|+||+||+|++. +++.||||++...... .+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3888999999999999999965 7889999998665433 2468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
||.+|+|..++.... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 96 ~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp CCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccc
Confidence 999999987766543 2899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
..... ....||+.|||||
T Consensus 164 ~~~~~------~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 164 IMAPA------NSFVGTPYWMAPE 181 (309)
T ss_dssp SSSSB------CCCCSCGGGCCHH
T ss_pred ccCCC------CccccCccccCHH
Confidence 65432 3457999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-42 Score=287.03 Aligned_cols=167 Identities=23% Similarity=0.360 Sum_probs=146.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc-hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||+|+++ +++.||||++...... .+.+.+|+.+|++++|||||++++++.+.+.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 568999999999999999999975 7899999999765433 45688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC--CCceEEecccCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLS 220 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~--~~~vkl~DfGla 220 (245)
+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 105 ~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 105 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp CCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999965432 2899999999999999999999998 999999999999964 578999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ ....||+.|||||
T Consensus 174 ~~~~~~~~~---~~~~gT~~Y~aPE 195 (350)
T d1koaa2 174 AHLDPKQSV---KVTTGTAEFAAPE 195 (350)
T ss_dssp EECCTTSCE---EEECSCTTTCCHH
T ss_pred eeccccccc---ceecCcccccCHH
Confidence 876543322 3457999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-42 Score=283.49 Aligned_cols=164 Identities=28% Similarity=0.397 Sum_probs=146.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 467999999999999999999975 7899999998542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.||+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 mE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999987653 788889999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+...... .+.+||+.|||||
T Consensus 151 a~~~~~~~-----~~~~Gt~~Y~APE 171 (316)
T d1fota_ 151 AKYVPDVT-----YTLCGTPDYIAPE 171 (316)
T ss_dssp CEECSSCB-----CCCCSCTTTCCHH
T ss_pred ceEecccc-----ccccCcccccCHH
Confidence 98765432 3468999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=284.23 Aligned_cols=166 Identities=25% Similarity=0.423 Sum_probs=130.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC--chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
.+.|++.+.||+|+||+||+|+++ +++.||||++..... ....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999976 788999999865432 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc---CCCceEEeccc
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFD 218 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~---~~~~vkl~DfG 218 (245)
|++||+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||
T Consensus 88 ~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp CCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred ccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccc
Confidence 9999999999976532 899999999999999999999998 99999999999995 47899999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+....... ..+.+||+.|||||
T Consensus 156 ~a~~~~~~~~---~~~~~GT~~y~APE 179 (307)
T d1a06a_ 156 LSKMEDPGSV---LSTACGTPGYVAPE 179 (307)
T ss_dssp --------------------CTTSCHH
T ss_pred eeEEccCCCe---eeeeeeCccccCcH
Confidence 9986643322 23467999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.2e-42 Score=284.24 Aligned_cols=167 Identities=25% Similarity=0.339 Sum_probs=145.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999975 789999999865442 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc--CCCceEEecccCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLS 220 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~--~~~~vkl~DfGla 220 (245)
|.+|+|.+++..... .+++.+++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|
T Consensus 108 ~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp CCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999998765432 2899999999999999999999998 99999999999997 5789999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ ....||+.|||||
T Consensus 177 ~~~~~~~~~---~~~~gt~~y~aPE 198 (352)
T d1koba_ 177 TKLNPDEIV---KVTTATAEFAAPE 198 (352)
T ss_dssp EECCTTSCE---EEECSSGGGCCHH
T ss_pred eecCCCCce---eeccCcccccCHH
Confidence 876543322 3457999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-41 Score=278.39 Aligned_cols=169 Identities=28% Similarity=0.446 Sum_probs=132.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CC---cEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
++|++.+.||+|+||+||+|.++ ++ ..||||.+...... .+.+.+|+.+|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 46778889999999999999975 33 25899988654433 35789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++|+|.+++..... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence 999999999998876542 2899999999999999999999997 99999999999999999999999999
Q ss_pred CCCCCccccccc---cccccccccccCCC
Q 025997 220 SNQAPDAAARLH---STRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~---~~~~~gt~~y~APE 245 (245)
|+.......... .....||+.|||||
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE 203 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPE 203 (299)
T ss_dssp ---------------------CGGGSCHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHH
Confidence 987654332211 12235799999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=273.13 Aligned_cols=163 Identities=27% Similarity=0.391 Sum_probs=137.7
Q ss_pred CCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe----CCceEEEE
Q 025997 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAY 140 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 140 (245)
++.+.||+|+||+||+|++. +++.||+|++...... .+.+.+|+++|++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999975 6889999998654322 3568899999999999999999999875 34689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEc-CCCceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~-~~~~vkl~DfGl 219 (245)
||+++|+|.+++..... +++..+..++.||+.||.|||+++ ++|+||||||+|||++ +++.+||+|||+
T Consensus 92 E~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp ECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 99999999999976532 899999999999999999999974 3499999999999996 478999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+...... ....+||+.|||||
T Consensus 162 a~~~~~~~----~~~~~GT~~Y~aPE 183 (270)
T d1t4ha_ 162 ATLKRASF----AKAVIGTPEFMAPE 183 (270)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGG
T ss_pred ceeccCCc----cCCcccCccccCHH
Confidence 97543322 23468999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=277.14 Aligned_cols=168 Identities=26% Similarity=0.457 Sum_probs=141.5
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
++|++.+.||+|+||.||+|++++++.||||+++......+.+.+|+.++++++|+|||++++++. .+..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 578899999999999999999988889999999887777889999999999999999999999985 4568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|..++...... .+++.+++.++.||+.||.|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 96 g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 96 GSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred Cchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999988754321 2899999999999999999999998 99999999999999999999999999987644
Q ss_pred cccccccccccccccccCCC
Q 025997 226 AAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~~~~~~~~gt~~y~APE 245 (245)
.... ......||+.|||||
T Consensus 166 ~~~~-~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 166 NEYT-ARQGAKFPIKWTAPE 184 (285)
T ss_dssp -----------CCGGGSCHH
T ss_pred CCce-eeccccccccccChH
Confidence 3322 223356999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=274.75 Aligned_cols=166 Identities=25% Similarity=0.385 Sum_probs=145.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC-------CchHHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-------QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.+.|++.+.||+|+||+||+|+++ +++.||||++.+.. ...+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356999999999999999999975 78999999985432 1246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC----ce
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~----~v 212 (245)
|+|||||++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccce
Confidence 999999999999999976542 899999999999999999999998 99999999999998776 59
Q ss_pred EEecccCCCCCCccccccccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|||+|+........ ....||+.|||||
T Consensus 157 kl~DfG~a~~~~~~~~~---~~~~~t~~y~APE 186 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186 (293)
T ss_dssp EECCCTTCEECTTSCBC---SCCCCCGGGCCHH
T ss_pred EecchhhhhhcCCCccc---cccCCCCcccCHH
Confidence 99999999876543322 3457999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=279.06 Aligned_cols=178 Identities=24% Similarity=0.388 Sum_probs=144.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC-C-----cEEEEEEcCCCC--CchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS-G-----RAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
.++|++.+.||+|+||+||+|++.. + ..||+|.+.... .....+.+|+.+++++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678899999999999999999642 2 268999885432 3346789999999998 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKG--------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
.++||||+++|+|.+++........ ......+++..++.++.||+.||.|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976542110 011234899999999999999999999998 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||++.++.+||+|||+|+............+..||+.|||||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 99999999999999999998765544333334567899999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-41 Score=282.32 Aligned_cols=164 Identities=24% Similarity=0.308 Sum_probs=146.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
.++|++.+.||+|+||.||+|+++ +++.||||++.+. ....+.+.+|+.+|+.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 467999999999999999999975 7899999998532 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999976542 899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+...... ....||+.|||||
T Consensus 188 a~~~~~~~-----~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 188 AKRVKGRT-----WTLCGTPEALAPE 208 (350)
T ss_dssp CEECSSCB-----CCCEECGGGCCHH
T ss_pred eeeccccc-----ccccCccccCCHH
Confidence 98765332 3467999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=277.06 Aligned_cols=167 Identities=18% Similarity=0.216 Sum_probs=147.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++|.+.+.||+|+||+||+|.+. +++.||||+++........+.+|+.+|+.++||||+++++++.+.+.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467999999999999999999975 7889999999876656667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC--CceEEecccCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLSN 221 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~--~~vkl~DfGla~ 221 (245)
.||+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++
T Consensus 84 ~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 84 SGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp CCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence 99999999976532 2899999999999999999999998 9999999999999854 589999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
........ ....||+.|||||
T Consensus 153 ~~~~~~~~---~~~~~t~~y~ape 173 (321)
T d1tkia_ 153 QLKPGDNF---RLLFTAPEYYAPE 173 (321)
T ss_dssp ECCTTCEE---EEEESCGGGSCHH
T ss_pred ccccCCcc---cccccccccccch
Confidence 76543322 3457899999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=271.83 Aligned_cols=168 Identities=30% Similarity=0.462 Sum_probs=140.3
Q ss_pred CCCCCCCe-eccCCceEEEEEEEC---CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEE
Q 025997 66 DNFGTNSL-IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (245)
Q Consensus 66 ~~~~~~~~-lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (245)
++|.+.+. ||+|+||.||+|.++ ++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 3457999999755433 4678999999999999999999999864 568999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccC
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGl 219 (245)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 999999999999865432 2899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccc-cccccccccccccCCC
Q 025997 220 SNQAPDAAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~APE 245 (245)
|+........ .......||+.|||||
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPE 182 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHH
T ss_pred hhcccccccccccccccccCccccChH
Confidence 9876543222 1223456899999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-41 Score=270.19 Aligned_cols=165 Identities=28% Similarity=0.400 Sum_probs=145.5
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----------hHHHHHHHHHHHccC-CCCcceEeEEEEeC
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLK-NENVVELVGYYVDG 133 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 133 (245)
++|++.+.||+|+||+||+|+.. +++.||||++.+.... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 7889999998654321 135788999999997 99999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vk 213 (245)
+.+|+||||+++|+|.+++..... +++.++..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeE
Confidence 999999999999999999976542 899999999999999999999998 99999999999999999999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+++........ ....||+.|+|||
T Consensus 151 l~DFG~a~~~~~~~~~---~~~~gt~~y~~PE 179 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKL---REVCGTPSYLAPE 179 (277)
T ss_dssp ECCCTTCEECCTTCCB---CCCCSCGGGCCHH
T ss_pred EccchheeEccCCCce---eeeeccCCCCCHH
Confidence 9999999876543222 4467999999997
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=269.88 Aligned_cols=161 Identities=27% Similarity=0.414 Sum_probs=132.9
Q ss_pred CeeccCCceEEEEEEEC---CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEecCC
Q 025997 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (245)
+.||+|+||.||+|.++ +++.||||+++....+ .+.+.+|+.+|++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 3467999998654332 3578999999999999999999999864 567899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCCCc
Q 025997 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (245)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 225 (245)
|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999986542 899999999999999999999997 99999999999999999999999999986543
Q ss_pred cccc-cccccccccccccCCC
Q 025997 226 AAAR-LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~APE 245 (245)
.... .......||+.|||||
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE 180 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPE 180 (277)
T ss_dssp TCSEEEC----CCCGGGCCHH
T ss_pred cccccccccccCCCceecCch
Confidence 3222 1223457999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=271.56 Aligned_cols=169 Identities=27% Similarity=0.444 Sum_probs=136.5
Q ss_pred CCCCCCCeeccCCceEEEEEEECCC-----cEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~-----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
+.|...++||+|+||.||+|.++.. ..||||++...... ...+.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577888999999999999996632 36999998655433 3468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
+|||+.++++.+++..... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999998876543 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCcccccc-ccccccccccccCCC
Q 025997 219 LSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
+|+......... ......||+.|||||
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE 183 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPE 183 (283)
T ss_dssp C-----------------CCCGGGSCHH
T ss_pred hhhcccCCCccceEeccCCCCccccCHH
Confidence 998765432221 223346899999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-40 Score=279.24 Aligned_cols=165 Identities=27% Similarity=0.364 Sum_probs=141.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCC----CchHHHHH---HHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|++.+.||+|+||.||+|++. +++.||||++.+.. .....+.+ |+.+++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999975 78999999985322 12233344 46677788999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEec
Q 025997 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~D 216 (245)
|+||||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999976542 789999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccccccCCC
Q 025997 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 217 fGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
||+|+...... ....+||+.|||||
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE 175 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPE 175 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHH
T ss_pred eceeeecCCCc----ccccccccccchhH
Confidence 99998665432 23457999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=271.69 Aligned_cols=167 Identities=23% Similarity=0.367 Sum_probs=144.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCC----CCchHHHHHHHHHHH-ccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVS-RLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||+||+|++. +++.||||++.+. ....+.+..|..++. .++||||+++++++.+++..|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999975 7899999998642 233456677777665 6899999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+++|+|.+++..... +++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 vmEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp EEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 9999999999999976542 889999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++........ .....||+.|||||
T Consensus 149 ~a~~~~~~~~~--~~~~~gt~~y~aPE 173 (320)
T d1xjda_ 149 MCKENMLGDAK--TNTFCGTPDYIAPE 173 (320)
T ss_dssp TCBCCCCTTCC--BCCCCSCGGGCCHH
T ss_pred hhhhccccccc--ccccCCCCCcCCHH
Confidence 99866543322 24467999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=269.09 Aligned_cols=161 Identities=25% Similarity=0.390 Sum_probs=135.4
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc------hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEec
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
.++||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999965 7899999998654322 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
.++++..+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp SEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred cchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccccc
Confidence 9877776654332 2788889999999999999999998 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
...... ....+||+.|||||
T Consensus 151 ~~~~~~--~~~~~gt~~y~aPE 170 (299)
T d1ua2a_ 151 GSPNRA--YTHQVVTRWYRAPE 170 (299)
T ss_dssp TSCCCC--CCCSCCCCTTCCHH
T ss_pred CCCccc--ccceecChhhccHH
Confidence 543322 23457999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=270.28 Aligned_cols=164 Identities=23% Similarity=0.340 Sum_probs=138.9
Q ss_pred hCCCCCCC-eeccCCceEEEEEEE-CCCcEEEEEEcCCCCCchHHHHHHHHHHHcc-CCCCcceEeEEEEe----CCceE
Q 025997 65 TDNFGTNS-LIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPLRV 137 (245)
Q Consensus 65 ~~~~~~~~-~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~ 137 (245)
.++|.+.. +||+|+||+||+|++ .+++.||||+++. ...+.+|+.++.++ +||||++++++|.+ ...+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46788764 699999999999996 4789999999853 35678899887655 89999999999875 45689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEE
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl 214 (245)
+|||||+||+|.+++...... .+++.++..++.||+.||.|||+++ |+||||||+|||+++ .+.+||
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccc
Confidence 999999999999999864322 2899999999999999999999998 999999999999985 467999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+|+........ ...+||+.|||||
T Consensus 156 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE 183 (335)
T d2ozaa1 156 TDFGFAKETTSHNSL---TTPCYTPYYVAPE 183 (335)
T ss_dssp CCCTTCEECCCCCCC---CCCSCCCSSCCCC
T ss_pred cccceeeeccCCCcc---ccccCCcccCCcH
Confidence 999999876543322 4467999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-40 Score=269.80 Aligned_cols=168 Identities=24% Similarity=0.415 Sum_probs=137.4
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEEcCCCC--CchHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
++|++.+.||+|+||+||+|.+. +++ .||+|++.... ...+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 56999999999999999999965 443 58999886432 3457899999999999999999999999764 5678
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
++|++.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence 8899999999998876543 2899999999999999999999997 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+...............||+.|||||
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE 183 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALE 183 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHH
T ss_pred cceecccccccccccccccCccccChH
Confidence 998765444333334456899999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-40 Score=269.18 Aligned_cols=179 Identities=26% Similarity=0.391 Sum_probs=146.9
Q ss_pred hhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCc
Q 025997 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (245)
Q Consensus 64 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 135 (245)
..++|++.+.||+|+||+||+|+++ +++.||||+++..... .+++.+|+.++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4568999999999999999999964 3568999999765433 3578999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlk 200 (245)
.+++|||+.+|+|.+++........ ......+++..++.++.||+.||.|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999975432110 011224889999999999999999999998 9999999
Q ss_pred CCCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 201 p~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||++.++.+||+|||+|+............+..||+.|||||
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 999999999999999999997655444333334567999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=267.65 Aligned_cols=184 Identities=21% Similarity=0.331 Sum_probs=138.7
Q ss_pred HHHHHhhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEE
Q 025997 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGY 129 (245)
Q Consensus 59 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~ 129 (245)
+++....++|++.+.||+|+||.||+|.+. +++.||||+++..... .+.+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344344578999999999999999999954 3468999998754433 35677888888777 68899999998
Q ss_pred EEeC-CceEEEEEecCCCCHHHHHhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 025997 130 YVDG-PLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (245)
Q Consensus 130 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp 201 (245)
+... +..+++||||++|+|.+++........ ......+++.+++.++.||+.||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8754 468999999999999999976532110 011234899999999999999999999998 99999999
Q ss_pred CCeEEcCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 202 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++++.+||+|||+|+...............||+.|||||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 206 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence 99999999999999999998765544443345567999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-40 Score=267.48 Aligned_cols=168 Identities=24% Similarity=0.389 Sum_probs=140.3
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (245)
.++|++.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 368999999999999999999974 789999999865432 2467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla 220 (245)
||+.+ ++.+++...... .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 81 e~~~~-~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp ECCSE-EHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred eecCC-chhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence 99976 455544433221 2899999999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCCC
Q 025997 221 NQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+........ .....||+.|+|||
T Consensus 150 ~~~~~~~~~--~~~~~gt~~y~apE 172 (298)
T d1gz8a_ 150 RAFGVPVRT--YTHEVVTLWYRAPE 172 (298)
T ss_dssp HHHCCCSBC--TTCCBCCCTTCCHH
T ss_pred eeccCCccc--ceeecccceeeehh
Confidence 765433222 23457999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-39 Score=262.54 Aligned_cols=169 Identities=21% Similarity=0.360 Sum_probs=136.8
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc----hHHHHHHHHHHHccCCCCcceEeEEEEeCC----c
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGP----L 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 135 (245)
.++|++.+.||+|+||.||+|++. +++.||||++...... .+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999965 7899999999765432 246889999999999999999999988654 3
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.|+||||++|++|.+++..... +++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 7999999999999998876542 899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCcccc-ccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAA-RLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~-~~~~~~~~gt~~y~APE 245 (245)
|||+++....... .......+||+.|||||
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 184 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184 (277)
T ss_dssp CCTTCEECC----------------TTCCHH
T ss_pred hhhhhhhhccccccccccccccCcccccCHH
Confidence 9999865433221 12234467999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=261.68 Aligned_cols=168 Identities=27% Similarity=0.399 Sum_probs=131.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|++.. +..||||.++..... .+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578899999999999999999652 346899998654433 357889999999999999999999985 567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEeccc
Q 025997 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfG 218 (245)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 9999999999998776543 2899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|+........ ......||+.|||||
T Consensus 154 ~a~~~~~~~~~-~~~~~~gt~~y~apE 179 (273)
T d1mp8a_ 154 LSRYMEDSTYY-KASKGKLPIKWMAPE 179 (273)
T ss_dssp ------------------CCGGGCCHH
T ss_pred hheeccCCcce-eccceecCcccchhh
Confidence 99876543322 223456899999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=262.52 Aligned_cols=164 Identities=22% Similarity=0.340 Sum_probs=139.7
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC-------chHHHHHHHHHHHccC--CCCcceEeEEEEeCCc
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLK--NENVVELVGYYVDGPL 135 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 135 (245)
++|++.+.||+|+||.||+|++. +++.||||++.+... ....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 789999999854321 1234678999999986 8999999999999999
Q ss_pred eEEEEEecCC-CCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-CCceE
Q 025997 136 RVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAK 213 (245)
Q Consensus 136 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-~~~vk 213 (245)
.++||||+.+ +++.+++..... +++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vk 151 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 151 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEE
T ss_pred EEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEE
Confidence 9999999975 688888865432 899999999999999999999998 999999999999985 57999
Q ss_pred EecccCCCCCCccccccccccccccccccCCC
Q 025997 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 214 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+|||+|+...... ..+..||+.|||||
T Consensus 152 l~DFG~a~~~~~~~----~~~~~GT~~y~aPE 179 (273)
T d1xwsa_ 152 LIDFGSGALLKDTV----YTDFDGTRVYSPPE 179 (273)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHH
T ss_pred ECccccceeccccc----ccccccCCCcCCHH
Confidence 99999997654322 24568999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=264.58 Aligned_cols=167 Identities=28% Similarity=0.444 Sum_probs=134.0
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHH--HHHHHHHccCCCCcceEeEEEEeCC----ceEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFL--AQVSMVSRLKNENVVELVGYYVDGP----LRVLA 139 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 139 (245)
.+|.+.+.||+|+||.||+|+++ ++.||||++.... .+.+. .|+..+..++||||+++++++.+.+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35667789999999999999874 7899999986443 33343 4555567789999999999998654 57999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCeEEcCCCceEE
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
|||+.+|+|.++++... +++..++.++.|++.||.|+|+.. ..+|+||||||+|||++.++.+||
T Consensus 80 ~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred EecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 99999999999998653 899999999999999999999731 124999999999999999999999
Q ss_pred ecccCCCCCCccccc--cccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
+|||+++........ .......||+.|||||
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHH
T ss_pred EecCccccccCCCcceeccccceecccCcCChh
Confidence 999999765432211 1223467999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.7e-39 Score=261.77 Aligned_cols=166 Identities=25% Similarity=0.377 Sum_probs=140.9
Q ss_pred CCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEEe
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
++|++.+.||+|+||+||+|++++++.||||++..... ..+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999966432 246889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
+.++.+..+..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 98877766665443 2899999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCCC
Q 025997 223 APDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~APE 245 (245)
....... .....||+.|+|||
T Consensus 150 ~~~~~~~--~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 150 FGIPVRK--YTHEIVTLWYRAPD 170 (286)
T ss_dssp HCC-----------CCCTTCCHH
T ss_pred cccCccc--cceecccchhhhHH
Confidence 5433221 23346899999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=258.37 Aligned_cols=164 Identities=30% Similarity=0.499 Sum_probs=134.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEe-CCceEEEEEec
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 143 (245)
.++|++.+.||+|+||.||+|.++ ++.||||+++.+ ...+.+.+|+.++++++||||+++++++.+ .+.+++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 457888899999999999999985 778999999654 345789999999999999999999999865 45689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 84 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 999999998654321 2799999999999999999999997 999999999999999999999999999865
Q ss_pred CccccccccccccccccccCCC
Q 025997 224 PDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~APE 245 (245)
.... ....+|+.|||||
T Consensus 154 ~~~~-----~~~~~~~~y~aPE 170 (262)
T d1byga_ 154 SSTQ-----DTGKLPVKWTAPE 170 (262)
T ss_dssp -------------CCTTTSCHH
T ss_pred CCCC-----ccccccccCCChH
Confidence 4332 3346899999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=260.80 Aligned_cols=178 Identities=22% Similarity=0.362 Sum_probs=148.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeCCc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 135 (245)
.++|++.+.||+|+||.||+|.++ +++.||||+++..... ...+.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888999999999999999852 4568999999765543 34688999999999 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
.+++|||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997654210 0011234899999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............||+.|||||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE 217 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHH
Confidence 999999999999998776554444445568999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=260.22 Aligned_cols=178 Identities=23% Similarity=0.389 Sum_probs=147.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEEcCCCCCch--HHHHHHHHHHHccCCCCcceEeEEEEeCCce
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 136 (245)
.++|.+.+.||+|+||.||+|.++ ++..||||+++...... ..+.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888999999999999999864 35689999997554332 4588999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 137 VLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
++||||+.+|+|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432100 0011123788999999999999999999997 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||+|+...............||+.|||||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred ecccceeccCCcceeeccceecccccCCHH
Confidence 999998776554444445567999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=259.62 Aligned_cols=175 Identities=29% Similarity=0.452 Sum_probs=140.7
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCc--EEEEEEcCCC--CCchHHHHHHHHHHHcc-CCCCcceEeEEEEeCCceEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (245)
.++|++.+.||+|+||.||+|.++ ++. .||||++... ....+.+.+|+.+|+++ +||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 367889999999999999999976 444 4778887433 23456799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 139 AYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 999999999999997542100 0001124899999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++........ ....||..|+|||
T Consensus 166 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE 196 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKK---TMGRLPVRWMAIE 196 (309)
T ss_dssp EEECCTTCEESSCEECCC-------CCTTTCCHH
T ss_pred eEEccccccccccccccc---cceecCCcccchH
Confidence 999999999866543322 3346899999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=256.90 Aligned_cols=168 Identities=30% Similarity=0.458 Sum_probs=131.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC--CC--cEEEEEEcCCCCC----chHHHHHHHHHHHccCCCCcceEeEEEEeCCceE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (245)
++|++.+.||+|+||.||+|++. ++ ..||||+++.... ..+.+.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999854 22 3689999865432 23578999999999999999999999965 5678
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
+||||+.+|++.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccc
Confidence 99999999999998775432 2899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCcccccc-ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
|+++......... ......||+.|||||
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE 184 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPE 184 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHH
T ss_pred hhhhhcccCCCcceecCccccCcccCCHH
Confidence 9998765433222 223346888999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-38 Score=256.81 Aligned_cols=178 Identities=28% Similarity=0.418 Sum_probs=143.0
Q ss_pred hCCCCCCCeeccCCceEEEEEEECC--------CcEEEEEEcCCCCCc--hHHHHHHHHHHHcc-CCCCcceEeEEEEeC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 133 (245)
.++|++.+.||+|+||.||+|+... +..||||++...... ...+.+|+..+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999998532 247999999765543 35788899999888 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEE
Q 025997 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (245)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill 206 (245)
+..++||||+.+|+|.+++....... .......+++.+++.++.||+.||.|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997654210 1112345899999999999999999999998 9999999999999
Q ss_pred cCCCceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 207 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+.++.+||+|||+++...............||+.|||||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 207 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence 999999999999998776544443345567999999997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=259.57 Aligned_cols=168 Identities=28% Similarity=0.366 Sum_probs=137.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeCC----ceE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRV 137 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 137 (245)
.++|++.+.||+|+||+||+|+.. +++.||||++.+.... .+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356899999999999999999964 8999999999765433 357889999999999999999999987643 234
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecc
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~Df 217 (245)
++++++.+|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 5556677899999997643 899999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCcccccc-ccccccccccccCCC
Q 025997 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPE 245 (245)
Q Consensus 218 Gla~~~~~~~~~~-~~~~~~gt~~y~APE 245 (245)
|+++......... .....+||+.|+|||
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPE 182 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred CceeeccCCCccceeeccccccceechHH
Confidence 9997664433221 224457999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=253.13 Aligned_cols=164 Identities=22% Similarity=0.377 Sum_probs=136.8
Q ss_pred CCeeccCCceEEEEEEECCC----cEEEEEEcCCCCCc--hHHHHHHHHHHHccCCCCcceEeEEEEeC-CceEEEEEec
Q 025997 71 NSLIGEGSYGRVYFGVLRSG----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-PLRVLAYEHA 143 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 143 (245)
.++||+|+||+||+|.+..+ ..||||+++..... .+++.+|+++|++++||||+++++++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996532 35899998754333 36799999999999999999999998764 5789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCCCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~~~ 223 (245)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999886543 2778889999999999999999998 999999999999999999999999999876
Q ss_pred Ccccccc--ccccccccccccCCC
Q 025997 224 PDAAARL--HSTRVLGTFGYHAPE 245 (245)
Q Consensus 224 ~~~~~~~--~~~~~~gt~~y~APE 245 (245)
....... ......||+.|+|||
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE 204 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALE 204 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHH
T ss_pred cccccccceecccccccccccChH
Confidence 5432221 122346899999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.8e-38 Score=258.61 Aligned_cols=161 Identities=17% Similarity=0.338 Sum_probs=138.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEe--CCceEEEE
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAY 140 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 140 (245)
.++|++.+.||+|+||+||+|+.. +++.||||+++.. ..+.+.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 367999999999999999999974 7899999998643 4567889999999995 9999999999974 35689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEecccC
Q 025997 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDL 219 (245)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfGl 219 (245)
||+.+++|.++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 112 e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp ECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred eecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccccc
Confidence 9999999976542 2899999999999999999999998 99999999999998654 699999999
Q ss_pred CCCCCccccccccccccccccccCCC
Q 025997 220 SNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|+........ ...+||+.|+|||
T Consensus 177 a~~~~~~~~~---~~~~~t~~y~aPE 199 (328)
T d3bqca1 177 AEFYHPGQEY---NVRVASRYFKGPE 199 (328)
T ss_dssp CEECCTTCCC---CSCCSCGGGCCHH
T ss_pred ceeccCCCcc---cccccCccccCcc
Confidence 9866543222 4457999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=258.26 Aligned_cols=162 Identities=28% Similarity=0.384 Sum_probs=134.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEeCC------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 134 (245)
.++|++.+.||+|+||+||+|.++ +++.||||++...... .+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367999999999999999999965 7899999999765433 346789999999999999999999997654
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.+|+||||+ +.+|.++++... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccc
Confidence 469999999 568888876543 899999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+|+...... ....||+.|||||
T Consensus 163 ~Dfg~a~~~~~~~-----~~~~~t~~y~aPE 188 (346)
T d1cm8a_ 163 LDFGLARQADSEM-----TGYVVTRWYRAPE 188 (346)
T ss_dssp CCCTTCEECCSSC-----CSSCSCGGGCCTH
T ss_pred ccccceeccCCcc-----ccccccccccCHH
Confidence 9999998664332 3457999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=252.19 Aligned_cols=167 Identities=25% Similarity=0.373 Sum_probs=135.5
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-C-CcEEEEEEcCCCC---CchHHHHHHHHHHHcc---CCCCcceEeEEEEe----
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSSK---QPDQEFLAQVSMVSRL---KNENVVELVGYYVD---- 132 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 132 (245)
.++|++.+.||+|+||+||+|++. + ++.||||++.... .....+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 5679999985322 2234566777776665 79999999999863
Q ss_pred -CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCc
Q 025997 133 -GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (245)
Q Consensus 133 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~ 211 (245)
....+++||++.++++......... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 2468999999998776655443322 2889999999999999999999998 999999999999999999
Q ss_pred eEEecccCCCCCCccccccccccccccccccCCC
Q 025997 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 212 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+||+|||+++....... .....||+.|||||
T Consensus 155 ~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE 185 (305)
T d1blxa_ 155 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPE 185 (305)
T ss_dssp EEECSCCSCCCCCGGGG---GCCCCCCCTTCCHH
T ss_pred eeecchhhhhhhccccc---CCCcccChhhcCcc
Confidence 99999999987654432 24568999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-37 Score=251.42 Aligned_cols=169 Identities=24% Similarity=0.364 Sum_probs=135.6
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEe--------
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 132 (245)
.++|++.+.||+|+||+||+|++. +++.||||++..... ....+.+|+.+|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 789999999855432 34678899999999999999999998865
Q ss_pred CCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCce
Q 025997 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (245)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~v 212 (245)
.+..+++|||+.++.+........ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 346899999998766554433322 2888999999999999999999998 9999999999999999999
Q ss_pred EEecccCCCCCCccccc--cccccccccccccCCC
Q 025997 213 KISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 213 kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~APE 245 (245)
||+|||+++........ ......+||+.|+|||
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHH
Confidence 99999999765432211 1123357999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=255.87 Aligned_cols=164 Identities=26% Similarity=0.348 Sum_probs=131.7
Q ss_pred CCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCcceEeEEEEeC------CceEEE
Q 025997 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRVLA 139 (245)
Q Consensus 67 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv 139 (245)
+|...++||+|+||+||+|++. +++.||||++...... ..+|+.+|++++|+||+++++++... .++++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4778889999999999999975 7899999998654322 34699999999999999999998543 357899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCC-ceEEeccc
Q 025997 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFD 218 (245)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~-~vkl~DfG 218 (245)
|||++++.+..+...... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 98 ~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence 999987543333321111 113899999999999999999999998 99999999999999775 89999999
Q ss_pred CCCCCCccccccccccccccccccCCC
Q 025997 219 LSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+++........ .+.+||+.|+|||
T Consensus 169 ~a~~~~~~~~~---~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 169 SAKQLVRGEPN---VSYICSRYYRAPE 192 (350)
T ss_dssp TCEECCTTSCC---CSCCSCTTSCCHH
T ss_pred chhhccCCccc---ccccccccccChH
Confidence 99866543322 3457999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-36 Score=247.36 Aligned_cols=167 Identities=20% Similarity=0.254 Sum_probs=140.3
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCC-CCcceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 143 (245)
++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 57999999999999999999965 78899999875432 33457789999999975 89999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC-----CCceEEeccc
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-----DDIAKISDFD 218 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~-----~~~vkl~DfG 218 (245)
+++|.+++..... .++...+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 84 -~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 84 -GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp -CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred -CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccc
Confidence 6799999876543 2889999999999999999999998 999999999999974 5789999999
Q ss_pred CCCCCCccccc-----cccccccccccccCCC
Q 025997 219 LSNQAPDAAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 219 la~~~~~~~~~-----~~~~~~~gt~~y~APE 245 (245)
+|+........ ......+||+.|||||
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE 183 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHH
Confidence 99865432211 1223467999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=246.73 Aligned_cols=166 Identities=20% Similarity=0.322 Sum_probs=143.6
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCC---chHHHHHHHHHHHccCCCCcceEeEEEEeCCceEEEEE
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (245)
++|++.+.||+|+||+||+|++. +++.||||+++.... ....+.+|+.+++.++|+||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 67999999999999999999965 788999999854432 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEecccCCC
Q 025997 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (245)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~DfGla~ 221 (245)
++.+++|..++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.++
T Consensus 82 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence 9999999888876542 889999999999999999999998 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCCC
Q 025997 222 QAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
......... ....+++.|+|||
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~pe 171 (292)
T d1unla_ 150 AFGIPVRCY--SAEVVTLWYRPPD 171 (292)
T ss_dssp ECCSCCSCC--CSCCSCGGGCCHH
T ss_pred cccCCCccc--eeeccccchhhhh
Confidence 765433221 2345778888886
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=252.32 Aligned_cols=163 Identities=29% Similarity=0.426 Sum_probs=136.9
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCch---HHHHHHHHHHHccCCCCcceEeEEEEeC-----Cc
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (245)
.++|++.+.||+|+||+||+|++. +++.||||++....... +.+.+|+.+|++++|+||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 367999999999999999999965 79999999997655442 4678999999999999999999998643 33
Q ss_pred eEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEEe
Q 025997 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (245)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl~ 215 (245)
.+++++++.+|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccc
Confidence 466778888999999996542 899999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccccccCCC
Q 025997 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 216 DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
|||++....... ....||+.|+|||
T Consensus 164 dfg~a~~~~~~~-----~~~~g~~~y~apE 188 (348)
T d2gfsa1 164 DFGLARHTDDEM-----TGYVATRWYRAPE 188 (348)
T ss_dssp CC----CCTGGG-----SSSCHHHHTSCHH
T ss_pred ccchhcccCccc-----ccccccccccCch
Confidence 999997664332 3457999999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=250.81 Aligned_cols=168 Identities=23% Similarity=0.319 Sum_probs=145.1
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEEcCCCC-----CchHHHHHHHHHHHccCC-CCcceEeEEEEeCC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGP 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 134 (245)
.++|++.+.||+|+||+||+|+.. +++.||||.+++.. ...+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 477999999999999999999852 57899999986432 234668899999999977 89999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
..+++|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred ceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEE
Confidence 99999999999999999976653 778889999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++......... .....||+.|+|||
T Consensus 171 ~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe 200 (322)
T d1vzoa_ 171 TDFGLSKEFVADETER-AYDFCGTIEYMAPD 200 (322)
T ss_dssp SCSSEEEECCGGGGGG-GCGGGSCCTTCCHH
T ss_pred eeccchhhhccccccc-ccccccccccchhH
Confidence 9999998765433322 23457999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-35 Score=240.38 Aligned_cols=167 Identities=23% Similarity=0.335 Sum_probs=134.1
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCC-cceEeEEEEeCCceEEEEEec
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHA 143 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~ 143 (245)
++|++.+.||+|+||.||+|++. +++.||||++.... ..+.+..|+++++.++|+| |+.+..++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 56999999999999999999965 78899999876543 2345788999999998766 455566667888899999998
Q ss_pred CCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcC---CCceEEecccCC
Q 025997 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLS 220 (245)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~---~~~vkl~DfGla 220 (245)
. ++|.+.+..... .+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|
T Consensus 86 ~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 86 G-PSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp C-CBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred C-CchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 5 577776654332 2899999999999999999999998 999999999999863 557999999999
Q ss_pred CCCCccccc-----cccccccccccccCCC
Q 025997 221 NQAPDAAAR-----LHSTRVLGTFGYHAPE 245 (245)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~APE 245 (245)
+........ .......||+.|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 183 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASIN 183 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred eeccccccccceeccccCCcCCCccccCHH
Confidence 876433221 1224567999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=247.76 Aligned_cols=163 Identities=25% Similarity=0.303 Sum_probs=128.2
Q ss_pred hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCc---hHHHHHHHHHHHccCCCCcceEeEEEEe------CC
Q 025997 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD------GP 134 (245)
Q Consensus 65 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 134 (245)
.++|++.+.||+|+||+||+|++. +++.||||++...... ...+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999976 7999999999655433 2457899999999999999999999964 36
Q ss_pred ceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCCCceEE
Q 025997 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (245)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~~~vkl 214 (245)
.+|+||||+.++ +.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 789999999764 5555532 2889999999999999999999998 999999999999999999999
Q ss_pred ecccCCCCCCccccccccccccccccccCCC
Q 025997 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 215 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+|||+++........ ....||+.|+|||
T Consensus 161 ~df~~~~~~~~~~~~---~~~~~t~~y~aPE 188 (355)
T d2b1pa1 161 LDFGLARTAGTSFMM---TPYVVTRYYRAPE 188 (355)
T ss_dssp CCCCC------------------CCTTCCHH
T ss_pred echhhhhcccccccc---ccccccccccChh
Confidence 999998866543322 4457999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.9e-30 Score=216.64 Aligned_cols=165 Identities=19% Similarity=0.252 Sum_probs=129.0
Q ss_pred CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEEcCCCCCchHHHHHHHHHHHccC-----------CCCcceEeEEEEe-
Q 025997 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD- 132 (245)
Q Consensus 66 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~- 132 (245)
++|++.+.||+|+||+||+|+.. +++.||||+++......+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999975 7899999999766545567788998888775 4789999988764
Q ss_pred -CCceEEEEEecCCCC-HHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCeEEcCC
Q 025997 133 -GPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 133 -~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrDlkp~Nill~~~ 209 (245)
....+++++++..+. .......... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 162 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred cccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence 355667777665543 3333332221 137889999999999999999998 76 9999999999999865
Q ss_pred C------ceEEecccCCCCCCccccccccccccccccccCCC
Q 025997 210 D------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (245)
Q Consensus 210 ~------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE 245 (245)
+ .++++|||.+....... ...+||+.|+|||
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE 199 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE 199 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH
T ss_pred CcccccceeeEeeccccccccccc-----ccccccccccChh
Confidence 4 49999999987654322 3457999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4.5e-27 Score=179.09 Aligned_cols=132 Identities=14% Similarity=0.129 Sum_probs=103.6
Q ss_pred CCCCeeccCCceEEEEEEECCCcEEEEEEcCCCCCc-------------------hHHHHHHHHHHHccCCCCcceEeEE
Q 025997 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------------------DQEFLAQVSMVSRLKNENVVELVGY 129 (245)
Q Consensus 69 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~~~~~ 129 (245)
.+.+.||+|+||.||+|...+++.||||++...... .....+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999888999999987532110 1223457888999999999988765
Q ss_pred EEeCCceEEEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEEcCC
Q 025997 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (245)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrDlkp~Nill~~~ 209 (245)
. ..+++|||+.+..+.+ ++......++.|++.+|.|||+++ |+||||||+|||++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 3 2479999998765432 233345678999999999999998 9999999999999865
Q ss_pred CceEEecccCCCCCC
Q 025997 210 DIAKISDFDLSNQAP 224 (245)
Q Consensus 210 ~~vkl~DfGla~~~~ 224 (245)
.++|+|||+|....
T Consensus 140 -~~~liDFG~a~~~~ 153 (191)
T d1zara2 140 -GIWIIDFPQSVEVG 153 (191)
T ss_dssp -EEEECCCTTCEETT
T ss_pred -CEEEEECCCcccCC
Confidence 48999999987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.93 E-value=3.9e-09 Score=82.24 Aligned_cols=148 Identities=18% Similarity=0.115 Sum_probs=97.9
Q ss_pred HHHHhhCCCCCCCeeccCCceEEEEEEECCCcEEEEEEcCCCC-CchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceE
Q 025997 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRV 137 (245)
Q Consensus 60 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 137 (245)
++......|...+..+-++.+.||+... +++.+++|+..... .....+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556676655444444578998764 45667788765332 23345677888877764 434678888888888999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--------------------------
Q 025997 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE-------------------------- 191 (245)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-------------------------- 191 (245)
+||++++|.++.+..... .. ...++.+++..+..||+...
T Consensus 87 lv~~~l~G~~~~~~~~~~-----------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EEEEeccccccccccccc-----------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence 999999998886654321 11 22244455555666664210
Q ss_pred ------------------------------CCeEecCCCCCCeEEcCCCceEEecccCCCC
Q 025997 192 ------------------------------PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (245)
Q Consensus 192 ------------------------------~~ivHrDlkp~Nill~~~~~vkl~DfGla~~ 222 (245)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999998776667999987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.50 E-value=9.2e-08 Score=73.84 Aligned_cols=73 Identities=12% Similarity=0.015 Sum_probs=51.8
Q ss_pred eccCC-ceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCC--CCcceEeEEEEeCCceEEEEEecCCCCH
Q 025997 74 IGEGS-YGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (245)
Q Consensus 74 lG~G~-fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (245)
+..|. -+.||+....++..+++|.-.... ...+..|...++.+.. -.+.+++.+..+++..+++|++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 33444 367899888777788888764432 3346778877777643 3467788888888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.27 E-value=4.7e-06 Score=68.39 Aligned_cols=75 Identities=20% Similarity=0.098 Sum_probs=48.3
Q ss_pred CCeeccCCceEEEEEEEC-CCcEEEEEEcCC--------CCCchHHHHHHHHHHHccC-C--CCcceEeEEEEeCCceEE
Q 025997 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS--------SKQPDQEFLAQVSMVSRLK-N--ENVVELVGYYVDGPLRVL 138 (245)
Q Consensus 71 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~l 138 (245)
.+.||.|....||+.... +++.++||.-.. ..........|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999855 467888885421 1123344566877776653 2 345566554 5566789
Q ss_pred EEEecCCCC
Q 025997 139 AYEHASKGS 147 (245)
Q Consensus 139 v~e~~~~gs 147 (245)
+||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.59 E-value=0.00017 Score=57.25 Aligned_cols=67 Identities=15% Similarity=0.129 Sum_probs=48.0
Q ss_pred ceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccCCCCc--ceEe-----EEEEeCCceEEEEEecCC
Q 025997 79 YGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV--VELV-----GYYVDGPLRVLAYEHASK 145 (245)
Q Consensus 79 fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~ 145 (245)
-..||++...+|..+++|+......+.+++..|...+..|...++ +... ..+...+..+.+++++.|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 458999999899999999987776677888889888877743222 1111 123345677888998876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.57 E-value=0.0002 Score=58.36 Aligned_cols=71 Identities=13% Similarity=0.118 Sum_probs=47.3
Q ss_pred CeeccCCceEEEEEEECC--------CcEEEEEEcCCCCCchHHHHHHHHHHHccC-CCCcceEeEEEEeCCceEEEEEe
Q 025997 72 SLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (245)
Q Consensus 72 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 142 (245)
+.|+.|-...+|++...+ ...|.+++.- ......+..+|..+++.+. +.-..++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 468888899999988643 2456666654 3334455667888888874 4334577777632 678899
Q ss_pred cCCCC
Q 025997 143 ASKGS 147 (245)
Q Consensus 143 ~~~gs 147 (245)
++|.+
T Consensus 123 i~g~~ 127 (395)
T d1nw1a_ 123 IPSRP 127 (395)
T ss_dssp CCEEE
T ss_pred ecccc
Confidence 88643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.97 E-value=0.00092 Score=52.39 Aligned_cols=62 Identities=15% Similarity=0.220 Sum_probs=37.5
Q ss_pred eeHHHHHHhhCCCCCCCee-----ccCCceEEEEEEECCCcEEEEEEcCCCCCchHHHHHHHHHHHccC
Q 025997 56 ISVDELKEKTDNFGTNSLI-----GEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119 (245)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~l-----G~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~ 119 (245)
++.+++.....+|.+.+.. ..|--.+.|+....++ .+++|+.... .+..++..|+.++..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhh
Confidence 3456777778888875543 4565677898887655 4888887543 23345555666666664
|